data_1y1c_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1y1c _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -42.03 138.81 2.73 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.601 2.2 . . . . 0.0 111.801 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 1.3 p -93.23 56.03 2.42 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.257 0.551 . . . . 0.0 111.532 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.538 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 2.6 mp -132.05 57.15 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.582 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -78.9 -41.16 30.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.101 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 10' ' ' MET . 6.4 t -173.65 -165.88 0.28 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.395 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.475 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -124.1 17.59 9.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.035 177.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -73.08 58.76 0.5 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.993 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.458 ' C ' ' O ' ' A' ' 11' ' ' GLN . 9.0 t80 -25.18 84.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.292 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -114.91 64.67 1.63 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -51.74 97.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.034 2.489 . . . . 0.0 112.331 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 27.8 m -99.49 127.38 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.524 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.599 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.26 121.47 24.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.0 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -113.52 142.41 17.44 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.161 -1.019 . . . . 0.0 113.184 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 45.0 t -40.1 98.01 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.333 -0.933 . . . . 0.0 109.771 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' SER . 1.7 t0 160.19 -22.71 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.985 -1.462 . . . . 0.0 108.748 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.476 ' O ' HD13 ' A' ' 21' ' ' ILE . . . 94.23 25.08 17.43 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.988 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.581 HG23 ' CE1' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -118.45 124.56 73.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.861 -179.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.491 ' CG2' ' HB2' ' A' ' 14' ' ' PRO . 3.1 m -86.36 98.18 10.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.494 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.591 ' CD1' HD21 ' A' ' 29' ' ' LEU . 52.3 m-85 -79.47 123.81 27.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.017 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -37.49 -27.84 0.03 OUTLIER Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.533 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.7 p30 -174.33 155.54 2.37 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.934 0.397 . . . . 0.0 110.996 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.47 -23.03 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.928 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 26.1 m -83.6 -46.77 12.0 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.526 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -48.62 -36.17 15.24 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 175.415 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.591 HD21 ' CD1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -55.93 -50.18 71.45 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 112.933 -1.939 . . . . 0.0 108.837 177.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 11.7 mt -48.27 -30.56 4.91 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.746 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -73.19 -35.74 66.42 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.61 -57.85 5.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.309 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -61.34 -16.88 50.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.365 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 30' ' ' LEU . . . -90.85 -38.19 13.11 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -149.64 42.66 0.9 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 31.0 t -96.09 -81.52 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.897 0.379 . . . . 0.0 110.978 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -175.39 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.242 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.448 HG23 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -144.97 154.18 54.53 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.253 179.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.448 ' HD2' HG23 ' A' ' 38' ' ' THR . 38.0 Cg_endo -66.54 81.27 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.586 2.19 . . . . 0.0 112.507 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.538 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -54.5 169.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.219 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 42' ' ' LEU . 19.5 mt-10 -148.68 100.9 3.16 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.89 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.593 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -31.02 148.65 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 111.227 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.584 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 2.7 t -144.98 -37.24 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.033 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.599 ' CD2' ' HB3' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -148.97 120.35 7.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.0 110.858 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.6 mttp -70.19 66.5 0.29 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.27 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' O ' HG21 ' A' ' 22' ' ' THR . . . 179.67 -160.26 25.35 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -90.12 55.14 3.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.904 0.383 . . . . 0.0 110.442 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.574 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 7.1 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.283 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.508 ' CB ' ' HD3' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 120.688 0.28 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 4' ' ' ALA . 35.7 Cg_exo -59.32 170.44 3.12 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.582 2.188 . . . . 0.0 112.026 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 28' ' ' MET . 25.4 p -165.77 72.64 0.17 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.441 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.532 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 26.8 mt -137.67 63.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 0.0 111.719 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 26.8 m -87.09 -40.14 14.94 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.411 0.624 . . . . 0.0 109.367 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 t -172.47 143.91 1.44 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.712 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.18 26.04 3.95 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 47.8 mt-30 -84.11 -103.45 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.322 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' A' ' 11' ' ' GLN . 2.4 t80 179.69 71.9 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.491 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER -106.98 71.07 0.27 Allowed Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 27.6 Cg_endo -61.97 101.49 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.654 2.236 . . . . 0.0 112.842 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.541 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 35.1 m -105.9 127.89 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.278 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.541 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -77.81 123.09 26.3 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.218 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -111.49 144.18 17.47 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.826 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.528 ' HB3' ' CG ' ' A' ' 41' ' ' GLU . 16.9 t -45.07 96.91 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.35 -0.925 . . . . 0.0 110.07 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' SER . 4.9 t0 163.76 -23.01 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.929 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.467 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 98.33 24.13 11.75 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.324 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.648 ' CG2' ' CE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -119.42 135.03 61.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.911 -179.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.442 ' CG2' ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -94.41 99.63 11.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.563 178.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.648 ' CE1' ' CG2' ' A' ' 21' ' ' ILE . 51.6 m-85 -82.64 122.56 28.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.055 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.479 ' HA3' ' CE ' ' A' ' 28' ' ' MET . . . -41.13 -27.22 0.21 Allowed Glycine 0 CA--C 1.507 -0.468 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.218 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.8 m-20 -164.47 146.32 8.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.74 0.305 . . . . 0.0 110.803 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.69 -25.14 2.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.227 0.537 . . . . 0.0 110.358 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -77.81 -50.55 12.1 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.479 ' CE ' ' HA3' ' A' ' 24' ' ' GLY . 2.8 mmm -45.99 -40.4 10.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.633 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -52.69 -55.94 19.07 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 113.445 -1.707 . . . . 0.0 109.775 176.284 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 13.8 mt -48.58 -32.57 8.29 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.4 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -75.75 -31.72 59.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -66.69 -59.23 3.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.951 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.47 ' OG ' HG12 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -52.29 -28.7 19.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.414 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.502 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . . . -70.16 -37.73 75.27 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -135.95 35.69 2.84 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 46.9 t -90.86 -95.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.691 0.281 . . . . 0.0 111.516 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -179.7 -35.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.124 0.488 . . . . 0.0 110.109 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.452 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 55.1 m -136.53 142.91 41.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.207 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.452 ' HD2' ' CG2' ' A' ' 38' ' ' THR . 10.5 Cg_endo -53.52 92.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.906 2.404 . . . . 0.0 112.928 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.591 ' CD1' ' CD2' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -78.57 148.34 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.139 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.528 ' CG ' ' HB3' ' A' ' 18' ' ' SER . 10.3 pt-20 -152.31 116.78 5.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.262 0.553 . . . . 0.0 111.123 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.564 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -21.61 145.25 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.794 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.617 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -136.4 -42.18 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.469 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.617 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.96 125.97 9.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.206 178.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -70.75 65.72 0.33 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.223 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.59 -160.61 27.37 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.442 ' HA ' ' CG2' ' A' ' 22' ' ' THR . 2.9 mtp180 -90.28 54.15 2.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.161 0.505 . . . . 0.0 110.845 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.592 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 4.2 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.215 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.469 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.812 0.339 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 4' ' ' ALA . 81.3 Cg_exo -43.61 135.92 6.71 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.611 2.207 . . . . 0.0 112.01 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 7.9 p -132.97 79.88 1.86 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.037 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.523 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 5.4 mp -133.93 52.47 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 55.3 m -84.39 -34.16 23.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.482 0.658 . . . . 0.0 109.627 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 11' ' ' GLN . 2.4 t -171.25 136.22 1.03 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.078 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.2 mtt -93.81 24.71 3.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.474 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.9 -100.66 0.17 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.366 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.473 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 1.5 t80 179.54 76.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.61 0.243 . . . . 0.0 110.977 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.5 69.94 0.29 Allowed Pre-proline 0 CA--C 1.516 -0.332 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.4 Cg_endo -56.31 102.64 0.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.779 2.319 . . . . 0.0 112.805 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.527 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 34.9 m -106.76 133.81 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.508 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.546 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.29 119.99 22.43 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.893 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -106.01 140.92 15.33 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.43 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 48.5 t -48.28 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.245 -0.978 . . . . 0.0 110.414 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' SER . 7.1 t0 171.68 -30.52 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.563 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.48 33.76 2.23 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.576 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.1 mt -135.49 154.39 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.46 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 2.5 m -109.66 99.25 8.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.373 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.638 ' CD1' HD23 ' A' ' 29' ' ' LEU . 53.9 m-85 -83.89 129.28 34.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.321 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.492 ' HA3' ' HE3' ' A' ' 28' ' ' MET . . . -41.35 -27.15 0.25 Allowed Glycine 0 CA--C 1.504 -0.652 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.328 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 81.6 m-20 -166.66 146.05 5.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.792 0.33 . . . . 0.0 111.149 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.02 -25.44 3.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.396 0.617 . . . . 0.0 109.868 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 1.1 m -79.89 -49.6 11.68 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.85 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.492 ' HE3' ' HA3' ' A' ' 24' ' ' GLY . 7.6 mmm -47.04 -37.65 9.74 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.638 HD23 ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -55.69 -56.99 13.94 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.258 -1.792 . . . . 0.0 109.498 176.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 27' ' ' CYS . 12.4 mt -48.24 -32.94 7.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.559 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -76.46 -32.11 58.2 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.49 -56.75 10.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.256 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.457 ' OG ' HD12 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -51.11 -36.31 39.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.033 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.432 ' CB ' ' HB1' ' A' ' 4' ' ' ALA . . . -90.69 -0.34 57.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.042 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 24.3 mtp180 -111.81 -38.86 4.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.6 t -85.36 -108.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.561 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p30 179.5 33.0 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.782 0.325 . . . . 0.0 110.944 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 m -146.79 134.12 10.23 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.795 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.71 83.98 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.814 2.343 . . . . 0.0 112.865 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.563 ' CD1' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -70.01 154.49 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.632 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.484 ' O ' ' O ' ' A' ' 42' ' ' LEU . 13.1 mt-10 -143.04 101.83 3.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.09 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.602 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -29.46 150.81 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.032 0.444 . . . . 0.0 111.632 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.63 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 1.4 t -144.6 -41.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.185 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.63 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -153.21 121.21 6.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.805 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.29 70.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.374 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.35 -164.88 34.94 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.3 56.35 3.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.104 0.478 . . . . 0.0 110.41 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.598 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 20.9 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.173 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.537 ' O ' ' CA ' ' A' ' 31' ' ' CYS . . . . . . . . 0 N--CA 1.45 -0.433 0 CA-C-O 120.516 0.198 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.457 ' C ' ' O ' ' A' ' 4' ' ' ALA . 96.4 Cg_exo -26.75 141.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.119 2.546 . . . . 0.0 112.104 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -92.91 52.87 1.9 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.003 0.43 . . . . 0.0 111.122 -179.27 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 6' ' ' CYS . 2.7 mm -145.92 90.75 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.782 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.01 -38.68 3.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.36 0.6 . . . . 0.0 109.894 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.478 HG22 ' HB2' ' A' ' 11' ' ' GLN . 10.0 t -172.5 -162.9 0.2 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.268 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.432 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -129.09 16.48 6.18 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.501 177.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -74.03 60.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.995 179.371 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.559 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 8.4 t80 -20.32 84.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.487 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 11' ' ' GLN . 20.5 t0 -114.47 59.29 1.0 Allowed Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.2 Cg_endo -54.28 96.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.754 2.303 . . . . 0.0 112.223 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.547 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 33.8 m -98.22 127.66 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.814 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.57 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.61 116.45 18.99 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.322 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.92 138.01 13.83 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.681 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 13.3 t -46.62 96.05 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.246 -0.977 . . . . 0.0 110.495 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 165.46 -23.53 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.235 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.77 32.97 4.88 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.318 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 36.3 mm -130.28 130.71 65.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.362 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.18 99.59 11.82 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.605 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.646 ' CD1' HD22 ' A' ' 29' ' ' LEU . 39.4 m-85 -83.03 121.8 27.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.824 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -36.28 -29.38 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.327 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.504 ' OD1' ' HG3' ' A' ' 28' ' ' MET . 2.1 p30 -173.37 154.82 2.71 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.098 0.475 . . . . 0.0 111.067 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.8 -23.53 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.807 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -78.48 -51.98 9.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.504 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 1.2 mtt -46.32 -42.1 14.24 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.646 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -52.46 -54.27 34.5 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.384 -1.735 . . . . 0.0 109.556 177.218 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 7.5 mt -48.22 -31.83 6.33 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.527 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.537 ' CA ' ' O ' ' A' ' 4' ' ' ALA . 7.3 t -76.76 -31.78 57.31 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.209 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -64.03 -58.65 6.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.349 178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.438 ' HB2' HD13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -63.98 -15.71 59.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.206 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 31' ' ' CYS . . . -90.05 -26.28 20.37 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HD2' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -131.23 18.95 4.89 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 10.2 t -105.62 -119.7 0.23 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p30 179.4 24.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.0 m -161.75 112.54 1.2 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.63 0.252 . . . . 0.0 110.523 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.1 94.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.603 2.202 . . . . 0.0 112.225 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.547 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -63.53 153.36 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.401 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 18' ' ' SER . 10.9 mt-10 -132.82 92.75 3.09 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.084 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.653 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -32.81 148.7 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.258 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.613 HG12 ' CE1' ' A' ' 44' ' ' HIS . 2.5 t -142.5 -38.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.646 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.613 ' CE1' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.29 117.75 6.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.471 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.23 65.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.641 -179.302 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.55 -163.21 29.49 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -85.59 59.02 5.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.084 0.468 . . . . 0.0 110.497 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.587 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 17.5 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.972 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.567 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 120.674 0.274 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' A' ' 4' ' ' ALA . 59.9 Cg_exo -27.38 144.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.309 2.673 . . . . 0.0 112.473 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.418 ' O ' HG12 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -102.01 54.05 0.8 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.97 0.414 . . . . 0.0 111.567 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 3.6 mm -146.49 78.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.644 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -103.14 -39.34 6.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.325 0.583 . . . . 0.0 110.29 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.498 HG21 ' HB2' ' A' ' 11' ' ' GLN . 9.8 t -173.19 -160.93 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.761 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.458 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -128.5 17.88 6.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.367 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.543 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -72.29 58.87 0.39 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.345 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -26.65 85.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.147 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -121.61 67.25 20.39 Favored Pre-proline 0 N--CA 1.454 -0.241 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.0 Cg_endo -53.0 95.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.897 2.398 . . . . 0.0 112.57 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.524 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 25.5 m -95.94 126.91 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.8 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.579 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.69 118.43 20.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.744 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -108.55 145.34 16.4 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.688 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 10.6 p -48.32 97.15 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.501 -0.849 . . . . 0.0 109.991 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 18' ' ' SER . 7.6 t70 168.84 -25.83 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.853 -1.521 . . . . 0.0 108.695 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.42 30.65 5.83 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.585 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -127.53 146.29 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.511 ' CG2' ' HB2' ' A' ' 14' ' ' PRO . 6.2 m -107.39 97.81 7.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.501 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.605 ' CD1' HD23 ' A' ' 29' ' ' LEU . 36.7 m-85 -81.74 123.1 28.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.403 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' A' ' 28' ' ' MET . . . -39.9 -26.52 0.1 OUTLIER Glycine 0 CA--C 1.508 -0.406 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.319 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.545 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -171.82 149.21 2.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.003 0.43 . . . . 0.0 110.684 179.132 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.91 -24.55 0.62 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.834 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.6 m -77.74 -50.78 11.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.196 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.545 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -46.79 -37.66 8.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.605 HD23 ' CD1' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.41 -52.66 63.81 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.987 -1.915 . . . . 0.0 109.246 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 5.5 mt -49.6 -32.12 12.15 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.6 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.531 ' CA ' ' O ' ' A' ' 4' ' ' ALA . 7.7 t -75.9 -29.3 58.39 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -69.5 -62.3 1.44 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.905 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.14 -13.51 27.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.446 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . . . -82.97 -29.75 28.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.302 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.429 ' CD ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -144.38 29.49 1.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.352 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 47.4 t -92.1 -97.04 0.13 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.618 0.247 . . . . 0.0 110.913 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 179.72 -32.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 0.0 110.731 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 9.2 m -127.53 133.06 24.68 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.939 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 35.0 Cg_exo -60.51 90.11 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.759 2.306 . . . . 0.0 112.579 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.532 ' CD1' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -63.9 163.02 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.543 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 18' ' ' SER . 1.5 mt-10 -149.86 107.13 3.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.809 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.536 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -29.27 148.92 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.08 0.466 . . . . 0.0 111.577 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.651 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.8 t -142.65 -39.2 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.416 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.651 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -153.86 121.06 5.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.523 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -69.27 68.3 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.106 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.3 -171.12 44.12 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.41 57.36 2.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.084 0.468 . . . . 0.0 110.504 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.556 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 21.1 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.052 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.565 ' O ' ' CB ' ' A' ' 31' ' ' CYS . . . . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 4' ' ' ALA . 33.5 Cg_exo -29.91 126.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.747 2.298 . . . . 0.0 112.158 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.444 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -93.12 44.97 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 110.988 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.561 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 31.5 mt -152.61 63.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.7 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -80.95 -41.6 22.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.916 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 t -172.02 162.23 5.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.88 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -92.47 18.66 8.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 2.1 tt0 -72.02 58.53 0.35 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.165 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.47 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -21.52 82.96 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.36 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -112.76 62.64 0.72 Allowed Pre-proline 0 N--CA 1.452 -0.341 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.4 Cg_endo -55.58 93.89 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.815 2.343 . . . . 0.0 112.455 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 5.7 m -97.29 125.92 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.719 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.582 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.55 117.23 19.54 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.749 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -106.16 143.56 15.75 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.298 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 4.2 t -49.27 95.06 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.301 -0.95 . . . . 0.0 110.001 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.7 -25.68 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.954 -1.476 . . . . 0.0 109.006 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.3 34.04 3.77 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.377 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.594 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 27.4 mm -137.19 136.19 47.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.472 HG21 ' O ' ' A' ' 46' ' ' GLY . 2.9 m -96.73 97.9 9.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.232 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.623 ' CD1' HD23 ' A' ' 29' ' ' LEU . 41.3 m-85 -80.07 126.37 30.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.299 -178.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.22 -25.51 0.05 OUTLIER Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.505 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 0.9 OUTLIER -176.41 150.27 0.88 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.2 -25.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.567 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -76.45 -52.86 9.01 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.535 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -44.77 -41.25 6.74 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.124 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.623 HD23 ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -53.93 -54.37 39.79 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 112.986 -1.916 . . . . 0.0 109.411 177.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 13.0 mt -48.88 -33.84 11.47 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.156 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -74.85 -32.62 61.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -62.63 -57.18 11.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.627 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -17.54 56.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.169 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 30' ' ' LEU . . . -88.39 -15.38 35.68 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -136.03 1.45 2.73 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -89.04 -99.15 0.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.546 0.213 . . . . 0.0 111.038 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 178.77 -31.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.36 . . . . 0.0 110.953 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.446 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -117.4 151.33 47.94 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.114 0.483 . . . . 0.0 111.42 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.446 ' HD2' ' CG2' ' A' ' 38' ' ' THR . 97.5 Cg_endo -80.13 86.51 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.997 2.465 . . . . 0.0 112.029 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.553 ' CD1' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.47 155.22 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.77 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 18' ' ' SER . 20.9 mt-10 -135.0 96.84 3.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.746 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.602 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.3 OUTLIER -29.26 147.41 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.224 0.535 . . . . 0.0 111.439 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.624 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 1.7 t -135.46 -41.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.295 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.624 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -153.35 121.24 6.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.58 -179.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -70.27 67.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.0 0.429 . . . . 0.0 111.148 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.472 ' O ' HG21 ' A' ' 22' ' ' THR . . . 179.05 -165.27 34.09 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.76 57.36 4.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.033 0.444 . . . . 0.0 110.649 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.588 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.8 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.546 ' HA ' ' CB ' ' A' ' 34' ' ' ALA . . . . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.772 0.32 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 4' ' ' ALA . 51.9 Cg_exo -53.7 178.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.511 2.14 . . . . 0.0 111.575 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.433 ' HB2' ' C ' ' A' ' 27' ' ' CYS . 26.2 p -170.47 76.33 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.657 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 2.8 mp -131.68 57.56 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.36 . . . . 0.0 111.667 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 57.6 m -83.08 -38.38 22.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.316 0.579 . . . . 0.0 110.099 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 11' ' ' GLN . 1.8 t -171.61 139.92 1.29 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.432 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.34 25.91 4.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.475 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 55.2 mt-30 -91.68 -100.79 0.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.647 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.483 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 179.83 77.55 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.117 -179.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.438 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.3 OUTLIER -111.22 65.07 0.53 Allowed Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.604 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 12.9 Cg_endo -56.29 98.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.032 2.488 . . . . 0.0 112.77 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.467 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 24.8 m -99.25 130.2 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.779 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.552 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.65 117.69 20.04 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.262 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -109.38 140.93 15.9 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.966 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 2.5 m -42.3 96.97 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.275 -0.963 . . . . 0.0 109.635 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' GLY . 7.3 t0 163.34 -22.87 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.913 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.477 ' O ' HD11 ' A' ' 21' ' ' ILE . . . 96.52 23.48 16.17 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.659 ' CG2' ' CE1' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -119.05 131.97 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.923 -179.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.467 HG21 ' HB2' ' A' ' 14' ' ' PRO . 1.6 m -92.77 98.2 11.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.418 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.682 ' CD1' HD22 ' A' ' 29' ' ' LEU . 47.3 m-85 -81.03 123.89 28.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.322 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -37.49 -30.47 0.06 OUTLIER Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.15 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 23' ' ' TYR . 83.8 m-20 -165.34 147.85 7.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.361 -0.419 . . . . 0.0 111.073 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.27 -25.74 2.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.298 0.571 . . . . 0.0 110.009 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -77.19 -51.94 10.11 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.534 178.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.452 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 2.0 mtt -44.69 -39.78 5.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 176.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.682 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -56.24 -54.61 43.24 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.686 176.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 27' ' ' CYS . 4.1 mt -47.68 -35.11 9.03 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.212 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -74.42 -33.28 62.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.022 178.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -63.12 -55.52 24.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.293 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.501 ' OG ' HD13 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -51.8 -35.08 42.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.44 179.486 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.546 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . . . -90.71 -2.49 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.482 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -120.66 -18.77 7.64 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.2 t -89.83 -98.67 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.456 0.169 . . . . 0.0 111.229 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 38' ' ' THR . 28.8 p30 179.11 -30.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.729 0.3 . . . . 0.0 111.058 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.515 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 3.3 t -107.88 137.18 19.71 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 0.0 110.767 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.74 89.47 0.99 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.74 2.293 . . . . 0.0 112.72 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.534 ' CD1' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -53.96 169.63 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.414 179.154 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.472 ' O ' ' C ' ' A' ' 42' ' ' LEU . 18.4 mt-10 -147.06 98.3 3.01 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.061 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.595 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -29.13 148.04 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.1 0.476 . . . . 0.0 111.212 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.676 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -138.33 -40.31 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.49 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.676 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -154.41 121.59 5.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.563 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -69.64 67.0 0.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.382 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.18 -161.74 28.12 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.2 56.45 3.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.114 0.483 . . . . 0.0 110.522 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.597 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 6.6 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.096 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.782 0.325 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 4' ' ' ALA . 83.8 Cg_exo -47.0 -176.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.639 2.226 . . . . 0.0 112.155 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.486 ' CA ' ' HB2' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -108.47 50.53 0.77 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.042 0.449 . . . . 0.0 111.301 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.8 mp -145.53 89.78 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.03 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.38 -42.1 3.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.58 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.9 t -171.7 -168.71 0.62 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.337 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.515 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -118.01 17.78 14.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.484 178.115 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 13' ' ' ASP . 24.8 mt-30 -69.53 57.67 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.389 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' GLN . 4.6 t80 -27.54 85.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.787 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -123.86 72.47 53.23 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.0 Cg_endo -55.54 99.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.493 2.129 . . . . 0.0 112.117 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.551 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 32.9 m -97.55 128.18 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.979 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.473 ' O ' HG21 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.51 116.93 19.24 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.642 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.65 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.35 135.99 12.91 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.74 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 11.1 m -49.45 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.319 -0.94 . . . . 0.0 110.756 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 t70 170.05 -26.13 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.05 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.32 31.19 3.59 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.378 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.516 HG22 ' CE1' ' A' ' 23' ' ' TYR . 19.3 mm -134.22 138.13 50.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.772 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 14' ' ' PRO . 1.8 m -100.32 99.64 10.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.414 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.63 ' CD1' HD22 ' A' ' 29' ' ' LEU . 34.3 m-85 -81.4 127.59 32.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.804 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.82 -21.57 0.6 Allowed Glycine 0 CA--C 1.509 -0.341 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.521 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.582 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -172.4 146.33 1.77 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 0.0 110.989 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.06 -24.67 1.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.506 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 30' ' ' LEU . 1.3 m -78.79 -50.36 11.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.334 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.556 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 16.3 mtt -48.27 -34.58 10.58 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.63 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -59.91 -51.86 67.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 113.098 -1.864 . . . . 0.0 108.833 177.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 27' ' ' CYS . 12.9 mt -48.3 -31.85 6.55 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.499 ' O ' ' NE ' ' A' ' 35' ' ' ARG . 13.9 t -72.86 -34.99 67.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.37 -59.95 2.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.63 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -19.23 3.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.383 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.72 -41.62 37.17 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -140.49 29.77 1.95 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.5 t -81.16 -93.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.718 0.294 . . . . 0.0 110.897 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.35 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.034 0.445 . . . . 0.0 110.466 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.14 129.06 17.8 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.5 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.52 94.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.959 2.439 . . . . 0.0 112.357 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.564 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -59.56 152.96 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.857 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 18' ' ' SER . 12.8 mt-10 -134.16 96.95 3.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.02 0.438 . . . . 0.0 110.838 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.65 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -36.9 148.7 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.455 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.626 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -137.45 -37.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.178 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.634 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -150.34 121.89 7.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.547 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 64.71 0.26 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.647 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -178.76 -158.27 20.94 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.02 57.84 3.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.23 0.538 . . . . 0.0 110.394 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.634 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 10.8 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.183 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.73 0.3 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.433 ' C ' ' HB2' ' A' ' 31' ' ' CYS . 22.4 Cg_exo -63.76 -166.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.669 2.246 . . . . 0.0 112.06 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.445 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -117.9 50.26 1.16 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.984 0.421 . . . . 0.0 110.951 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.525 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 3.3 mp -146.62 62.61 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.297 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -36.88 18.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.446 0.641 . . . . 0.0 109.826 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.1 t -171.67 -172.32 1.02 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.015 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.509 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.5 OUTLIER -119.28 17.41 13.09 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.012 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 21.0 mm-40 -71.18 59.22 0.25 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.031 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 11' ' ' GLN . 22.2 t80 -19.83 82.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.198 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -118.54 69.26 8.32 Favored Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.869 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 19.5 Cg_endo -59.12 94.77 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.412 2.075 . . . . 0.0 112.068 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 22.6 m -99.33 127.01 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.824 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.59 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.36 122.35 25.65 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.751 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -109.15 144.88 16.55 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.956 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 2.5 t -50.8 95.35 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 114.121 -1.04 . . . . 0.0 110.602 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.478 ' HB2' HG23 ' A' ' 40' ' ' ILE . 5.7 t0 171.67 -30.27 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.66 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.88 33.83 1.96 Allowed Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.184 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 1.2 mt -138.62 149.53 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.496 HG21 ' HB2' ' A' ' 14' ' ' PRO . 5.2 m -107.39 99.56 9.07 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.181 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.628 ' CD1' HD21 ' A' ' 29' ' ' LEU . 41.9 m-85 -82.17 123.18 28.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.427 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -40.07 -27.33 0.13 Allowed Glycine 0 CA--C 1.505 -0.557 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.031 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.2 m-20 -164.38 146.24 8.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.779 0.323 . . . . 0.0 111.19 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.18 -27.85 3.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.305 0.574 . . . . 0.0 109.719 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -76.55 -50.12 14.71 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.401 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.466 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -46.5 -39.79 11.41 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 176.118 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.628 HD21 ' CD1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -52.61 -54.59 31.01 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 113.34 -1.754 . . . . 0.0 109.488 176.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.543 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 12.9 mt -48.47 -32.5 7.91 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.223 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 28' ' ' MET . 6.6 t -73.63 -32.69 64.18 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.072 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.63 -59.94 3.43 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.675 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.468 ' HB2' ' CD1' ' A' ' 40' ' ' ILE . 5.1 t -56.27 -19.14 12.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.029 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 30' ' ' LEU . . . -82.13 -54.52 5.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.536 ' CZ ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -100.5 11.94 38.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 22.0 t -96.34 -116.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' A' ' 36' ' ' SER . 19.0 p-10 179.11 26.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.21 146.44 10.66 Favored Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.024 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -79.47 85.06 1.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.686 2.257 . . . . 0.0 112.125 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.538 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -62.23 153.57 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.124 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 42' ' ' LEU . 24.5 mt-10 -136.87 102.24 4.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.262 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.58 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -28.96 149.9 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.918 0.389 . . . . 0.0 111.604 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.634 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.7 t -142.37 -39.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.046 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.634 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -152.36 123.41 7.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.927 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 7.5 ptmt -70.4 65.54 0.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.458 ' O ' HG23 ' A' ' 22' ' ' THR . . . 178.99 -167.76 38.2 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.435 ' HA ' HG22 ' A' ' 22' ' ' THR . 3.8 mtt180 -83.47 55.84 3.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.977 0.418 . . . . 0.0 110.674 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.562 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 9.8 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.858 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.85 0.357 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -50.96 172.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.519 2.146 . . . . 0.0 111.917 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.81 46.97 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.016 0.436 . . . . 0.0 110.745 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.525 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 16.4 mt -150.29 72.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.063 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.17 -41.12 13.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.358 0.599 . . . . 0.0 110.158 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.481 HG22 ' HB2' ' A' ' 11' ' ' GLN . 4.2 t -171.5 -178.8 2.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.12 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.405 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -107.43 17.25 23.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.605 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -71.89 58.59 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.906 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.441 ' C ' ' O ' ' A' ' 11' ' ' GLN . 5.6 t80 -30.33 87.93 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.838 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -120.65 66.96 13.66 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -52.03 97.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.001 2.467 . . . . 0.0 112.442 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.551 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 28.8 m -97.43 123.83 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.613 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.509 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -77.85 118.05 19.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.541 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.636 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.71 142.53 15.57 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.883 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 16.0 t -52.29 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.297 -0.951 . . . . 0.0 110.179 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 3.1 t0 171.01 -25.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.745 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.58 32.85 3.04 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.532 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.471 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 42.0 mm -139.27 144.48 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 14' ' ' PRO . 11.7 m -105.31 98.66 8.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.384 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.624 ' CD1' HD22 ' A' ' 29' ' ' LEU . 35.3 m-85 -80.0 124.21 28.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.926 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.464 ' HA3' ' SD ' ' A' ' 28' ' ' MET . . . -42.0 -24.52 0.18 Allowed Glycine 0 CA--C 1.508 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.266 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.585 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -172.23 147.22 1.98 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.959 0.409 . . . . 0.0 110.714 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -46.7 -25.03 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.679 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 30' ' ' LEU . 1.6 m -77.75 -50.46 12.33 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.331 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.585 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 2.6 mtt -47.96 -35.03 10.08 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 175.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.624 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -58.22 -51.75 68.43 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.735 177.46 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 27' ' ' CYS . 14.3 mt -49.6 -31.96 11.77 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.476 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 28' ' ' MET . 37.4 t -76.77 -31.0 56.75 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -66.94 -60.57 2.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.389 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -53.78 -25.31 18.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.896 178.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 30' ' ' LEU . . . -84.64 -15.3 45.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.482 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 -97.34 -44.38 6.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.923 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.9 t -81.18 -102.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.618 0.247 . . . . 0.0 111.102 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 178.39 -27.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.742 0.306 . . . . 0.0 111.185 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -94.01 123.13 60.21 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.949 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.465 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 23.4 Cg_exo -63.53 86.56 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.679 2.253 . . . . 0.0 112.472 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.551 ' CD1' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -39.15 155.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.156 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 18' ' ' SER . 45.0 mt-10 -127.09 94.47 4.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.158 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.636 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -31.96 146.71 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.313 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.603 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -131.71 -45.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.1 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.615 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -145.86 123.43 11.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.416 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -70.87 58.58 0.21 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.3 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.18 -160.03 20.92 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -89.67 57.45 3.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.027 0.442 . . . . 0.0 110.692 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.615 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.8 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.141 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.855 0.36 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.36 177.23 2.74 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.77 2.314 . . . . 0.0 112.342 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.468 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -115.16 45.57 1.61 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 111.123 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.547 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 38.1 mt -147.11 62.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.78 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.63 -39.22 24.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.121 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.445 HG23 ' CG ' ' A' ' 11' ' ' GLN . 10.3 t -171.68 -166.05 0.41 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.047 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.65 17.95 9.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.307 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 13' ' ' ASP . 13.6 mm-40 -70.81 58.53 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.196 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.472 ' C ' ' O ' ' A' ' 11' ' ' GLN . 2.5 t80 -20.13 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.037 0.836 . . . . 0.0 112.234 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -120.46 69.33 15.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.685 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 17.8 Cg_endo -58.16 101.85 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.581 2.188 . . . . 0.0 112.35 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.551 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 30.1 m -99.58 130.35 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.202 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.466 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -79.27 118.35 21.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.555 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.67 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.2 136.41 13.37 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.193 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 2.2 t -44.15 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.201 -1.0 . . . . 0.0 110.314 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER 166.39 -24.09 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.404 -179.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.74 27.53 6.67 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.0 mm -123.72 140.64 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.421 HG22 ' HB2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -101.78 99.7 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.656 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.626 ' CD2' HD23 ' A' ' 29' ' ' LEU . 39.4 m-85 -81.88 120.78 25.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.664 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -41.1 -26.85 0.19 Allowed Glycine 0 CA--C 1.506 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.276 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.5 m-20 -165.11 146.12 7.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.778 0.323 . . . . 0.0 111.092 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -48.92 -27.46 3.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.256 0.551 . . . . 0.0 109.781 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.1 m -76.47 -50.62 13.59 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.783 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -47.24 -37.25 10.14 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.626 HD23 ' CD2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.29 -52.25 65.19 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.326 176.67 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 12.2 mt -48.02 -32.43 6.62 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.336 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.3 t -73.91 -33.4 63.97 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.11 -61.36 1.97 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.602 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 t -50.56 -22.87 2.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.033 0.444 . . . . 0.0 109.803 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.65 -41.12 32.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.264 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.42 ' HD3' ' C ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -158.84 51.92 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.744 0.307 . . . . 0.0 111.743 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.526 ' HB2' ' CA ' ' A' ' 32' ' ' ALA . 23.1 t -95.26 -78.95 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.259 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -170.17 -37.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.955 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.416 ' O ' HG21 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -154.46 159.16 32.2 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.55 93.62 0.07 OUTLIER 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.782 2.321 . . . . 0.0 112.21 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.554 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -76.16 154.68 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.138 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 16.6 mt-10 -143.66 97.52 3.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.027 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.67 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -33.16 149.82 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.363 0.601 . . . . 0.0 111.859 -179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.622 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -142.05 -39.54 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.365 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.622 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -148.56 121.36 8.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.37 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -68.56 68.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.553 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 175.2 -166.75 38.48 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -83.63 58.76 4.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.288 0.566 . . . . 0.0 110.291 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.604 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 33.5 m . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.063 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.459 ' HB1' HD23 ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.873 0.368 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.01 157.92 41.46 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.598 2.198 . . . . 0.0 111.846 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 28' ' ' MET . 2.6 p -115.78 72.74 0.81 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.27 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.506 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 4.1 mt -135.93 55.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.664 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 55.7 m -79.6 -37.91 35.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.484 0.659 . . . . 0.0 109.514 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t -171.23 141.99 1.68 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 31.8 mtm -91.7 21.12 4.95 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 0.4 OUTLIER -78.42 -108.24 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.873 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.581 ' CD1' ' HD3' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 178.99 76.09 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.655 0.265 . . . . 0.0 111.427 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.432 ' O ' HG11 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -106.77 68.39 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 15.2 Cg_endo -58.98 97.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.639 2.226 . . . . 0.0 112.767 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.548 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 19.9 m -99.66 131.01 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.53 0.681 . . . . 0.0 110.783 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.517 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -79.06 119.06 21.66 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.061 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.71 136.33 13.37 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.678 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 28.8 t -44.73 96.29 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.463 -0.869 . . . . 0.0 109.891 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.3 OUTLIER 166.59 -25.21 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.618 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.498 ' O ' HD11 ' A' ' 21' ' ' ILE . . . 101.61 25.29 8.21 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.455 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.644 ' CG2' ' CE1' ' A' ' 23' ' ' TYR . 1.2 mp -122.37 126.97 74.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.107 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 14' ' ' PRO . 2.2 m -88.46 98.88 11.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.268 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.644 ' CE1' ' CG2' ' A' ' 21' ' ' ILE . 33.7 m-85 -81.0 122.13 26.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.7 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -43.15 -24.67 0.32 Allowed Glycine 0 CA--C 1.503 -0.7 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.12 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -169.65 145.47 3.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.966 0.412 . . . . 0.0 111.015 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . -46.63 -26.77 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.929 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -74.26 -55.59 5.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.976 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.535 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 4.3 mtt -46.67 -34.71 5.31 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.632 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -59.69 -53.78 53.99 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.296 -1.774 . . . . 0.0 109.155 177.105 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 27' ' ' CYS . 4.8 mt -48.44 -33.55 9.47 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -73.97 -34.46 64.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.96 177.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.49 -58.46 5.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.355 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.448 ' HB2' HD13 ' A' ' 40' ' ' ILE . 1.4 t -55.98 -22.79 28.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.758 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.35 -16.74 30.34 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -133.67 17.65 3.92 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.222 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 t -93.77 -95.98 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.6 0.238 . . . . 0.0 111.224 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 p30 179.68 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.203 0.525 . . . . 0.0 109.935 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.9 t -132.57 127.9 20.76 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.962 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.51 93.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.608 2.206 . . . . 0.0 112.588 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.547 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -53.84 171.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.256 179.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.448 ' O ' HG22 ' A' ' 43' ' ' VAL . 16.0 mt-10 -146.11 101.1 3.48 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.437 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.644 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -33.59 149.47 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.274 0.559 . . . . 0.0 111.486 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 3.1 t -141.65 -33.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.677 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.643 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -157.48 122.2 4.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.534 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -69.22 67.53 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.528 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.72 -168.46 40.81 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.403 ' HA ' HG23 ' A' ' 22' ' ' THR . 9.2 mtp85 -81.0 57.72 3.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.006 0.431 . . . . 0.0 110.393 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.599 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 25.6 m . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.126 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 31' ' ' CYS . . . . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.422 0.153 . . . . 0.0 110.632 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 4' ' ' ALA . 83.0 Cg_exo -28.69 142.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.77 2.313 . . . . 0.0 111.713 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -96.42 55.28 1.45 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.187 0.517 . . . . 0.0 111.574 -178.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.8 mm -147.74 87.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.631 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.55 -40.07 4.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.432 0.634 . . . . 0.0 110.084 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 10' ' ' MET . 5.6 t -172.5 -163.27 0.22 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.477 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.52 ' N ' ' OG1' ' A' ' 9' ' ' THR . 5.5 mtt -126.01 17.99 7.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.352 177.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -69.84 59.52 0.16 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.493 179.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.468 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -24.6 84.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.078 -179.478 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' GLN . 1.9 t70 -120.77 61.79 9.5 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.6 Cg_endo -53.07 90.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.68 2.254 . . . . 0.0 111.831 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.555 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 21.5 m -93.2 123.94 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.941 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.501 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -77.92 116.9 18.76 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.974 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.44 141.84 15.43 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.97 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 13.7 t -48.56 94.72 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.165 -1.018 . . . . 0.0 109.734 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.482 ' HB2' HG22 ' A' ' 40' ' ' ILE . 5.2 t0 171.21 -27.49 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.606 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.28 31.58 4.01 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.218 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.537 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 11.4 mm -135.6 139.73 45.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 46' ' ' GLY . 6.4 m -99.18 99.35 10.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.429 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.607 ' CD1' HD22 ' A' ' 29' ' ' LEU . 35.7 m-85 -82.16 124.06 29.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.2 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -38.82 -25.58 0.04 OUTLIER Glycine 0 CA--C 1.508 -0.375 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.571 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.491 ' OD1' ' HG3' ' A' ' 28' ' ' MET . 2.7 p30 -175.83 153.1 1.33 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.942 0.401 . . . . 0.0 111.363 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.89 -24.45 0.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.752 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.513 ' O ' ' N ' ' A' ' 30' ' ' LEU . 1.2 m -79.24 -51.79 9.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.493 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -45.57 -38.62 6.64 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.607 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -56.06 -53.09 61.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.952 -1.931 . . . . 0.0 109.172 177.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 27' ' ' CYS . 13.0 mt -48.65 -31.13 6.25 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.551 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 49.7 t -78.48 -31.41 47.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.21 -56.62 11.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.839 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.423 ' OG ' HD13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -67.46 -16.53 64.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.472 179.103 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 30' ' ' LEU . . . -90.83 -19.64 23.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.29 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.526 ' CG ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -120.66 3.97 10.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.115 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.6 t -105.71 -117.83 0.23 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.545 -0.168 . . . . 0.0 110.545 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 179.58 32.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.934 0.397 . . . . 0.0 110.775 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -160.51 126.81 2.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.558 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.05 88.4 0.38 Allowed 'Trans proline' 0 N--CA 1.466 -0.133 0 C-N-CA 122.588 2.192 . . . . 0.0 112.344 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.555 ' CD1' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -53.07 155.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.373 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.502 ' O ' ' CB ' ' A' ' 18' ' ' SER . 17.3 mt-10 -134.41 96.99 3.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.233 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.618 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -29.92 147.71 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.647 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.615 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -136.87 -43.27 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.111 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.615 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.26 120.35 7.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.577 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.93 68.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.063 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.489 ' O ' HG22 ' A' ' 22' ' ' THR . . . 179.23 -165.74 34.76 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -86.13 58.1 4.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.386 0.612 . . . . 0.0 110.533 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.608 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.7 m . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.068 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.554 ' CB ' ' HD3' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 120.585 0.231 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 4' ' ' ALA . 32.2 Cg_exo -58.48 178.63 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.51 2.14 . . . . 0.0 111.917 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 28' ' ' MET . 26.0 p -170.59 71.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.786 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 7' ' ' ILE . 57.4 mt -138.77 69.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.953 0.406 . . . . 0.0 111.484 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 13.8 m -86.45 -46.66 10.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.373 0.606 . . . . 0.0 109.978 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 t -172.82 163.58 5.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.38 22.26 8.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 1.0 OUTLIER -90.09 64.48 6.19 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.741 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' GLN . 10.0 t80 -21.04 83.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.848 0.717 . . . . 0.0 112.206 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -109.45 71.93 0.53 Allowed Pre-proline 0 CA--C 1.517 -0.32 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.567 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.9 Cg_endo -55.08 95.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.837 2.358 . . . . 0.0 112.593 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.538 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 3.6 m -97.06 129.75 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.637 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.538 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.15 118.95 20.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.346 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.21 142.67 15.78 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.004 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 2.4 t -46.47 94.48 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 113.986 -1.107 . . . . 0.0 110.215 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.482 ' HB2' HG23 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 168.28 -26.82 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.884 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.431 ' O ' HD13 ' A' ' 21' ' ' ILE . . . 103.85 33.58 4.04 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.279 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.566 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 42.2 mm -135.16 138.2 49.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.518 ' CG2' ' HB2' ' A' ' 14' ' ' PRO . 3.6 m -95.54 99.91 11.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.927 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.641 ' CD1' HD22 ' A' ' 29' ' ' LEU . 43.1 m-85 -84.46 123.57 30.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.13 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -40.22 -26.57 0.12 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.288 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.465 ' CG ' ' O ' ' A' ' 24' ' ' GLY . 80.9 m-20 -168.46 151.14 5.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.728 0.299 . . . . 0.0 111.571 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.35 -24.56 3.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.182 0.515 . . . . 0.0 110.014 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -81.24 -50.81 9.1 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.488 ' HA ' ' HB2' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -47.74 -35.36 9.71 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.359 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.641 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.44 -53.5 56.74 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.78 176.422 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' CYS . 13.3 mt -49.29 -33.81 13.92 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.302 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.449 ' O ' ' HD2' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -73.84 -31.39 63.17 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.08 -62.11 1.59 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.59 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.05 -30.97 0.81 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.79 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 4' ' ' ALA . . . -78.22 -25.27 46.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.244 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -143.02 38.08 1.43 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.258 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' ALA . 7.0 t -107.26 -79.04 0.58 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.672 0.272 . . . . 0.0 111.059 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 36' ' ' SER . 10.2 t70 179.23 -50.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.906 0.384 . . . . 0.0 110.9 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.443 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -135.85 167.53 21.62 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.063 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.443 ' HD2' ' CB ' ' A' ' 38' ' ' THR . 36.9 Cg_endo -65.36 88.8 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.803 2.335 . . . . 0.0 112.213 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.573 ' CD1' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -61.65 153.33 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.989 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 18' ' ' SER . 10.0 mt-10 -140.51 103.48 4.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.478 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.606 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -27.93 148.95 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.08 0.467 . . . . 0.0 111.852 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.647 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 12.6 p -141.59 -39.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.213 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.647 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.69 119.64 6.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.167 178.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 1.4 pttt -69.49 68.11 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 0.0 111.173 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.53 -170.75 42.87 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.4 mtp85 -81.64 56.68 3.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.165 0.507 . . . . 0.0 110.511 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.575 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 9.1 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.036 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.536 ' HA ' ' CB ' ' A' ' 34' ' ' ALA . . . . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.773 0.321 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' A' ' 4' ' ' ALA . 15.4 Cg_endo -57.64 147.98 76.45 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.47 2.113 . . . . 0.0 111.836 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 13.0 p -140.73 77.44 1.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.426 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.46 ' O ' HG21 ' A' ' 7' ' ' ILE . 2.7 mp -133.54 61.78 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.394 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 44.9 m -89.67 -34.7 16.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.416 0.627 . . . . 0.0 110.02 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.519 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -168.5 130.77 1.38 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.616 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.6 mmm -88.25 19.19 3.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.032 0.444 . . . . 0.0 110.191 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -93.89 -101.04 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.725 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.447 ' CD1' ' HD3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER 179.66 82.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 111.542 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -108.91 69.07 0.37 Allowed Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.7 Cg_endo -55.72 104.48 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.675 2.25 . . . . 0.0 112.74 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.49 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 34.8 m -108.42 133.64 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.773 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.567 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.76 121.6 24.97 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.696 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -108.19 140.9 15.66 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.285 -0.96 . . . . 0.0 112.858 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 44.8 m -48.71 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.156 -1.022 . . . . 0.0 110.692 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.456 ' HB2' HG23 ' A' ' 40' ' ' ILE . 0.2 OUTLIER 167.76 -26.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.813 -179.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.25 33.36 3.45 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.633 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.587 HG22 ' CE1' ' A' ' 23' ' ' TYR . 11.2 mm -136.61 136.75 48.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.739 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.0 101.8 13.58 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.07 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.67 ' CD1' HD23 ' A' ' 29' ' ' LEU . 45.2 m-85 -84.33 127.13 33.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.453 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.531 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -42.96 -29.95 0.93 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.833 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -160.23 144.12 14.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.943 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.94 -24.32 2.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.346 0.593 . . . . 0.0 110.293 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -80.47 -50.25 10.32 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.828 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.549 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 5.2 mtt -46.92 -33.83 4.94 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.67 HD23 ' CD1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -58.33 -55.3 36.78 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.056 176.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 27' ' ' CYS . 10.7 mt -48.75 -32.49 8.63 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.235 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -76.19 -32.15 58.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.991 178.119 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.91 -58.98 4.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.103 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.55 -34.41 17.47 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.154 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.536 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . . . -90.61 -4.97 56.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.331 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -100.81 -48.83 4.35 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.649 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 43.2 t -81.7 -98.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.433 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 36' ' ' SER . 16.3 t0 179.02 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.336 . . . . 0.0 111.255 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.5 132.93 60.57 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 121.046 0.45 . . . . 0.0 111.26 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.3 87.96 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.941 2.428 . . . . 0.0 112.452 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.569 ' CD1' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -71.71 155.9 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.731 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 18' ' ' SER . 0.6 OUTLIER -146.04 104.47 3.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.862 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.61 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -27.46 148.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.39 0.614 . . . . 0.0 112.181 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.644 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 1.9 t -137.46 -37.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.378 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.644 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -154.13 125.76 7.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.04 61.47 0.28 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.623 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.52 -162.27 27.85 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.409 ' O ' ' OXT' ' A' ' 48' ' ' CYS . 6.1 mtm180 -88.03 56.67 3.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.93 0.395 . . . . 0.0 110.478 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.577 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 5.5 m . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.029 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.574 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.851 0.357 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 4' ' ' ALA . 86.6 Cg_exo -46.08 -179.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.667 2.244 . . . . 0.0 112.176 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -107.15 45.61 0.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.035 0.445 . . . . 0.0 110.963 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.544 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 28.4 mm -151.44 63.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.612 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.86 -43.28 22.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.091 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.7 t -172.47 -172.15 0.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.192 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.497 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -112.61 17.79 18.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 13' ' ' ASP . 1.1 tp60 -69.1 60.41 0.11 Allowed 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.155 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.98 83.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.5 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -117.65 60.24 3.14 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.8 Cg_endo -57.2 94.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.732 2.288 . . . . 0.0 112.554 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.548 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 26.1 m -96.79 126.87 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.126 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.492 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -79.25 115.53 18.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.293 179.388 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -104.77 139.54 14.66 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.234 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 7.7 t -49.7 93.47 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.115 -1.042 . . . . 0.0 110.416 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 18' ' ' SER . 34.5 t0 171.37 -27.01 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.973 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.83 32.95 3.18 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.358 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.557 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 29.5 mm -136.87 133.53 48.17 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 46' ' ' GLY . 1.4 m -95.26 99.1 11.1 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.642 ' CD1' HD22 ' A' ' 29' ' ' LEU . 38.1 m-85 -79.99 124.02 28.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.097 -178.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.19 -26.89 0.06 OUTLIER Glycine 0 CA--C 1.507 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.394 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.54 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -173.45 150.47 1.83 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.002 0.429 . . . . 0.0 110.979 179.341 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.49 -25.15 1.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.464 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -74.3 -52.54 11.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.54 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -47.86 -40.93 22.85 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.146 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.642 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -53.26 -54.09 41.32 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.29 177.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.574 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 13.5 mt -49.15 -33.44 12.08 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.564 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 4.2 t -76.67 -29.88 56.54 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.62 -55.83 15.47 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.295 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -18.8 62.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.587 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.02 -44.15 10.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -98.05 -7.02 30.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.091 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 44.6 t -86.33 -105.66 0.06 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.583 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 36' ' ' SER . 14.3 t0 177.54 -28.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.89 0.376 . . . . 0.0 110.568 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.35 139.1 20.44 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.044 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.16 89.06 1.07 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.795 2.33 . . . . 0.0 112.34 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.541 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -56.12 156.26 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.379 179.499 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 18' ' ' SER . 42.1 mt-10 -134.44 97.33 3.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 111.153 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.637 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -33.65 148.87 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.387 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.646 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 8.6 p -138.76 -38.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.053 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.646 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -149.44 120.38 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.156 178.26 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -70.47 63.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.454 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 22' ' ' THR . . . -177.28 -159.86 23.13 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -89.93 58.3 4.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.156 0.503 . . . . 0.0 110.486 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.615 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.9 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.146 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.531 ' CB ' ' HD3' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.817 0.341 . . . . 0.0 111.558 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.531 ' HD3' ' CB ' ' A' ' 4' ' ' ALA . 82.1 Cg_exo -43.96 159.01 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.678 2.252 . . . . 0.0 112.405 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 26.1 p -163.18 72.65 0.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.523 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 44.8 mm -132.48 54.03 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.285 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 36.0 m -79.2 -37.9 37.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.162 0.506 . . . . 0.0 110.087 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -172.2 144.54 1.63 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.183 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.9 26.18 4.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -85.79 -102.55 0.06 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.102 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.487 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER 178.75 73.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.603 0.24 . . . . 0.0 111.048 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.45 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 0.4 OUTLIER -107.41 66.91 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 109.757 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 18.9 Cg_endo -60.34 94.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.62 2.213 . . . . 0.0 111.949 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.548 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 27.6 m -99.06 129.84 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.032 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.58 120.7 23.65 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.553 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -111.36 144.57 17.5 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.996 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -44.87 97.75 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.215 -0.993 . . . . 0.0 109.618 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.462 ' HB2' HG22 ' A' ' 40' ' ' ILE . 9.0 t0 165.14 -24.6 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.804 -1.543 . . . . 0.0 108.685 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.472 ' O ' HD13 ' A' ' 21' ' ' ILE . . . 100.54 27.45 7.59 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.52 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.598 ' CG2' ' CE1' ' A' ' 23' ' ' TYR . 1.5 mp -128.8 144.16 38.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.304 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.531 ' CG2' ' HB2' ' A' ' 14' ' ' PRO . 13.4 m -101.32 99.03 9.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.611 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.631 ' CD1' HD21 ' A' ' 29' ' ' LEU . 49.0 m-85 -80.15 123.37 27.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.287 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -37.45 -29.51 0.04 OUTLIER Glycine 0 CA--C 1.504 -0.648 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.239 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 23' ' ' TYR . 84.6 m-20 -165.14 147.95 8.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.795 0.331 . . . . 0.0 111.092 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.87 -25.75 2.06 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.309 0.576 . . . . 0.0 110.15 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -78.84 -51.49 9.66 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.428 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.47 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -45.13 -38.97 5.57 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 176.177 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.631 HD21 ' CD1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -54.11 -56.62 16.34 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 113.242 -1.799 . . . . 0.0 109.78 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 4.5 mt -47.12 -34.08 5.7 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.286 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 28' ' ' MET . 1.2 m -75.27 -33.58 61.28 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.137 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -64.66 -55.45 20.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.267 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.413 ' N ' HD12 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -52.23 -32.58 37.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.499 179.392 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.512 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . . . -82.76 -15.51 51.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.288 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 9.6 ptm180 -109.75 -18.28 13.48 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.7 t -83.94 -98.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 111.455 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.8 t70 179.26 -31.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 0.0 110.84 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.408 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 13.9 t -114.03 145.13 32.93 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 51.1 Cg_endo -69.81 80.93 0.86 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.755 2.303 . . . . 0.0 112.769 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.565 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -44.27 157.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.239 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 42' ' ' LEU . 27.2 mt-10 -140.62 102.92 4.42 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.828 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.565 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -28.95 149.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.191 0.519 . . . . 0.0 111.857 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.655 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.8 t -141.01 -38.54 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.092 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.655 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.51 122.36 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.47 179.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -71.5 61.96 0.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.223 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.455 ' O ' HG22 ' A' ' 22' ' ' THR . . . -176.05 -160.15 23.0 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.46 ' HA ' HG22 ' A' ' 22' ' ' THR . 9.0 mtp85 -90.26 56.92 3.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.395 . . . . 0.0 110.67 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.569 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.9 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.138 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.538 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.79 0.329 . . . . 0.0 111.432 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.426 ' C ' ' HB2' ' A' ' 31' ' ' CYS . 50.6 Cg_exo -53.18 -164.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.646 2.23 . . . . 0.0 111.969 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.455 ' CA ' ' HB2' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -116.57 50.68 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.589 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.471 HG21 HD12 ' A' ' 7' ' ' ILE . 12.7 mt -148.88 86.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.946 0.403 . . . . 0.0 111.321 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -112.86 -37.51 4.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.838 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -171.78 175.71 3.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.287 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.2 mtm -113.63 17.79 17.98 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -75.02 58.95 0.9 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.0 179.509 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 11' ' ' GLN . 29.6 t80 -19.37 82.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.436 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -114.27 63.86 1.31 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.0 Cg_endo -53.45 96.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.952 2.435 . . . . 0.0 112.594 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.556 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 28.5 m -98.66 126.33 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.487 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.548 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.31 120.44 23.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.02 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -108.12 144.77 16.21 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.858 -178.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -48.23 93.73 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.066 -1.067 . . . . 0.0 110.364 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.7 t70 167.99 -24.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.241 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.0 32.43 5.0 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.023 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.587 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 26.6 mm -132.82 136.51 55.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.564 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -97.04 101.88 13.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.798 178.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.622 ' CD1' HD21 ' A' ' 29' ' ' LEU . 30.8 m-85 -85.77 121.11 27.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.989 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -40.73 -27.15 0.16 Allowed Glycine 0 CA--C 1.506 -0.523 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.053 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 83.9 m-20 -164.63 145.42 7.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.741 0.305 . . . . 0.0 111.079 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -48.06 -26.8 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.166 0.508 . . . . 0.0 109.891 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -77.18 -51.4 11.03 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.494 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.435 ' HE2' ' HA3' ' A' ' 24' ' ' GLY . 0.6 OUTLIER -46.63 -37.17 7.81 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 176.09 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.622 HD21 ' CD1' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -54.95 -54.5 42.04 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.263 176.408 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.538 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 12.3 mt -47.5 -32.57 5.36 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.67 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 35' ' ' ARG . 5.8 t -78.43 -32.26 48.51 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -63.95 -58.72 5.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.576 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.425 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -55.95 -25.97 45.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.488 179.048 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.2 -34.04 61.46 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -129.83 27.3 5.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 43.5 t -92.74 -94.95 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.632 0.253 . . . . 0.0 111.323 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.79 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.935 0.397 . . . . 0.0 110.541 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.419 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 7.9 t -138.41 147.16 54.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.721 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.419 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 16.4 Cg_endo -57.74 93.27 0.06 OUTLIER 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.841 2.361 . . . . 0.0 112.393 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.577 ' CG1' ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -79.45 126.85 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.98 0.419 . . . . 0.0 111.075 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.582 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 2.6 mm-40 -97.36 -156.9 0.56 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.073 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.602 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -120.97 149.45 42.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.515 178.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.649 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.4 t -138.36 -36.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.921 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.649 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -157.35 122.13 4.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.815 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -71.2 65.88 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.139 -179.62 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 22' ' ' THR . . . -179.22 -162.25 28.14 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.451 ' HA ' ' CG2' ' A' ' 22' ' ' THR . 4.2 mtt180 -87.27 57.64 4.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.944 0.402 . . . . 0.0 110.545 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.607 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 10.9 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.11 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 121.006 0.431 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.42 -163.64 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.914 2.409 . . . . 0.0 112.081 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.446 ' CA ' ' HB2' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -119.15 50.02 1.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 111.271 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 13.5 mm -146.96 80.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -104.13 -38.06 7.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.456 0.646 . . . . 0.0 109.972 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.505 ' OG1' ' N ' ' A' ' 10' ' ' MET . 6.2 t -171.96 -163.0 0.23 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.112 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.505 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.9 OUTLIER -128.05 16.69 6.74 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.486 178.101 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 2.4 mt-30 -71.53 58.94 0.29 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.906 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.514 ' CD1' ' HD3' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -25.99 87.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.942 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.4 OUTLIER -121.86 71.29 30.05 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.802 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.0 Cg_endo -55.62 95.95 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.843 2.362 . . . . 0.0 112.545 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.545 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 4.4 m -96.74 126.83 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.485 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.525 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.23 118.86 20.85 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.211 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.56 143.16 15.65 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.983 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 40.4 t -50.98 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.253 -0.974 . . . . 0.0 110.17 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.485 ' HB2' HG21 ' A' ' 40' ' ' ILE . 12.7 t0 171.65 -27.69 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.616 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.85 31.06 3.75 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.39 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.574 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 23.0 mm -136.91 139.91 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 119.753 -0.779 . . . . 0.0 113.011 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 46' ' ' GLY . 3.9 m -98.42 102.64 14.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.879 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.63 ' CD1' HD23 ' A' ' 29' ' ' LEU . 37.3 m-85 -84.94 123.96 31.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.887 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -41.25 -25.99 0.17 Allowed Glycine 0 CA--C 1.505 -0.534 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.127 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.8 m-20 -164.91 145.91 7.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.912 0.387 . . . . 0.0 111.454 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.41 -27.46 4.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.347 0.594 . . . . 0.0 109.554 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -78.1 -49.09 14.6 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -47.8 -37.92 14.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 175.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.63 HD23 ' CD1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -54.96 -52.77 62.01 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 112.908 -1.951 . . . . 0.0 109.168 176.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 13.2 mt -48.07 -33.35 7.98 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 28' ' ' MET . 24.9 t -75.09 -32.89 61.56 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.1 -57.71 7.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.481 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.97 -23.01 29.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.145 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 30' ' ' LEU . . . -85.83 -17.6 35.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.377 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -133.44 18.11 3.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.2 t -100.72 -97.57 0.26 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.334 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 56.5 t0 179.52 -32.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 0.0 110.643 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.405 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 1.4 t -126.97 149.5 69.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.801 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.405 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 53.2 Cg_endo -70.03 87.22 0.59 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.613 2.209 . . . . 0.0 112.205 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.555 ' CD1' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -49.88 149.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.427 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 18' ' ' SER . 31.5 mt-10 -130.68 101.88 5.87 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.101 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.6 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -28.32 146.54 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.223 0.535 . . . . 0.0 111.517 -179.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.617 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -132.58 -46.85 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.221 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.618 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -150.45 123.8 8.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.394 179.671 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -70.25 68.58 0.34 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.201 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 22' ' ' THR . . . 178.42 -158.92 23.9 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 57.36 3.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.165 0.507 . . . . 0.0 110.176 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.618 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 7.0 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.918 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 121.009 0.433 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -38.17 120.26 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.8 2.334 . . . . 0.0 112.553 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 4.2 p -84.7 77.36 10.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.159 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.454 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 8.3 mm -130.36 52.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.508 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 46.0 m -79.53 -35.73 39.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.355 0.598 . . . . 0.0 109.842 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.466 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -170.36 138.41 1.56 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.627 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.7 mtt -94.84 20.65 8.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.902 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 2.8 mm-40 -84.62 -99.75 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.245 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 11' ' ' GLN . 7.9 t80 178.18 79.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.528 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.06 64.38 0.48 Allowed Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.1 Cg_endo -56.63 92.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.65 2.233 . . . . 0.0 112.198 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.55 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 19.6 m -95.09 126.43 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.516 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.572 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -77.85 117.4 19.18 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.264 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.42 141.11 15.14 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.513 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 38.1 m -48.86 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.21 -0.995 . . . . 0.0 110.359 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.457 ' HB2' HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 169.07 -25.93 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.142 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.72 30.74 4.47 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.337 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 9.7 mm -131.77 138.91 51.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.667 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.465 HG21 ' HB2' ' A' ' 14' ' ' PRO . 3.1 m -99.76 99.48 10.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.729 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.654 ' CD1' HD21 ' A' ' 29' ' ' LEU . 33.1 m-85 -83.69 122.89 29.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.721 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -42.28 -24.15 0.19 Allowed Glycine 0 CA--C 1.505 -0.579 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.134 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.595 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -169.83 146.68 3.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.754 0.312 . . . . 0.0 111.108 -179.328 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -47.19 -25.54 0.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.292 0.568 . . . . 0.0 110.263 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -76.95 -54.77 6.14 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.817 178.651 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.548 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 36.4 mtp -45.53 -33.3 2.66 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.654 HD21 ' CD1' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -59.42 -54.36 47.53 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.469 -1.696 . . . . 0.0 108.892 177.315 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' CYS . 11.8 mt -49.07 -29.43 5.11 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.556 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 28' ' ' MET . 1.4 m -79.64 -31.12 41.52 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -68.93 -58.75 3.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.157 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.433 ' CB ' HD13 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -55.46 -33.02 63.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.268 179.262 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.44 -3.12 57.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.333 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 4.5 mtp180 -96.56 -51.09 4.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.942 0.401 . . . . 0.0 111.024 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.7 t -86.82 -99.15 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.437 ' O ' ' HD3' ' A' ' 39' ' ' PRO . 6.5 p30 178.92 -26.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.411 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -79.15 111.45 20.33 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.928 0.394 . . . . 0.0 111.121 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 33.5 Cg_exo -57.82 93.75 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.844 2.362 . . . . 0.0 112.486 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.539 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -69.54 157.49 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.767 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 18' ' ' SER . 36.9 mt-10 -140.95 103.46 4.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.049 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.572 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.3 OUTLIER -28.24 147.09 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.169 0.509 . . . . 0.0 111.315 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.64 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 13.6 p -139.39 -38.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.495 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.64 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.78 123.29 7.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.529 178.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 64.75 0.41 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.294 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.37 -160.31 24.89 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -90.12 54.22 2.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.972 0.415 . . . . 0.0 110.664 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.597 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 4.9 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.056 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.991 0.424 . . . . 0.0 111.061 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.81 176.71 8.57 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.698 2.266 . . . . 0.0 112.11 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 0.6 OUTLIER -66.69 123.76 21.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.859 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 30' ' ' LEU . . . -115.78 113.25 42.41 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -42.03 138.81 2.73 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.601 2.2 . . . . 0.0 111.801 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 1.3 p -93.23 56.03 2.42 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.257 0.551 . . . . 0.0 111.532 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.538 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 2.6 mp -132.05 57.15 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.582 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -78.9 -41.16 30.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.101 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 10' ' ' MET . 6.4 t -173.65 -165.88 0.28 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.395 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.475 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -124.1 17.59 9.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.035 177.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -73.08 58.76 0.5 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.993 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.458 ' C ' ' O ' ' A' ' 11' ' ' GLN . 9.0 t80 -25.18 84.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.292 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -114.91 64.67 1.63 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -51.74 97.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.034 2.489 . . . . 0.0 112.331 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 27.8 m -99.49 127.38 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.524 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.599 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.26 121.47 24.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.0 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -113.52 142.41 17.44 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.161 -1.019 . . . . 0.0 113.184 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.423 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 45.0 t -40.1 98.01 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.333 -0.933 . . . . 0.0 109.771 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' SER . 1.7 t0 160.19 -22.71 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.985 -1.462 . . . . 0.0 108.748 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.476 ' O ' HD13 ' A' ' 21' ' ' ILE . . . 94.23 25.08 17.43 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.988 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.581 HG23 ' CE1' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -118.45 124.56 73.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.861 -179.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.491 ' CG2' ' HB2' ' A' ' 14' ' ' PRO . 3.1 m -86.36 98.18 10.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.494 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.591 ' CD1' HD21 ' A' ' 29' ' ' LEU . 52.3 m-85 -79.47 123.81 27.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.017 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -37.49 -27.84 0.03 OUTLIER Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.533 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.7 p30 -174.33 155.54 2.37 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.934 0.397 . . . . 0.0 110.996 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.47 -23.03 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.928 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.58 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 26.1 m -83.6 -46.77 12.0 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.526 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -48.62 -36.17 15.24 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 175.415 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.591 HD21 ' CD1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -55.93 -50.18 71.45 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 112.933 -1.939 . . . . 0.0 108.837 177.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 11.7 mt -48.27 -30.56 4.91 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.746 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -73.19 -35.74 66.42 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.61 -57.85 5.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.309 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -61.34 -16.88 50.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.365 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 30' ' ' LEU . . . -90.85 -38.19 13.11 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -149.64 42.66 0.9 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 31.0 t -96.09 -81.52 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.897 0.379 . . . . 0.0 110.978 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -175.39 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.242 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.448 HG23 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -144.97 154.18 54.53 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.253 179.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.448 ' HD2' HG23 ' A' ' 38' ' ' THR . 38.0 Cg_endo -66.54 81.27 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.586 2.19 . . . . 0.0 112.507 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.538 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -54.5 169.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.219 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 42' ' ' LEU . 19.5 mt-10 -148.68 100.9 3.16 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.89 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.593 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -31.02 148.65 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 111.227 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.584 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 2.7 t -144.98 -37.24 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.033 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.599 ' CD2' ' HB3' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -148.97 120.35 7.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.0 110.858 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.6 mttp -70.19 66.5 0.29 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.27 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' O ' HG21 ' A' ' 22' ' ' THR . . . 179.67 -160.26 25.35 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -90.12 55.14 3.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.904 0.383 . . . . 0.0 110.442 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.574 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 7.1 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.283 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.483 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 3.1 mmtp . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.878 0.37 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 1' ' ' LYS . 59.5 Cg_endo -73.53 -165.34 0.24 Allowed 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.691 2.261 . . . . 0.0 112.551 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.09 123.52 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.95 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.508 ' CB ' ' HD3' ' A' ' 5' ' ' PRO . . . -168.29 -55.25 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.322 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 4' ' ' ALA . 35.7 Cg_exo -59.32 170.44 3.12 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.582 2.188 . . . . 0.0 112.026 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 28' ' ' MET . 25.4 p -165.77 72.64 0.17 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.441 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.532 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 26.8 mt -137.67 63.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 0.0 111.719 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 26.8 m -87.09 -40.14 14.94 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.411 0.624 . . . . 0.0 109.367 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 t -172.47 143.91 1.44 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.712 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.18 26.04 3.95 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 47.8 mt-30 -84.11 -103.45 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.322 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' A' ' 11' ' ' GLN . 2.4 t80 179.69 71.9 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.491 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER -106.98 71.07 0.27 Allowed Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 27.6 Cg_endo -61.97 101.49 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.654 2.236 . . . . 0.0 112.842 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.541 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 35.1 m -105.9 127.89 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.278 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.541 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -77.81 123.09 26.3 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.218 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -111.49 144.18 17.47 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.826 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.528 ' HB3' ' CG ' ' A' ' 41' ' ' GLU . 16.9 t -45.07 96.91 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.35 -0.925 . . . . 0.0 110.07 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' SER . 4.9 t0 163.76 -23.01 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.929 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.467 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 98.33 24.13 11.75 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.324 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.648 ' CG2' ' CE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -119.42 135.03 61.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.911 -179.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.442 ' CG2' ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -94.41 99.63 11.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.563 178.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.648 ' CE1' ' CG2' ' A' ' 21' ' ' ILE . 51.6 m-85 -82.64 122.56 28.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.055 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.479 ' HA3' ' CE ' ' A' ' 28' ' ' MET . . . -41.13 -27.22 0.21 Allowed Glycine 0 CA--C 1.507 -0.468 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.218 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.8 m-20 -164.47 146.32 8.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.74 0.305 . . . . 0.0 110.803 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.69 -25.14 2.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.227 0.537 . . . . 0.0 110.358 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -77.81 -50.55 12.1 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.479 ' CE ' ' HA3' ' A' ' 24' ' ' GLY . 2.8 mmm -45.99 -40.4 10.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.633 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -52.69 -55.94 19.07 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 113.445 -1.707 . . . . 0.0 109.775 176.284 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 13.8 mt -48.58 -32.57 8.29 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.4 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -75.75 -31.72 59.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -66.69 -59.23 3.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.951 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.47 ' OG ' HG12 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -52.29 -28.7 19.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.414 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.502 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . . . -70.16 -37.73 75.27 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -135.95 35.69 2.84 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 46.9 t -90.86 -95.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.691 0.281 . . . . 0.0 111.516 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -179.7 -35.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.124 0.488 . . . . 0.0 110.109 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.452 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 55.1 m -136.53 142.91 41.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.207 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.452 ' HD2' ' CG2' ' A' ' 38' ' ' THR . 10.5 Cg_endo -53.52 92.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.906 2.404 . . . . 0.0 112.928 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.591 ' CD1' ' CD2' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -78.57 148.34 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.139 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.528 ' CG ' ' HB3' ' A' ' 18' ' ' SER . 10.3 pt-20 -152.31 116.78 5.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.262 0.553 . . . . 0.0 111.123 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.564 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -21.61 145.25 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.794 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.617 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -136.4 -42.18 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.469 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.617 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.96 125.97 9.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.206 178.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -70.75 65.72 0.33 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.223 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.59 -160.61 27.37 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.442 ' HA ' ' CG2' ' A' ' 22' ' ' THR . 2.9 mtp180 -90.28 54.15 2.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.161 0.505 . . . . 0.0 110.845 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.592 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 4.2 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.215 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.484 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.951 0.405 . . . . 0.0 111.128 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.484 ' HD3' ' CB ' ' A' ' 1' ' ' LYS . 48.7 Cg_exo -55.83 -166.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.867 2.378 . . . . 0.0 112.504 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 7.3 p-10 -148.56 120.78 8.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.607 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.469 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . . . -173.64 -59.36 0.0 OUTLIER Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 4' ' ' ALA . 81.3 Cg_exo -43.61 135.92 6.71 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.611 2.207 . . . . 0.0 112.01 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 7.9 p -132.97 79.88 1.86 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.037 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.523 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 5.4 mp -133.93 52.47 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 55.3 m -84.39 -34.16 23.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.482 0.658 . . . . 0.0 109.627 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 11' ' ' GLN . 2.4 t -171.25 136.22 1.03 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.078 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.2 mtt -93.81 24.71 3.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.474 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.9 -100.66 0.17 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.366 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.473 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 1.5 t80 179.54 76.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.61 0.243 . . . . 0.0 110.977 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.5 69.94 0.29 Allowed Pre-proline 0 CA--C 1.516 -0.332 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.4 Cg_endo -56.31 102.64 0.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.779 2.319 . . . . 0.0 112.805 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.527 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 34.9 m -106.76 133.81 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.508 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.546 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.29 119.99 22.43 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.893 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -106.01 140.92 15.33 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.43 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 48.5 t -48.28 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.245 -0.978 . . . . 0.0 110.414 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' SER . 7.1 t0 171.68 -30.52 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.563 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.48 33.76 2.23 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.576 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.1 mt -135.49 154.39 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.46 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 2.5 m -109.66 99.25 8.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.373 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.638 ' CD1' HD23 ' A' ' 29' ' ' LEU . 53.9 m-85 -83.89 129.28 34.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.321 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.492 ' HA3' ' HE3' ' A' ' 28' ' ' MET . . . -41.35 -27.15 0.25 Allowed Glycine 0 CA--C 1.504 -0.652 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.328 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 81.6 m-20 -166.66 146.05 5.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.792 0.33 . . . . 0.0 111.149 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.02 -25.44 3.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.396 0.617 . . . . 0.0 109.868 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 1.1 m -79.89 -49.6 11.68 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.85 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.492 ' HE3' ' HA3' ' A' ' 24' ' ' GLY . 7.6 mmm -47.04 -37.65 9.74 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.638 HD23 ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -55.69 -56.99 13.94 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.258 -1.792 . . . . 0.0 109.498 176.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 27' ' ' CYS . 12.4 mt -48.24 -32.94 7.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.559 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -76.46 -32.11 58.2 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.49 -56.75 10.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.256 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.457 ' OG ' HD12 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -51.11 -36.31 39.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.033 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.432 ' CB ' ' HB1' ' A' ' 4' ' ' ALA . . . -90.69 -0.34 57.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.042 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 24.3 mtp180 -111.81 -38.86 4.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.6 t -85.36 -108.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.561 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p30 179.5 33.0 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.782 0.325 . . . . 0.0 110.944 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 m -146.79 134.12 10.23 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.795 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.71 83.98 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.814 2.343 . . . . 0.0 112.865 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.563 ' CD1' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -70.01 154.49 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.632 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.484 ' O ' ' O ' ' A' ' 42' ' ' LEU . 13.1 mt-10 -143.04 101.83 3.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.09 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.602 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -29.46 150.81 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.032 0.444 . . . . 0.0 111.632 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.63 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 1.4 t -144.6 -41.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.185 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.63 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -153.21 121.21 6.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.805 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.29 70.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.374 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.35 -164.88 34.94 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.3 56.35 3.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.104 0.478 . . . . 0.0 110.41 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.598 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 20.9 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.173 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.882 0.372 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.21 -166.4 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.804 2.336 . . . . 0.0 112.288 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.93 97.86 8.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.701 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.537 ' O ' ' CA ' ' A' ' 31' ' ' CYS . . . -164.93 -63.54 0.01 OUTLIER Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.777 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.457 ' C ' ' O ' ' A' ' 4' ' ' ALA . 96.4 Cg_exo -26.75 141.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.119 2.546 . . . . 0.0 112.104 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -92.91 52.87 1.9 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.003 0.43 . . . . 0.0 111.122 -179.27 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 6' ' ' CYS . 2.7 mm -145.92 90.75 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.782 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.01 -38.68 3.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.36 0.6 . . . . 0.0 109.894 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.478 HG22 ' HB2' ' A' ' 11' ' ' GLN . 10.0 t -172.5 -162.9 0.2 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.268 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.432 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -129.09 16.48 6.18 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.501 177.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -74.03 60.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.995 179.371 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.559 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 8.4 t80 -20.32 84.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.487 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 11' ' ' GLN . 20.5 t0 -114.47 59.29 1.0 Allowed Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.2 Cg_endo -54.28 96.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.754 2.303 . . . . 0.0 112.223 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.547 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 33.8 m -98.22 127.66 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.814 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.57 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.61 116.45 18.99 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.322 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.653 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.92 138.01 13.83 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.681 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 13.3 t -46.62 96.05 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.246 -0.977 . . . . 0.0 110.495 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 165.46 -23.53 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.235 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.77 32.97 4.88 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.318 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 36.3 mm -130.28 130.71 65.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.362 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.18 99.59 11.82 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.605 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.646 ' CD1' HD22 ' A' ' 29' ' ' LEU . 39.4 m-85 -83.03 121.8 27.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.824 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -36.28 -29.38 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.327 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.504 ' OD1' ' HG3' ' A' ' 28' ' ' MET . 2.1 p30 -173.37 154.82 2.71 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.098 0.475 . . . . 0.0 111.067 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.8 -23.53 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.807 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -78.48 -51.98 9.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.504 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 1.2 mtt -46.32 -42.1 14.24 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.646 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -52.46 -54.27 34.5 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.384 -1.735 . . . . 0.0 109.556 177.218 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 7.5 mt -48.22 -31.83 6.33 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.527 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.537 ' CA ' ' O ' ' A' ' 4' ' ' ALA . 7.3 t -76.76 -31.78 57.31 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.209 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -64.03 -58.65 6.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.349 178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.438 ' HB2' HD13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -63.98 -15.71 59.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.206 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 31' ' ' CYS . . . -90.05 -26.28 20.37 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HD2' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -131.23 18.95 4.89 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 10.2 t -105.62 -119.7 0.23 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p30 179.4 24.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.0 m -161.75 112.54 1.2 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.63 0.252 . . . . 0.0 110.523 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.1 94.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.603 2.202 . . . . 0.0 112.225 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.547 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -63.53 153.36 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.401 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 18' ' ' SER . 10.9 mt-10 -132.82 92.75 3.09 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.084 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.653 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -32.81 148.7 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.258 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.613 HG12 ' CE1' ' A' ' 44' ' ' HIS . 2.5 t -142.5 -38.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.646 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.613 ' CE1' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.29 117.75 6.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.471 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.23 65.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.641 -179.302 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.55 -163.21 29.49 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -85.59 59.02 5.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.084 0.468 . . . . 0.0 110.497 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.587 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 17.5 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.972 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.933 0.397 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.93 -163.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.918 2.412 . . . . 0.0 112.557 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.29 -167.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.374 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.567 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . . . -162.13 -70.11 0.01 OUTLIER Pre-proline 0 N--CA 1.452 -0.343 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.629 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' A' ' 4' ' ' ALA . 59.9 Cg_exo -27.38 144.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.309 2.673 . . . . 0.0 112.473 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.418 ' O ' HG12 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -102.01 54.05 0.8 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.97 0.414 . . . . 0.0 111.567 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 3.6 mm -146.49 78.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.644 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -103.14 -39.34 6.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.325 0.583 . . . . 0.0 110.29 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.498 HG21 ' HB2' ' A' ' 11' ' ' GLN . 9.8 t -173.19 -160.93 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.761 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.458 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -128.5 17.88 6.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.367 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.543 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -72.29 58.87 0.39 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.345 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -26.65 85.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.147 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -121.61 67.25 20.39 Favored Pre-proline 0 N--CA 1.454 -0.241 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.0 Cg_endo -53.0 95.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.897 2.398 . . . . 0.0 112.57 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.524 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 25.5 m -95.94 126.91 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.8 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.579 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.69 118.43 20.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.744 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -108.55 145.34 16.4 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.688 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 10.6 p -48.32 97.15 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.501 -0.849 . . . . 0.0 109.991 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 18' ' ' SER . 7.6 t70 168.84 -25.83 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.853 -1.521 . . . . 0.0 108.695 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.42 30.65 5.83 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.585 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -127.53 146.29 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.511 ' CG2' ' HB2' ' A' ' 14' ' ' PRO . 6.2 m -107.39 97.81 7.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.501 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.605 ' CD1' HD23 ' A' ' 29' ' ' LEU . 36.7 m-85 -81.74 123.1 28.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.403 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.448 ' HA3' ' HE2' ' A' ' 28' ' ' MET . . . -39.9 -26.52 0.1 OUTLIER Glycine 0 CA--C 1.508 -0.406 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.319 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.545 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -171.82 149.21 2.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.003 0.43 . . . . 0.0 110.684 179.132 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.91 -24.55 0.62 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.834 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.6 m -77.74 -50.78 11.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.196 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.545 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -46.79 -37.66 8.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.605 HD23 ' CD1' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.41 -52.66 63.81 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.987 -1.915 . . . . 0.0 109.246 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 5.5 mt -49.6 -32.12 12.15 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.6 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.531 ' CA ' ' O ' ' A' ' 4' ' ' ALA . 7.7 t -75.9 -29.3 58.39 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -69.5 -62.3 1.44 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.905 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.14 -13.51 27.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.446 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . . . -82.97 -29.75 28.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.302 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.429 ' CD ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -144.38 29.49 1.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.352 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 47.4 t -92.1 -97.04 0.13 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.618 0.247 . . . . 0.0 110.913 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 179.72 -32.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 0.0 110.731 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 9.2 m -127.53 133.06 24.68 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.939 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 35.0 Cg_exo -60.51 90.11 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.759 2.306 . . . . 0.0 112.579 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.532 ' CD1' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -63.9 163.02 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.543 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 18' ' ' SER . 1.5 mt-10 -149.86 107.13 3.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.809 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.536 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -29.27 148.92 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.08 0.466 . . . . 0.0 111.577 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.651 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.8 t -142.65 -39.2 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.416 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.651 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -153.86 121.06 5.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.523 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -69.27 68.3 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.106 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.3 -171.12 44.12 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.41 57.36 2.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.084 0.468 . . . . 0.0 110.504 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.556 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 21.1 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.052 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.458 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 2.5 ttmm . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.839 0.352 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.458 ' HD3' ' HB3' ' A' ' 1' ' ' LYS . 73.2 Cg_endo -77.14 -172.8 1.54 Allowed 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.716 2.277 . . . . 0.0 112.459 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.541 ' CB ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -107.45 48.05 0.86 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.903 0.383 . . . . 0.0 111.062 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.565 ' O ' ' CB ' ' A' ' 31' ' ' CYS . . . -35.86 -53.37 1.47 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.539 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 4' ' ' ALA . 33.5 Cg_exo -29.91 126.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.747 2.298 . . . . 0.0 112.158 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.444 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -93.12 44.97 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 110.988 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.561 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 31.5 mt -152.61 63.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.7 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -80.95 -41.6 22.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.916 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 t -172.02 162.23 5.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.88 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -92.47 18.66 8.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 2.1 tt0 -72.02 58.53 0.35 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.165 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.47 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -21.52 82.96 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.36 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -112.76 62.64 0.72 Allowed Pre-proline 0 N--CA 1.452 -0.341 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.4 Cg_endo -55.58 93.89 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.815 2.343 . . . . 0.0 112.455 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 5.7 m -97.29 125.92 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.719 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.582 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.55 117.23 19.54 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.749 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -106.16 143.56 15.75 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.298 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 4.2 t -49.27 95.06 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.301 -0.95 . . . . 0.0 110.001 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.7 -25.68 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.954 -1.476 . . . . 0.0 109.006 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.3 34.04 3.77 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.377 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.594 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 27.4 mm -137.19 136.19 47.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.472 HG21 ' O ' ' A' ' 46' ' ' GLY . 2.9 m -96.73 97.9 9.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.232 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.623 ' CD1' HD23 ' A' ' 29' ' ' LEU . 41.3 m-85 -80.07 126.37 30.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.299 -178.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.22 -25.51 0.05 OUTLIER Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.505 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 0.9 OUTLIER -176.41 150.27 0.88 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.2 -25.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.567 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -76.45 -52.86 9.01 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.535 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -44.77 -41.25 6.74 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.124 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.623 HD23 ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -53.93 -54.37 39.79 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 112.986 -1.916 . . . . 0.0 109.411 177.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.541 HD12 ' CB ' ' A' ' 3' ' ' ASP . 13.0 mt -48.88 -33.84 11.47 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.156 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -74.85 -32.62 61.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -62.63 -57.18 11.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.627 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -17.54 56.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.169 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 30' ' ' LEU . . . -88.39 -15.38 35.68 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -136.03 1.45 2.73 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -89.04 -99.15 0.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.546 0.213 . . . . 0.0 111.038 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 178.77 -31.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.36 . . . . 0.0 110.953 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.446 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -117.4 151.33 47.94 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.114 0.483 . . . . 0.0 111.42 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.446 ' HD2' ' CG2' ' A' ' 38' ' ' THR . 97.5 Cg_endo -80.13 86.51 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.997 2.465 . . . . 0.0 112.029 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.553 ' CD1' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.47 155.22 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.77 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 18' ' ' SER . 20.9 mt-10 -135.0 96.84 3.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.746 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.602 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.3 OUTLIER -29.26 147.41 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.224 0.535 . . . . 0.0 111.439 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.624 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 1.7 t -135.46 -41.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.295 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.624 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -153.35 121.24 6.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.58 -179.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -70.27 67.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.0 0.429 . . . . 0.0 111.148 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.472 ' O ' HG21 ' A' ' 22' ' ' THR . . . 179.05 -165.27 34.09 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.76 57.36 4.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.033 0.444 . . . . 0.0 110.649 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.588 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.8 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.576 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 12.0 mttt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.88 0.371 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 1' ' ' LYS . 58.3 Cg_endo -71.21 -168.3 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.713 2.275 . . . . 0.0 112.27 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.525 ' CB ' HD21 ' A' ' 30' ' ' LEU . 43.4 m-20 -139.53 -176.12 4.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.008 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.546 ' HA ' ' CB ' ' A' ' 34' ' ' ALA . . . -171.99 -58.84 0.0 OUTLIER Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.793 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 4' ' ' ALA . 51.9 Cg_exo -53.7 178.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.511 2.14 . . . . 0.0 111.575 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.433 ' HB2' ' C ' ' A' ' 27' ' ' CYS . 26.2 p -170.47 76.33 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.657 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 2.8 mp -131.68 57.56 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.36 . . . . 0.0 111.667 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 57.6 m -83.08 -38.38 22.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.316 0.579 . . . . 0.0 110.099 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 11' ' ' GLN . 1.8 t -171.61 139.92 1.29 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.432 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.34 25.91 4.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.475 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 55.2 mt-30 -91.68 -100.79 0.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.647 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.483 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 179.83 77.55 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.117 -179.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.438 ' CB ' ' OD1' ' A' ' 25' ' ' ASN . 0.3 OUTLIER -111.22 65.07 0.53 Allowed Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.604 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 12.9 Cg_endo -56.29 98.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.032 2.488 . . . . 0.0 112.77 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.467 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 24.8 m -99.25 130.2 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.779 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.552 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.65 117.69 20.04 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.262 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -109.38 140.93 15.9 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.966 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 2.5 m -42.3 96.97 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.275 -0.963 . . . . 0.0 109.635 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' GLY . 7.3 t0 163.34 -22.87 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.913 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.477 ' O ' HD11 ' A' ' 21' ' ' ILE . . . 96.52 23.48 16.17 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.659 ' CG2' ' CE1' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -119.05 131.97 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.923 -179.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.467 HG21 ' HB2' ' A' ' 14' ' ' PRO . 1.6 m -92.77 98.2 11.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.418 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.682 ' CD1' HD22 ' A' ' 29' ' ' LEU . 47.3 m-85 -81.03 123.89 28.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.322 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -37.49 -30.47 0.06 OUTLIER Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.15 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 23' ' ' TYR . 83.8 m-20 -165.34 147.85 7.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.361 -0.419 . . . . 0.0 111.073 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.27 -25.74 2.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.298 0.571 . . . . 0.0 110.009 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -77.19 -51.94 10.11 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.534 178.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.452 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 2.0 mtt -44.69 -39.78 5.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 176.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.682 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -56.24 -54.61 43.24 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.686 176.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.525 HD21 ' CB ' ' A' ' 3' ' ' ASP . 4.1 mt -47.68 -35.11 9.03 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.212 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -74.42 -33.28 62.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.022 178.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -63.12 -55.52 24.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.293 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.501 ' OG ' HD13 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -51.8 -35.08 42.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.44 179.486 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.546 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . . . -90.71 -2.49 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.482 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -120.66 -18.77 7.64 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.2 t -89.83 -98.67 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.456 0.169 . . . . 0.0 111.229 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 38' ' ' THR . 28.8 p30 179.11 -30.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.729 0.3 . . . . 0.0 111.058 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.515 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 3.3 t -107.88 137.18 19.71 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 0.0 110.767 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.74 89.47 0.99 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.74 2.293 . . . . 0.0 112.72 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.534 ' CD1' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -53.96 169.63 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.414 179.154 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.472 ' O ' ' C ' ' A' ' 42' ' ' LEU . 18.4 mt-10 -147.06 98.3 3.01 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.061 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.595 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -29.13 148.04 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.1 0.476 . . . . 0.0 111.212 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.676 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -138.33 -40.31 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.49 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.676 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -154.41 121.59 5.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.563 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -69.64 67.0 0.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.382 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.18 -161.74 28.12 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.2 56.45 3.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.114 0.483 . . . . 0.0 110.522 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.597 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 6.6 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.096 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.83 0.348 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 3' ' ' ASP . 51.3 Cg_endo -69.03 -167.25 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.762 2.308 . . . . 0.0 112.417 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 2' ' ' PRO . 0.2 OUTLIER -36.19 145.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.738 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . . . -133.82 120.63 15.5 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.234 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 4' ' ' ALA . 83.8 Cg_exo -47.0 -176.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.639 2.226 . . . . 0.0 112.155 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.486 ' CA ' ' HB2' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -108.47 50.53 0.77 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.042 0.449 . . . . 0.0 111.301 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.8 mp -145.53 89.78 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.03 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.38 -42.1 3.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.58 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.9 t -171.7 -168.71 0.62 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.337 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.515 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -118.01 17.78 14.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.484 178.115 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 13' ' ' ASP . 24.8 mt-30 -69.53 57.67 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.389 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' GLN . 4.6 t80 -27.54 85.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.787 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -123.86 72.47 53.23 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.0 Cg_endo -55.54 99.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.493 2.129 . . . . 0.0 112.117 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.551 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 32.9 m -97.55 128.18 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.979 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.473 ' O ' HG21 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.51 116.93 19.24 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.642 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.65 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.35 135.99 12.91 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.74 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 11.1 m -49.45 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.319 -0.94 . . . . 0.0 110.756 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 t70 170.05 -26.13 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.05 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.32 31.19 3.59 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.378 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.516 HG22 ' CE1' ' A' ' 23' ' ' TYR . 19.3 mm -134.22 138.13 50.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.772 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 14' ' ' PRO . 1.8 m -100.32 99.64 10.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.414 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.63 ' CD1' HD22 ' A' ' 29' ' ' LEU . 34.3 m-85 -81.4 127.59 32.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.804 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.82 -21.57 0.6 Allowed Glycine 0 CA--C 1.509 -0.341 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.521 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.582 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -172.4 146.33 1.77 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 0.0 110.989 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.06 -24.67 1.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.506 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 30' ' ' LEU . 1.3 m -78.79 -50.36 11.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.334 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.556 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 16.3 mtt -48.27 -34.58 10.58 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.63 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -59.91 -51.86 67.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 113.098 -1.864 . . . . 0.0 108.833 177.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 27' ' ' CYS . 12.9 mt -48.3 -31.85 6.55 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.499 ' O ' ' NE ' ' A' ' 35' ' ' ARG . 13.9 t -72.86 -34.99 67.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.37 -59.95 2.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.63 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -19.23 3.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.383 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.72 -41.62 37.17 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -140.49 29.77 1.95 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.5 t -81.16 -93.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.718 0.294 . . . . 0.0 110.897 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.35 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.034 0.445 . . . . 0.0 110.466 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.14 129.06 17.8 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.5 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.52 94.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.959 2.439 . . . . 0.0 112.357 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.564 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -59.56 152.96 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.857 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 18' ' ' SER . 12.8 mt-10 -134.16 96.95 3.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.02 0.438 . . . . 0.0 110.838 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.65 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -36.9 148.7 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.455 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.626 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -137.45 -37.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.178 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.634 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -150.34 121.89 7.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.547 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 64.71 0.26 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.647 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -178.76 -158.27 20.94 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.02 57.84 3.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.23 0.538 . . . . 0.0 110.394 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.634 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 10.8 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.183 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.475 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.97 0.414 . . . . 0.0 111.204 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.475 ' HD3' ' CB ' ' A' ' 1' ' ' LYS . 47.1 Cg_endo -84.87 39.59 0.76 Allowed 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.095 2.53 . . . . 0.0 112.538 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -173.54 57.12 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.7 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . . . -100.13 125.74 38.79 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.233 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.433 ' C ' ' HB2' ' A' ' 31' ' ' CYS . 22.4 Cg_exo -63.76 -166.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.669 2.246 . . . . 0.0 112.06 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.445 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -117.9 50.26 1.16 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.984 0.421 . . . . 0.0 110.951 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.525 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 3.3 mp -146.62 62.61 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.297 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -36.88 18.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.446 0.641 . . . . 0.0 109.826 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.1 t -171.67 -172.32 1.02 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.015 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.509 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.5 OUTLIER -119.28 17.41 13.09 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.012 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 21.0 mm-40 -71.18 59.22 0.25 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.031 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 11' ' ' GLN . 22.2 t80 -19.83 82.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.198 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -118.54 69.26 8.32 Favored Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.869 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 19.5 Cg_endo -59.12 94.77 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.412 2.075 . . . . 0.0 112.068 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 22.6 m -99.33 127.01 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.824 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.59 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.36 122.35 25.65 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.751 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -109.15 144.88 16.55 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.956 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 2.5 t -50.8 95.35 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 114.121 -1.04 . . . . 0.0 110.602 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.478 ' HB2' HG23 ' A' ' 40' ' ' ILE . 5.7 t0 171.67 -30.27 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.66 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.88 33.83 1.96 Allowed Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.184 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 1.2 mt -138.62 149.53 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.496 HG21 ' HB2' ' A' ' 14' ' ' PRO . 5.2 m -107.39 99.56 9.07 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.181 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.628 ' CD1' HD21 ' A' ' 29' ' ' LEU . 41.9 m-85 -82.17 123.18 28.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.427 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -40.07 -27.33 0.13 Allowed Glycine 0 CA--C 1.505 -0.557 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.031 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.2 m-20 -164.38 146.24 8.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.779 0.323 . . . . 0.0 111.19 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.18 -27.85 3.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.305 0.574 . . . . 0.0 109.719 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -76.55 -50.12 14.71 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.401 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.466 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -46.5 -39.79 11.41 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 176.118 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.628 HD21 ' CD1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -52.61 -54.59 31.01 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 113.34 -1.754 . . . . 0.0 109.488 176.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.543 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 12.9 mt -48.47 -32.5 7.91 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.223 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 28' ' ' MET . 6.6 t -73.63 -32.69 64.18 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.072 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.63 -59.94 3.43 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.675 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.468 ' HB2' ' CD1' ' A' ' 40' ' ' ILE . 5.1 t -56.27 -19.14 12.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.029 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 30' ' ' LEU . . . -82.13 -54.52 5.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.536 ' CZ ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -100.5 11.94 38.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 22.0 t -96.34 -116.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' A' ' 36' ' ' SER . 19.0 p-10 179.11 26.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.21 146.44 10.66 Favored Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.024 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -79.47 85.06 1.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.686 2.257 . . . . 0.0 112.125 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.538 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -62.23 153.57 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.124 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 42' ' ' LEU . 24.5 mt-10 -136.87 102.24 4.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.262 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.58 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -28.96 149.9 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.918 0.389 . . . . 0.0 111.604 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.634 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.7 t -142.37 -39.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.046 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.634 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -152.36 123.41 7.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.927 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 7.5 ptmt -70.4 65.54 0.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.458 ' O ' HG23 ' A' ' 22' ' ' THR . . . 178.99 -167.76 38.2 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.435 ' HA ' HG22 ' A' ' 22' ' ' THR . 3.8 mtt180 -83.47 55.84 3.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.977 0.418 . . . . 0.0 110.674 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.562 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 9.8 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.858 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.562 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.58 0.229 . . . . 0.0 111.034 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 1' ' ' LYS . 56.2 Cg_endo -70.25 178.59 4.72 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.581 2.187 . . . . 0.0 112.375 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -76.4 67.84 2.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.731 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . . . -84.64 115.84 62.5 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.204 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -50.96 172.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.519 2.146 . . . . 0.0 111.917 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.81 46.97 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.016 0.436 . . . . 0.0 110.745 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.525 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 16.4 mt -150.29 72.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.063 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.17 -41.12 13.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.358 0.599 . . . . 0.0 110.158 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.481 HG22 ' HB2' ' A' ' 11' ' ' GLN . 4.2 t -171.5 -178.8 2.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.12 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.405 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -107.43 17.25 23.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.605 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -71.89 58.59 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.906 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.441 ' C ' ' O ' ' A' ' 11' ' ' GLN . 5.6 t80 -30.33 87.93 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.838 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -120.65 66.96 13.66 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -52.03 97.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.001 2.467 . . . . 0.0 112.442 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.551 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 28.8 m -97.43 123.83 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.613 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.509 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -77.85 118.05 19.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.541 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.636 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.71 142.53 15.57 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.883 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 16.0 t -52.29 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.297 -0.951 . . . . 0.0 110.179 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 3.1 t0 171.01 -25.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.745 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.58 32.85 3.04 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.532 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.471 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 42.0 mm -139.27 144.48 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 14' ' ' PRO . 11.7 m -105.31 98.66 8.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.384 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.624 ' CD1' HD22 ' A' ' 29' ' ' LEU . 35.3 m-85 -80.0 124.21 28.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.926 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.464 ' HA3' ' SD ' ' A' ' 28' ' ' MET . . . -42.0 -24.52 0.18 Allowed Glycine 0 CA--C 1.508 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.266 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.585 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -172.23 147.22 1.98 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.959 0.409 . . . . 0.0 110.714 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -46.7 -25.03 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.679 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 30' ' ' LEU . 1.6 m -77.75 -50.46 12.33 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.331 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.585 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 2.6 mtt -47.96 -35.03 10.08 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 175.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.624 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -58.22 -51.75 68.43 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.735 177.46 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 27' ' ' CYS . 14.3 mt -49.6 -31.96 11.77 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.476 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 28' ' ' MET . 37.4 t -76.77 -31.0 56.75 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -66.94 -60.57 2.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.389 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -53.78 -25.31 18.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.896 178.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 30' ' ' LEU . . . -84.64 -15.3 45.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.482 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 -97.34 -44.38 6.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.923 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.9 t -81.18 -102.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.618 0.247 . . . . 0.0 111.102 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 178.39 -27.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.742 0.306 . . . . 0.0 111.185 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -94.01 123.13 60.21 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.949 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.465 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 23.4 Cg_exo -63.53 86.56 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.679 2.253 . . . . 0.0 112.472 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.551 ' CD1' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -39.15 155.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.156 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 18' ' ' SER . 45.0 mt-10 -127.09 94.47 4.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.158 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.636 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -31.96 146.71 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.313 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.603 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -131.71 -45.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.1 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.615 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -145.86 123.43 11.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.416 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -70.87 58.58 0.21 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.3 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.18 -160.03 20.92 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -89.67 57.45 3.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.027 0.442 . . . . 0.0 110.692 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.615 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.8 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.141 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.88 0.371 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.37 -177.95 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.611 2.207 . . . . 0.0 112.208 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.461 ' HB3' ' CB ' ' A' ' 34' ' ' ALA . 16.7 m-20 -80.6 164.6 22.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . . . -148.5 151.07 35.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.027 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.36 177.23 2.74 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.77 2.314 . . . . 0.0 112.342 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.468 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -115.16 45.57 1.61 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 111.123 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.547 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 38.1 mt -147.11 62.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.78 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.63 -39.22 24.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.121 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.445 HG23 ' CG ' ' A' ' 11' ' ' GLN . 10.3 t -171.68 -166.05 0.41 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.047 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.65 17.95 9.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.307 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 13' ' ' ASP . 13.6 mm-40 -70.81 58.53 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.196 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.472 ' C ' ' O ' ' A' ' 11' ' ' GLN . 2.5 t80 -20.13 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.037 0.836 . . . . 0.0 112.234 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -120.46 69.33 15.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.685 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 17.8 Cg_endo -58.16 101.85 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.581 2.188 . . . . 0.0 112.35 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.551 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 30.1 m -99.58 130.35 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.202 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.466 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -79.27 118.35 21.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.555 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.67 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.2 136.41 13.37 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.193 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 2.2 t -44.15 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.201 -1.0 . . . . 0.0 110.314 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER 166.39 -24.09 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.404 -179.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.74 27.53 6.67 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.0 mm -123.72 140.64 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.421 HG22 ' HB2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -101.78 99.7 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.656 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.626 ' CD2' HD23 ' A' ' 29' ' ' LEU . 39.4 m-85 -81.88 120.78 25.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.664 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -41.1 -26.85 0.19 Allowed Glycine 0 CA--C 1.506 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.276 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.5 m-20 -165.11 146.12 7.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.778 0.323 . . . . 0.0 111.092 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -48.92 -27.46 3.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.256 0.551 . . . . 0.0 109.781 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.1 m -76.47 -50.62 13.59 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.783 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -47.24 -37.25 10.14 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.626 HD23 ' CD2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.29 -52.25 65.19 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.326 176.67 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 12.2 mt -48.02 -32.43 6.62 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.336 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.3 t -73.91 -33.4 63.97 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.11 -61.36 1.97 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.602 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 t -50.56 -22.87 2.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.033 0.444 . . . . 0.0 109.803 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 3' ' ' ASP . . . -78.65 -41.12 32.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.264 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.42 ' HD3' ' C ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -158.84 51.92 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.744 0.307 . . . . 0.0 111.743 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.526 ' HB2' ' CA ' ' A' ' 32' ' ' ALA . 23.1 t -95.26 -78.95 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.259 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -170.17 -37.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.955 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.416 ' O ' HG21 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -154.46 159.16 32.2 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.55 93.62 0.07 OUTLIER 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.782 2.321 . . . . 0.0 112.21 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.554 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -76.16 154.68 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.138 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 16.6 mt-10 -143.66 97.52 3.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.027 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.67 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -33.16 149.82 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.363 0.601 . . . . 0.0 111.859 -179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.622 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -142.05 -39.54 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.365 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.622 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -148.56 121.36 8.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.37 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -68.56 68.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.553 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 175.2 -166.75 38.48 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -83.63 58.76 4.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.288 0.566 . . . . 0.0 110.291 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.604 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 33.5 m . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.063 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.528 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.85 0.357 . . . . 0.0 111.208 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 1' ' ' LYS . 35.1 Cg_exo -60.46 -165.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.677 2.251 . . . . 0.0 112.16 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 9.2 p-10 -47.75 108.29 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.53 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.459 ' HB1' HD23 ' A' ' 30' ' ' LEU . . . -121.11 150.72 54.17 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.26 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.01 157.92 41.46 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.598 2.198 . . . . 0.0 111.846 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 28' ' ' MET . 2.6 p -115.78 72.74 0.81 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.27 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.506 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 4.1 mt -135.93 55.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.664 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 55.7 m -79.6 -37.91 35.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.484 0.659 . . . . 0.0 109.514 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t -171.23 141.99 1.68 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 31.8 mtm -91.7 21.12 4.95 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 0.4 OUTLIER -78.42 -108.24 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.873 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.581 ' CD1' ' HD3' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 178.99 76.09 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.655 0.265 . . . . 0.0 111.427 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.432 ' O ' HG11 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -106.77 68.39 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 15.2 Cg_endo -58.98 97.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.639 2.226 . . . . 0.0 112.767 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.548 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 19.9 m -99.66 131.01 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.53 0.681 . . . . 0.0 110.783 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.517 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -79.06 119.06 21.66 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.061 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.71 136.33 13.37 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.678 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 28.8 t -44.73 96.29 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.463 -0.869 . . . . 0.0 109.891 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.3 OUTLIER 166.59 -25.21 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.618 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.498 ' O ' HD11 ' A' ' 21' ' ' ILE . . . 101.61 25.29 8.21 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.455 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.644 ' CG2' ' CE1' ' A' ' 23' ' ' TYR . 1.2 mp -122.37 126.97 74.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.107 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 14' ' ' PRO . 2.2 m -88.46 98.88 11.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.268 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.644 ' CE1' ' CG2' ' A' ' 21' ' ' ILE . 33.7 m-85 -81.0 122.13 26.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.7 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -43.15 -24.67 0.32 Allowed Glycine 0 CA--C 1.503 -0.7 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.12 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -169.65 145.47 3.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.966 0.412 . . . . 0.0 111.015 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . -46.63 -26.77 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.929 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -74.26 -55.59 5.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.976 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.535 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 4.3 mtt -46.67 -34.71 5.31 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.632 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -59.69 -53.78 53.99 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.296 -1.774 . . . . 0.0 109.155 177.105 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 27' ' ' CYS . 4.8 mt -48.44 -33.55 9.47 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -73.97 -34.46 64.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.96 177.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.49 -58.46 5.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.355 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.448 ' HB2' HD13 ' A' ' 40' ' ' ILE . 1.4 t -55.98 -22.79 28.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.758 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.35 -16.74 30.34 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -133.67 17.65 3.92 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.222 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 t -93.77 -95.98 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.6 0.238 . . . . 0.0 111.224 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 p30 179.68 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.203 0.525 . . . . 0.0 109.935 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.9 t -132.57 127.9 20.76 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.962 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.51 93.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.608 2.206 . . . . 0.0 112.588 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.547 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -53.84 171.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.256 179.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.448 ' O ' HG22 ' A' ' 43' ' ' VAL . 16.0 mt-10 -146.11 101.1 3.48 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.437 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.644 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -33.59 149.47 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.274 0.559 . . . . 0.0 111.486 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 3.1 t -141.65 -33.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.677 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.643 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -157.48 122.2 4.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.534 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -69.22 67.53 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.528 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.72 -168.46 40.81 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.403 ' HA ' HG23 ' A' ' 22' ' ' THR . 9.2 mtp85 -81.0 57.72 3.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.006 0.431 . . . . 0.0 110.393 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.599 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 25.6 m . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.126 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 2' ' ' PRO . 14.5 mmtt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.91 0.386 . . . . 0.0 111.303 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 1' ' ' LYS . 52.7 Cg_exo -52.33 -164.03 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.788 2.325 . . . . 0.0 112.289 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.424 ' HB3' ' CD1' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -78.67 108.82 12.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.918 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 31' ' ' CYS . . . -159.9 -69.13 0.02 OUTLIER Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.632 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 4' ' ' ALA . 83.0 Cg_exo -28.69 142.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.77 2.313 . . . . 0.0 111.713 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -96.42 55.28 1.45 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.187 0.517 . . . . 0.0 111.574 -178.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.8 mm -147.74 87.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.631 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.55 -40.07 4.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.432 0.634 . . . . 0.0 110.084 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 10' ' ' MET . 5.6 t -172.5 -163.27 0.22 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.477 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.52 ' N ' ' OG1' ' A' ' 9' ' ' THR . 5.5 mtt -126.01 17.99 7.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.352 177.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -69.84 59.52 0.16 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.493 179.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.468 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -24.6 84.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.078 -179.478 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' GLN . 1.9 t70 -120.77 61.79 9.5 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.6 Cg_endo -53.07 90.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.68 2.254 . . . . 0.0 111.831 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.555 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 21.5 m -93.2 123.94 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.941 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.501 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -77.92 116.9 18.76 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.974 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.44 141.84 15.43 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.97 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 13.7 t -48.56 94.72 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.165 -1.018 . . . . 0.0 109.734 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.482 ' HB2' HG22 ' A' ' 40' ' ' ILE . 5.2 t0 171.21 -27.49 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.606 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.28 31.58 4.01 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.218 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.537 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 11.4 mm -135.6 139.73 45.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 46' ' ' GLY . 6.4 m -99.18 99.35 10.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.429 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.607 ' CD1' HD22 ' A' ' 29' ' ' LEU . 35.7 m-85 -82.16 124.06 29.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.2 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -38.82 -25.58 0.04 OUTLIER Glycine 0 CA--C 1.508 -0.375 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.571 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.491 ' OD1' ' HG3' ' A' ' 28' ' ' MET . 2.7 p30 -175.83 153.1 1.33 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.942 0.401 . . . . 0.0 111.363 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.89 -24.45 0.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.752 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.513 ' O ' ' N ' ' A' ' 30' ' ' LEU . 1.2 m -79.24 -51.79 9.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.493 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -45.57 -38.62 6.64 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.607 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -56.06 -53.09 61.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.952 -1.931 . . . . 0.0 109.172 177.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 27' ' ' CYS . 13.0 mt -48.65 -31.13 6.25 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.551 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 49.7 t -78.48 -31.41 47.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.21 -56.62 11.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.839 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.423 ' OG ' HD13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -67.46 -16.53 64.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.472 179.103 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 30' ' ' LEU . . . -90.83 -19.64 23.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.29 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.526 ' CG ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -120.66 3.97 10.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.115 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.6 t -105.71 -117.83 0.23 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.545 -0.168 . . . . 0.0 110.545 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 179.58 32.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.934 0.397 . . . . 0.0 110.775 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -160.51 126.81 2.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.558 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.05 88.4 0.38 Allowed 'Trans proline' 0 N--CA 1.466 -0.133 0 C-N-CA 122.588 2.192 . . . . 0.0 112.344 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.555 ' CD1' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -53.07 155.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.373 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.502 ' O ' ' CB ' ' A' ' 18' ' ' SER . 17.3 mt-10 -134.41 96.99 3.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.233 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.618 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -29.92 147.71 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.647 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.615 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -136.87 -43.27 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.111 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.615 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.26 120.35 7.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.577 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.93 68.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.063 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.489 ' O ' HG22 ' A' ' 22' ' ' THR . . . 179.23 -165.74 34.76 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -86.13 58.1 4.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.386 0.612 . . . . 0.0 110.533 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.608 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.7 m . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.068 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.918 0.389 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.86 173.71 13.98 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.942 2.428 . . . . 0.0 112.277 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.27 62.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.421 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.554 ' CB ' ' HD3' ' A' ' 5' ' ' PRO . . . -172.18 -59.55 0.0 OUTLIER Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.364 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 4' ' ' ALA . 32.2 Cg_exo -58.48 178.63 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.51 2.14 . . . . 0.0 111.917 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 28' ' ' MET . 26.0 p -170.59 71.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.786 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 7' ' ' ILE . 57.4 mt -138.77 69.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.953 0.406 . . . . 0.0 111.484 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 13.8 m -86.45 -46.66 10.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.373 0.606 . . . . 0.0 109.978 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 t -172.82 163.58 5.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.38 22.26 8.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 1.0 OUTLIER -90.09 64.48 6.19 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.741 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' GLN . 10.0 t80 -21.04 83.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.848 0.717 . . . . 0.0 112.206 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -109.45 71.93 0.53 Allowed Pre-proline 0 CA--C 1.517 -0.32 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.567 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.9 Cg_endo -55.08 95.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.837 2.358 . . . . 0.0 112.593 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.538 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 3.6 m -97.06 129.75 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.637 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.538 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.15 118.95 20.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.346 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.21 142.67 15.78 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.004 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 2.4 t -46.47 94.48 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 113.986 -1.107 . . . . 0.0 110.215 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.482 ' HB2' HG23 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 168.28 -26.82 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.884 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.431 ' O ' HD13 ' A' ' 21' ' ' ILE . . . 103.85 33.58 4.04 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.279 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.566 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 42.2 mm -135.16 138.2 49.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.518 ' CG2' ' HB2' ' A' ' 14' ' ' PRO . 3.6 m -95.54 99.91 11.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.927 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.641 ' CD1' HD22 ' A' ' 29' ' ' LEU . 43.1 m-85 -84.46 123.57 30.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.13 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -40.22 -26.57 0.12 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.288 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.465 ' CG ' ' O ' ' A' ' 24' ' ' GLY . 80.9 m-20 -168.46 151.14 5.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.728 0.299 . . . . 0.0 111.571 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.35 -24.56 3.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.182 0.515 . . . . 0.0 110.014 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -81.24 -50.81 9.1 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.488 ' HA ' ' HB2' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -47.74 -35.36 9.71 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.359 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.641 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.44 -53.5 56.74 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.78 176.422 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' CYS . 13.3 mt -49.29 -33.81 13.92 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.302 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.449 ' O ' ' HD2' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -73.84 -31.39 63.17 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.08 -62.11 1.59 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.59 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.05 -30.97 0.81 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.79 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 4' ' ' ALA . . . -78.22 -25.27 46.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.244 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -143.02 38.08 1.43 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.258 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' ALA . 7.0 t -107.26 -79.04 0.58 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.672 0.272 . . . . 0.0 111.059 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 36' ' ' SER . 10.2 t70 179.23 -50.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.906 0.384 . . . . 0.0 110.9 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.443 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -135.85 167.53 21.62 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.063 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.443 ' HD2' ' CB ' ' A' ' 38' ' ' THR . 36.9 Cg_endo -65.36 88.8 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.803 2.335 . . . . 0.0 112.213 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.573 ' CD1' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -61.65 153.33 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.989 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 18' ' ' SER . 10.0 mt-10 -140.51 103.48 4.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.478 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.606 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -27.93 148.95 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.08 0.467 . . . . 0.0 111.852 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.647 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 12.6 p -141.59 -39.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.213 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.647 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.69 119.64 6.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.167 178.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 1.4 pttt -69.49 68.11 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 0.0 111.173 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.53 -170.75 42.87 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.4 mtp85 -81.64 56.68 3.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.165 0.507 . . . . 0.0 110.511 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.575 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 9.1 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.036 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.933 0.397 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.01 176.34 6.32 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.704 2.269 . . . . 0.0 112.429 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.421 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 7.4 p-10 179.75 51.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.068 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.536 ' HA ' ' CB ' ' A' ' 34' ' ' ALA . . . -161.27 -66.62 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.268 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' A' ' 4' ' ' ALA . 15.4 Cg_endo -57.64 147.98 76.45 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.47 2.113 . . . . 0.0 111.836 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 13.0 p -140.73 77.44 1.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.426 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.46 ' O ' HG21 ' A' ' 7' ' ' ILE . 2.7 mp -133.54 61.78 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.394 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 44.9 m -89.67 -34.7 16.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.416 0.627 . . . . 0.0 110.02 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.519 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -168.5 130.77 1.38 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.616 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.6 mmm -88.25 19.19 3.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.032 0.444 . . . . 0.0 110.191 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -93.89 -101.04 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.725 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.447 ' CD1' ' HD3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER 179.66 82.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 111.542 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -108.91 69.07 0.37 Allowed Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.7 Cg_endo -55.72 104.48 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.675 2.25 . . . . 0.0 112.74 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.49 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 34.8 m -108.42 133.64 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.773 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.567 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.76 121.6 24.97 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.696 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -108.19 140.9 15.66 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.285 -0.96 . . . . 0.0 112.858 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 44.8 m -48.71 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.156 -1.022 . . . . 0.0 110.692 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' HB2' HG23 ' A' ' 40' ' ' ILE . 0.2 OUTLIER 167.76 -26.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.813 -179.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.25 33.36 3.45 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.633 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.587 HG22 ' CE1' ' A' ' 23' ' ' TYR . 11.2 mm -136.61 136.75 48.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.739 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.0 101.8 13.58 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.07 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.67 ' CD1' HD23 ' A' ' 29' ' ' LEU . 45.2 m-85 -84.33 127.13 33.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.453 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.531 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -42.96 -29.95 0.93 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.833 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -160.23 144.12 14.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.943 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.94 -24.32 2.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.346 0.593 . . . . 0.0 110.293 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -80.47 -50.25 10.32 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.828 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.549 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 5.2 mtt -46.92 -33.83 4.94 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.67 HD23 ' CD1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -58.33 -55.3 36.78 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.056 176.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 27' ' ' CYS . 10.7 mt -48.75 -32.49 8.63 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.235 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -76.19 -32.15 58.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.991 178.119 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.91 -58.98 4.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.103 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.55 -34.41 17.47 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.154 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.536 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . . . -90.61 -4.97 56.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.331 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -100.81 -48.83 4.35 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.649 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 43.2 t -81.7 -98.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.433 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 36' ' ' SER . 16.3 t0 179.02 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.336 . . . . 0.0 111.255 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.5 132.93 60.57 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 121.046 0.45 . . . . 0.0 111.26 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.3 87.96 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.941 2.428 . . . . 0.0 112.452 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.569 ' CD1' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -71.71 155.9 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.731 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 18' ' ' SER . 0.6 OUTLIER -146.04 104.47 3.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.862 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.61 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -27.46 148.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.39 0.614 . . . . 0.0 112.181 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.644 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 1.9 t -137.46 -37.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.378 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.644 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -154.13 125.76 7.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.04 61.47 0.28 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.623 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.52 -162.27 27.85 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.409 ' O ' ' OXT' ' A' ' 48' ' ' CYS . 6.1 mtm180 -88.03 56.67 3.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.93 0.395 . . . . 0.0 110.478 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.577 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 5.5 m . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.029 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.86 0.362 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.8 -166.15 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.794 2.33 . . . . 0.0 112.214 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.4 t0 179.46 155.07 0.51 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.574 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . . . -128.11 95.57 33.61 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.961 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 4' ' ' ALA . 86.6 Cg_exo -46.08 -179.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.667 2.244 . . . . 0.0 112.176 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -107.15 45.61 0.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.035 0.445 . . . . 0.0 110.963 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.544 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 28.4 mm -151.44 63.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.612 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.86 -43.28 22.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.091 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.7 t -172.47 -172.15 0.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.192 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.497 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -112.61 17.79 18.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 13' ' ' ASP . 1.1 tp60 -69.1 60.41 0.11 Allowed 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.155 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.98 83.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.5 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -117.65 60.24 3.14 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.8 Cg_endo -57.2 94.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.732 2.288 . . . . 0.0 112.554 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.548 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 26.1 m -96.79 126.87 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.126 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.492 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -79.25 115.53 18.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.293 179.388 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -104.77 139.54 14.66 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.234 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 7.7 t -49.7 93.47 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.115 -1.042 . . . . 0.0 110.416 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 18' ' ' SER . 34.5 t0 171.37 -27.01 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.973 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.83 32.95 3.18 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.358 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.557 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 29.5 mm -136.87 133.53 48.17 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 46' ' ' GLY . 1.4 m -95.26 99.1 11.1 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.642 ' CD1' HD22 ' A' ' 29' ' ' LEU . 38.1 m-85 -79.99 124.02 28.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.097 -178.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.19 -26.89 0.06 OUTLIER Glycine 0 CA--C 1.507 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.394 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.54 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -173.45 150.47 1.83 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.002 0.429 . . . . 0.0 110.979 179.341 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.49 -25.15 1.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.464 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -74.3 -52.54 11.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.54 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -47.86 -40.93 22.85 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.146 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.642 HD22 ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -53.26 -54.09 41.32 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.29 177.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.574 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 13.5 mt -49.15 -33.44 12.08 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.564 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 4.2 t -76.67 -29.88 56.54 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.62 -55.83 15.47 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.295 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -18.8 62.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.587 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.02 -44.15 10.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -98.05 -7.02 30.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.091 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 44.6 t -86.33 -105.66 0.06 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.583 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 36' ' ' SER . 14.3 t0 177.54 -28.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.89 0.376 . . . . 0.0 110.568 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.35 139.1 20.44 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.044 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.16 89.06 1.07 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.795 2.33 . . . . 0.0 112.34 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.541 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -56.12 156.26 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.379 179.499 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 18' ' ' SER . 42.1 mt-10 -134.44 97.33 3.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 111.153 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.637 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -33.65 148.87 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.387 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.646 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 8.6 p -138.76 -38.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.053 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.646 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -149.44 120.38 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.156 178.26 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -70.47 63.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.454 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 22' ' ' THR . . . -177.28 -159.86 23.13 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -89.93 58.3 4.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.156 0.503 . . . . 0.0 110.486 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.615 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.9 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.146 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 15.4 mttp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.914 0.388 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.58 178.06 5.87 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.976 2.45 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -111.55 134.74 52.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.582 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.531 ' CB ' ' HD3' ' A' ' 5' ' ' PRO . . . -160.96 -63.9 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 111.558 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.531 ' HD3' ' CB ' ' A' ' 4' ' ' ALA . 82.1 Cg_exo -43.96 159.01 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.678 2.252 . . . . 0.0 112.405 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 26.1 p -163.18 72.65 0.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.523 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 44.8 mm -132.48 54.03 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.285 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 36.0 m -79.2 -37.9 37.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.162 0.506 . . . . 0.0 110.087 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -172.2 144.54 1.63 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.183 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.9 26.18 4.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -85.79 -102.55 0.06 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.102 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.487 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER 178.75 73.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.603 0.24 . . . . 0.0 111.048 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.45 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 0.4 OUTLIER -107.41 66.91 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 109.757 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 18.9 Cg_endo -60.34 94.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.62 2.213 . . . . 0.0 111.949 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.548 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 27.6 m -99.06 129.84 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.032 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.58 120.7 23.65 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.553 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -111.36 144.57 17.5 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.996 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -44.87 97.75 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.215 -0.993 . . . . 0.0 109.618 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.462 ' HB2' HG22 ' A' ' 40' ' ' ILE . 9.0 t0 165.14 -24.6 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.804 -1.543 . . . . 0.0 108.685 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.472 ' O ' HD13 ' A' ' 21' ' ' ILE . . . 100.54 27.45 7.59 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.52 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.598 ' CG2' ' CE1' ' A' ' 23' ' ' TYR . 1.5 mp -128.8 144.16 38.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.304 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.531 ' CG2' ' HB2' ' A' ' 14' ' ' PRO . 13.4 m -101.32 99.03 9.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.611 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.631 ' CD1' HD21 ' A' ' 29' ' ' LEU . 49.0 m-85 -80.15 123.37 27.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.287 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -37.45 -29.51 0.04 OUTLIER Glycine 0 CA--C 1.504 -0.648 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.239 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 23' ' ' TYR . 84.6 m-20 -165.14 147.95 8.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.795 0.331 . . . . 0.0 111.092 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.87 -25.75 2.06 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.309 0.576 . . . . 0.0 110.15 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -78.84 -51.49 9.66 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.428 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.47 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -45.13 -38.97 5.57 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 176.177 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.631 HD21 ' CD1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -54.11 -56.62 16.34 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 113.242 -1.799 . . . . 0.0 109.78 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 4.5 mt -47.12 -34.08 5.7 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.286 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 28' ' ' MET . 1.2 m -75.27 -33.58 61.28 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.137 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -64.66 -55.45 20.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.267 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.413 ' N ' HD12 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -52.23 -32.58 37.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.499 179.392 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.512 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . . . -82.76 -15.51 51.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.288 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 9.6 ptm180 -109.75 -18.28 13.48 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.7 t -83.94 -98.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 111.455 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.8 t70 179.26 -31.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 0.0 110.84 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.408 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 13.9 t -114.03 145.13 32.93 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 51.1 Cg_endo -69.81 80.93 0.86 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.755 2.303 . . . . 0.0 112.769 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.565 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -44.27 157.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.239 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 42' ' ' LEU . 27.2 mt-10 -140.62 102.92 4.42 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.828 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.565 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -28.95 149.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.191 0.519 . . . . 0.0 111.857 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.655 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.8 t -141.01 -38.54 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.092 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.655 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.51 122.36 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.47 179.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -71.5 61.96 0.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.223 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' O ' HG22 ' A' ' 22' ' ' THR . . . -176.05 -160.15 23.0 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.46 ' HA ' HG22 ' A' ' 22' ' ' THR . 9.0 mtp85 -90.26 56.92 3.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.395 . . . . 0.0 110.67 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.569 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.9 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.138 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 1' ' ' LYS . 16.2 tttt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.973 0.416 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.32 -167.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.77 2.313 . . . . 0.0 112.507 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.67 134.86 32.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.655 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.538 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . . . -129.25 115.47 18.61 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.432 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.426 ' C ' ' HB2' ' A' ' 31' ' ' CYS . 50.6 Cg_exo -53.18 -164.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.646 2.23 . . . . 0.0 111.969 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.455 ' CA ' ' HB2' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -116.57 50.68 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.589 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.471 HG21 HD12 ' A' ' 7' ' ' ILE . 12.7 mt -148.88 86.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.946 0.403 . . . . 0.0 111.321 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -112.86 -37.51 4.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.838 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -171.78 175.71 3.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.287 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.2 mtm -113.63 17.79 17.98 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -75.02 58.95 0.9 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.0 179.509 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 11' ' ' GLN . 29.6 t80 -19.37 82.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.436 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -114.27 63.86 1.31 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.0 Cg_endo -53.45 96.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.952 2.435 . . . . 0.0 112.594 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.556 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 28.5 m -98.66 126.33 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.487 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.548 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.31 120.44 23.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.02 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 41' ' ' GLU . . . -108.12 144.77 16.21 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.858 -178.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -48.23 93.73 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.066 -1.067 . . . . 0.0 110.364 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.7 t70 167.99 -24.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.241 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.0 32.43 5.0 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.023 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.587 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 26.6 mm -132.82 136.51 55.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.564 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -97.04 101.88 13.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.798 178.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.622 ' CD1' HD21 ' A' ' 29' ' ' LEU . 30.8 m-85 -85.77 121.11 27.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.989 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -40.73 -27.15 0.16 Allowed Glycine 0 CA--C 1.506 -0.523 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.053 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 83.9 m-20 -164.63 145.42 7.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.741 0.305 . . . . 0.0 111.079 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -48.06 -26.8 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.166 0.508 . . . . 0.0 109.891 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -77.18 -51.4 11.03 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.494 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.435 ' HE2' ' HA3' ' A' ' 24' ' ' GLY . 0.6 OUTLIER -46.63 -37.17 7.81 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 176.09 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.622 HD21 ' CD1' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -54.95 -54.5 42.04 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.263 176.408 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.538 ' HB3' ' CB ' ' A' ' 4' ' ' ALA . 12.3 mt -47.5 -32.57 5.36 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.67 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 35' ' ' ARG . 5.8 t -78.43 -32.26 48.51 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -63.95 -58.72 5.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.576 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.425 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -55.95 -25.97 45.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.488 179.048 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.2 -34.04 61.46 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -129.83 27.3 5.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 43.5 t -92.74 -94.95 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.632 0.253 . . . . 0.0 111.323 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.79 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.935 0.397 . . . . 0.0 110.541 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.419 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 7.9 t -138.41 147.16 54.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.721 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.419 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 16.4 Cg_endo -57.74 93.27 0.06 OUTLIER 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.841 2.361 . . . . 0.0 112.393 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.577 ' CG1' ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -79.45 126.85 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.98 0.419 . . . . 0.0 111.075 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.582 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 2.6 mm-40 -97.36 -156.9 0.56 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.073 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.602 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -120.97 149.45 42.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.515 178.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.649 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.4 t -138.36 -36.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.921 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.649 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -157.35 122.13 4.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.815 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -71.2 65.88 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.139 -179.62 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 22' ' ' THR . . . -179.22 -162.25 28.14 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.451 ' HA ' ' CG2' ' A' ' 22' ' ' THR . 4.2 mtt180 -87.27 57.64 4.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.944 0.402 . . . . 0.0 110.545 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.607 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 10.9 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.11 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.902 0.382 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.55 -173.68 1.23 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.717 2.278 . . . . 0.0 112.333 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.66 158.23 44.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.609 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -142.24 151.15 57.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.006 0.431 . . . . 0.0 111.567 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.42 -163.64 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.914 2.409 . . . . 0.0 112.081 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.446 ' CA ' ' HB2' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -119.15 50.02 1.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 111.271 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 13.5 mm -146.96 80.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -104.13 -38.06 7.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.456 0.646 . . . . 0.0 109.972 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.505 ' OG1' ' N ' ' A' ' 10' ' ' MET . 6.2 t -171.96 -163.0 0.23 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.112 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.505 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.9 OUTLIER -128.05 16.69 6.74 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.486 178.101 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 2.4 mt-30 -71.53 58.94 0.29 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.906 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.514 ' CD1' ' HD3' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -25.99 87.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.942 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.4 OUTLIER -121.86 71.29 30.05 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.802 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.0 Cg_endo -55.62 95.95 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.843 2.362 . . . . 0.0 112.545 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.545 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 4.4 m -96.74 126.83 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.485 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.525 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.23 118.86 20.85 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.211 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.56 143.16 15.65 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.983 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 40.4 t -50.98 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.253 -0.974 . . . . 0.0 110.17 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.485 ' HB2' HG21 ' A' ' 40' ' ' ILE . 12.7 t0 171.65 -27.69 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.616 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.85 31.06 3.75 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.39 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.574 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 23.0 mm -136.91 139.91 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 119.753 -0.779 . . . . 0.0 113.011 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 46' ' ' GLY . 3.9 m -98.42 102.64 14.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.879 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.63 ' CD1' HD23 ' A' ' 29' ' ' LEU . 37.3 m-85 -84.94 123.96 31.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.887 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -41.25 -25.99 0.17 Allowed Glycine 0 CA--C 1.505 -0.534 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.127 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.8 m-20 -164.91 145.91 7.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.912 0.387 . . . . 0.0 111.454 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.41 -27.46 4.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.347 0.594 . . . . 0.0 109.554 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -78.1 -49.09 14.6 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -47.8 -37.92 14.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 175.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.63 HD23 ' CD1' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -54.96 -52.77 62.01 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 112.908 -1.951 . . . . 0.0 109.168 176.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 13.2 mt -48.07 -33.35 7.98 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 28' ' ' MET . 24.9 t -75.09 -32.89 61.56 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.1 -57.71 7.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.481 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.97 -23.01 29.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.145 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 30' ' ' LEU . . . -85.83 -17.6 35.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.377 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -133.44 18.11 3.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.2 t -100.72 -97.57 0.26 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.334 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 56.5 t0 179.52 -32.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 0.0 110.643 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.405 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 1.4 t -126.97 149.5 69.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.801 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.405 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 53.2 Cg_endo -70.03 87.22 0.59 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.613 2.209 . . . . 0.0 112.205 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.555 ' CD1' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -49.88 149.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.427 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 18' ' ' SER . 31.5 mt-10 -130.68 101.88 5.87 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.101 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.6 ' CD2' ' CD1' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -28.32 146.54 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.223 0.535 . . . . 0.0 111.517 -179.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.617 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -132.58 -46.85 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.221 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.618 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -150.45 123.8 8.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.394 179.671 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -70.25 68.58 0.34 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.201 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 22' ' ' THR . . . 178.42 -158.92 23.9 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 57.36 3.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.165 0.507 . . . . 0.0 110.176 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.618 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 7.0 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.918 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.585 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.964 0.412 . . . . 0.0 111.168 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 1' ' ' LYS . 61.1 Cg_endo -73.17 -167.04 0.33 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.785 2.323 . . . . 0.0 112.523 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.437 ' HA ' ' CB ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -34.48 134.03 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.637 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.68 110.24 52.51 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.724 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -38.17 120.26 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.8 2.334 . . . . 0.0 112.553 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 4.2 p -84.7 77.36 10.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.159 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.454 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 8.3 mm -130.36 52.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.508 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 46.0 m -79.53 -35.73 39.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.355 0.598 . . . . 0.0 109.842 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.466 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -170.36 138.41 1.56 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.627 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.7 mtt -94.84 20.65 8.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.902 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 2.8 mm-40 -84.62 -99.75 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.245 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 11' ' ' GLN . 7.9 t80 178.18 79.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.528 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.06 64.38 0.48 Allowed Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.1 Cg_endo -56.63 92.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.65 2.233 . . . . 0.0 112.198 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.55 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 19.6 m -95.09 126.43 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.516 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.572 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -77.85 117.4 19.18 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.264 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.42 141.11 15.14 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.513 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 38.1 m -48.86 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.21 -0.995 . . . . 0.0 110.359 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.457 ' HB2' HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 169.07 -25.93 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.142 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.72 30.74 4.47 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.337 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 9.7 mm -131.77 138.91 51.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.667 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.465 HG21 ' HB2' ' A' ' 14' ' ' PRO . 3.1 m -99.76 99.48 10.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.729 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.654 ' CD1' HD21 ' A' ' 29' ' ' LEU . 33.1 m-85 -83.69 122.89 29.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.721 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -42.28 -24.15 0.19 Allowed Glycine 0 CA--C 1.505 -0.579 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.134 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.595 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -169.83 146.68 3.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.754 0.312 . . . . 0.0 111.108 -179.328 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -47.19 -25.54 0.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.292 0.568 . . . . 0.0 110.263 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -76.95 -54.77 6.14 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.817 178.651 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.548 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 36.4 mtp -45.53 -33.3 2.66 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.654 HD21 ' CD1' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -59.42 -54.36 47.53 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.469 -1.696 . . . . 0.0 108.892 177.315 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' CYS . 11.8 mt -49.07 -29.43 5.11 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.556 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 28' ' ' MET . 1.4 m -79.64 -31.12 41.52 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -68.93 -58.75 3.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.157 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.433 ' CB ' HD13 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -55.46 -33.02 63.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.268 179.262 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 3' ' ' ASP . . . -90.44 -3.12 57.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.333 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 4.5 mtp180 -96.56 -51.09 4.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.942 0.401 . . . . 0.0 111.024 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.7 t -86.82 -99.15 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.437 ' O ' ' HD3' ' A' ' 39' ' ' PRO . 6.5 p30 178.92 -26.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.411 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -79.15 111.45 20.33 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.928 0.394 . . . . 0.0 111.121 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 33.5 Cg_exo -57.82 93.75 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.844 2.362 . . . . 0.0 112.486 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.539 HG13 ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -69.54 157.49 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.767 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 18' ' ' SER . 36.9 mt-10 -140.95 103.46 4.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.049 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.572 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 0.3 OUTLIER -28.24 147.09 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.169 0.509 . . . . 0.0 111.315 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.64 ' CG2' ' CE1' ' A' ' 44' ' ' HIS . 13.6 p -139.39 -38.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.495 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.64 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.78 123.29 7.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.529 178.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 64.75 0.41 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.294 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.37 -160.31 24.89 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -90.12 54.22 2.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.972 0.415 . . . . 0.0 110.664 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.597 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 4.9 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.056 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -42.03 138.81 2.73 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.601 2.2 . . . . 0.0 111.801 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 1.3 p -93.23 56.03 2.42 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.257 0.551 . . . . 0.0 111.532 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.811 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.6 mp -132.05 57.15 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.582 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -78.9 -41.16 30.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.101 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.481 ' OG1' ' N ' ' A' ' 10' ' ' MET . 6.4 t -173.65 -165.88 0.28 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.395 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.481 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -124.1 17.59 9.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.035 177.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -73.08 58.76 0.5 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.993 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.471 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 9.0 t80 -25.18 84.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.292 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.701 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -114.91 64.67 1.63 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.473 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -51.74 97.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.034 2.489 . . . . 0.0 112.331 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.963 ' HB ' HD11 ' A' ' 42' ' ' LEU . 27.8 m -99.49 127.38 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.524 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.425 ' HB3' ' ND1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.26 121.47 24.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.0 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -113.52 142.41 17.44 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.161 -1.019 . . . . 0.0 113.184 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 45.0 t -40.1 98.01 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.333 -0.933 . . . . 0.0 109.771 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' SER . 1.7 t0 160.19 -22.71 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.985 -1.462 . . . . 0.0 108.748 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.688 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 94.23 25.08 17.43 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.988 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 20' ' ' GLY . 0.9 OUTLIER -118.45 124.56 73.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.861 -179.252 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.55 HG22 ' HB2' ' A' ' 14' ' ' PRO . 3.1 m -86.36 98.18 10.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.494 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.809 ' OH ' HG21 ' A' ' 40' ' ' ILE . 52.3 m-85 -79.47 123.81 27.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.017 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -37.49 -27.84 0.03 OUTLIER Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.533 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.7 p30 -174.33 155.54 2.37 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.934 0.397 . . . . 0.0 110.996 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -48.47 -23.03 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.928 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.584 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 26.1 m -83.6 -46.77 12.0 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.526 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -48.62 -36.17 15.24 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 175.415 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.991 HD11 HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -55.93 -50.18 71.45 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 112.933 -1.939 . . . . 0.0 108.837 177.29 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.584 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 11.7 mt -48.27 -30.56 4.91 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.746 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -73.19 -35.74 66.42 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.61 -57.85 5.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.309 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -61.34 -16.88 50.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.365 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.85 -38.19 13.11 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -149.64 42.66 0.9 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.736 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 31.0 t -96.09 -81.52 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.897 0.379 . . . . 0.0 110.978 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -175.39 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.242 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.804 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -144.97 154.18 54.53 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.253 179.452 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.804 ' HD2' HG22 ' A' ' 38' ' ' THR . 38.0 Cg_endo -66.54 81.27 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.586 2.19 . . . . 0.0 112.507 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.809 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -54.5 169.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.219 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 42' ' ' LEU . 19.5 mt-10 -148.68 100.9 3.16 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.89 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.991 HD23 HD11 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -31.02 148.65 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 111.227 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.433 HG12 ' CD2' ' A' ' 44' ' ' HIS . 2.7 t -144.98 -37.24 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.033 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.51 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -148.97 120.35 7.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.0 110.858 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.6 mttp -70.19 66.5 0.29 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.27 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 22' ' ' THR . . . 179.67 -160.26 25.35 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -90.12 55.14 3.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.904 0.383 . . . . 0.0 110.442 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.51 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 7.1 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.283 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.921 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 120.688 0.28 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.902 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 35.7 Cg_exo -59.32 170.44 3.12 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.582 2.188 . . . . 0.0 112.026 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.4 p -165.77 72.64 0.17 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.441 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.795 HG22 ' O ' ' A' ' 7' ' ' ILE . 26.8 mt -137.67 63.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 0.0 111.719 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 26.8 m -87.09 -40.14 14.94 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.411 0.624 . . . . 0.0 109.367 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 t -172.47 143.91 1.44 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.712 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.18 26.04 3.95 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 47.8 mt-30 -84.11 -103.45 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.322 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.446 ' O ' ' CD ' ' A' ' 14' ' ' PRO . 2.4 t80 179.69 71.9 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.491 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER -106.98 71.07 0.27 Allowed Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 27.6 Cg_endo -61.97 101.49 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.654 2.236 . . . . 0.0 112.842 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.006 ' HB ' HD11 ' A' ' 42' ' ' LEU . 35.1 m -105.9 127.89 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.278 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.507 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.81 123.09 26.3 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.218 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -111.49 144.18 17.47 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.826 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.541 ' HB3' ' CG ' ' A' ' 41' ' ' GLU . 16.9 t -45.07 96.91 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.35 -0.925 . . . . 0.0 110.07 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.578 ' HB2' HG22 ' A' ' 40' ' ' ILE . 4.9 t0 163.76 -23.01 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.929 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.659 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 98.33 24.13 11.75 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.324 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.661 HG21 ' CE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -119.42 135.03 61.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.911 -179.015 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.449 ' CG2' ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -94.41 99.63 11.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.563 178.403 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.833 ' CE2' HD21 ' A' ' 29' ' ' LEU . 51.6 m-85 -82.64 122.56 28.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.055 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.476 ' HA3' ' CE ' ' A' ' 28' ' ' MET . . . -41.13 -27.22 0.21 Allowed Glycine 0 CA--C 1.507 -0.468 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.218 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.8 m-20 -164.47 146.32 8.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.74 0.305 . . . . 0.0 110.803 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.69 -25.14 2.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.227 0.537 . . . . 0.0 110.358 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -77.81 -50.55 12.1 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.28 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.476 ' CE ' ' HA3' ' A' ' 24' ' ' GLY . 2.8 mmm -45.99 -40.4 10.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.882 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -52.69 -55.94 19.07 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 113.445 -1.707 . . . . 0.0 109.775 176.284 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 13.8 mt -48.58 -32.57 8.29 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.4 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -75.75 -31.72 59.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.632 ' HB3' HD11 ' A' ' 40' ' ' ILE . . . -66.69 -59.23 3.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.951 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.473 ' OG ' HG12 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -52.29 -28.7 19.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.414 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.921 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . . . -70.16 -37.73 75.27 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -135.95 35.69 2.84 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 46.9 t -90.86 -95.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.691 0.281 . . . . 0.0 111.516 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -179.7 -35.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.124 0.488 . . . . 0.0 110.109 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.642 HG23 ' HD2' ' A' ' 39' ' ' PRO . 55.1 m -136.53 142.91 41.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.207 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.642 ' HD2' HG23 ' A' ' 38' ' ' THR . 10.5 Cg_endo -53.52 92.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.906 2.404 . . . . 0.0 112.928 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.632 HD11 ' HB3' ' A' ' 32' ' ' ALA . 0.9 OUTLIER -78.57 148.34 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.139 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.541 ' CG ' ' HB3' ' A' ' 18' ' ' SER . 10.3 pt-20 -152.31 116.78 5.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.262 0.553 . . . . 0.0 111.123 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.006 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -21.61 145.25 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.794 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -136.4 -42.18 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.469 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.536 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -150.96 125.97 9.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.206 178.914 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -70.75 65.72 0.33 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.223 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.59 -160.61 27.37 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.449 ' HA ' ' CG2' ' A' ' 22' ' ' THR . 2.9 mtp180 -90.28 54.15 2.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.161 0.505 . . . . 0.0 110.845 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.536 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 4.2 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.215 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.912 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.812 0.339 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.912 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 81.3 Cg_exo -43.61 135.92 6.71 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.611 2.207 . . . . 0.0 112.01 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 7.9 p -132.97 79.88 1.86 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.037 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.762 HG22 ' O ' ' A' ' 7' ' ' ILE . 5.4 mp -133.93 52.47 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 55.3 m -84.39 -34.16 23.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.482 0.658 . . . . 0.0 109.627 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.658 HG23 ' ND2' ' A' ' 25' ' ' ASN . 2.4 t -171.25 136.22 1.03 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.078 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.2 mtt -93.81 24.71 3.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.476 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.9 -100.66 0.17 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.366 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.509 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 1.5 t80 179.54 76.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.61 0.243 . . . . 0.0 110.977 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.528 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.5 69.94 0.29 Allowed Pre-proline 0 CA--C 1.516 -0.332 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.697 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.4 Cg_endo -56.31 102.64 0.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.779 2.319 . . . . 0.0 112.805 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.016 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.9 m -106.76 133.81 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.508 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -78.29 119.99 22.43 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.893 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -106.01 140.92 15.33 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.43 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 48.5 t -48.28 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.245 -0.978 . . . . 0.0 110.414 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.521 ' HB2' HG22 ' A' ' 40' ' ' ILE . 7.1 t0 171.68 -30.52 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.563 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.48 33.76 2.23 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.587 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.1 mt -135.49 154.39 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 14' ' ' PRO . 2.5 m -109.66 99.25 8.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.373 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.88 ' CE2' HD21 ' A' ' 29' ' ' LEU . 53.9 m-85 -83.89 129.28 34.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.321 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.445 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -41.35 -27.15 0.25 Allowed Glycine 0 CA--C 1.504 -0.652 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.328 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.658 ' ND2' HG23 ' A' ' 9' ' ' THR . 81.6 m-20 -166.66 146.05 5.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.792 0.33 . . . . 0.0 111.149 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.02 -25.44 3.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.396 0.617 . . . . 0.0 109.868 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 1.1 m -79.89 -49.6 11.68 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.85 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 27' ' ' CYS . 7.6 mmm -47.04 -37.65 9.74 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.062 HD12 HD23 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -55.69 -56.99 13.94 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.258 -1.792 . . . . 0.0 109.498 176.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 27' ' ' CYS . 12.4 mt -48.24 -32.94 7.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.559 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -76.46 -32.11 58.2 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.49 -56.75 10.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.256 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.634 ' OG ' HD11 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -51.11 -36.31 39.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.033 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.69 -0.34 57.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.042 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 24.3 mtp180 -111.81 -38.86 4.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.6 t -85.36 -108.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.561 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p30 179.5 33.0 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.782 0.325 . . . . 0.0 110.944 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 m -146.79 134.12 10.23 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.795 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.71 83.98 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.814 2.343 . . . . 0.0 112.865 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.705 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -70.01 154.49 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.632 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.484 ' O ' ' O ' ' A' ' 42' ' ' LEU . 13.1 mt-10 -143.04 101.83 3.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.09 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.062 HD23 HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -29.46 150.81 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.032 0.444 . . . . 0.0 111.632 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.443 ' HB ' ' CD2' ' A' ' 44' ' ' HIS . 1.4 t -144.6 -41.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.185 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.525 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -153.21 121.21 6.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.805 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.29 70.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.374 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.35 -164.88 34.94 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.3 56.35 3.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.104 0.478 . . . . 0.0 110.41 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.525 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 20.9 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.173 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.796 ' HB1' ' CB ' ' A' ' 34' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.433 0 CA-C-O 120.516 0.198 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.652 ' CD ' ' HB3' ' A' ' 4' ' ' ALA . 96.4 Cg_exo -26.75 141.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.119 2.546 . . . . 0.0 112.104 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -92.91 52.87 1.9 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.003 0.43 . . . . 0.0 111.122 -179.27 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.7 mm -145.92 90.75 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.782 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.01 -38.68 3.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.36 0.6 . . . . 0.0 109.894 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 11' ' ' GLN . 10.0 t -172.5 -162.9 0.2 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.268 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.463 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -129.09 16.48 6.18 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.501 177.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -74.03 60.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.995 179.371 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.56 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 8.4 t80 -20.32 84.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.487 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.658 ' O ' HG13 ' A' ' 15' ' ' VAL . 20.5 t0 -114.47 59.29 1.0 Allowed Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.2 Cg_endo -54.28 96.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.754 2.303 . . . . 0.0 112.223 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.976 ' HB ' HD11 ' A' ' 42' ' ' LEU . 33.8 m -98.22 127.66 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.814 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.61 116.45 18.99 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.322 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.697 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.92 138.01 13.83 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.681 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 13.3 t -46.62 96.05 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.246 -0.977 . . . . 0.0 110.495 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 165.46 -23.53 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.235 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.77 32.97 4.88 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.318 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 36.3 mm -130.28 130.71 65.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.362 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.18 99.59 11.82 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.605 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.76 ' CE2' HD21 ' A' ' 29' ' ' LEU . 39.4 m-85 -83.03 121.8 27.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.824 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -36.28 -29.38 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.327 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.523 ' OD1' ' HG3' ' A' ' 28' ' ' MET . 2.1 p30 -173.37 154.82 2.71 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.098 0.475 . . . . 0.0 111.067 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.8 -23.53 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.807 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.518 ' HA ' HD12 ' A' ' 30' ' ' LEU . 1.2 m -78.48 -51.98 9.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.523 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 1.2 mtt -46.32 -42.1 14.24 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.931 HD11 HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -52.46 -54.27 34.5 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.384 -1.735 . . . . 0.0 109.556 177.218 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 27' ' ' CYS . 7.5 mt -48.22 -31.83 6.33 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.527 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.537 ' CA ' ' O ' ' A' ' 4' ' ' ALA . 7.3 t -76.76 -31.78 57.31 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.209 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -64.03 -58.65 6.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.349 178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.579 ' HB2' HD11 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -63.98 -15.71 59.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.206 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.796 ' CB ' ' HB1' ' A' ' 4' ' ' ALA . . . -90.05 -26.28 20.37 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HD2' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -131.23 18.95 4.89 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 10.2 t -105.62 -119.7 0.23 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p30 179.4 24.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.0 m -161.75 112.54 1.2 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.63 0.252 . . . . 0.0 110.523 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.1 94.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.603 2.202 . . . . 0.0 112.225 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.721 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -63.53 153.36 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.401 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 18' ' ' SER . 10.9 mt-10 -132.82 92.75 3.09 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.084 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.976 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -32.81 148.7 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.258 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.428 ' HB ' ' CD2' ' A' ' 44' ' ' HIS . 2.5 t -142.5 -38.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.646 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.519 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -150.29 117.75 6.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.471 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.23 65.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.641 -179.302 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.55 -163.21 29.49 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -85.59 59.02 5.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.084 0.468 . . . . 0.0 110.497 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.519 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 17.5 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.972 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.808 ' HB3' ' CD ' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 120.674 0.274 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.808 ' CD ' ' HB3' ' A' ' 4' ' ' ALA . 59.9 Cg_exo -27.38 144.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.309 2.673 . . . . 0.0 112.473 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.411 ' O ' HG12 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -102.01 54.05 0.8 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.97 0.414 . . . . 0.0 111.567 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 7' ' ' ILE . 3.6 mm -146.49 78.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.644 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -103.14 -39.34 6.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.325 0.583 . . . . 0.0 110.29 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.582 HG23 ' H ' ' A' ' 11' ' ' GLN . 9.8 t -173.19 -160.93 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.761 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.506 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -128.5 17.88 6.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.367 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.582 ' H ' HG23 ' A' ' 9' ' ' THR . 0.1 OUTLIER -72.29 58.87 0.39 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.345 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -26.65 85.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.147 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.69 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -121.61 67.25 20.39 Favored Pre-proline 0 N--CA 1.454 -0.241 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.0 Cg_endo -53.0 95.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.897 2.398 . . . . 0.0 112.57 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.961 ' HB ' HD11 ' A' ' 42' ' ' LEU . 25.5 m -95.94 126.91 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.8 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -78.69 118.43 20.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.744 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -108.55 145.34 16.4 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.688 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 10.6 p -48.32 97.15 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.501 -0.849 . . . . 0.0 109.991 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.535 ' HB2' HG22 ' A' ' 40' ' ' ILE . 7.6 t70 168.84 -25.83 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.853 -1.521 . . . . 0.0 108.695 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.42 30.65 5.83 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.603 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -127.53 146.29 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.569 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.543 HG22 ' HB2' ' A' ' 14' ' ' PRO . 6.2 m -107.39 97.81 7.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.501 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.854 ' CE2' HD21 ' A' ' 29' ' ' LEU . 36.7 m-85 -81.74 123.1 28.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.403 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.46 ' H ' ' HE3' ' A' ' 28' ' ' MET . . . -39.9 -26.52 0.1 OUTLIER Glycine 0 CA--C 1.508 -0.406 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.319 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.545 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -171.82 149.21 2.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.003 0.43 . . . . 0.0 110.684 179.132 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.91 -24.55 0.62 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.834 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.615 ' HA ' HD12 ' A' ' 30' ' ' LEU . 1.6 m -77.74 -50.78 11.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.196 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.545 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -46.79 -37.66 8.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.854 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.41 -52.66 63.81 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.987 -1.915 . . . . 0.0 109.246 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.621 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 5.5 mt -49.6 -32.12 12.15 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.6 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.531 ' CA ' ' O ' ' A' ' 4' ' ' ALA . 7.7 t -75.9 -29.3 58.39 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -69.5 -62.3 1.44 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.905 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.14 -13.51 27.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.446 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 30' ' ' LEU . . . -82.97 -29.75 28.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.302 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.429 ' CD ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -144.38 29.49 1.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.352 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 47.4 t -92.1 -97.04 0.13 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.618 0.247 . . . . 0.0 110.913 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 179.72 -32.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 0.0 110.731 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 9.2 m -127.53 133.06 24.68 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.939 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 35.0 Cg_exo -60.51 90.11 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.759 2.306 . . . . 0.0 112.579 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.627 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -63.9 163.02 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.543 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 18' ' ' SER . 1.5 mt-10 -149.86 107.13 3.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.809 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.961 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -29.27 148.92 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.08 0.466 . . . . 0.0 111.577 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.62 HG12 ' CD2' ' A' ' 44' ' ' HIS . 2.8 t -142.65 -39.2 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.416 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.62 ' CD2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -153.86 121.06 5.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.523 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -69.27 68.3 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.106 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.3 -171.12 44.12 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.41 57.36 2.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.084 0.468 . . . . 0.0 110.504 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.526 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 21.1 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.052 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.565 ' O ' ' CB ' ' A' ' 31' ' ' CYS . . . . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 4' ' ' ALA . 33.5 Cg_exo -29.91 126.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.747 2.298 . . . . 0.0 112.158 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.444 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -93.12 44.97 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 110.988 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.815 HG22 ' O ' ' A' ' 7' ' ' ILE . 31.5 mt -152.61 63.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.7 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -80.95 -41.6 22.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.916 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 t -172.02 162.23 5.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.88 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -92.47 18.66 8.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 2.1 tt0 -72.02 58.53 0.35 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.165 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.509 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -21.52 82.96 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.36 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.762 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -112.76 62.64 0.72 Allowed Pre-proline 0 N--CA 1.452 -0.341 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.4 Cg_endo -55.58 93.89 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.815 2.343 . . . . 0.0 112.455 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.006 ' HB ' HD11 ' A' ' 42' ' ' LEU . 5.7 m -97.29 125.92 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.719 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.403 ' HB3' ' ND1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.55 117.23 19.54 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.749 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.647 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -106.16 143.56 15.75 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.298 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 4.2 t -49.27 95.06 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.301 -0.95 . . . . 0.0 110.001 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.7 -25.68 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.954 -1.476 . . . . 0.0 109.006 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.3 34.04 3.77 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.377 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.6 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 27.4 mm -137.19 136.19 47.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 14' ' ' PRO . 2.9 m -96.73 97.9 9.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.232 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.82 ' CE2' HD21 ' A' ' 29' ' ' LEU . 41.3 m-85 -80.07 126.37 30.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.299 -178.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.22 -25.51 0.05 OUTLIER Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.505 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 0.9 OUTLIER -176.41 150.27 0.88 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.2 -25.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.567 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -76.45 -52.86 9.01 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.535 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -44.77 -41.25 6.74 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.124 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.82 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -53.93 -54.37 39.79 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 112.986 -1.916 . . . . 0.0 109.411 177.482 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 13.0 mt -48.88 -33.84 11.47 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.156 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -74.85 -32.62 61.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -62.63 -57.18 11.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.627 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -17.54 56.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.169 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.39 -15.38 35.68 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -136.03 1.45 2.73 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -89.04 -99.15 0.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.546 0.213 . . . . 0.0 111.038 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 178.77 -31.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.36 . . . . 0.0 110.953 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.871 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -117.4 151.33 47.94 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.114 0.483 . . . . 0.0 111.42 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.871 ' HD2' HG22 ' A' ' 38' ' ' THR . 97.5 Cg_endo -80.13 86.51 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.997 2.465 . . . . 0.0 112.029 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.717 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.47 155.22 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.77 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 18' ' ' SER . 20.9 mt-10 -135.0 96.84 3.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.746 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.006 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -29.26 147.41 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.224 0.535 . . . . 0.0 111.439 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.435 ' HB ' ' CD2' ' A' ' 44' ' ' HIS . 1.7 t -135.46 -41.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.295 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.543 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -153.35 121.24 6.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.58 -179.645 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -70.27 67.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.0 0.429 . . . . 0.0 111.148 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 22' ' ' THR . . . 179.05 -165.27 34.09 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.76 57.36 4.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.033 0.444 . . . . 0.0 110.649 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 8.8 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.938 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.772 0.32 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.938 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 51.9 Cg_exo -53.7 178.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.511 2.14 . . . . 0.0 111.575 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.78 ' C ' HD12 ' A' ' 7' ' ' ILE . 26.2 p -170.47 76.33 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.657 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.786 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.8 mp -131.68 57.56 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.36 . . . . 0.0 111.667 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 57.6 m -83.08 -38.38 22.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.316 0.579 . . . . 0.0 110.099 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 11' ' ' GLN . 1.8 t -171.61 139.92 1.29 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.432 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.34 25.91 4.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.469 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 55.2 mt-30 -91.68 -100.79 0.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.647 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.521 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 179.83 77.55 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.117 -179.465 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.56 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -111.22 65.07 0.53 Allowed Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.666 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 12.9 Cg_endo -56.29 98.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.032 2.488 . . . . 0.0 112.77 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.998 ' HB ' HD11 ' A' ' 42' ' ' LEU . 24.8 m -99.25 130.2 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.779 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.409 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.65 117.69 20.04 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.262 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -109.38 140.93 15.9 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.966 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 2.5 m -42.3 96.97 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.275 -0.963 . . . . 0.0 109.635 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 18' ' ' SER . 7.3 t0 163.34 -22.87 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.913 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.675 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 96.52 23.48 16.17 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.675 HD12 ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -119.05 131.97 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.923 -179.105 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 14' ' ' PRO . 1.6 m -92.77 98.2 11.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.418 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.838 ' CE2' HD21 ' A' ' 29' ' ' LEU . 47.3 m-85 -81.03 123.89 28.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.322 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -37.49 -30.47 0.06 OUTLIER Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.15 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' HB2' ' HG3' ' A' ' 28' ' ' MET . 83.8 m-20 -165.34 147.85 7.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.361 -0.419 . . . . 0.0 111.073 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.27 -25.74 2.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.298 0.571 . . . . 0.0 110.009 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -77.19 -51.94 10.11 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.534 178.507 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.471 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 2.0 mtt -44.69 -39.78 5.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 176.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.844 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -56.24 -54.61 43.24 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.686 176.405 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 27' ' ' CYS . 4.1 mt -47.68 -35.11 9.03 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.212 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -74.42 -33.28 62.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.022 178.203 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -63.12 -55.52 24.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.293 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.658 ' OG ' HD11 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -51.8 -35.08 42.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.44 179.486 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.652 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . . . -90.71 -2.49 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.493 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -120.66 -18.77 7.64 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.328 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.2 t -89.83 -98.67 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.456 0.169 . . . . 0.0 111.229 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 38' ' ' THR . 28.8 p30 179.11 -30.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.729 0.3 . . . . 0.0 111.058 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.515 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 3.3 t -107.88 137.18 19.71 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 0.0 110.767 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.74 89.47 0.99 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.74 2.293 . . . . 0.0 112.72 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.677 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -53.96 169.63 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.414 179.154 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 18' ' ' SER . 18.4 mt-10 -147.06 98.3 3.01 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.061 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.998 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -29.13 148.04 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.1 0.476 . . . . 0.0 111.212 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.515 ' HB ' ' CD2' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -138.33 -40.31 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.49 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.542 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -154.41 121.59 5.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.563 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -69.64 67.0 0.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.382 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.18 -161.74 28.12 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.2 56.45 3.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.114 0.483 . . . . 0.0 110.522 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.542 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 6.6 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.096 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.782 0.325 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 4' ' ' ALA . 83.8 Cg_exo -47.0 -176.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.639 2.226 . . . . 0.0 112.155 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.704 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -108.47 50.53 0.77 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.042 0.449 . . . . 0.0 111.301 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.704 HD12 ' C ' ' A' ' 6' ' ' CYS . 4.8 mp -145.53 89.78 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.03 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.38 -42.1 3.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.58 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.9 t -171.7 -168.71 0.62 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.337 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.515 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -118.01 17.78 14.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.484 178.115 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 13' ' ' ASP . 24.8 mt-30 -69.53 57.67 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.389 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' GLN . 4.6 t80 -27.54 85.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.787 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.579 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -123.86 72.47 53.23 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.0 Cg_endo -55.54 99.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.493 2.129 . . . . 0.0 112.117 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.046 ' HB ' HD11 ' A' ' 42' ' ' LEU . 32.9 m -97.55 128.18 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.979 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.51 116.93 19.24 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.642 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.35 135.99 12.91 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.74 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 11.1 m -49.45 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.319 -0.94 . . . . 0.0 110.756 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 t70 170.05 -26.13 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.05 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.32 31.19 3.59 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.378 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.517 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 19.3 mm -134.22 138.13 50.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.772 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.428 HG22 ' HB2' ' A' ' 14' ' ' PRO . 1.8 m -100.32 99.64 10.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.414 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.725 ' CE2' HD21 ' A' ' 29' ' ' LEU . 34.3 m-85 -81.4 127.59 32.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.804 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.82 -21.57 0.6 Allowed Glycine 0 CA--C 1.509 -0.341 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.521 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.582 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -172.4 146.33 1.77 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 0.0 110.989 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.06 -24.67 1.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.506 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.3 m -78.79 -50.36 11.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.334 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.556 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 16.3 mtt -48.27 -34.58 10.58 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.828 HD11 HD23 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -59.91 -51.86 67.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 113.098 -1.864 . . . . 0.0 108.833 177.352 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 12.9 mt -48.3 -31.85 6.55 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 28' ' ' MET . 13.9 t -72.86 -34.99 67.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.37 -59.95 2.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.63 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -19.23 3.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.383 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.553 ' HB3' ' HE ' ' A' ' 35' ' ' ARG . . . -77.72 -41.62 37.17 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.553 ' HE ' ' HB3' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -140.49 29.77 1.95 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.756 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.5 t -81.16 -93.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.718 0.294 . . . . 0.0 110.897 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.35 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.034 0.445 . . . . 0.0 110.466 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.14 129.06 17.8 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.5 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.52 94.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.959 2.439 . . . . 0.0 112.357 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.712 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -59.56 152.96 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.857 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 18' ' ' SER . 12.8 mt-10 -134.16 96.95 3.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.02 0.438 . . . . 0.0 110.838 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.046 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -36.9 148.7 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.455 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.544 ' HB ' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -137.45 -37.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.178 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.544 ' CD2' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.34 121.89 7.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.547 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 64.71 0.26 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.647 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -178.76 -158.27 20.94 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.02 57.84 3.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.23 0.538 . . . . 0.0 110.394 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.538 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 10.8 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.183 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 1.01 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.73 0.3 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.42 ' C ' ' HB2' ' A' ' 31' ' ' CYS . 22.4 Cg_exo -63.76 -166.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.669 2.246 . . . . 0.0 112.06 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.435 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -117.9 50.26 1.16 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.984 0.421 . . . . 0.0 110.951 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.817 HG22 ' O ' ' A' ' 7' ' ' ILE . 3.3 mp -146.62 62.61 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.297 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -36.88 18.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.446 0.641 . . . . 0.0 109.826 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.511 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.1 t -171.67 -172.32 1.02 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.015 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.511 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.5 OUTLIER -119.28 17.41 13.09 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.012 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 21.0 mm-40 -71.18 59.22 0.25 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.031 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 11' ' ' GLN . 22.2 t80 -19.83 82.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.198 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.614 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -118.54 69.26 8.32 Favored Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.869 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 19.5 Cg_endo -59.12 94.77 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.412 2.075 . . . . 0.0 112.068 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.011 ' HB ' HD11 ' A' ' 42' ' ' LEU . 22.6 m -99.33 127.01 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.824 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -78.36 122.35 25.65 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.751 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -109.15 144.88 16.55 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.956 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 2.5 t -50.8 95.35 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 114.121 -1.04 . . . . 0.0 110.602 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.605 ' HB2' HG22 ' A' ' 40' ' ' ILE . 5.7 t0 171.67 -30.27 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.66 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.88 33.83 1.96 Allowed Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.184 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.592 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 1.2 mt -138.62 149.53 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 46' ' ' GLY . 5.2 m -107.39 99.56 9.07 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.181 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.86 ' CE2' HD21 ' A' ' 29' ' ' LEU . 41.9 m-85 -82.17 123.18 28.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.427 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -40.07 -27.33 0.13 Allowed Glycine 0 CA--C 1.505 -0.557 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.031 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.2 m-20 -164.38 146.24 8.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.779 0.323 . . . . 0.0 111.19 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.18 -27.85 3.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.305 0.574 . . . . 0.0 109.719 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -76.55 -50.12 14.71 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.401 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.492 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -46.5 -39.79 11.41 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 176.118 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.86 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -52.61 -54.59 31.01 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 113.34 -1.754 . . . . 0.0 109.488 176.213 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.01 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 12.9 mt -48.47 -32.5 7.91 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.223 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 28' ' ' MET . 6.6 t -73.63 -32.69 64.18 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.072 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.63 -59.94 3.43 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.675 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.575 ' HB2' HD11 ' A' ' 40' ' ' ILE . 5.1 t -56.27 -19.14 12.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.029 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.13 -54.52 5.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.546 ' CZ ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -100.5 11.94 38.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.413 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 22.0 t -96.34 -116.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 179.11 26.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.43 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -161.21 146.44 10.66 Favored Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.024 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.43 ' HD2' HG22 ' A' ' 38' ' ' THR . 78.3 Cg_endo -79.47 85.06 1.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.686 2.257 . . . . 0.0 112.125 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.661 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -62.23 153.57 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.124 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 18' ' ' SER . 24.5 mt-10 -136.87 102.24 4.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.262 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.011 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.4 OUTLIER -28.96 149.9 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.918 0.389 . . . . 0.0 111.604 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.609 HG12 ' CD2' ' A' ' 44' ' ' HIS . 2.7 t -142.37 -39.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.046 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.609 ' CD2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -152.36 123.41 7.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.927 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 7.5 ptmt -70.4 65.54 0.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 22' ' ' THR . . . 178.99 -167.76 38.2 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -83.47 55.84 3.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.977 0.418 . . . . 0.0 110.674 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.53 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 9.8 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.858 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.95 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.85 0.357 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -50.96 172.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.519 2.146 . . . . 0.0 111.917 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.81 46.97 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.016 0.436 . . . . 0.0 110.745 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 7' ' ' ILE . 16.4 mt -150.29 72.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.063 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.17 -41.12 13.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.358 0.599 . . . . 0.0 110.158 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.405 ' OG1' ' N ' ' A' ' 10' ' ' MET . 4.2 t -171.5 -178.8 2.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.12 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.405 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -107.43 17.25 23.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.605 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -71.89 58.59 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.906 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.441 ' C ' ' O ' ' A' ' 11' ' ' GLN . 5.6 t80 -30.33 87.93 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.838 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.688 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -120.65 66.96 13.66 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -52.03 97.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.001 2.467 . . . . 0.0 112.442 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.0 ' HB ' HD11 ' A' ' 42' ' ' LEU . 28.8 m -97.43 123.83 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.613 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.535 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.85 118.05 19.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.541 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.71 142.53 15.57 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.883 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 16.0 t -52.29 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.297 -0.951 . . . . 0.0 110.179 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 3.1 t0 171.01 -25.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.745 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' ILE . . . 108.58 32.85 3.04 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.532 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' GLY . 42.0 mm -139.27 144.48 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.483 HG21 ' HA ' ' A' ' 47' ' ' ARG . 11.7 m -105.31 98.66 8.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.384 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.849 ' CE2' HD21 ' A' ' 29' ' ' LEU . 35.3 m-85 -80.0 124.21 28.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.926 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA3' ' SD ' ' A' ' 28' ' ' MET . . . -42.0 -24.52 0.18 Allowed Glycine 0 CA--C 1.508 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.266 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.585 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -172.23 147.22 1.98 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.959 0.409 . . . . 0.0 110.714 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -46.7 -25.03 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.679 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 30' ' ' LEU . 1.6 m -77.75 -50.46 12.33 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.331 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.585 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 2.6 mtt -47.96 -35.03 10.08 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 175.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.849 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -58.22 -51.75 68.43 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.735 177.46 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.95 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 14.3 mt -49.6 -31.96 11.77 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.476 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 28' ' ' MET . 37.4 t -76.77 -31.0 56.75 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -66.94 -60.57 2.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.389 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -53.78 -25.31 18.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.896 178.696 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.64 -15.3 45.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.482 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 -97.34 -44.38 6.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.923 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.9 t -81.18 -102.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.618 0.247 . . . . 0.0 111.102 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 178.39 -27.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.742 0.306 . . . . 0.0 111.185 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -94.01 123.13 60.21 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.949 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.483 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 23.4 Cg_exo -63.53 86.56 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.679 2.253 . . . . 0.0 112.472 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.689 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -39.15 155.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.156 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 18' ' ' SER . 45.0 mt-10 -127.09 94.47 4.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.158 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.0 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -31.96 146.71 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.313 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -131.71 -45.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.1 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.529 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -145.86 123.43 11.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.416 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -70.87 58.58 0.21 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.3 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.18 -160.03 20.92 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.483 ' HA ' HG21 ' A' ' 22' ' ' THR . 6.0 mtp180 -89.67 57.45 3.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.027 0.442 . . . . 0.0 110.692 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.529 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 1.8 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.141 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 1.02 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.855 0.36 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.36 177.23 2.74 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.77 2.314 . . . . 0.0 112.342 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.49 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -115.16 45.57 1.61 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 111.123 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.839 HG22 ' O ' ' A' ' 7' ' ' ILE . 38.1 mt -147.11 62.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.78 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.63 -39.22 24.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.121 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.684 HG23 ' H ' ' A' ' 11' ' ' GLN . 10.3 t -171.68 -166.05 0.41 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.047 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.4 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -123.65 17.95 9.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.307 178.086 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.684 ' H ' HG23 ' A' ' 9' ' ' THR . 13.6 mm-40 -70.81 58.53 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.196 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.472 ' C ' ' O ' ' A' ' 11' ' ' GLN . 2.5 t80 -20.13 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.037 0.836 . . . . 0.0 112.234 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -120.46 69.33 15.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.685 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 17.8 Cg_endo -58.16 101.85 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.581 2.188 . . . . 0.0 112.35 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.964 ' HB ' HD11 ' A' ' 42' ' ' LEU . 30.1 m -99.58 130.35 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.202 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.447 ' O ' HD22 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -79.27 118.35 21.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.555 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.2 136.41 13.37 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.193 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 2.2 t -44.15 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.201 -1.0 . . . . 0.0 110.314 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER 166.39 -24.09 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.404 -179.745 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.74 27.53 6.67 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.0 mm -123.72 140.64 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.78 99.7 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.656 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.815 ' OH ' HG21 ' A' ' 40' ' ' ILE . 39.4 m-85 -81.88 120.78 25.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.664 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -41.1 -26.85 0.19 Allowed Glycine 0 CA--C 1.506 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.276 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.5 m-20 -165.11 146.12 7.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.778 0.323 . . . . 0.0 111.092 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -48.92 -27.46 3.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.256 0.551 . . . . 0.0 109.781 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.1 m -76.47 -50.62 13.59 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.783 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -47.24 -37.25 10.14 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.253 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.002 HD11 HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -56.29 -52.25 65.19 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.326 176.67 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.02 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 12.2 mt -48.02 -32.43 6.62 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.336 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.3 t -73.91 -33.4 63.97 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.11 -61.36 1.97 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.602 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 t -50.56 -22.87 2.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.033 0.444 . . . . 0.0 109.803 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.65 -41.12 32.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.264 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.412 ' HD3' ' C ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -158.84 51.92 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.744 0.307 . . . . 0.0 111.743 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.536 ' HB2' ' CA ' ' A' ' 32' ' ' ALA . 23.1 t -95.26 -78.95 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.259 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -170.17 -37.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.955 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.777 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -154.46 159.16 32.2 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.777 ' HD2' HG22 ' A' ' 38' ' ' THR . 32.1 Cg_exo -58.55 93.62 0.07 OUTLIER 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.782 2.321 . . . . 0.0 112.21 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.815 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -76.16 154.68 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.138 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 16.6 mt-10 -143.66 97.52 3.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.027 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.002 HD23 HD11 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -33.16 149.82 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.363 0.601 . . . . 0.0 111.859 -179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.572 ' HB ' ' CD2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -142.05 -39.54 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.365 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.572 ' CD2' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -148.56 121.36 8.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.37 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HA ' HG12 ' A' ' 15' ' ' VAL . 18.0 mttt -68.56 68.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.553 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 175.2 -166.75 38.48 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -83.63 58.76 4.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.288 0.566 . . . . 0.0 110.291 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.512 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 33.5 m . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.063 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.838 ' HB3' HD22 ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.873 0.368 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.01 157.92 41.46 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.598 2.198 . . . . 0.0 111.846 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 28' ' ' MET . 2.6 p -115.78 72.74 0.81 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.27 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.782 HG22 ' O ' ' A' ' 7' ' ' ILE . 4.1 mt -135.93 55.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.664 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 55.7 m -79.6 -37.91 35.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.484 0.659 . . . . 0.0 109.514 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t -171.23 141.99 1.68 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 31.8 mtm -91.7 21.12 4.95 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 0.4 OUTLIER -78.42 -108.24 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.873 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.583 ' CD1' ' HD3' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 178.99 76.09 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.655 0.265 . . . . 0.0 111.427 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.551 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -106.77 68.39 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 15.2 Cg_endo -58.98 97.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.639 2.226 . . . . 0.0 112.767 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.038 ' HB ' HD11 ' A' ' 42' ' ' LEU . 19.9 m -99.66 131.01 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.53 0.681 . . . . 0.0 110.783 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.06 119.06 21.66 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.061 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.682 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.71 136.33 13.37 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.678 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 28.8 t -44.73 96.29 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.463 -0.869 . . . . 0.0 109.891 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.3 OUTLIER 166.59 -25.21 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.618 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.783 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 101.61 25.29 8.21 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.455 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.783 HD12 ' O ' ' A' ' 20' ' ' GLY . 1.2 mp -122.37 126.97 74.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.107 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.406 HG22 ' HB2' ' A' ' 14' ' ' PRO . 2.2 m -88.46 98.88 11.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.268 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.677 ' CE2' HD21 ' A' ' 29' ' ' LEU . 33.7 m-85 -81.0 122.13 26.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.7 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -43.15 -24.67 0.32 Allowed Glycine 0 CA--C 1.503 -0.7 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.12 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -169.65 145.47 3.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.966 0.412 . . . . 0.0 111.015 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . -46.63 -26.77 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.929 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.806 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -74.26 -55.59 5.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.976 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.535 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 4.3 mtt -46.67 -34.71 5.31 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.901 HD11 HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -59.69 -53.78 53.99 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.296 -1.774 . . . . 0.0 109.155 177.105 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.838 HD22 ' HB3' ' A' ' 4' ' ' ALA . 4.8 mt -48.44 -33.55 9.47 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -73.97 -34.46 64.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.96 177.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.49 -58.46 5.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.355 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.462 ' HB2' HD11 ' A' ' 40' ' ' ILE . 1.4 t -55.98 -22.79 28.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.758 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.35 -16.74 30.34 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -133.67 17.65 3.92 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.222 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 t -93.77 -95.98 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.6 0.238 . . . . 0.0 111.224 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 p30 179.68 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.203 0.525 . . . . 0.0 109.935 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.9 t -132.57 127.9 20.76 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.962 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.51 93.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.608 2.206 . . . . 0.0 112.588 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.579 ' N ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -53.84 171.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.256 179.429 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 42' ' ' LEU . 16.0 mt-10 -146.11 101.1 3.48 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.437 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.038 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -33.59 149.47 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.274 0.559 . . . . 0.0 111.486 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.604 HG12 ' CD2' ' A' ' 44' ' ' HIS . 3.1 t -141.65 -33.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.677 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.604 ' CD2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -157.48 122.2 4.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.534 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -69.22 67.53 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.528 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.72 -168.46 40.81 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.2 mtp85 -81.0 57.72 3.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.006 0.431 . . . . 0.0 110.393 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.53 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 25.6 m . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.126 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.751 ' HB3' ' CD ' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.422 0.153 . . . . 0.0 110.632 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.751 ' CD ' ' HB3' ' A' ' 4' ' ' ALA . 83.0 Cg_exo -28.69 142.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.77 2.313 . . . . 0.0 111.713 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -96.42 55.28 1.45 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.187 0.517 . . . . 0.0 111.574 -178.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 7' ' ' ILE . 26.8 mm -147.74 87.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.631 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.55 -40.07 4.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.432 0.634 . . . . 0.0 110.084 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 10' ' ' MET . 5.6 t -172.5 -163.27 0.22 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.477 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.52 ' N ' ' OG1' ' A' ' 9' ' ' THR . 5.5 mtt -126.01 17.99 7.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.352 177.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -69.84 59.52 0.16 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.493 179.627 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.468 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -24.6 84.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.078 -179.478 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.802 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.9 t70 -120.77 61.79 9.5 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.6 Cg_endo -53.07 90.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.68 2.254 . . . . 0.0 111.831 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.96 ' HB ' HD11 ' A' ' 42' ' ' LEU . 21.5 m -93.2 123.94 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.941 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.476 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.92 116.9 18.76 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.974 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.44 141.84 15.43 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.97 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 13.7 t -48.56 94.72 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.165 -1.018 . . . . 0.0 109.734 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.481 ' HB2' HG22 ' A' ' 40' ' ' ILE . 5.2 t0 171.21 -27.49 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.606 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.28 31.58 4.01 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.218 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.542 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 11.4 mm -135.6 139.73 45.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 14' ' ' PRO . 6.4 m -99.18 99.35 10.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.429 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.819 ' CE2' HD21 ' A' ' 29' ' ' LEU . 35.7 m-85 -82.16 124.06 29.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.2 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -38.82 -25.58 0.04 OUTLIER Glycine 0 CA--C 1.508 -0.375 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.571 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.507 ' OD1' ' HG3' ' A' ' 28' ' ' MET . 2.7 p30 -175.83 153.1 1.33 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.942 0.401 . . . . 0.0 111.363 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.89 -24.45 0.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.752 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -79.24 -51.79 9.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.513 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -45.57 -38.62 6.64 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.093 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.819 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -56.06 -53.09 61.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.952 -1.931 . . . . 0.0 109.172 177.506 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 13.0 mt -48.65 -31.13 6.25 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.551 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 49.7 t -78.48 -31.41 47.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.21 -56.62 11.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.839 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.452 ' OG ' HD13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -67.46 -16.53 64.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.472 179.103 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.733 ' HB1' ' HB1' ' A' ' 4' ' ' ALA . . . -90.83 -19.64 23.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.29 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.526 ' CG ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -120.66 3.97 10.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.115 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.6 t -105.71 -117.83 0.23 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.545 -0.168 . . . . 0.0 110.545 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 179.58 32.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.934 0.397 . . . . 0.0 110.775 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -160.51 126.81 2.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.558 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.05 88.4 0.38 Allowed 'Trans proline' 0 N--CA 1.466 -0.133 0 C-N-CA 122.588 2.192 . . . . 0.0 112.344 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.683 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -53.07 155.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.373 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.502 ' O ' ' CB ' ' A' ' 18' ' ' SER . 17.3 mt-10 -134.41 96.99 3.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.233 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.96 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -29.92 147.71 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.647 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.525 ' HB ' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -136.87 -43.27 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.111 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.531 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -150.26 120.35 7.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.577 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.93 68.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.063 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 22' ' ' THR . . . 179.23 -165.74 34.76 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -86.13 58.1 4.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.386 0.612 . . . . 0.0 110.533 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.531 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 8.7 m . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.068 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.931 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 120.585 0.231 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 32.2 Cg_exo -58.48 178.63 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.51 2.14 . . . . 0.0 111.917 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 28' ' ' MET . 26.0 p -170.59 71.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.786 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 7' ' ' ILE . 57.4 mt -138.77 69.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.953 0.406 . . . . 0.0 111.484 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.8 m -86.45 -46.66 10.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.373 0.606 . . . . 0.0 109.978 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 t -172.82 163.58 5.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.38 22.26 8.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 1.0 OUTLIER -90.09 64.48 6.19 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.741 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' GLN . 10.0 t80 -21.04 83.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.848 0.717 . . . . 0.0 112.206 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.73 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -109.45 71.93 0.53 Allowed Pre-proline 0 CA--C 1.517 -0.32 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.551 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.9 Cg_endo -55.08 95.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.837 2.358 . . . . 0.0 112.593 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.996 ' HB ' HD11 ' A' ' 42' ' ' LEU . 3.6 m -97.06 129.75 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.637 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.542 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.15 118.95 20.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.346 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.632 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.21 142.67 15.78 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.004 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 2.4 t -46.47 94.48 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 113.986 -1.107 . . . . 0.0 110.215 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.47 ' HB2' HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 168.28 -26.82 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.884 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.85 33.58 4.04 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.279 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.571 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 42.2 mm -135.16 138.2 49.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.616 HG22 ' HB2' ' A' ' 14' ' ' PRO . 3.6 m -95.54 99.91 11.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.927 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.886 ' CE2' HD21 ' A' ' 29' ' ' LEU . 43.1 m-85 -84.46 123.57 30.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.13 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -40.22 -26.57 0.12 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.288 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.467 ' HB2' ' SD ' ' A' ' 28' ' ' MET . 80.9 m-20 -168.46 151.14 5.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.728 0.299 . . . . 0.0 111.571 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.35 -24.56 3.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.182 0.515 . . . . 0.0 110.014 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -81.24 -50.81 9.1 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.538 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.482 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -47.74 -35.36 9.71 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.359 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.886 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.44 -53.5 56.74 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.78 176.422 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' CYS . 13.3 mt -49.29 -33.81 13.92 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.302 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.466 ' O ' ' HD2' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -73.84 -31.39 63.17 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.08 -62.11 1.59 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.59 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.05 -30.97 0.81 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.79 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.774 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . . . -78.22 -25.27 46.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.244 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -143.02 38.08 1.43 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.258 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' ALA . 7.0 t -107.26 -79.04 0.58 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.672 0.272 . . . . 0.0 111.059 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 36' ' ' SER . 10.2 t70 179.23 -50.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.906 0.384 . . . . 0.0 110.9 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.496 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -135.85 167.53 21.62 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.063 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.496 ' HD2' HG22 ' A' ' 38' ' ' THR . 36.9 Cg_endo -65.36 88.8 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.803 2.335 . . . . 0.0 112.213 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.672 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -61.65 153.33 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.989 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.497 ' O ' ' HB3' ' A' ' 18' ' ' SER . 10.0 mt-10 -140.51 103.48 4.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.478 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.996 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -27.93 148.95 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.08 0.467 . . . . 0.0 111.852 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.877 HG22 ' CD2' ' A' ' 44' ' ' HIS . 12.6 p -141.59 -39.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.213 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.877 ' CD2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.69 119.64 6.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.167 178.478 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 1.4 pttt -69.49 68.11 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 0.0 111.173 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.53 -170.75 42.87 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.4 mtp85 -81.64 56.68 3.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.165 0.507 . . . . 0.0 110.511 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.551 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 9.1 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.036 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.746 ' HB3' ' CD ' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.773 0.321 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.746 ' CD ' ' HB3' ' A' ' 4' ' ' ALA . 15.4 Cg_endo -57.64 147.98 76.45 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.47 2.113 . . . . 0.0 111.836 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 13.0 p -140.73 77.44 1.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.426 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.7 mp -133.54 61.78 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.394 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 44.9 m -89.67 -34.7 16.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.416 0.627 . . . . 0.0 110.02 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.519 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -168.5 130.77 1.38 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.616 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.6 mmm -88.25 19.19 3.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.032 0.444 . . . . 0.0 110.191 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -93.89 -101.04 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.725 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.477 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER 179.66 82.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 111.542 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.535 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -108.91 69.07 0.37 Allowed Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.534 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.7 Cg_endo -55.72 104.48 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.675 2.25 . . . . 0.0 112.74 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.985 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.8 m -108.42 133.64 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.773 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 121.6 24.97 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.696 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -108.19 140.9 15.66 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.285 -0.96 . . . . 0.0 112.858 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.721 ' OG ' HG22 ' A' ' 43' ' ' VAL . 44.8 m -48.71 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.156 -1.022 . . . . 0.0 110.692 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.5 ' OD2' HG22 ' A' ' 40' ' ' ILE . 0.2 OUTLIER 167.76 -26.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.813 -179.586 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.25 33.36 3.45 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.633 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.542 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 11.2 mm -136.61 136.75 48.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.739 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.403 ' CG2' ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -95.0 101.8 13.58 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.07 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.851 ' CE2' HD21 ' A' ' 29' ' ' LEU . 45.2 m-85 -84.33 127.13 33.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.453 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.531 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -42.96 -29.95 0.93 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.833 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -160.23 144.12 14.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.943 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.94 -24.32 2.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.346 0.593 . . . . 0.0 110.293 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -80.47 -50.25 10.32 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.828 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.549 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 5.2 mtt -46.92 -33.83 4.94 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.907 HD12 HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -58.33 -55.3 36.78 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.056 176.703 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 27' ' ' CYS . 10.7 mt -48.75 -32.49 8.63 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.235 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -76.19 -32.15 58.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.991 178.119 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.91 -58.98 4.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.103 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.55 -34.41 17.47 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.154 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . . . -90.61 -4.97 56.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.331 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -100.81 -48.83 4.35 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.649 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 43.2 t -81.7 -98.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.433 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 36' ' ' SER . 16.3 t0 179.02 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.336 . . . . 0.0 111.255 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.5 132.93 60.57 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 121.046 0.45 . . . . 0.0 111.26 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.3 87.96 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.941 2.428 . . . . 0.0 112.452 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.668 HG13 HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -71.71 155.9 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.731 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 18' ' ' SER . 0.6 OUTLIER -146.04 104.47 3.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.862 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.985 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -27.46 148.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.39 0.614 . . . . 0.0 112.181 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.721 HG22 ' OG ' ' A' ' 18' ' ' SER . 1.9 t -137.46 -37.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.378 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.522 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -154.13 125.76 7.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.541 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -71.04 61.47 0.28 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.623 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.52 -162.27 27.85 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.409 ' O ' ' OXT' ' A' ' 48' ' ' CYS . 6.1 mtm180 -88.03 56.67 3.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.93 0.395 . . . . 0.0 110.478 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.522 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 5.5 m . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.029 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.986 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.851 0.357 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 4' ' ' ALA . 86.6 Cg_exo -46.08 -179.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.667 2.244 . . . . 0.0 112.176 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.453 ' O ' HD13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.15 45.61 0.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.035 0.445 . . . . 0.0 110.963 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.798 HG22 ' O ' ' A' ' 7' ' ' ILE . 28.4 mm -151.44 63.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.612 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.86 -43.28 22.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.091 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.7 t -172.47 -172.15 0.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.192 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.497 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -112.61 17.79 18.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 13' ' ' ASP . 1.1 tp60 -69.1 60.41 0.11 Allowed 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.155 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.98 83.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.5 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.624 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -117.65 60.24 3.14 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.839 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.8 Cg_endo -57.2 94.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.732 2.288 . . . . 0.0 112.554 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.011 ' HB ' HD11 ' A' ' 42' ' ' LEU . 26.1 m -96.79 126.87 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.126 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.4 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -79.25 115.53 18.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.293 179.388 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.681 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -104.77 139.54 14.66 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.234 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 7.7 t -49.7 93.47 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.115 -1.042 . . . . 0.0 110.416 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' SER . 34.5 t0 171.37 -27.01 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.973 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.83 32.95 3.18 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.358 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.56 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 29.5 mm -136.87 133.53 48.17 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 46' ' ' GLY . 1.4 m -95.26 99.1 11.1 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.708 ' CE2' HD21 ' A' ' 29' ' ' LEU . 38.1 m-85 -79.99 124.02 28.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.097 -178.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.19 -26.89 0.06 OUTLIER Glycine 0 CA--C 1.507 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.394 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.54 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -173.45 150.47 1.83 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.002 0.429 . . . . 0.0 110.979 179.341 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.49 -25.15 1.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.464 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -74.3 -52.54 11.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.54 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -47.86 -40.93 22.85 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.146 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.931 HD11 HD23 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -53.26 -54.09 41.32 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.29 177.433 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.986 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 13.5 mt -49.15 -33.44 12.08 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.564 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 4.2 t -76.67 -29.88 56.54 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.62 -55.83 15.47 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.295 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -18.8 62.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.587 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.02 -44.15 10.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -98.05 -7.02 30.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.091 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 44.6 t -86.33 -105.66 0.06 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.583 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 36' ' ' SER . 14.3 t0 177.54 -28.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.89 0.376 . . . . 0.0 110.568 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.35 139.1 20.44 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.044 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.16 89.06 1.07 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.795 2.33 . . . . 0.0 112.34 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.557 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -56.12 156.26 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.379 179.499 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 18' ' ' SER . 42.1 mt-10 -134.44 97.33 3.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 111.153 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.011 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -33.65 148.87 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.387 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.885 HG22 ' CD2' ' A' ' 44' ' ' HIS . 8.6 p -138.76 -38.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.053 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.885 ' CD2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -149.44 120.38 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.156 178.26 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -70.47 63.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.454 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 22' ' ' THR . . . -177.28 -159.86 23.13 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -89.93 58.3 4.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.156 0.503 . . . . 0.0 110.486 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.515 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 8.9 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.146 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.959 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.817 0.341 . . . . 0.0 111.558 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.959 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 82.1 Cg_exo -43.96 159.01 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.678 2.252 . . . . 0.0 112.405 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 26.1 p -163.18 72.65 0.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 7' ' ' ILE . 44.8 mm -132.48 54.03 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.285 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.0 m -79.2 -37.9 37.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.162 0.506 . . . . 0.0 110.087 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -172.2 144.54 1.63 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.183 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.9 26.18 4.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -85.79 -102.55 0.06 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.102 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.526 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER 178.75 73.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.603 0.24 . . . . 0.0 111.048 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.569 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.41 66.91 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 109.757 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 18.9 Cg_endo -60.34 94.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.62 2.213 . . . . 0.0 111.949 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.025 ' HB ' HD11 ' A' ' 42' ' ' LEU . 27.6 m -99.06 129.84 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.032 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -78.58 120.7 23.65 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.553 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -111.36 144.57 17.5 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.996 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -44.87 97.75 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.215 -0.993 . . . . 0.0 109.618 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.532 ' HB2' HG22 ' A' ' 40' ' ' ILE . 9.0 t0 165.14 -24.6 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.804 -1.543 . . . . 0.0 108.685 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.895 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 100.54 27.45 7.59 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.52 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.895 HD12 ' O ' ' A' ' 20' ' ' GLY . 1.5 mp -128.8 144.16 38.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.304 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.56 HG22 ' HB2' ' A' ' 14' ' ' PRO . 13.4 m -101.32 99.03 9.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.611 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.897 ' CE2' HD21 ' A' ' 29' ' ' LEU . 49.0 m-85 -80.15 123.37 27.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.287 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -37.45 -29.51 0.04 OUTLIER Glycine 0 CA--C 1.504 -0.648 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.239 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 23' ' ' TYR . 84.6 m-20 -165.14 147.95 8.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.795 0.331 . . . . 0.0 111.092 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.87 -25.75 2.06 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.309 0.576 . . . . 0.0 110.15 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.62 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -78.84 -51.49 9.66 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.428 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.498 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -45.13 -38.97 5.57 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 176.177 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.897 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -54.11 -56.62 16.34 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 113.242 -1.799 . . . . 0.0 109.78 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 27' ' ' CYS . 4.5 mt -47.12 -34.08 5.7 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.286 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 28' ' ' MET . 1.2 m -75.27 -33.58 61.28 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.137 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -64.66 -55.45 20.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.267 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.413 ' OG ' ' HA ' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -52.23 -32.58 37.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.499 179.392 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.659 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . . . -82.76 -15.51 51.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.288 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.471 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 9.6 ptm180 -109.75 -18.28 13.48 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.7 t -83.94 -98.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 111.455 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.8 t70 179.26 -31.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 0.0 110.84 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.408 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 13.9 t -114.03 145.13 32.93 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 51.1 Cg_endo -69.81 80.93 0.86 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.755 2.303 . . . . 0.0 112.769 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.674 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -44.27 157.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.239 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 27.2 mt-10 -140.62 102.92 4.42 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.828 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.025 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.4 OUTLIER -28.95 149.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.191 0.519 . . . . 0.0 111.857 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.592 HG12 ' CD2' ' A' ' 44' ' ' HIS . 2.8 t -141.01 -38.54 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.092 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.592 ' CD2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.51 122.36 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.47 179.781 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -71.5 61.96 0.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.223 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 22' ' ' THR . . . -176.05 -160.15 23.0 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.0 mtp85 -90.26 56.92 3.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.395 . . . . 0.0 110.67 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.516 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 2.9 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.138 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.96 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.79 0.329 . . . . 0.0 111.432 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 4' ' ' ALA . 50.6 Cg_exo -53.18 -164.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.646 2.23 . . . . 0.0 111.969 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.458 ' CA ' ' HB2' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -116.57 50.68 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.589 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 7' ' ' ILE . 12.7 mt -148.88 86.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.946 0.403 . . . . 0.0 111.321 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -112.86 -37.51 4.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.838 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -171.78 175.71 3.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.287 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.2 mtm -113.63 17.79 17.98 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -75.02 58.95 0.9 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.0 179.509 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 11' ' ' GLN . 29.6 t80 -19.37 82.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.436 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.664 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -114.27 63.86 1.31 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.672 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.0 Cg_endo -53.45 96.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.952 2.435 . . . . 0.0 112.594 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.03 ' HB ' HD11 ' A' ' 42' ' ' LEU . 28.5 m -98.66 126.33 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.487 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.462 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.31 120.44 23.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.02 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -108.12 144.77 16.21 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.858 -178.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.47 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -48.23 93.73 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.066 -1.067 . . . . 0.0 110.364 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.7 t70 167.99 -24.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.241 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.0 32.43 5.0 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.023 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.597 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 26.6 mm -132.82 136.51 55.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.564 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.526 HG21 ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -97.04 101.88 13.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.798 178.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.723 ' CE2' HD21 ' A' ' 29' ' ' LEU . 30.8 m-85 -85.77 121.11 27.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.989 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -40.73 -27.15 0.16 Allowed Glycine 0 CA--C 1.506 -0.523 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.053 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 83.9 m-20 -164.63 145.42 7.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.741 0.305 . . . . 0.0 111.079 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -48.06 -26.8 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.166 0.508 . . . . 0.0 109.891 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -77.18 -51.4 11.03 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.494 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 27' ' ' CYS . 0.6 OUTLIER -46.63 -37.17 7.81 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 176.09 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.723 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -54.95 -54.5 42.04 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.263 176.408 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.96 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 12.3 mt -47.5 -32.57 5.36 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.67 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 5.8 t -78.43 -32.26 48.51 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -63.95 -58.72 5.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.576 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.425 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -55.95 -25.97 45.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.488 179.048 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.2 -34.04 61.46 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -129.83 27.3 5.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.84 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 43.5 t -92.74 -94.95 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.632 0.253 . . . . 0.0 111.323 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.79 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.935 0.397 . . . . 0.0 110.541 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.41 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 7.9 t -138.41 147.16 54.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.721 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 16.4 Cg_endo -57.74 93.27 0.06 OUTLIER 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.841 2.361 . . . . 0.0 112.393 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.577 ' CG1' ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -79.45 126.85 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.98 0.419 . . . . 0.0 111.075 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.582 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 2.6 mm-40 -97.36 -156.9 0.56 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.073 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.03 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.7 OUTLIER -120.97 149.45 42.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.515 178.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.58 HG12 ' CD2' ' A' ' 44' ' ' HIS . 2.4 t -138.36 -36.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.921 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.58 ' CD2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -157.35 122.13 4.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.815 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -71.2 65.88 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.139 -179.62 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 22' ' ' THR . . . -179.22 -162.25 28.14 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HA ' HG21 ' A' ' 22' ' ' THR . 4.2 mtt180 -87.27 57.64 4.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.944 0.402 . . . . 0.0 110.545 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.54 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 10.9 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.11 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.82 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 121.006 0.431 . . . . 0.0 111.567 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.42 -163.64 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.914 2.409 . . . . 0.0 112.081 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.449 ' CA ' ' HB2' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -119.15 50.02 1.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 111.271 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 7' ' ' ILE . 13.5 mm -146.96 80.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -104.13 -38.06 7.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.456 0.646 . . . . 0.0 109.972 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.505 ' OG1' ' N ' ' A' ' 10' ' ' MET . 6.2 t -171.96 -163.0 0.23 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.112 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.505 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.9 OUTLIER -128.05 16.69 6.74 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.486 178.101 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 2.4 mt-30 -71.53 58.94 0.29 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.906 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.525 ' CD1' ' HD3' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -25.99 87.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.942 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.683 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -121.86 71.29 30.05 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.802 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.0 Cg_endo -55.62 95.95 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.843 2.362 . . . . 0.0 112.545 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.041 ' HB ' HD11 ' A' ' 42' ' ' LEU . 4.4 m -96.74 126.83 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.485 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.525 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.23 118.86 20.85 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.211 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.56 143.16 15.65 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.983 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 40.4 t -50.98 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.253 -0.974 . . . . 0.0 110.17 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.523 ' HB2' HG22 ' A' ' 40' ' ' ILE . 12.7 t0 171.65 -27.69 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.616 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.85 31.06 3.75 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.39 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 23.0 mm -136.91 139.91 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 119.753 -0.779 . . . . 0.0 113.011 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.48 HG22 ' HB2' ' A' ' 14' ' ' PRO . 3.9 m -98.42 102.64 14.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.879 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.877 ' CE2' HD21 ' A' ' 29' ' ' LEU . 37.3 m-85 -84.94 123.96 31.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.887 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -41.25 -25.99 0.17 Allowed Glycine 0 CA--C 1.505 -0.534 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.127 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.8 m-20 -164.91 145.91 7.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.912 0.387 . . . . 0.0 111.454 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.41 -27.46 4.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.347 0.594 . . . . 0.0 109.554 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -78.1 -49.09 14.6 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.49 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -47.8 -37.92 14.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 175.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.877 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -54.96 -52.77 62.01 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 112.908 -1.951 . . . . 0.0 109.168 176.348 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.82 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 13.2 mt -48.07 -33.35 7.98 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 28' ' ' MET . 24.9 t -75.09 -32.89 61.56 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.1 -57.71 7.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.481 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.97 -23.01 29.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.145 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.83 -17.6 35.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.377 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -133.44 18.11 3.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.2 t -100.72 -97.57 0.26 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.334 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 56.5 t0 179.52 -32.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 0.0 110.643 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 t -126.97 149.5 69.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.801 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -70.03 87.22 0.59 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.613 2.209 . . . . 0.0 112.205 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.676 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -49.88 149.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.427 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 18' ' ' SER . 31.5 mt-10 -130.68 101.88 5.87 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.101 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.041 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -28.32 146.54 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.223 0.535 . . . . 0.0 111.517 -179.354 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -132.58 -46.85 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.221 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.546 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -150.45 123.8 8.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.394 179.671 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -70.25 68.58 0.34 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.201 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 22' ' ' THR . . . 178.42 -158.92 23.9 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 57.36 3.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.165 0.507 . . . . 0.0 110.176 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.546 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 7.0 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.918 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.424 ' HB3' HD22 ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 121.009 0.433 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -38.17 120.26 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.8 2.334 . . . . 0.0 112.553 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 4.2 p -84.7 77.36 10.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.159 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.714 HG22 ' O ' ' A' ' 7' ' ' ILE . 8.3 mm -130.36 52.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.508 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 46.0 m -79.53 -35.73 39.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.355 0.598 . . . . 0.0 109.842 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.466 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -170.36 138.41 1.56 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.627 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.7 mtt -94.84 20.65 8.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.902 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 2.8 mm-40 -84.62 -99.75 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.245 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.504 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 7.9 t80 178.18 79.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.528 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.67 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -111.06 64.38 0.48 Allowed Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.622 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.1 Cg_endo -56.63 92.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.65 2.233 . . . . 0.0 112.198 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.034 ' HB ' HD11 ' A' ' 42' ' ' LEU . 19.6 m -95.09 126.43 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.516 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.681 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.85 117.4 19.18 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.264 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.42 141.11 15.14 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.513 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 38.1 m -48.86 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.21 -0.995 . . . . 0.0 110.359 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.544 ' OD2' HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 169.07 -25.93 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.142 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.72 30.74 4.47 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.337 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 9.7 mm -131.77 138.91 51.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.667 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.515 HG22 ' HB2' ' A' ' 14' ' ' PRO . 3.1 m -99.76 99.48 10.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.729 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.833 ' CE2' HD21 ' A' ' 29' ' ' LEU . 33.1 m-85 -83.69 122.89 29.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.721 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -42.28 -24.15 0.19 Allowed Glycine 0 CA--C 1.505 -0.579 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.134 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.595 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -169.83 146.68 3.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.754 0.312 . . . . 0.0 111.108 -179.328 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -47.19 -25.54 0.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.292 0.568 . . . . 0.0 110.263 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -76.95 -54.77 6.14 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.817 178.651 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.548 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 36.4 mtp -45.53 -33.3 2.66 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.833 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -59.42 -54.36 47.53 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.469 -1.696 . . . . 0.0 108.892 177.315 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' CYS . 11.8 mt -49.07 -29.43 5.11 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.556 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 28' ' ' MET . 1.4 m -79.64 -31.12 41.52 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -68.93 -58.75 3.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.157 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.46 -33.02 63.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.268 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.44 -3.12 57.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.333 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 4.5 mtp180 -96.56 -51.09 4.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.942 0.401 . . . . 0.0 111.024 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.7 t -86.82 -99.15 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.436 ' O ' ' HD3' ' A' ' 39' ' ' PRO . 6.5 p30 178.92 -26.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.411 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -79.15 111.45 20.33 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.928 0.394 . . . . 0.0 111.121 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 33.5 Cg_exo -57.82 93.75 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.844 2.362 . . . . 0.0 112.486 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.695 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -69.54 157.49 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.767 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 18' ' ' SER . 36.9 mt-10 -140.95 103.46 4.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.049 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.034 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -28.24 147.09 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.169 0.509 . . . . 0.0 111.315 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.82 HG22 ' CD2' ' A' ' 44' ' ' HIS . 13.6 p -139.39 -38.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.495 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.82 ' CD2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.78 123.29 7.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.529 178.524 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 64.75 0.41 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.294 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.37 -160.31 24.89 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -90.12 54.22 2.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.972 0.415 . . . . 0.0 110.664 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.529 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 4.9 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.056 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.991 0.424 . . . . 0.0 111.061 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.81 176.71 8.57 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.698 2.266 . . . . 0.0 112.11 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 0.6 OUTLIER -66.69 123.76 21.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.859 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -115.78 113.25 42.41 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -42.03 138.81 2.73 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.601 2.2 . . . . 0.0 111.801 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 1.3 p -93.23 56.03 2.42 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.257 0.551 . . . . 0.0 111.532 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.811 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.6 mp -132.05 57.15 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.582 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -78.9 -41.16 30.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.101 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.481 ' OG1' ' N ' ' A' ' 10' ' ' MET . 6.4 t -173.65 -165.88 0.28 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.395 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.481 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -124.1 17.59 9.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.035 177.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -73.08 58.76 0.5 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.993 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.471 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 9.0 t80 -25.18 84.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.292 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.701 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -114.91 64.67 1.63 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.473 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -51.74 97.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.034 2.489 . . . . 0.0 112.331 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.963 ' HB ' HD11 ' A' ' 42' ' ' LEU . 27.8 m -99.49 127.38 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.524 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.425 ' HB3' ' ND1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.26 121.47 24.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.0 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -113.52 142.41 17.44 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.161 -1.019 . . . . 0.0 113.184 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 45.0 t -40.1 98.01 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.333 -0.933 . . . . 0.0 109.771 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' SER . 1.7 t0 160.19 -22.71 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.985 -1.462 . . . . 0.0 108.748 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.688 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 94.23 25.08 17.43 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.988 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 20' ' ' GLY . 0.9 OUTLIER -118.45 124.56 73.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.861 -179.252 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.55 HG22 ' HB2' ' A' ' 14' ' ' PRO . 3.1 m -86.36 98.18 10.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.494 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.809 ' OH ' HG21 ' A' ' 40' ' ' ILE . 52.3 m-85 -79.47 123.81 27.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.017 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -37.49 -27.84 0.03 OUTLIER Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.533 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.7 p30 -174.33 155.54 2.37 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.934 0.397 . . . . 0.0 110.996 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -48.47 -23.03 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.928 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.584 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 26.1 m -83.6 -46.77 12.0 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.526 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -48.62 -36.17 15.24 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 175.415 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.991 HD11 HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -55.93 -50.18 71.45 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 112.933 -1.939 . . . . 0.0 108.837 177.29 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.584 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 11.7 mt -48.27 -30.56 4.91 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.746 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -73.19 -35.74 66.42 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.61 -57.85 5.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.309 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -61.34 -16.88 50.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.365 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.85 -38.19 13.11 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -149.64 42.66 0.9 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 31.0 t -96.09 -81.52 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.897 0.379 . . . . 0.0 110.978 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -175.39 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.242 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.804 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -144.97 154.18 54.53 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.253 179.452 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.804 ' HD2' HG22 ' A' ' 38' ' ' THR . 38.0 Cg_endo -66.54 81.27 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.586 2.19 . . . . 0.0 112.507 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.809 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -54.5 169.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.219 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 42' ' ' LEU . 19.5 mt-10 -148.68 100.9 3.16 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.89 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.991 HD23 HD11 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -31.02 148.65 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 111.227 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.433 HG12 ' CD2' ' A' ' 44' ' ' HIS . 2.7 t -144.98 -37.24 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.033 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.51 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -148.97 120.35 7.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.0 110.858 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.6 mttp -70.19 66.5 0.29 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.27 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 22' ' ' THR . . . 179.67 -160.26 25.35 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -90.12 55.14 3.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.904 0.383 . . . . 0.0 110.442 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.51 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 7.1 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.283 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.483 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 3.1 mmtp . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.878 0.37 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 1' ' ' LYS . 59.5 Cg_endo -73.53 -165.34 0.24 Allowed 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.691 2.261 . . . . 0.0 112.551 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.09 123.52 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.95 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.921 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -168.29 -55.25 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.322 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.902 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 35.7 Cg_exo -59.32 170.44 3.12 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.582 2.188 . . . . 0.0 112.026 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.4 p -165.77 72.64 0.17 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.441 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.795 HG22 ' O ' ' A' ' 7' ' ' ILE . 26.8 mt -137.67 63.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 0.0 111.719 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 26.8 m -87.09 -40.14 14.94 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.411 0.624 . . . . 0.0 109.367 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 t -172.47 143.91 1.44 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.712 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.18 26.04 3.95 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 47.8 mt-30 -84.11 -103.45 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.322 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.446 ' O ' ' CD ' ' A' ' 14' ' ' PRO . 2.4 t80 179.69 71.9 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.491 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER -106.98 71.07 0.27 Allowed Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 27.6 Cg_endo -61.97 101.49 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.654 2.236 . . . . 0.0 112.842 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.006 ' HB ' HD11 ' A' ' 42' ' ' LEU . 35.1 m -105.9 127.89 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.278 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.507 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.81 123.09 26.3 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.218 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -111.49 144.18 17.47 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.826 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.541 ' HB3' ' CG ' ' A' ' 41' ' ' GLU . 16.9 t -45.07 96.91 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.35 -0.925 . . . . 0.0 110.07 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.578 ' HB2' HG22 ' A' ' 40' ' ' ILE . 4.9 t0 163.76 -23.01 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.929 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.659 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 98.33 24.13 11.75 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.324 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.661 HG21 ' CE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -119.42 135.03 61.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.911 -179.015 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.449 ' CG2' ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -94.41 99.63 11.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.563 178.403 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.833 ' CE2' HD21 ' A' ' 29' ' ' LEU . 51.6 m-85 -82.64 122.56 28.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.055 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.476 ' HA3' ' CE ' ' A' ' 28' ' ' MET . . . -41.13 -27.22 0.21 Allowed Glycine 0 CA--C 1.507 -0.468 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.218 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.8 m-20 -164.47 146.32 8.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.74 0.305 . . . . 0.0 110.803 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.69 -25.14 2.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.227 0.537 . . . . 0.0 110.358 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -77.81 -50.55 12.1 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.28 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.476 ' CE ' ' HA3' ' A' ' 24' ' ' GLY . 2.8 mmm -45.99 -40.4 10.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.882 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -52.69 -55.94 19.07 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 113.445 -1.707 . . . . 0.0 109.775 176.284 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 13.8 mt -48.58 -32.57 8.29 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.4 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -75.75 -31.72 59.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.632 ' HB3' HD11 ' A' ' 40' ' ' ILE . . . -66.69 -59.23 3.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.951 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.473 ' OG ' HG12 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -52.29 -28.7 19.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.414 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.921 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . . . -70.16 -37.73 75.27 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -135.95 35.69 2.84 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 46.9 t -90.86 -95.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.691 0.281 . . . . 0.0 111.516 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -179.7 -35.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.124 0.488 . . . . 0.0 110.109 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.642 HG23 ' HD2' ' A' ' 39' ' ' PRO . 55.1 m -136.53 142.91 41.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.207 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.642 ' HD2' HG23 ' A' ' 38' ' ' THR . 10.5 Cg_endo -53.52 92.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.906 2.404 . . . . 0.0 112.928 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.632 HD11 ' HB3' ' A' ' 32' ' ' ALA . 0.9 OUTLIER -78.57 148.34 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.139 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.541 ' CG ' ' HB3' ' A' ' 18' ' ' SER . 10.3 pt-20 -152.31 116.78 5.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.262 0.553 . . . . 0.0 111.123 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.006 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -21.61 145.25 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.794 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -136.4 -42.18 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.469 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.536 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -150.96 125.97 9.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.206 178.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -70.75 65.72 0.33 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.223 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.59 -160.61 27.37 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.449 ' HA ' ' CG2' ' A' ' 22' ' ' THR . 2.9 mtp180 -90.28 54.15 2.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.161 0.505 . . . . 0.0 110.845 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.536 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 4.2 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.215 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.491 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.951 0.405 . . . . 0.0 111.128 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 1' ' ' LYS . 48.7 Cg_exo -55.83 -166.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.867 2.378 . . . . 0.0 112.504 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 7.3 p-10 -148.56 120.78 8.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.607 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.912 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -173.64 -59.36 0.0 OUTLIER Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.912 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 81.3 Cg_exo -43.61 135.92 6.71 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.611 2.207 . . . . 0.0 112.01 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 7.9 p -132.97 79.88 1.86 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.037 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.762 HG22 ' O ' ' A' ' 7' ' ' ILE . 5.4 mp -133.93 52.47 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 55.3 m -84.39 -34.16 23.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.482 0.658 . . . . 0.0 109.627 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.658 HG23 ' ND2' ' A' ' 25' ' ' ASN . 2.4 t -171.25 136.22 1.03 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.078 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.2 mtt -93.81 24.71 3.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.476 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.9 -100.66 0.17 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.366 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.509 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 1.5 t80 179.54 76.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.61 0.243 . . . . 0.0 110.977 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.528 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.5 69.94 0.29 Allowed Pre-proline 0 CA--C 1.516 -0.332 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.697 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.4 Cg_endo -56.31 102.64 0.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.779 2.319 . . . . 0.0 112.805 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.016 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.9 m -106.76 133.81 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.508 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -78.29 119.99 22.43 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.893 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -106.01 140.92 15.33 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.43 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 48.5 t -48.28 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.245 -0.978 . . . . 0.0 110.414 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.521 ' HB2' HG22 ' A' ' 40' ' ' ILE . 7.1 t0 171.68 -30.52 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.563 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.48 33.76 2.23 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.587 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.1 mt -135.49 154.39 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 14' ' ' PRO . 2.5 m -109.66 99.25 8.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.373 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.88 ' CE2' HD21 ' A' ' 29' ' ' LEU . 53.9 m-85 -83.89 129.28 34.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.321 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.445 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -41.35 -27.15 0.25 Allowed Glycine 0 CA--C 1.504 -0.652 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.328 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.658 ' ND2' HG23 ' A' ' 9' ' ' THR . 81.6 m-20 -166.66 146.05 5.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.792 0.33 . . . . 0.0 111.149 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.02 -25.44 3.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.396 0.617 . . . . 0.0 109.868 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 1.1 m -79.89 -49.6 11.68 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.85 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 27' ' ' CYS . 7.6 mmm -47.04 -37.65 9.74 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.062 HD12 HD23 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -55.69 -56.99 13.94 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.258 -1.792 . . . . 0.0 109.498 176.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 27' ' ' CYS . 12.4 mt -48.24 -32.94 7.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.559 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -76.46 -32.11 58.2 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.49 -56.75 10.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.256 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.634 ' OG ' HD11 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -51.11 -36.31 39.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.033 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.69 -0.34 57.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.042 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 24.3 mtp180 -111.81 -38.86 4.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.6 t -85.36 -108.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.561 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p30 179.5 33.0 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.782 0.325 . . . . 0.0 110.944 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 m -146.79 134.12 10.23 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.795 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.71 83.98 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.814 2.343 . . . . 0.0 112.865 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.705 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -70.01 154.49 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.632 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.484 ' O ' ' O ' ' A' ' 42' ' ' LEU . 13.1 mt-10 -143.04 101.83 3.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.09 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.062 HD23 HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -29.46 150.81 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.032 0.444 . . . . 0.0 111.632 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.443 ' HB ' ' CD2' ' A' ' 44' ' ' HIS . 1.4 t -144.6 -41.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.185 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.525 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -153.21 121.21 6.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.805 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.29 70.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.374 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.35 -164.88 34.94 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.3 56.35 3.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.104 0.478 . . . . 0.0 110.41 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.525 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 20.9 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.173 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.882 0.372 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.21 -166.4 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.804 2.336 . . . . 0.0 112.288 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.93 97.86 8.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.701 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.796 ' HB1' ' CB ' ' A' ' 34' ' ' ALA . . . -164.93 -63.54 0.01 OUTLIER Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.777 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.652 ' CD ' ' HB3' ' A' ' 4' ' ' ALA . 96.4 Cg_exo -26.75 141.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.119 2.546 . . . . 0.0 112.104 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -92.91 52.87 1.9 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.003 0.43 . . . . 0.0 111.122 -179.27 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.7 mm -145.92 90.75 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.782 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.01 -38.68 3.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.36 0.6 . . . . 0.0 109.894 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 11' ' ' GLN . 10.0 t -172.5 -162.9 0.2 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.268 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.463 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -129.09 16.48 6.18 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.501 177.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -74.03 60.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.995 179.371 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.56 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 8.4 t80 -20.32 84.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.487 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.658 ' O ' HG13 ' A' ' 15' ' ' VAL . 20.5 t0 -114.47 59.29 1.0 Allowed Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.2 Cg_endo -54.28 96.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.754 2.303 . . . . 0.0 112.223 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.976 ' HB ' HD11 ' A' ' 42' ' ' LEU . 33.8 m -98.22 127.66 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.814 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.61 116.45 18.99 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.322 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.697 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.92 138.01 13.83 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.681 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 13.3 t -46.62 96.05 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.246 -0.977 . . . . 0.0 110.495 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 165.46 -23.53 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.235 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.77 32.97 4.88 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.318 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 36.3 mm -130.28 130.71 65.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.362 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.18 99.59 11.82 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.605 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.76 ' CE2' HD21 ' A' ' 29' ' ' LEU . 39.4 m-85 -83.03 121.8 27.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.824 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -36.28 -29.38 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.327 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.523 ' OD1' ' HG3' ' A' ' 28' ' ' MET . 2.1 p30 -173.37 154.82 2.71 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.098 0.475 . . . . 0.0 111.067 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.8 -23.53 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.807 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.518 ' HA ' HD12 ' A' ' 30' ' ' LEU . 1.2 m -78.48 -51.98 9.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.523 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 1.2 mtt -46.32 -42.1 14.24 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.931 HD11 HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -52.46 -54.27 34.5 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.384 -1.735 . . . . 0.0 109.556 177.218 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 27' ' ' CYS . 7.5 mt -48.22 -31.83 6.33 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.527 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.537 ' CA ' ' O ' ' A' ' 4' ' ' ALA . 7.3 t -76.76 -31.78 57.31 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.209 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -64.03 -58.65 6.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.349 178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.579 ' HB2' HD11 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -63.98 -15.71 59.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.206 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.796 ' CB ' ' HB1' ' A' ' 4' ' ' ALA . . . -90.05 -26.28 20.37 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HD2' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -131.23 18.95 4.89 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 10.2 t -105.62 -119.7 0.23 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p30 179.4 24.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.0 m -161.75 112.54 1.2 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.63 0.252 . . . . 0.0 110.523 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.1 94.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.603 2.202 . . . . 0.0 112.225 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.721 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -63.53 153.36 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.401 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 18' ' ' SER . 10.9 mt-10 -132.82 92.75 3.09 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.084 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.976 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -32.81 148.7 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.258 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.428 ' HB ' ' CD2' ' A' ' 44' ' ' HIS . 2.5 t -142.5 -38.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.646 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.519 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -150.29 117.75 6.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.471 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.23 65.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.641 -179.302 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.55 -163.21 29.49 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -85.59 59.02 5.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.084 0.468 . . . . 0.0 110.497 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.519 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 17.5 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.972 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.933 0.397 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.93 -163.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.918 2.412 . . . . 0.0 112.557 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.554 ' HB3' HD13 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -66.29 -167.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.374 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.808 ' HB3' ' CD ' ' A' ' 5' ' ' PRO . . . -162.13 -70.11 0.01 OUTLIER Pre-proline 0 N--CA 1.452 -0.343 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.629 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.808 ' CD ' ' HB3' ' A' ' 4' ' ' ALA . 59.9 Cg_exo -27.38 144.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.309 2.673 . . . . 0.0 112.473 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.411 ' O ' HG12 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -102.01 54.05 0.8 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.97 0.414 . . . . 0.0 111.567 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 7' ' ' ILE . 3.6 mm -146.49 78.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.644 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -103.14 -39.34 6.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.325 0.583 . . . . 0.0 110.29 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.582 HG23 ' H ' ' A' ' 11' ' ' GLN . 9.8 t -173.19 -160.93 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.761 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.506 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -128.5 17.88 6.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.367 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.582 ' H ' HG23 ' A' ' 9' ' ' THR . 0.1 OUTLIER -72.29 58.87 0.39 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.345 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -26.65 85.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.147 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.69 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -121.61 67.25 20.39 Favored Pre-proline 0 N--CA 1.454 -0.241 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.0 Cg_endo -53.0 95.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.897 2.398 . . . . 0.0 112.57 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.961 ' HB ' HD11 ' A' ' 42' ' ' LEU . 25.5 m -95.94 126.91 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.8 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -78.69 118.43 20.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.744 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -108.55 145.34 16.4 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.688 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 10.6 p -48.32 97.15 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.501 -0.849 . . . . 0.0 109.991 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.535 ' HB2' HG22 ' A' ' 40' ' ' ILE . 7.6 t70 168.84 -25.83 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.853 -1.521 . . . . 0.0 108.695 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.42 30.65 5.83 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.603 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -127.53 146.29 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.569 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.543 HG22 ' HB2' ' A' ' 14' ' ' PRO . 6.2 m -107.39 97.81 7.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.501 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.854 ' CE2' HD21 ' A' ' 29' ' ' LEU . 36.7 m-85 -81.74 123.1 28.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.403 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.46 ' H ' ' HE3' ' A' ' 28' ' ' MET . . . -39.9 -26.52 0.1 OUTLIER Glycine 0 CA--C 1.508 -0.406 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.319 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.545 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -171.82 149.21 2.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.003 0.43 . . . . 0.0 110.684 179.132 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.91 -24.55 0.62 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.834 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.615 ' HA ' HD12 ' A' ' 30' ' ' LEU . 1.6 m -77.74 -50.78 11.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.196 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.545 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -46.79 -37.66 8.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.854 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.41 -52.66 63.81 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.987 -1.915 . . . . 0.0 109.246 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.621 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 5.5 mt -49.6 -32.12 12.15 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.6 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.531 ' CA ' ' O ' ' A' ' 4' ' ' ALA . 7.7 t -75.9 -29.3 58.39 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -69.5 -62.3 1.44 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.905 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.14 -13.51 27.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.446 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 30' ' ' LEU . . . -82.97 -29.75 28.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.302 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.429 ' CD ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -144.38 29.49 1.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.352 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 47.4 t -92.1 -97.04 0.13 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.618 0.247 . . . . 0.0 110.913 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 179.72 -32.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 0.0 110.731 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 9.2 m -127.53 133.06 24.68 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.939 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 35.0 Cg_exo -60.51 90.11 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.759 2.306 . . . . 0.0 112.579 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.627 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -63.9 163.02 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.543 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 18' ' ' SER . 1.5 mt-10 -149.86 107.13 3.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.809 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.961 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -29.27 148.92 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.08 0.466 . . . . 0.0 111.577 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.62 HG12 ' CD2' ' A' ' 44' ' ' HIS . 2.8 t -142.65 -39.2 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.416 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.62 ' CD2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -153.86 121.06 5.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.523 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -69.27 68.3 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.106 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.3 -171.12 44.12 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.41 57.36 2.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.084 0.468 . . . . 0.0 110.504 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.526 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 21.1 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.052 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.472 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 2.5 ttmm . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.839 0.352 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' A' ' 1' ' ' LYS . 73.2 Cg_endo -77.14 -172.8 1.54 Allowed 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.716 2.277 . . . . 0.0 112.459 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.695 ' H ' HD13 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -107.45 48.05 0.86 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.903 0.383 . . . . 0.0 111.062 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.565 ' O ' ' CB ' ' A' ' 31' ' ' CYS . . . -35.86 -53.37 1.47 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.539 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 4' ' ' ALA . 33.5 Cg_exo -29.91 126.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.747 2.298 . . . . 0.0 112.158 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.444 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -93.12 44.97 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 110.988 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.815 HG22 ' O ' ' A' ' 7' ' ' ILE . 31.5 mt -152.61 63.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.7 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -80.95 -41.6 22.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.916 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 t -172.02 162.23 5.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.88 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -92.47 18.66 8.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 2.1 tt0 -72.02 58.53 0.35 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.165 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.509 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -21.52 82.96 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.36 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.762 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -112.76 62.64 0.72 Allowed Pre-proline 0 N--CA 1.452 -0.341 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.4 Cg_endo -55.58 93.89 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.815 2.343 . . . . 0.0 112.455 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.006 ' HB ' HD11 ' A' ' 42' ' ' LEU . 5.7 m -97.29 125.92 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.719 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.403 ' HB3' ' ND1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.55 117.23 19.54 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.749 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.647 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -106.16 143.56 15.75 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.298 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 4.2 t -49.27 95.06 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.301 -0.95 . . . . 0.0 110.001 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.7 -25.68 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.954 -1.476 . . . . 0.0 109.006 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.3 34.04 3.77 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.377 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.6 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 27.4 mm -137.19 136.19 47.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 14' ' ' PRO . 2.9 m -96.73 97.9 9.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.232 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.82 ' CE2' HD21 ' A' ' 29' ' ' LEU . 41.3 m-85 -80.07 126.37 30.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.299 -178.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.22 -25.51 0.05 OUTLIER Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.505 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 0.9 OUTLIER -176.41 150.27 0.88 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.2 -25.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.567 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -76.45 -52.86 9.01 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.535 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -44.77 -41.25 6.74 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.124 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.82 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -53.93 -54.37 39.79 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 112.986 -1.916 . . . . 0.0 109.411 177.482 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.695 HD13 ' H ' ' A' ' 3' ' ' ASP . 13.0 mt -48.88 -33.84 11.47 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.156 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -74.85 -32.62 61.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -62.63 -57.18 11.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.627 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -17.54 56.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.169 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.39 -15.38 35.68 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -136.03 1.45 2.73 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -89.04 -99.15 0.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.546 0.213 . . . . 0.0 111.038 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 178.77 -31.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.36 . . . . 0.0 110.953 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.871 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -117.4 151.33 47.94 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.114 0.483 . . . . 0.0 111.42 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.871 ' HD2' HG22 ' A' ' 38' ' ' THR . 97.5 Cg_endo -80.13 86.51 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.997 2.465 . . . . 0.0 112.029 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.717 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.47 155.22 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.77 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 18' ' ' SER . 20.9 mt-10 -135.0 96.84 3.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.746 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.006 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -29.26 147.41 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.224 0.535 . . . . 0.0 111.439 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.435 ' HB ' ' CD2' ' A' ' 44' ' ' HIS . 1.7 t -135.46 -41.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.295 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.543 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -153.35 121.24 6.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.58 -179.645 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -70.27 67.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.0 0.429 . . . . 0.0 111.148 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 22' ' ' THR . . . 179.05 -165.27 34.09 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.76 57.36 4.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.033 0.444 . . . . 0.0 110.649 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 8.8 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.576 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 12.0 mttt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.88 0.371 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 1' ' ' LYS . 58.3 Cg_endo -71.21 -168.3 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.713 2.275 . . . . 0.0 112.27 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.551 ' CB ' HD22 ' A' ' 30' ' ' LEU . 43.4 m-20 -139.53 -176.12 4.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.008 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.938 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -171.99 -58.84 0.0 OUTLIER Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.793 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.938 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 51.9 Cg_exo -53.7 178.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.511 2.14 . . . . 0.0 111.575 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.78 ' C ' HD12 ' A' ' 7' ' ' ILE . 26.2 p -170.47 76.33 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.657 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.786 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.8 mp -131.68 57.56 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.36 . . . . 0.0 111.667 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 57.6 m -83.08 -38.38 22.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.316 0.579 . . . . 0.0 110.099 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 11' ' ' GLN . 1.8 t -171.61 139.92 1.29 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.432 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.34 25.91 4.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.469 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 55.2 mt-30 -91.68 -100.79 0.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.647 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.521 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 179.83 77.55 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.117 -179.465 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.56 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -111.22 65.07 0.53 Allowed Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.666 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 12.9 Cg_endo -56.29 98.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.032 2.488 . . . . 0.0 112.77 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.998 ' HB ' HD11 ' A' ' 42' ' ' LEU . 24.8 m -99.25 130.2 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.779 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.409 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.65 117.69 20.04 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.262 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -109.38 140.93 15.9 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.966 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 2.5 m -42.3 96.97 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.275 -0.963 . . . . 0.0 109.635 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 18' ' ' SER . 7.3 t0 163.34 -22.87 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.913 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.675 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 96.52 23.48 16.17 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.675 HD12 ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -119.05 131.97 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.923 -179.105 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 14' ' ' PRO . 1.6 m -92.77 98.2 11.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.418 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.838 ' CE2' HD21 ' A' ' 29' ' ' LEU . 47.3 m-85 -81.03 123.89 28.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.322 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -37.49 -30.47 0.06 OUTLIER Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.15 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' HB2' ' HG3' ' A' ' 28' ' ' MET . 83.8 m-20 -165.34 147.85 7.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.361 -0.419 . . . . 0.0 111.073 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.27 -25.74 2.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.298 0.571 . . . . 0.0 110.009 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -77.19 -51.94 10.11 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.534 178.507 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.471 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 2.0 mtt -44.69 -39.78 5.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 176.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.844 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -56.24 -54.61 43.24 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.686 176.405 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.551 HD22 ' CB ' ' A' ' 3' ' ' ASP . 4.1 mt -47.68 -35.11 9.03 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.212 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -74.42 -33.28 62.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.022 178.203 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -63.12 -55.52 24.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.293 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.658 ' OG ' HD11 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -51.8 -35.08 42.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.44 179.486 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.652 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . . . -90.71 -2.49 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.493 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -120.66 -18.77 7.64 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.328 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.2 t -89.83 -98.67 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.456 0.169 . . . . 0.0 111.229 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 38' ' ' THR . 28.8 p30 179.11 -30.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.729 0.3 . . . . 0.0 111.058 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.515 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 3.3 t -107.88 137.18 19.71 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 0.0 110.767 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.74 89.47 0.99 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.74 2.293 . . . . 0.0 112.72 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.677 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -53.96 169.63 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.414 179.154 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 18' ' ' SER . 18.4 mt-10 -147.06 98.3 3.01 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.061 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.998 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -29.13 148.04 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.1 0.476 . . . . 0.0 111.212 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.515 ' HB ' ' CD2' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -138.33 -40.31 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.49 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.542 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -154.41 121.59 5.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.563 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -69.64 67.0 0.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.382 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.18 -161.74 28.12 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.2 56.45 3.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.114 0.483 . . . . 0.0 110.522 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.542 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 6.6 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.096 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.83 0.348 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 3' ' ' ASP . 51.3 Cg_endo -69.03 -167.25 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.762 2.308 . . . . 0.0 112.417 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 2' ' ' PRO . 0.2 OUTLIER -36.19 145.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.738 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -133.82 120.63 15.5 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.234 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 4' ' ' ALA . 83.8 Cg_exo -47.0 -176.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.639 2.226 . . . . 0.0 112.155 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.704 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -108.47 50.53 0.77 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.042 0.449 . . . . 0.0 111.301 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.704 HD12 ' C ' ' A' ' 6' ' ' CYS . 4.8 mp -145.53 89.78 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.03 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.38 -42.1 3.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.58 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.9 t -171.7 -168.71 0.62 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.337 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.515 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -118.01 17.78 14.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.484 178.115 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 13' ' ' ASP . 24.8 mt-30 -69.53 57.67 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.389 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' GLN . 4.6 t80 -27.54 85.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.787 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.579 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -123.86 72.47 53.23 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.0 Cg_endo -55.54 99.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.493 2.129 . . . . 0.0 112.117 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.046 ' HB ' HD11 ' A' ' 42' ' ' LEU . 32.9 m -97.55 128.18 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.979 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.51 116.93 19.24 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.642 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.35 135.99 12.91 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.74 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 11.1 m -49.45 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.319 -0.94 . . . . 0.0 110.756 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 t70 170.05 -26.13 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.05 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.32 31.19 3.59 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.378 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.517 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 19.3 mm -134.22 138.13 50.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.772 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.428 HG22 ' HB2' ' A' ' 14' ' ' PRO . 1.8 m -100.32 99.64 10.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.414 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.725 ' CE2' HD21 ' A' ' 29' ' ' LEU . 34.3 m-85 -81.4 127.59 32.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.804 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.82 -21.57 0.6 Allowed Glycine 0 CA--C 1.509 -0.341 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.521 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.582 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -172.4 146.33 1.77 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 0.0 110.989 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.06 -24.67 1.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.506 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.3 m -78.79 -50.36 11.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.334 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.556 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 16.3 mtt -48.27 -34.58 10.58 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.828 HD11 HD23 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -59.91 -51.86 67.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 113.098 -1.864 . . . . 0.0 108.833 177.352 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 12.9 mt -48.3 -31.85 6.55 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 28' ' ' MET . 13.9 t -72.86 -34.99 67.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.37 -59.95 2.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.63 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -19.23 3.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.383 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.553 ' HB3' ' HE ' ' A' ' 35' ' ' ARG . . . -77.72 -41.62 37.17 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.553 ' HE ' ' HB3' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -140.49 29.77 1.95 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.756 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.5 t -81.16 -93.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.718 0.294 . . . . 0.0 110.897 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.35 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.034 0.445 . . . . 0.0 110.466 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.14 129.06 17.8 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.5 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.52 94.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.959 2.439 . . . . 0.0 112.357 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.712 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -59.56 152.96 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.857 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 18' ' ' SER . 12.8 mt-10 -134.16 96.95 3.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.02 0.438 . . . . 0.0 110.838 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.046 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -36.9 148.7 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.455 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.544 ' HB ' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -137.45 -37.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.178 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.544 ' CD2' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.34 121.89 7.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.547 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 64.71 0.26 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.647 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -178.76 -158.27 20.94 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.02 57.84 3.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.23 0.538 . . . . 0.0 110.394 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.538 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 10.8 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.183 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.49 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.97 0.414 . . . . 0.0 111.204 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.49 ' HD3' ' CB ' ' A' ' 1' ' ' LYS . 47.1 Cg_endo -84.87 39.59 0.76 Allowed 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.095 2.53 . . . . 0.0 112.538 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -173.54 57.12 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.7 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.01 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -100.13 125.74 38.79 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.233 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.42 ' C ' ' HB2' ' A' ' 31' ' ' CYS . 22.4 Cg_exo -63.76 -166.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.669 2.246 . . . . 0.0 112.06 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.435 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -117.9 50.26 1.16 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.984 0.421 . . . . 0.0 110.951 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.817 HG22 ' O ' ' A' ' 7' ' ' ILE . 3.3 mp -146.62 62.61 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.297 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -36.88 18.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.446 0.641 . . . . 0.0 109.826 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.511 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.1 t -171.67 -172.32 1.02 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.015 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.511 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.5 OUTLIER -119.28 17.41 13.09 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.012 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 21.0 mm-40 -71.18 59.22 0.25 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.031 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 11' ' ' GLN . 22.2 t80 -19.83 82.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.198 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.614 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -118.54 69.26 8.32 Favored Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.869 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 19.5 Cg_endo -59.12 94.77 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.412 2.075 . . . . 0.0 112.068 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.011 ' HB ' HD11 ' A' ' 42' ' ' LEU . 22.6 m -99.33 127.01 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.824 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -78.36 122.35 25.65 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.751 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -109.15 144.88 16.55 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.956 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 2.5 t -50.8 95.35 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 114.121 -1.04 . . . . 0.0 110.602 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.605 ' HB2' HG22 ' A' ' 40' ' ' ILE . 5.7 t0 171.67 -30.27 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.66 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.88 33.83 1.96 Allowed Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.184 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.592 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 1.2 mt -138.62 149.53 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 46' ' ' GLY . 5.2 m -107.39 99.56 9.07 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.181 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.86 ' CE2' HD21 ' A' ' 29' ' ' LEU . 41.9 m-85 -82.17 123.18 28.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.427 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -40.07 -27.33 0.13 Allowed Glycine 0 CA--C 1.505 -0.557 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.031 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.2 m-20 -164.38 146.24 8.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.779 0.323 . . . . 0.0 111.19 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.18 -27.85 3.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.305 0.574 . . . . 0.0 109.719 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -76.55 -50.12 14.71 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.401 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.492 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -46.5 -39.79 11.41 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 176.118 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.86 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -52.61 -54.59 31.01 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 113.34 -1.754 . . . . 0.0 109.488 176.213 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.01 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 12.9 mt -48.47 -32.5 7.91 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.223 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 28' ' ' MET . 6.6 t -73.63 -32.69 64.18 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.072 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.63 -59.94 3.43 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.675 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.575 ' HB2' HD11 ' A' ' 40' ' ' ILE . 5.1 t -56.27 -19.14 12.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.029 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.13 -54.52 5.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.546 ' CZ ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -100.5 11.94 38.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.413 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 22.0 t -96.34 -116.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 179.11 26.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.43 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -161.21 146.44 10.66 Favored Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.024 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.43 ' HD2' HG22 ' A' ' 38' ' ' THR . 78.3 Cg_endo -79.47 85.06 1.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.686 2.257 . . . . 0.0 112.125 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.661 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -62.23 153.57 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.124 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 18' ' ' SER . 24.5 mt-10 -136.87 102.24 4.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.262 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.011 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.4 OUTLIER -28.96 149.9 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.918 0.389 . . . . 0.0 111.604 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.609 HG12 ' CD2' ' A' ' 44' ' ' HIS . 2.7 t -142.37 -39.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.046 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.609 ' CD2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -152.36 123.41 7.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.927 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 7.5 ptmt -70.4 65.54 0.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 22' ' ' THR . . . 178.99 -167.76 38.2 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -83.47 55.84 3.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.977 0.418 . . . . 0.0 110.674 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.53 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 9.8 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.858 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.562 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.58 0.229 . . . . 0.0 111.034 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 1' ' ' LYS . 56.2 Cg_endo -70.25 178.59 4.72 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.581 2.187 . . . . 0.0 112.375 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -76.4 67.84 2.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.731 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.95 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -84.64 115.84 62.5 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.204 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -50.96 172.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.519 2.146 . . . . 0.0 111.917 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.81 46.97 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.016 0.436 . . . . 0.0 110.745 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 7' ' ' ILE . 16.4 mt -150.29 72.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.063 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.17 -41.12 13.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.358 0.599 . . . . 0.0 110.158 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.405 ' OG1' ' N ' ' A' ' 10' ' ' MET . 4.2 t -171.5 -178.8 2.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.12 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.405 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -107.43 17.25 23.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.605 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -71.89 58.59 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.906 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.441 ' C ' ' O ' ' A' ' 11' ' ' GLN . 5.6 t80 -30.33 87.93 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.838 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.688 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -120.65 66.96 13.66 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -52.03 97.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.001 2.467 . . . . 0.0 112.442 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.0 ' HB ' HD11 ' A' ' 42' ' ' LEU . 28.8 m -97.43 123.83 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.613 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.535 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.85 118.05 19.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.541 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.71 142.53 15.57 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.883 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 16.0 t -52.29 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.297 -0.951 . . . . 0.0 110.179 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 3.1 t0 171.01 -25.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.745 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' ILE . . . 108.58 32.85 3.04 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.532 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' GLY . 42.0 mm -139.27 144.48 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.483 HG21 ' HA ' ' A' ' 47' ' ' ARG . 11.7 m -105.31 98.66 8.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.384 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.849 ' CE2' HD21 ' A' ' 29' ' ' LEU . 35.3 m-85 -80.0 124.21 28.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.926 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA3' ' SD ' ' A' ' 28' ' ' MET . . . -42.0 -24.52 0.18 Allowed Glycine 0 CA--C 1.508 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.266 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.585 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -172.23 147.22 1.98 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.959 0.409 . . . . 0.0 110.714 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -46.7 -25.03 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.679 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 30' ' ' LEU . 1.6 m -77.75 -50.46 12.33 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.331 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.585 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 2.6 mtt -47.96 -35.03 10.08 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 175.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.849 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -58.22 -51.75 68.43 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.735 177.46 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.95 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 14.3 mt -49.6 -31.96 11.77 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.476 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 28' ' ' MET . 37.4 t -76.77 -31.0 56.75 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -66.94 -60.57 2.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.389 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -53.78 -25.31 18.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.896 178.696 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.64 -15.3 45.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.482 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 -97.34 -44.38 6.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.923 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.9 t -81.18 -102.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.618 0.247 . . . . 0.0 111.102 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 178.39 -27.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.742 0.306 . . . . 0.0 111.185 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -94.01 123.13 60.21 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.949 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.483 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 23.4 Cg_exo -63.53 86.56 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.679 2.253 . . . . 0.0 112.472 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.689 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -39.15 155.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.156 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 18' ' ' SER . 45.0 mt-10 -127.09 94.47 4.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.158 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.0 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -31.96 146.71 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.313 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -131.71 -45.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.1 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.529 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -145.86 123.43 11.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.416 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -70.87 58.58 0.21 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.3 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.18 -160.03 20.92 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.483 ' HA ' HG21 ' A' ' 22' ' ' THR . 6.0 mtp180 -89.67 57.45 3.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.027 0.442 . . . . 0.0 110.692 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.529 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 1.8 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.141 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.88 0.371 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.37 -177.95 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.611 2.207 . . . . 0.0 112.208 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.461 ' HB3' ' CB ' ' A' ' 34' ' ' ALA . 16.7 m-20 -80.6 164.6 22.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.02 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -148.5 151.07 35.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.027 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.36 177.23 2.74 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.77 2.314 . . . . 0.0 112.342 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.49 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -115.16 45.57 1.61 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 111.123 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.839 HG22 ' O ' ' A' ' 7' ' ' ILE . 38.1 mt -147.11 62.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.78 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.63 -39.22 24.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.121 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.684 HG23 ' H ' ' A' ' 11' ' ' GLN . 10.3 t -171.68 -166.05 0.41 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.047 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.4 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -123.65 17.95 9.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.307 178.086 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.684 ' H ' HG23 ' A' ' 9' ' ' THR . 13.6 mm-40 -70.81 58.53 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.196 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.472 ' C ' ' O ' ' A' ' 11' ' ' GLN . 2.5 t80 -20.13 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.037 0.836 . . . . 0.0 112.234 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -120.46 69.33 15.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.685 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 17.8 Cg_endo -58.16 101.85 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.581 2.188 . . . . 0.0 112.35 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.964 ' HB ' HD11 ' A' ' 42' ' ' LEU . 30.1 m -99.58 130.35 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.202 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.447 ' O ' HD22 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -79.27 118.35 21.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.555 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.2 136.41 13.37 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.193 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 2.2 t -44.15 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.201 -1.0 . . . . 0.0 110.314 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER 166.39 -24.09 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.404 -179.745 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.74 27.53 6.67 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.0 mm -123.72 140.64 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.78 99.7 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.656 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.815 ' OH ' HG21 ' A' ' 40' ' ' ILE . 39.4 m-85 -81.88 120.78 25.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.664 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -41.1 -26.85 0.19 Allowed Glycine 0 CA--C 1.506 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.276 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.5 m-20 -165.11 146.12 7.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.778 0.323 . . . . 0.0 111.092 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -48.92 -27.46 3.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.256 0.551 . . . . 0.0 109.781 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.1 m -76.47 -50.62 13.59 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.783 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -47.24 -37.25 10.14 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.253 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.002 HD11 HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -56.29 -52.25 65.19 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.326 176.67 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.02 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 12.2 mt -48.02 -32.43 6.62 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.336 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.3 t -73.91 -33.4 63.97 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.11 -61.36 1.97 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.602 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 t -50.56 -22.87 2.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.033 0.444 . . . . 0.0 109.803 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 3' ' ' ASP . . . -78.65 -41.12 32.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.264 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.412 ' HD3' ' C ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -158.84 51.92 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.744 0.307 . . . . 0.0 111.743 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.536 ' HB2' ' CA ' ' A' ' 32' ' ' ALA . 23.1 t -95.26 -78.95 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.259 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -170.17 -37.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.955 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.777 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -154.46 159.16 32.2 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.777 ' HD2' HG22 ' A' ' 38' ' ' THR . 32.1 Cg_exo -58.55 93.62 0.07 OUTLIER 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.782 2.321 . . . . 0.0 112.21 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.815 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -76.16 154.68 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.138 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 16.6 mt-10 -143.66 97.52 3.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.027 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.002 HD23 HD11 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -33.16 149.82 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.363 0.601 . . . . 0.0 111.859 -179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.572 ' HB ' ' CD2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -142.05 -39.54 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.365 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.572 ' CD2' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -148.56 121.36 8.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.37 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HA ' HG12 ' A' ' 15' ' ' VAL . 18.0 mttt -68.56 68.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.553 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 175.2 -166.75 38.48 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -83.63 58.76 4.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.288 0.566 . . . . 0.0 110.291 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.512 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 33.5 m . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.063 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.534 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.85 0.357 . . . . 0.0 111.208 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 1' ' ' LYS . 35.1 Cg_exo -60.46 -165.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.677 2.251 . . . . 0.0 112.16 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 9.2 p-10 -47.75 108.29 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.53 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.838 ' HB3' HD22 ' A' ' 30' ' ' LEU . . . -121.11 150.72 54.17 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.26 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.01 157.92 41.46 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.598 2.198 . . . . 0.0 111.846 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 28' ' ' MET . 2.6 p -115.78 72.74 0.81 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.27 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.782 HG22 ' O ' ' A' ' 7' ' ' ILE . 4.1 mt -135.93 55.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.664 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 55.7 m -79.6 -37.91 35.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.484 0.659 . . . . 0.0 109.514 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t -171.23 141.99 1.68 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 31.8 mtm -91.7 21.12 4.95 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 0.4 OUTLIER -78.42 -108.24 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.873 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.583 ' CD1' ' HD3' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 178.99 76.09 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.655 0.265 . . . . 0.0 111.427 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.551 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -106.77 68.39 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 15.2 Cg_endo -58.98 97.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.639 2.226 . . . . 0.0 112.767 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.038 ' HB ' HD11 ' A' ' 42' ' ' LEU . 19.9 m -99.66 131.01 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.53 0.681 . . . . 0.0 110.783 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.06 119.06 21.66 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.061 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.682 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.71 136.33 13.37 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.678 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 28.8 t -44.73 96.29 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.463 -0.869 . . . . 0.0 109.891 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.3 OUTLIER 166.59 -25.21 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.618 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.783 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 101.61 25.29 8.21 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.455 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.783 HD12 ' O ' ' A' ' 20' ' ' GLY . 1.2 mp -122.37 126.97 74.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.107 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.406 HG22 ' HB2' ' A' ' 14' ' ' PRO . 2.2 m -88.46 98.88 11.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.268 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.677 ' CE2' HD21 ' A' ' 29' ' ' LEU . 33.7 m-85 -81.0 122.13 26.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.7 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -43.15 -24.67 0.32 Allowed Glycine 0 CA--C 1.503 -0.7 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.12 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -169.65 145.47 3.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.966 0.412 . . . . 0.0 111.015 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . -46.63 -26.77 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.929 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.806 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -74.26 -55.59 5.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.976 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.535 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 4.3 mtt -46.67 -34.71 5.31 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.901 HD11 HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -59.69 -53.78 53.99 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.296 -1.774 . . . . 0.0 109.155 177.105 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.838 HD22 ' HB3' ' A' ' 4' ' ' ALA . 4.8 mt -48.44 -33.55 9.47 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -73.97 -34.46 64.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.96 177.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.49 -58.46 5.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.355 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.462 ' HB2' HD11 ' A' ' 40' ' ' ILE . 1.4 t -55.98 -22.79 28.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.758 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 3' ' ' ASP . . . -89.35 -16.74 30.34 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -133.67 17.65 3.92 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.222 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 t -93.77 -95.98 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.6 0.238 . . . . 0.0 111.224 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 p30 179.68 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.203 0.525 . . . . 0.0 109.935 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.9 t -132.57 127.9 20.76 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.962 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.51 93.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.608 2.206 . . . . 0.0 112.588 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.579 ' N ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -53.84 171.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.256 179.429 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 42' ' ' LEU . 16.0 mt-10 -146.11 101.1 3.48 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.437 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.038 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -33.59 149.47 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.274 0.559 . . . . 0.0 111.486 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.604 HG12 ' CD2' ' A' ' 44' ' ' HIS . 3.1 t -141.65 -33.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.677 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.604 ' CD2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -157.48 122.2 4.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.534 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -69.22 67.53 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.528 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.72 -168.46 40.81 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.2 mtp85 -81.0 57.72 3.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.006 0.431 . . . . 0.0 110.393 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.53 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 25.6 m . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.126 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 2' ' ' PRO . 14.5 mmtt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.91 0.386 . . . . 0.0 111.303 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 1' ' ' LYS . 52.7 Cg_exo -52.33 -164.03 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.788 2.325 . . . . 0.0 112.289 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.819 ' HB3' HD13 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -78.67 108.82 12.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.918 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.751 ' HB3' ' CD ' ' A' ' 5' ' ' PRO . . . -159.9 -69.13 0.02 OUTLIER Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.632 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.751 ' CD ' ' HB3' ' A' ' 4' ' ' ALA . 83.0 Cg_exo -28.69 142.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.77 2.313 . . . . 0.0 111.713 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -96.42 55.28 1.45 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.187 0.517 . . . . 0.0 111.574 -178.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 7' ' ' ILE . 26.8 mm -147.74 87.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.631 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.55 -40.07 4.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.432 0.634 . . . . 0.0 110.084 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 10' ' ' MET . 5.6 t -172.5 -163.27 0.22 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.477 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.52 ' N ' ' OG1' ' A' ' 9' ' ' THR . 5.5 mtt -126.01 17.99 7.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.352 177.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -69.84 59.52 0.16 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.493 179.627 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.468 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -24.6 84.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.078 -179.478 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.802 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.9 t70 -120.77 61.79 9.5 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.6 Cg_endo -53.07 90.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.68 2.254 . . . . 0.0 111.831 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.96 ' HB ' HD11 ' A' ' 42' ' ' LEU . 21.5 m -93.2 123.94 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.941 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.476 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.92 116.9 18.76 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.974 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.44 141.84 15.43 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.97 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 13.7 t -48.56 94.72 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.165 -1.018 . . . . 0.0 109.734 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.481 ' HB2' HG22 ' A' ' 40' ' ' ILE . 5.2 t0 171.21 -27.49 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.606 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.28 31.58 4.01 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.218 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.542 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 11.4 mm -135.6 139.73 45.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 14' ' ' PRO . 6.4 m -99.18 99.35 10.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.429 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.819 ' CE2' HD21 ' A' ' 29' ' ' LEU . 35.7 m-85 -82.16 124.06 29.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.2 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -38.82 -25.58 0.04 OUTLIER Glycine 0 CA--C 1.508 -0.375 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.571 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.507 ' OD1' ' HG3' ' A' ' 28' ' ' MET . 2.7 p30 -175.83 153.1 1.33 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.942 0.401 . . . . 0.0 111.363 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.89 -24.45 0.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.752 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -79.24 -51.79 9.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.513 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -45.57 -38.62 6.64 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.093 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.819 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -56.06 -53.09 61.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.952 -1.931 . . . . 0.0 109.172 177.506 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.819 HD13 ' HB3' ' A' ' 3' ' ' ASP . 13.0 mt -48.65 -31.13 6.25 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.551 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 49.7 t -78.48 -31.41 47.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.21 -56.62 11.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.839 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.452 ' OG ' HD13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -67.46 -16.53 64.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.472 179.103 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.733 ' HB1' ' HB1' ' A' ' 4' ' ' ALA . . . -90.83 -19.64 23.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.29 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.526 ' CG ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -120.66 3.97 10.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.115 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.6 t -105.71 -117.83 0.23 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.545 -0.168 . . . . 0.0 110.545 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 179.58 32.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.934 0.397 . . . . 0.0 110.775 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -160.51 126.81 2.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.558 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.05 88.4 0.38 Allowed 'Trans proline' 0 N--CA 1.466 -0.133 0 C-N-CA 122.588 2.192 . . . . 0.0 112.344 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.683 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -53.07 155.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.373 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.502 ' O ' ' CB ' ' A' ' 18' ' ' SER . 17.3 mt-10 -134.41 96.99 3.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.233 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.96 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -29.92 147.71 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.647 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.525 ' HB ' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -136.87 -43.27 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.111 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.531 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -150.26 120.35 7.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.577 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.93 68.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.063 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 22' ' ' THR . . . 179.23 -165.74 34.76 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -86.13 58.1 4.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.386 0.612 . . . . 0.0 110.533 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.531 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 8.7 m . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.068 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.918 0.389 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.86 173.71 13.98 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.942 2.428 . . . . 0.0 112.277 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.27 62.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.421 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.931 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -172.18 -59.55 0.0 OUTLIER Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.364 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 32.2 Cg_exo -58.48 178.63 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.51 2.14 . . . . 0.0 111.917 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 28' ' ' MET . 26.0 p -170.59 71.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.786 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 7' ' ' ILE . 57.4 mt -138.77 69.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.953 0.406 . . . . 0.0 111.484 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.8 m -86.45 -46.66 10.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.373 0.606 . . . . 0.0 109.978 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 t -172.82 163.58 5.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.38 22.26 8.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 1.0 OUTLIER -90.09 64.48 6.19 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.741 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' GLN . 10.0 t80 -21.04 83.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.848 0.717 . . . . 0.0 112.206 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.73 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -109.45 71.93 0.53 Allowed Pre-proline 0 CA--C 1.517 -0.32 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.551 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.9 Cg_endo -55.08 95.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.837 2.358 . . . . 0.0 112.593 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.996 ' HB ' HD11 ' A' ' 42' ' ' LEU . 3.6 m -97.06 129.75 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.637 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.542 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.15 118.95 20.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.346 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.632 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.21 142.67 15.78 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.004 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 2.4 t -46.47 94.48 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 113.986 -1.107 . . . . 0.0 110.215 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.47 ' HB2' HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 168.28 -26.82 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.884 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.85 33.58 4.04 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.279 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.571 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 42.2 mm -135.16 138.2 49.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.616 HG22 ' HB2' ' A' ' 14' ' ' PRO . 3.6 m -95.54 99.91 11.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.927 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.886 ' CE2' HD21 ' A' ' 29' ' ' LEU . 43.1 m-85 -84.46 123.57 30.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.13 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -40.22 -26.57 0.12 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.288 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.467 ' HB2' ' SD ' ' A' ' 28' ' ' MET . 80.9 m-20 -168.46 151.14 5.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.728 0.299 . . . . 0.0 111.571 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.35 -24.56 3.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.182 0.515 . . . . 0.0 110.014 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -81.24 -50.81 9.1 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.538 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.482 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -47.74 -35.36 9.71 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.359 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.886 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.44 -53.5 56.74 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.78 176.422 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' CYS . 13.3 mt -49.29 -33.81 13.92 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.302 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.466 ' O ' ' HD2' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -73.84 -31.39 63.17 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.08 -62.11 1.59 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.59 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.05 -30.97 0.81 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.79 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.774 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . . . -78.22 -25.27 46.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.244 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -143.02 38.08 1.43 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.258 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' ALA . 7.0 t -107.26 -79.04 0.58 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.672 0.272 . . . . 0.0 111.059 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 36' ' ' SER . 10.2 t70 179.23 -50.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.906 0.384 . . . . 0.0 110.9 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.496 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -135.85 167.53 21.62 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.063 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.496 ' HD2' HG22 ' A' ' 38' ' ' THR . 36.9 Cg_endo -65.36 88.8 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.803 2.335 . . . . 0.0 112.213 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.672 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -61.65 153.33 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.989 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.497 ' O ' ' HB3' ' A' ' 18' ' ' SER . 10.0 mt-10 -140.51 103.48 4.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.478 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.996 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -27.93 148.95 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.08 0.467 . . . . 0.0 111.852 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.877 HG22 ' CD2' ' A' ' 44' ' ' HIS . 12.6 p -141.59 -39.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.213 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.877 ' CD2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.69 119.64 6.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.167 178.478 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 1.4 pttt -69.49 68.11 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 0.0 111.173 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.53 -170.75 42.87 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.4 mtp85 -81.64 56.68 3.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.165 0.507 . . . . 0.0 110.511 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.551 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 9.1 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.036 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.933 0.397 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.01 176.34 6.32 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.704 2.269 . . . . 0.0 112.429 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 7.4 p-10 179.75 51.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.068 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.746 ' HB3' ' CD ' ' A' ' 5' ' ' PRO . . . -161.27 -66.62 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.268 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.746 ' CD ' ' HB3' ' A' ' 4' ' ' ALA . 15.4 Cg_endo -57.64 147.98 76.45 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.47 2.113 . . . . 0.0 111.836 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 13.0 p -140.73 77.44 1.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.426 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.7 mp -133.54 61.78 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.394 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 44.9 m -89.67 -34.7 16.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.416 0.627 . . . . 0.0 110.02 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.519 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -168.5 130.77 1.38 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.616 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.6 mmm -88.25 19.19 3.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.032 0.444 . . . . 0.0 110.191 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -93.89 -101.04 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.725 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.477 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER 179.66 82.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 111.542 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.535 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -108.91 69.07 0.37 Allowed Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.534 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.7 Cg_endo -55.72 104.48 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.675 2.25 . . . . 0.0 112.74 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.985 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.8 m -108.42 133.64 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.773 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 121.6 24.97 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.696 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -108.19 140.9 15.66 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.285 -0.96 . . . . 0.0 112.858 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.721 ' OG ' HG22 ' A' ' 43' ' ' VAL . 44.8 m -48.71 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.156 -1.022 . . . . 0.0 110.692 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.5 ' OD2' HG22 ' A' ' 40' ' ' ILE . 0.2 OUTLIER 167.76 -26.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.813 -179.586 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.25 33.36 3.45 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.633 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.542 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 11.2 mm -136.61 136.75 48.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.739 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.403 ' CG2' ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -95.0 101.8 13.58 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.07 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.851 ' CE2' HD21 ' A' ' 29' ' ' LEU . 45.2 m-85 -84.33 127.13 33.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.453 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.531 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -42.96 -29.95 0.93 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.833 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -160.23 144.12 14.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.943 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.94 -24.32 2.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.346 0.593 . . . . 0.0 110.293 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -80.47 -50.25 10.32 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.828 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.549 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 5.2 mtt -46.92 -33.83 4.94 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.907 HD12 HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -58.33 -55.3 36.78 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.056 176.703 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 27' ' ' CYS . 10.7 mt -48.75 -32.49 8.63 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.235 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -76.19 -32.15 58.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.991 178.119 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.91 -58.98 4.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.103 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.55 -34.41 17.47 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.154 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . . . -90.61 -4.97 56.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.331 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -100.81 -48.83 4.35 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.649 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 43.2 t -81.7 -98.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.433 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 36' ' ' SER . 16.3 t0 179.02 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.336 . . . . 0.0 111.255 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.5 132.93 60.57 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 121.046 0.45 . . . . 0.0 111.26 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.3 87.96 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.941 2.428 . . . . 0.0 112.452 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.668 HG13 HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -71.71 155.9 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.731 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 18' ' ' SER . 0.6 OUTLIER -146.04 104.47 3.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.862 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.985 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -27.46 148.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.39 0.614 . . . . 0.0 112.181 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.721 HG22 ' OG ' ' A' ' 18' ' ' SER . 1.9 t -137.46 -37.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.378 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.522 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -154.13 125.76 7.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.541 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -71.04 61.47 0.28 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.623 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.52 -162.27 27.85 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.409 ' O ' ' OXT' ' A' ' 48' ' ' CYS . 6.1 mtm180 -88.03 56.67 3.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.93 0.395 . . . . 0.0 110.478 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.522 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 5.5 m . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.029 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.86 0.362 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.8 -166.15 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.794 2.33 . . . . 0.0 112.214 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.4 t0 179.46 155.07 0.51 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.986 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -128.11 95.57 33.61 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.961 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 4' ' ' ALA . 86.6 Cg_exo -46.08 -179.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.667 2.244 . . . . 0.0 112.176 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.453 ' O ' HD13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.15 45.61 0.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.035 0.445 . . . . 0.0 110.963 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.798 HG22 ' O ' ' A' ' 7' ' ' ILE . 28.4 mm -151.44 63.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.612 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.86 -43.28 22.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.091 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.7 t -172.47 -172.15 0.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.192 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.497 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -112.61 17.79 18.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 13' ' ' ASP . 1.1 tp60 -69.1 60.41 0.11 Allowed 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.155 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.98 83.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.5 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.624 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -117.65 60.24 3.14 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.8 Cg_endo -57.2 94.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.732 2.288 . . . . 0.0 112.554 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.011 ' HB ' HD11 ' A' ' 42' ' ' LEU . 26.1 m -96.79 126.87 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.126 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.4 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -79.25 115.53 18.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.293 179.388 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.681 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -104.77 139.54 14.66 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.234 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 7.7 t -49.7 93.47 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.115 -1.042 . . . . 0.0 110.416 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' SER . 34.5 t0 171.37 -27.01 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.973 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.83 32.95 3.18 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.358 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.56 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 29.5 mm -136.87 133.53 48.17 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 46' ' ' GLY . 1.4 m -95.26 99.1 11.1 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.708 ' CE2' HD21 ' A' ' 29' ' ' LEU . 38.1 m-85 -79.99 124.02 28.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.097 -178.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.19 -26.89 0.06 OUTLIER Glycine 0 CA--C 1.507 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.394 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.54 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -173.45 150.47 1.83 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.002 0.429 . . . . 0.0 110.979 179.341 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.49 -25.15 1.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.464 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -74.3 -52.54 11.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.54 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -47.86 -40.93 22.85 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.146 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.931 HD11 HD23 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -53.26 -54.09 41.32 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.29 177.433 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.986 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 13.5 mt -49.15 -33.44 12.08 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.564 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 4.2 t -76.67 -29.88 56.54 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.62 -55.83 15.47 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.295 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -18.8 62.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.587 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.02 -44.15 10.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -98.05 -7.02 30.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.091 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 44.6 t -86.33 -105.66 0.06 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.583 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 36' ' ' SER . 14.3 t0 177.54 -28.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.89 0.376 . . . . 0.0 110.568 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.35 139.1 20.44 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.044 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.16 89.06 1.07 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.795 2.33 . . . . 0.0 112.34 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.557 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -56.12 156.26 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.379 179.499 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 18' ' ' SER . 42.1 mt-10 -134.44 97.33 3.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 111.153 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.011 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -33.65 148.87 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.387 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.885 HG22 ' CD2' ' A' ' 44' ' ' HIS . 8.6 p -138.76 -38.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.053 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.885 ' CD2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -149.44 120.38 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.156 178.26 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -70.47 63.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.454 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 22' ' ' THR . . . -177.28 -159.86 23.13 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -89.93 58.3 4.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.156 0.503 . . . . 0.0 110.486 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.515 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 8.9 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.146 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 15.4 mttp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.914 0.388 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.58 178.06 5.87 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.976 2.45 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -111.55 134.74 52.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.582 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.959 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -160.96 -63.9 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 111.558 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.959 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 82.1 Cg_exo -43.96 159.01 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.678 2.252 . . . . 0.0 112.405 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 26.1 p -163.18 72.65 0.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 7' ' ' ILE . 44.8 mm -132.48 54.03 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.285 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.0 m -79.2 -37.9 37.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.162 0.506 . . . . 0.0 110.087 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -172.2 144.54 1.63 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.183 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.9 26.18 4.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -85.79 -102.55 0.06 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.102 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.526 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER 178.75 73.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.603 0.24 . . . . 0.0 111.048 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.569 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.41 66.91 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 109.757 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 18.9 Cg_endo -60.34 94.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.62 2.213 . . . . 0.0 111.949 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.025 ' HB ' HD11 ' A' ' 42' ' ' LEU . 27.6 m -99.06 129.84 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.032 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -78.58 120.7 23.65 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.553 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -111.36 144.57 17.5 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.996 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -44.87 97.75 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.215 -0.993 . . . . 0.0 109.618 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.532 ' HB2' HG22 ' A' ' 40' ' ' ILE . 9.0 t0 165.14 -24.6 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.804 -1.543 . . . . 0.0 108.685 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.895 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 100.54 27.45 7.59 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.52 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.895 HD12 ' O ' ' A' ' 20' ' ' GLY . 1.5 mp -128.8 144.16 38.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.304 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.56 HG22 ' HB2' ' A' ' 14' ' ' PRO . 13.4 m -101.32 99.03 9.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.611 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.897 ' CE2' HD21 ' A' ' 29' ' ' LEU . 49.0 m-85 -80.15 123.37 27.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.287 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -37.45 -29.51 0.04 OUTLIER Glycine 0 CA--C 1.504 -0.648 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.239 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 23' ' ' TYR . 84.6 m-20 -165.14 147.95 8.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.795 0.331 . . . . 0.0 111.092 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.87 -25.75 2.06 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.309 0.576 . . . . 0.0 110.15 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.62 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -78.84 -51.49 9.66 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.428 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.498 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -45.13 -38.97 5.57 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 176.177 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.897 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -54.11 -56.62 16.34 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 113.242 -1.799 . . . . 0.0 109.78 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 27' ' ' CYS . 4.5 mt -47.12 -34.08 5.7 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.286 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 28' ' ' MET . 1.2 m -75.27 -33.58 61.28 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.137 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -64.66 -55.45 20.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.267 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.413 ' OG ' ' HA ' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -52.23 -32.58 37.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.499 179.392 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.659 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . . . -82.76 -15.51 51.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.288 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.471 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 9.6 ptm180 -109.75 -18.28 13.48 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.7 t -83.94 -98.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 111.455 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.8 t70 179.26 -31.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 0.0 110.84 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.408 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 13.9 t -114.03 145.13 32.93 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 51.1 Cg_endo -69.81 80.93 0.86 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.755 2.303 . . . . 0.0 112.769 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.674 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -44.27 157.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.239 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 27.2 mt-10 -140.62 102.92 4.42 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.828 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.025 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.4 OUTLIER -28.95 149.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.191 0.519 . . . . 0.0 111.857 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.592 HG12 ' CD2' ' A' ' 44' ' ' HIS . 2.8 t -141.01 -38.54 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.092 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.592 ' CD2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.51 122.36 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.47 179.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -71.5 61.96 0.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.223 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 22' ' ' THR . . . -176.05 -160.15 23.0 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.0 mtp85 -90.26 56.92 3.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.395 . . . . 0.0 110.67 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.516 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 2.9 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.138 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 1' ' ' LYS . 16.2 tttt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.973 0.416 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.32 -167.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.77 2.313 . . . . 0.0 112.507 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.67 134.86 32.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.655 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.96 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -129.25 115.47 18.61 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.432 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 4' ' ' ALA . 50.6 Cg_exo -53.18 -164.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.646 2.23 . . . . 0.0 111.969 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.458 ' CA ' ' HB2' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -116.57 50.68 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.589 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 7' ' ' ILE . 12.7 mt -148.88 86.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.946 0.403 . . . . 0.0 111.321 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -112.86 -37.51 4.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.838 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -171.78 175.71 3.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.287 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.2 mtm -113.63 17.79 17.98 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -75.02 58.95 0.9 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.0 179.509 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 11' ' ' GLN . 29.6 t80 -19.37 82.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.436 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.664 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -114.27 63.86 1.31 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.672 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.0 Cg_endo -53.45 96.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.952 2.435 . . . . 0.0 112.594 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.03 ' HB ' HD11 ' A' ' 42' ' ' LEU . 28.5 m -98.66 126.33 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.487 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.462 ' O ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -78.31 120.44 23.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.02 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -108.12 144.77 16.21 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.858 -178.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.47 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -48.23 93.73 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.066 -1.067 . . . . 0.0 110.364 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.7 t70 167.99 -24.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.241 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.0 32.43 5.0 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.023 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.597 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 26.6 mm -132.82 136.51 55.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.564 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.526 HG21 ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -97.04 101.88 13.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.798 178.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.723 ' CE2' HD21 ' A' ' 29' ' ' LEU . 30.8 m-85 -85.77 121.11 27.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.989 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -40.73 -27.15 0.16 Allowed Glycine 0 CA--C 1.506 -0.523 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.053 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 83.9 m-20 -164.63 145.42 7.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.741 0.305 . . . . 0.0 111.079 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -48.06 -26.8 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.166 0.508 . . . . 0.0 109.891 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -77.18 -51.4 11.03 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.494 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 27' ' ' CYS . 0.6 OUTLIER -46.63 -37.17 7.81 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 176.09 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.723 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -54.95 -54.5 42.04 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.263 176.408 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.96 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 12.3 mt -47.5 -32.57 5.36 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.67 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 5.8 t -78.43 -32.26 48.51 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -63.95 -58.72 5.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.576 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.425 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -55.95 -25.97 45.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.488 179.048 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.2 -34.04 61.46 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -129.83 27.3 5.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.84 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 43.5 t -92.74 -94.95 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.632 0.253 . . . . 0.0 111.323 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.79 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.935 0.397 . . . . 0.0 110.541 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.41 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 7.9 t -138.41 147.16 54.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.721 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 16.4 Cg_endo -57.74 93.27 0.06 OUTLIER 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.841 2.361 . . . . 0.0 112.393 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.577 ' CG1' ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -79.45 126.85 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.98 0.419 . . . . 0.0 111.075 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.582 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 2.6 mm-40 -97.36 -156.9 0.56 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.073 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.03 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.7 OUTLIER -120.97 149.45 42.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.515 178.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.58 HG12 ' CD2' ' A' ' 44' ' ' HIS . 2.4 t -138.36 -36.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.921 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.58 ' CD2' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -157.35 122.13 4.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.815 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -71.2 65.88 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.139 -179.62 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 22' ' ' THR . . . -179.22 -162.25 28.14 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HA ' HG21 ' A' ' 22' ' ' THR . 4.2 mtt180 -87.27 57.64 4.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.944 0.402 . . . . 0.0 110.545 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.54 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 10.9 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.11 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.902 0.382 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.55 -173.68 1.23 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.717 2.278 . . . . 0.0 112.333 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.66 158.23 44.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.609 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.82 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -142.24 151.15 57.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.006 0.431 . . . . 0.0 111.567 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.42 -163.64 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.914 2.409 . . . . 0.0 112.081 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.449 ' CA ' ' HB2' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -119.15 50.02 1.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 111.271 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 7' ' ' ILE . 13.5 mm -146.96 80.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -104.13 -38.06 7.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.456 0.646 . . . . 0.0 109.972 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.505 ' OG1' ' N ' ' A' ' 10' ' ' MET . 6.2 t -171.96 -163.0 0.23 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.112 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.505 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.9 OUTLIER -128.05 16.69 6.74 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.486 178.101 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 2.4 mt-30 -71.53 58.94 0.29 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.906 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.525 ' CD1' ' HD3' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -25.99 87.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.942 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.683 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -121.86 71.29 30.05 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.802 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.0 Cg_endo -55.62 95.95 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.843 2.362 . . . . 0.0 112.545 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.041 ' HB ' HD11 ' A' ' 42' ' ' LEU . 4.4 m -96.74 126.83 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.485 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.525 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.23 118.86 20.85 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.211 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.56 143.16 15.65 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.983 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 40.4 t -50.98 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.253 -0.974 . . . . 0.0 110.17 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.523 ' HB2' HG22 ' A' ' 40' ' ' ILE . 12.7 t0 171.65 -27.69 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.616 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.85 31.06 3.75 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.39 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 23.0 mm -136.91 139.91 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 119.753 -0.779 . . . . 0.0 113.011 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.48 HG22 ' HB2' ' A' ' 14' ' ' PRO . 3.9 m -98.42 102.64 14.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.879 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.877 ' CE2' HD21 ' A' ' 29' ' ' LEU . 37.3 m-85 -84.94 123.96 31.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.887 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -41.25 -25.99 0.17 Allowed Glycine 0 CA--C 1.505 -0.534 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.127 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.8 m-20 -164.91 145.91 7.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.912 0.387 . . . . 0.0 111.454 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.41 -27.46 4.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.347 0.594 . . . . 0.0 109.554 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -78.1 -49.09 14.6 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.49 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -47.8 -37.92 14.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 175.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.877 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -54.96 -52.77 62.01 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 112.908 -1.951 . . . . 0.0 109.168 176.348 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.82 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 13.2 mt -48.07 -33.35 7.98 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 28' ' ' MET . 24.9 t -75.09 -32.89 61.56 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.1 -57.71 7.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.481 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.97 -23.01 29.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.145 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.83 -17.6 35.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.377 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -133.44 18.11 3.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.2 t -100.72 -97.57 0.26 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.334 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 56.5 t0 179.52 -32.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 0.0 110.643 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 t -126.97 149.5 69.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.801 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -70.03 87.22 0.59 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.613 2.209 . . . . 0.0 112.205 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.676 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -49.88 149.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.427 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 18' ' ' SER . 31.5 mt-10 -130.68 101.88 5.87 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.101 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.041 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -28.32 146.54 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.223 0.535 . . . . 0.0 111.517 -179.354 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -132.58 -46.85 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.221 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.546 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -150.45 123.8 8.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.394 179.671 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -70.25 68.58 0.34 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.201 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 22' ' ' THR . . . 178.42 -158.92 23.9 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 57.36 3.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.165 0.507 . . . . 0.0 110.176 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.546 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 7.0 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.918 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.585 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.964 0.412 . . . . 0.0 111.168 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 1' ' ' LYS . 61.1 Cg_endo -73.17 -167.04 0.33 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.785 2.323 . . . . 0.0 112.523 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.446 ' HA ' ' CB ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -34.48 134.03 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.637 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.424 ' HB3' HD22 ' A' ' 30' ' ' LEU . . . -112.68 110.24 52.51 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.724 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -38.17 120.26 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.8 2.334 . . . . 0.0 112.553 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 4.2 p -84.7 77.36 10.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.159 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.714 HG22 ' O ' ' A' ' 7' ' ' ILE . 8.3 mm -130.36 52.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.508 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 46.0 m -79.53 -35.73 39.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.355 0.598 . . . . 0.0 109.842 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.466 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -170.36 138.41 1.56 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.627 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.7 mtt -94.84 20.65 8.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.902 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 2.8 mm-40 -84.62 -99.75 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.245 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.504 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 7.9 t80 178.18 79.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.528 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.67 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -111.06 64.38 0.48 Allowed Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.622 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.1 Cg_endo -56.63 92.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.65 2.233 . . . . 0.0 112.198 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.034 ' HB ' HD11 ' A' ' 42' ' ' LEU . 19.6 m -95.09 126.43 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.516 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.681 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.85 117.4 19.18 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.264 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.42 141.11 15.14 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.513 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 38.1 m -48.86 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.21 -0.995 . . . . 0.0 110.359 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.544 ' OD2' HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 169.07 -25.93 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.142 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.72 30.74 4.47 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.337 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 9.7 mm -131.77 138.91 51.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.667 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.515 HG22 ' HB2' ' A' ' 14' ' ' PRO . 3.1 m -99.76 99.48 10.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.729 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.833 ' CE2' HD21 ' A' ' 29' ' ' LEU . 33.1 m-85 -83.69 122.89 29.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.721 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -42.28 -24.15 0.19 Allowed Glycine 0 CA--C 1.505 -0.579 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.134 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.595 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -169.83 146.68 3.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.754 0.312 . . . . 0.0 111.108 -179.328 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -47.19 -25.54 0.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.292 0.568 . . . . 0.0 110.263 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -76.95 -54.77 6.14 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.817 178.651 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.548 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 36.4 mtp -45.53 -33.3 2.66 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.833 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -59.42 -54.36 47.53 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.469 -1.696 . . . . 0.0 108.892 177.315 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' CYS . 11.8 mt -49.07 -29.43 5.11 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.556 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 28' ' ' MET . 1.4 m -79.64 -31.12 41.52 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -68.93 -58.75 3.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.157 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.46 -33.02 63.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.268 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 3' ' ' ASP . . . -90.44 -3.12 57.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.333 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 4.5 mtp180 -96.56 -51.09 4.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.942 0.401 . . . . 0.0 111.024 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.7 t -86.82 -99.15 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.436 ' O ' ' HD3' ' A' ' 39' ' ' PRO . 6.5 p30 178.92 -26.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.411 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -79.15 111.45 20.33 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.928 0.394 . . . . 0.0 111.121 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 33.5 Cg_exo -57.82 93.75 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.844 2.362 . . . . 0.0 112.486 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.695 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -69.54 157.49 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.767 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 18' ' ' SER . 36.9 mt-10 -140.95 103.46 4.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.049 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.034 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -28.24 147.09 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.169 0.509 . . . . 0.0 111.315 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.82 HG22 ' CD2' ' A' ' 44' ' ' HIS . 13.6 p -139.39 -38.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.495 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.82 ' CD2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.78 123.29 7.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.529 178.524 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 64.75 0.41 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.294 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.37 -160.31 24.89 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -90.12 54.22 2.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.972 0.415 . . . . 0.0 110.664 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.529 ' SG ' ' CE1' ' A' ' 44' ' ' HIS . 4.9 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.056 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -42.03 138.81 2.73 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.601 2.2 . . . . 0.0 111.801 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 1.3 p -93.23 56.03 2.42 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.257 0.551 . . . . 0.0 111.532 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.811 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.6 mp -132.05 57.15 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.582 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -78.9 -41.16 30.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.101 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.481 ' OG1' ' N ' ' A' ' 10' ' ' MET . 6.4 t -173.65 -165.88 0.28 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.395 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.481 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -124.1 17.59 9.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.035 177.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -73.08 58.76 0.5 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.993 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.471 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 9.0 t80 -25.18 84.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.292 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.701 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -114.91 64.67 1.63 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -51.74 97.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.034 2.489 . . . . 0.0 112.331 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.963 ' HB ' HD11 ' A' ' 42' ' ' LEU . 27.8 m -99.49 127.38 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.524 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.618 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.26 121.47 24.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.0 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -113.52 142.41 17.44 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.161 -1.019 . . . . 0.0 113.184 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 45.0 t -40.1 98.01 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.333 -0.933 . . . . 0.0 109.771 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' SER . 1.7 t0 160.19 -22.71 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.985 -1.462 . . . . 0.0 108.748 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.688 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 94.23 25.08 17.43 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.988 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 20' ' ' GLY . 0.9 OUTLIER -118.45 124.56 73.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.861 -179.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.55 HG22 ' HB2' ' A' ' 14' ' ' PRO . 3.1 m -86.36 98.18 10.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.494 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.809 ' OH ' HG21 ' A' ' 40' ' ' ILE . 52.3 m-85 -79.47 123.81 27.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.017 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -37.49 -27.84 0.03 OUTLIER Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.533 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.7 p30 -174.33 155.54 2.37 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.934 0.397 . . . . 0.0 110.996 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -48.47 -23.03 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.928 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.584 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 26.1 m -83.6 -46.77 12.0 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.526 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -48.62 -36.17 15.24 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 175.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.991 HD11 HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -55.93 -50.18 71.45 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 112.933 -1.939 . . . . 0.0 108.837 177.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.584 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 11.7 mt -48.27 -30.56 4.91 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.746 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -73.19 -35.74 66.42 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.61 -57.85 5.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.309 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -61.34 -16.88 50.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.365 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.85 -38.19 13.11 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -149.64 42.66 0.9 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 31.0 t -96.09 -81.52 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.897 0.379 . . . . 0.0 110.978 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -175.39 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.242 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.804 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -144.97 154.18 54.53 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.253 179.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.804 ' HD2' HG22 ' A' ' 38' ' ' THR . 38.0 Cg_endo -66.54 81.27 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.586 2.19 . . . . 0.0 112.507 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.809 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -54.5 169.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.219 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 42' ' ' LEU . 19.5 mt-10 -148.68 100.9 3.16 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.89 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.991 HD23 HD11 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -31.02 148.65 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 111.227 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.594 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 2.7 t -144.98 -37.24 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.033 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.618 ' CD2' ' HB3' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -148.97 120.35 7.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.0 110.858 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.6 mttp -70.19 66.5 0.29 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.27 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 22' ' ' THR . . . 179.67 -160.26 25.35 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -90.12 55.14 3.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.904 0.383 . . . . 0.0 110.442 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.577 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 7.1 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.283 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.921 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 120.688 0.28 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.902 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 35.7 Cg_exo -59.32 170.44 3.12 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.582 2.188 . . . . 0.0 112.026 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.4 p -165.77 72.64 0.17 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.441 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.795 HG22 ' O ' ' A' ' 7' ' ' ILE . 26.8 mt -137.67 63.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 0.0 111.719 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 26.8 m -87.09 -40.14 14.94 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.411 0.624 . . . . 0.0 109.367 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 t -172.47 143.91 1.44 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.712 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.18 26.04 3.95 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 47.8 mt-30 -84.11 -103.45 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.322 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.446 ' O ' ' CD ' ' A' ' 14' ' ' PRO . 2.4 t80 179.69 71.9 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.491 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER -106.98 71.07 0.27 Allowed Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 27.6 Cg_endo -61.97 101.49 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.654 2.236 . . . . 0.0 112.842 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.006 ' HB ' HD11 ' A' ' 42' ' ' LEU . 35.1 m -105.9 127.89 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.278 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.554 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -77.81 123.09 26.3 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.218 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -111.49 144.18 17.47 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.826 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.541 ' HB3' ' CG ' ' A' ' 41' ' ' GLU . 16.9 t -45.07 96.91 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.35 -0.925 . . . . 0.0 110.07 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.578 ' HB2' HG22 ' A' ' 40' ' ' ILE . 4.9 t0 163.76 -23.01 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.929 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.659 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 98.33 24.13 11.75 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.324 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.661 HG21 ' CE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -119.42 135.03 61.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.911 -179.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.449 ' CG2' ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -94.41 99.63 11.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.563 178.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.833 ' CE2' HD21 ' A' ' 29' ' ' LEU . 51.6 m-85 -82.64 122.56 28.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.055 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.476 ' HA3' ' CE ' ' A' ' 28' ' ' MET . . . -41.13 -27.22 0.21 Allowed Glycine 0 CA--C 1.507 -0.468 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.218 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.8 m-20 -164.47 146.32 8.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.74 0.305 . . . . 0.0 110.803 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.69 -25.14 2.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.227 0.537 . . . . 0.0 110.358 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -77.81 -50.55 12.1 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.476 ' CE ' ' HA3' ' A' ' 24' ' ' GLY . 2.8 mmm -45.99 -40.4 10.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.882 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -52.69 -55.94 19.07 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 113.445 -1.707 . . . . 0.0 109.775 176.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 13.8 mt -48.58 -32.57 8.29 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.4 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -75.75 -31.72 59.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.632 ' HB3' HD11 ' A' ' 40' ' ' ILE . . . -66.69 -59.23 3.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.951 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.473 ' OG ' HG12 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -52.29 -28.7 19.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.414 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.921 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . . . -70.16 -37.73 75.27 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -135.95 35.69 2.84 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 46.9 t -90.86 -95.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.691 0.281 . . . . 0.0 111.516 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -179.7 -35.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.124 0.488 . . . . 0.0 110.109 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.642 HG23 ' HD2' ' A' ' 39' ' ' PRO . 55.1 m -136.53 142.91 41.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.207 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.642 ' HD2' HG23 ' A' ' 38' ' ' THR . 10.5 Cg_endo -53.52 92.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.906 2.404 . . . . 0.0 112.928 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.632 HD11 ' HB3' ' A' ' 32' ' ' ALA . 0.9 OUTLIER -78.57 148.34 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.139 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.541 ' CG ' ' HB3' ' A' ' 18' ' ' SER . 10.3 pt-20 -152.31 116.78 5.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.262 0.553 . . . . 0.0 111.123 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.006 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -21.61 145.25 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.794 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.636 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -136.4 -42.18 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.469 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.636 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.96 125.97 9.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.206 178.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -70.75 65.72 0.33 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.223 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.59 -160.61 27.37 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.449 ' HA ' ' CG2' ' A' ' 22' ' ' THR . 2.9 mtp180 -90.28 54.15 2.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.161 0.505 . . . . 0.0 110.845 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.594 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 4.2 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.215 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.912 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.812 0.339 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.912 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 81.3 Cg_exo -43.61 135.92 6.71 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.611 2.207 . . . . 0.0 112.01 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 7.9 p -132.97 79.88 1.86 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.037 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.762 HG22 ' O ' ' A' ' 7' ' ' ILE . 5.4 mp -133.93 52.47 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 55.3 m -84.39 -34.16 23.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.482 0.658 . . . . 0.0 109.627 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.658 HG23 ' ND2' ' A' ' 25' ' ' ASN . 2.4 t -171.25 136.22 1.03 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.078 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.2 mtt -93.81 24.71 3.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.476 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.9 -100.66 0.17 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.366 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.509 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 1.5 t80 179.54 76.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.61 0.243 . . . . 0.0 110.977 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.528 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.5 69.94 0.29 Allowed Pre-proline 0 CA--C 1.516 -0.332 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.697 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.4 Cg_endo -56.31 102.64 0.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.779 2.319 . . . . 0.0 112.805 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.016 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.9 m -106.76 133.81 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.508 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.561 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.29 119.99 22.43 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.893 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -106.01 140.92 15.33 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.43 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 48.5 t -48.28 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.245 -0.978 . . . . 0.0 110.414 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.521 ' HB2' HG22 ' A' ' 40' ' ' ILE . 7.1 t0 171.68 -30.52 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.563 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.48 33.76 2.23 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.587 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.1 mt -135.49 154.39 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 14' ' ' PRO . 2.5 m -109.66 99.25 8.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.373 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.88 ' CE2' HD21 ' A' ' 29' ' ' LEU . 53.9 m-85 -83.89 129.28 34.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.321 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.445 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -41.35 -27.15 0.25 Allowed Glycine 0 CA--C 1.504 -0.652 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.328 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.658 ' ND2' HG23 ' A' ' 9' ' ' THR . 81.6 m-20 -166.66 146.05 5.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.792 0.33 . . . . 0.0 111.149 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.02 -25.44 3.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.396 0.617 . . . . 0.0 109.868 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 1.1 m -79.89 -49.6 11.68 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.85 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 27' ' ' CYS . 7.6 mmm -47.04 -37.65 9.74 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.062 HD12 HD23 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -55.69 -56.99 13.94 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.258 -1.792 . . . . 0.0 109.498 176.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 27' ' ' CYS . 12.4 mt -48.24 -32.94 7.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.559 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -76.46 -32.11 58.2 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.49 -56.75 10.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.256 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.634 ' OG ' HD11 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -51.11 -36.31 39.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.033 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.69 -0.34 57.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.042 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 24.3 mtp180 -111.81 -38.86 4.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.6 t -85.36 -108.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.561 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p30 179.5 33.0 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.782 0.325 . . . . 0.0 110.944 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 m -146.79 134.12 10.23 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.795 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.71 83.98 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.814 2.343 . . . . 0.0 112.865 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.705 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -70.01 154.49 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.632 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.484 ' O ' ' O ' ' A' ' 42' ' ' LEU . 13.1 mt-10 -143.04 101.83 3.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.09 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.062 HD23 HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -29.46 150.81 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.032 0.444 . . . . 0.0 111.632 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.639 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 1.4 t -144.6 -41.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.185 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.639 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -153.21 121.21 6.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.805 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.29 70.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.374 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.35 -164.88 34.94 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.3 56.35 3.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.104 0.478 . . . . 0.0 110.41 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.597 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 20.9 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.173 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.796 ' HB1' ' CB ' ' A' ' 34' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.433 0 CA-C-O 120.516 0.198 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.652 ' CD ' ' HB3' ' A' ' 4' ' ' ALA . 96.4 Cg_exo -26.75 141.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.119 2.546 . . . . 0.0 112.104 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -92.91 52.87 1.9 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.003 0.43 . . . . 0.0 111.122 -179.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.7 mm -145.92 90.75 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.782 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.01 -38.68 3.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.36 0.6 . . . . 0.0 109.894 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 11' ' ' GLN . 10.0 t -172.5 -162.9 0.2 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.268 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.463 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -129.09 16.48 6.18 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.501 177.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -74.03 60.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.995 179.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.56 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 8.4 t80 -20.32 84.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.487 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.658 ' O ' HG13 ' A' ' 15' ' ' VAL . 20.5 t0 -114.47 59.29 1.0 Allowed Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.2 Cg_endo -54.28 96.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.754 2.303 . . . . 0.0 112.223 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.976 ' HB ' HD11 ' A' ' 42' ' ' LEU . 33.8 m -98.22 127.66 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.814 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.586 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.61 116.45 18.99 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.322 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.697 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.92 138.01 13.83 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.681 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 13.3 t -46.62 96.05 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.246 -0.977 . . . . 0.0 110.495 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 165.46 -23.53 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.235 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.77 32.97 4.88 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.318 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 36.3 mm -130.28 130.71 65.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.362 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.18 99.59 11.82 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.605 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.76 ' CE2' HD21 ' A' ' 29' ' ' LEU . 39.4 m-85 -83.03 121.8 27.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.824 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -36.28 -29.38 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.327 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.523 ' OD1' ' HG3' ' A' ' 28' ' ' MET . 2.1 p30 -173.37 154.82 2.71 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.098 0.475 . . . . 0.0 111.067 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.8 -23.53 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.807 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.518 ' HA ' HD12 ' A' ' 30' ' ' LEU . 1.2 m -78.48 -51.98 9.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.523 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 1.2 mtt -46.32 -42.1 14.24 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.931 HD11 HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -52.46 -54.27 34.5 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.384 -1.735 . . . . 0.0 109.556 177.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 27' ' ' CYS . 7.5 mt -48.22 -31.83 6.33 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.527 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.537 ' CA ' ' O ' ' A' ' 4' ' ' ALA . 7.3 t -76.76 -31.78 57.31 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.209 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -64.03 -58.65 6.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.349 178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.579 ' HB2' HD11 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -63.98 -15.71 59.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.206 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.796 ' CB ' ' HB1' ' A' ' 4' ' ' ALA . . . -90.05 -26.28 20.37 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HD2' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -131.23 18.95 4.89 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 10.2 t -105.62 -119.7 0.23 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p30 179.4 24.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.0 m -161.75 112.54 1.2 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.63 0.252 . . . . 0.0 110.523 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.1 94.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.603 2.202 . . . . 0.0 112.225 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.721 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -63.53 153.36 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.401 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 18' ' ' SER . 10.9 mt-10 -132.82 92.75 3.09 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.084 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.976 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -32.81 148.7 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.258 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.6 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 2.5 t -142.5 -38.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.646 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.6 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.29 117.75 6.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.471 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.23 65.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.641 -179.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.55 -163.21 29.49 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -85.59 59.02 5.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.084 0.468 . . . . 0.0 110.497 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.594 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 17.5 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.972 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.808 ' HB3' ' CD ' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 120.674 0.274 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.808 ' CD ' ' HB3' ' A' ' 4' ' ' ALA . 59.9 Cg_exo -27.38 144.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.309 2.673 . . . . 0.0 112.473 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.411 ' O ' HG12 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -102.01 54.05 0.8 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.97 0.414 . . . . 0.0 111.567 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 7' ' ' ILE . 3.6 mm -146.49 78.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.644 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -103.14 -39.34 6.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.325 0.583 . . . . 0.0 110.29 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.582 HG23 ' H ' ' A' ' 11' ' ' GLN . 9.8 t -173.19 -160.93 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.761 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.506 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -128.5 17.88 6.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.367 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.582 ' H ' HG23 ' A' ' 9' ' ' THR . 0.1 OUTLIER -72.29 58.87 0.39 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.345 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -26.65 85.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.147 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.69 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -121.61 67.25 20.39 Favored Pre-proline 0 N--CA 1.454 -0.241 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.0 Cg_endo -53.0 95.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.897 2.398 . . . . 0.0 112.57 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.961 ' HB ' HD11 ' A' ' 42' ' ' LEU . 25.5 m -95.94 126.91 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.8 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.602 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.69 118.43 20.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.744 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -108.55 145.34 16.4 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.688 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 10.6 p -48.32 97.15 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.501 -0.849 . . . . 0.0 109.991 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.535 ' HB2' HG22 ' A' ' 40' ' ' ILE . 7.6 t70 168.84 -25.83 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.853 -1.521 . . . . 0.0 108.695 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.42 30.65 5.83 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.603 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -127.53 146.29 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.543 HG22 ' HB2' ' A' ' 14' ' ' PRO . 6.2 m -107.39 97.81 7.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.501 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.854 ' CE2' HD21 ' A' ' 29' ' ' LEU . 36.7 m-85 -81.74 123.1 28.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.403 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.46 ' H ' ' HE3' ' A' ' 28' ' ' MET . . . -39.9 -26.52 0.1 OUTLIER Glycine 0 CA--C 1.508 -0.406 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.319 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.545 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -171.82 149.21 2.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.003 0.43 . . . . 0.0 110.684 179.132 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.91 -24.55 0.62 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.834 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.615 ' HA ' HD12 ' A' ' 30' ' ' LEU . 1.6 m -77.74 -50.78 11.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.196 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.545 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -46.79 -37.66 8.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.854 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.41 -52.66 63.81 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.987 -1.915 . . . . 0.0 109.246 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.621 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 5.5 mt -49.6 -32.12 12.15 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.6 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.531 ' CA ' ' O ' ' A' ' 4' ' ' ALA . 7.7 t -75.9 -29.3 58.39 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -69.5 -62.3 1.44 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.905 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.14 -13.51 27.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.446 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 30' ' ' LEU . . . -82.97 -29.75 28.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.302 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.429 ' CD ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -144.38 29.49 1.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 47.4 t -92.1 -97.04 0.13 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.618 0.247 . . . . 0.0 110.913 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 179.72 -32.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 0.0 110.731 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 9.2 m -127.53 133.06 24.68 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.939 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 35.0 Cg_exo -60.51 90.11 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.759 2.306 . . . . 0.0 112.579 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.627 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -63.9 163.02 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.543 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 18' ' ' SER . 1.5 mt-10 -149.86 107.13 3.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.809 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.961 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -29.27 148.92 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.08 0.466 . . . . 0.0 111.577 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.651 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.8 t -142.65 -39.2 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.416 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.651 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -153.86 121.06 5.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.523 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -69.27 68.3 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.106 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.3 -171.12 44.12 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.41 57.36 2.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.084 0.468 . . . . 0.0 110.504 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.56 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 21.1 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.052 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.565 ' O ' ' CB ' ' A' ' 31' ' ' CYS . . . . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 4' ' ' ALA . 33.5 Cg_exo -29.91 126.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.747 2.298 . . . . 0.0 112.158 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.444 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -93.12 44.97 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 110.988 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.815 HG22 ' O ' ' A' ' 7' ' ' ILE . 31.5 mt -152.61 63.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.7 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -80.95 -41.6 22.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.916 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 t -172.02 162.23 5.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.88 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -92.47 18.66 8.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 2.1 tt0 -72.02 58.53 0.35 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.165 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.509 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -21.52 82.96 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.36 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.762 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -112.76 62.64 0.72 Allowed Pre-proline 0 N--CA 1.452 -0.341 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.4 Cg_endo -55.58 93.89 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.815 2.343 . . . . 0.0 112.455 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.006 ' HB ' HD11 ' A' ' 42' ' ' LEU . 5.7 m -97.29 125.92 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.719 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.6 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.55 117.23 19.54 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.749 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.647 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -106.16 143.56 15.75 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.298 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 4.2 t -49.27 95.06 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.301 -0.95 . . . . 0.0 110.001 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.7 -25.68 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.954 -1.476 . . . . 0.0 109.006 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.3 34.04 3.77 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.377 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.6 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 27.4 mm -137.19 136.19 47.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 14' ' ' PRO . 2.9 m -96.73 97.9 9.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.232 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.82 ' CE2' HD21 ' A' ' 29' ' ' LEU . 41.3 m-85 -80.07 126.37 30.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.299 -178.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.22 -25.51 0.05 OUTLIER Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.505 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 0.9 OUTLIER -176.41 150.27 0.88 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.2 -25.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.567 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -76.45 -52.86 9.01 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.535 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -44.77 -41.25 6.74 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.124 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.82 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -53.93 -54.37 39.79 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 112.986 -1.916 . . . . 0.0 109.411 177.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 13.0 mt -48.88 -33.84 11.47 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.156 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -74.85 -32.62 61.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -62.63 -57.18 11.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.627 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -17.54 56.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.169 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.39 -15.38 35.68 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -136.03 1.45 2.73 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -89.04 -99.15 0.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.546 0.213 . . . . 0.0 111.038 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 178.77 -31.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.36 . . . . 0.0 110.953 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.871 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -117.4 151.33 47.94 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.114 0.483 . . . . 0.0 111.42 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.871 ' HD2' HG22 ' A' ' 38' ' ' THR . 97.5 Cg_endo -80.13 86.51 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.997 2.465 . . . . 0.0 112.029 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.717 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.47 155.22 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.77 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 18' ' ' SER . 20.9 mt-10 -135.0 96.84 3.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.746 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.006 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -29.26 147.41 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.224 0.535 . . . . 0.0 111.439 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.628 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 1.7 t -135.46 -41.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.295 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.628 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -153.35 121.24 6.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.58 -179.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -70.27 67.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.0 0.429 . . . . 0.0 111.148 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 22' ' ' THR . . . 179.05 -165.27 34.09 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.76 57.36 4.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.033 0.444 . . . . 0.0 110.649 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.595 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.8 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.938 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.772 0.32 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.938 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 51.9 Cg_exo -53.7 178.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.511 2.14 . . . . 0.0 111.575 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.78 ' C ' HD12 ' A' ' 7' ' ' ILE . 26.2 p -170.47 76.33 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.657 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.786 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.8 mp -131.68 57.56 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.36 . . . . 0.0 111.667 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 57.6 m -83.08 -38.38 22.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.316 0.579 . . . . 0.0 110.099 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 11' ' ' GLN . 1.8 t -171.61 139.92 1.29 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.432 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.34 25.91 4.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.469 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 55.2 mt-30 -91.68 -100.79 0.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.647 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.521 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 179.83 77.55 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.117 -179.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.56 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -111.22 65.07 0.53 Allowed Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.666 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 12.9 Cg_endo -56.29 98.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.032 2.488 . . . . 0.0 112.77 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.998 ' HB ' HD11 ' A' ' 42' ' ' LEU . 24.8 m -99.25 130.2 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.779 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.565 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.65 117.69 20.04 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.262 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -109.38 140.93 15.9 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.966 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 2.5 m -42.3 96.97 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.275 -0.963 . . . . 0.0 109.635 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 18' ' ' SER . 7.3 t0 163.34 -22.87 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.913 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.675 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 96.52 23.48 16.17 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.675 HD12 ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -119.05 131.97 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.923 -179.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 14' ' ' PRO . 1.6 m -92.77 98.2 11.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.418 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.838 ' CE2' HD21 ' A' ' 29' ' ' LEU . 47.3 m-85 -81.03 123.89 28.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.322 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -37.49 -30.47 0.06 OUTLIER Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.15 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' HB2' ' HG3' ' A' ' 28' ' ' MET . 83.8 m-20 -165.34 147.85 7.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.361 -0.419 . . . . 0.0 111.073 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.27 -25.74 2.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.298 0.571 . . . . 0.0 110.009 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -77.19 -51.94 10.11 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.534 178.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.471 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 2.0 mtt -44.69 -39.78 5.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 176.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.844 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -56.24 -54.61 43.24 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.686 176.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 27' ' ' CYS . 4.1 mt -47.68 -35.11 9.03 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.212 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -74.42 -33.28 62.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.022 178.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -63.12 -55.52 24.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.293 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.658 ' OG ' HD11 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -51.8 -35.08 42.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.44 179.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.652 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . . . -90.71 -2.49 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.493 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -120.66 -18.77 7.64 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.2 t -89.83 -98.67 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.456 0.169 . . . . 0.0 111.229 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 38' ' ' THR . 28.8 p30 179.11 -30.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.729 0.3 . . . . 0.0 111.058 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.515 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 3.3 t -107.88 137.18 19.71 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 0.0 110.767 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.74 89.47 0.99 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.74 2.293 . . . . 0.0 112.72 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.677 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -53.96 169.63 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.414 179.154 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 18' ' ' SER . 18.4 mt-10 -147.06 98.3 3.01 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.061 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.998 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -29.13 148.04 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.1 0.476 . . . . 0.0 111.212 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.686 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -138.33 -40.31 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.49 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.686 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -154.41 121.59 5.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.563 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -69.64 67.0 0.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.382 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.18 -161.74 28.12 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.2 56.45 3.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.114 0.483 . . . . 0.0 110.522 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.599 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 6.6 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.096 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.782 0.325 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 4' ' ' ALA . 83.8 Cg_exo -47.0 -176.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.639 2.226 . . . . 0.0 112.155 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.704 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -108.47 50.53 0.77 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.042 0.449 . . . . 0.0 111.301 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.704 HD12 ' C ' ' A' ' 6' ' ' CYS . 4.8 mp -145.53 89.78 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.03 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.38 -42.1 3.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.58 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.9 t -171.7 -168.71 0.62 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.337 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.515 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -118.01 17.78 14.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.484 178.115 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 13' ' ' ASP . 24.8 mt-30 -69.53 57.67 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.389 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' GLN . 4.6 t80 -27.54 85.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.787 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.579 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -123.86 72.47 53.23 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.0 Cg_endo -55.54 99.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.493 2.129 . . . . 0.0 112.117 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.046 ' HB ' HD11 ' A' ' 42' ' ' LEU . 32.9 m -97.55 128.18 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.979 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.51 116.93 19.24 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.642 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.35 135.99 12.91 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.74 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 11.1 m -49.45 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.319 -0.94 . . . . 0.0 110.756 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 t70 170.05 -26.13 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.05 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.32 31.19 3.59 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.378 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.517 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 19.3 mm -134.22 138.13 50.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.772 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.428 HG22 ' HB2' ' A' ' 14' ' ' PRO . 1.8 m -100.32 99.64 10.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.414 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.725 ' CE2' HD21 ' A' ' 29' ' ' LEU . 34.3 m-85 -81.4 127.59 32.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.804 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.82 -21.57 0.6 Allowed Glycine 0 CA--C 1.509 -0.341 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.521 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.582 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -172.4 146.33 1.77 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 0.0 110.989 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.06 -24.67 1.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.506 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.3 m -78.79 -50.36 11.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.334 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.556 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 16.3 mtt -48.27 -34.58 10.58 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.828 HD11 HD23 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -59.91 -51.86 67.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 113.098 -1.864 . . . . 0.0 108.833 177.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 12.9 mt -48.3 -31.85 6.55 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 28' ' ' MET . 13.9 t -72.86 -34.99 67.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.37 -59.95 2.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.63 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -19.23 3.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.383 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.553 ' HB3' ' HE ' ' A' ' 35' ' ' ARG . . . -77.72 -41.62 37.17 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.553 ' HE ' ' HB3' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -140.49 29.77 1.95 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.5 t -81.16 -93.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.718 0.294 . . . . 0.0 110.897 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.35 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.034 0.445 . . . . 0.0 110.466 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.14 129.06 17.8 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.5 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.52 94.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.959 2.439 . . . . 0.0 112.357 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.712 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -59.56 152.96 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.857 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 18' ' ' SER . 12.8 mt-10 -134.16 96.95 3.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.02 0.438 . . . . 0.0 110.838 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.046 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -36.9 148.7 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.455 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.643 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -137.45 -37.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.178 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.643 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.34 121.89 7.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.547 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 64.71 0.26 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.647 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -178.76 -158.27 20.94 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.02 57.84 3.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.23 0.538 . . . . 0.0 110.394 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.64 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 10.8 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.183 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 1.01 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.73 0.3 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.42 ' C ' ' HB2' ' A' ' 31' ' ' CYS . 22.4 Cg_exo -63.76 -166.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.669 2.246 . . . . 0.0 112.06 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.435 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -117.9 50.26 1.16 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.984 0.421 . . . . 0.0 110.951 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.817 HG22 ' O ' ' A' ' 7' ' ' ILE . 3.3 mp -146.62 62.61 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.297 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -36.88 18.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.446 0.641 . . . . 0.0 109.826 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.511 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.1 t -171.67 -172.32 1.02 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.015 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.511 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.5 OUTLIER -119.28 17.41 13.09 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 21.0 mm-40 -71.18 59.22 0.25 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.031 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 11' ' ' GLN . 22.2 t80 -19.83 82.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.198 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.614 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -118.54 69.26 8.32 Favored Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.869 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 19.5 Cg_endo -59.12 94.77 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.412 2.075 . . . . 0.0 112.068 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.011 ' HB ' HD11 ' A' ' 42' ' ' LEU . 22.6 m -99.33 127.01 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.824 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.603 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.36 122.35 25.65 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.751 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -109.15 144.88 16.55 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.956 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 2.5 t -50.8 95.35 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 114.121 -1.04 . . . . 0.0 110.602 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.605 ' HB2' HG22 ' A' ' 40' ' ' ILE . 5.7 t0 171.67 -30.27 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.66 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.88 33.83 1.96 Allowed Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.184 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.592 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 1.2 mt -138.62 149.53 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 46' ' ' GLY . 5.2 m -107.39 99.56 9.07 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.181 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.86 ' CE2' HD21 ' A' ' 29' ' ' LEU . 41.9 m-85 -82.17 123.18 28.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.427 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -40.07 -27.33 0.13 Allowed Glycine 0 CA--C 1.505 -0.557 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.031 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.2 m-20 -164.38 146.24 8.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.779 0.323 . . . . 0.0 111.19 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.18 -27.85 3.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.305 0.574 . . . . 0.0 109.719 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -76.55 -50.12 14.71 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.401 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.492 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -46.5 -39.79 11.41 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 176.118 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.86 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -52.61 -54.59 31.01 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 113.34 -1.754 . . . . 0.0 109.488 176.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.01 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 12.9 mt -48.47 -32.5 7.91 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.223 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 28' ' ' MET . 6.6 t -73.63 -32.69 64.18 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.072 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.63 -59.94 3.43 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.675 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.575 ' HB2' HD11 ' A' ' 40' ' ' ILE . 5.1 t -56.27 -19.14 12.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.029 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.13 -54.52 5.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.546 ' CZ ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -100.5 11.94 38.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 22.0 t -96.34 -116.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 179.11 26.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.43 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -161.21 146.44 10.66 Favored Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.024 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.43 ' HD2' HG22 ' A' ' 38' ' ' THR . 78.3 Cg_endo -79.47 85.06 1.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.686 2.257 . . . . 0.0 112.125 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.661 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -62.23 153.57 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.124 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 18' ' ' SER . 24.5 mt-10 -136.87 102.24 4.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.262 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.011 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.4 OUTLIER -28.96 149.9 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.918 0.389 . . . . 0.0 111.604 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.634 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.7 t -142.37 -39.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.046 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.634 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -152.36 123.41 7.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.927 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 7.5 ptmt -70.4 65.54 0.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 22' ' ' THR . . . 178.99 -167.76 38.2 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -83.47 55.84 3.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.977 0.418 . . . . 0.0 110.674 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.567 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 9.8 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.858 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.95 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.85 0.357 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -50.96 172.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.519 2.146 . . . . 0.0 111.917 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.81 46.97 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.016 0.436 . . . . 0.0 110.745 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 7' ' ' ILE . 16.4 mt -150.29 72.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.063 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.17 -41.12 13.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.358 0.599 . . . . 0.0 110.158 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.405 ' OG1' ' N ' ' A' ' 10' ' ' MET . 4.2 t -171.5 -178.8 2.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.12 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.405 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -107.43 17.25 23.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.605 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -71.89 58.59 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.906 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.441 ' C ' ' O ' ' A' ' 11' ' ' GLN . 5.6 t80 -30.33 87.93 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.838 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.688 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -120.65 66.96 13.66 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -52.03 97.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.001 2.467 . . . . 0.0 112.442 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.0 ' HB ' HD11 ' A' ' 42' ' ' LEU . 28.8 m -97.43 123.83 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.613 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.535 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.85 118.05 19.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.541 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.71 142.53 15.57 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.883 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 16.0 t -52.29 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.297 -0.951 . . . . 0.0 110.179 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 3.1 t0 171.01 -25.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.745 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' ILE . . . 108.58 32.85 3.04 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.532 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' GLY . 42.0 mm -139.27 144.48 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.483 HG21 ' HA ' ' A' ' 47' ' ' ARG . 11.7 m -105.31 98.66 8.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.384 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.849 ' CE2' HD21 ' A' ' 29' ' ' LEU . 35.3 m-85 -80.0 124.21 28.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.926 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA3' ' SD ' ' A' ' 28' ' ' MET . . . -42.0 -24.52 0.18 Allowed Glycine 0 CA--C 1.508 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.266 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.585 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -172.23 147.22 1.98 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.959 0.409 . . . . 0.0 110.714 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -46.7 -25.03 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.679 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 30' ' ' LEU . 1.6 m -77.75 -50.46 12.33 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.331 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.585 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 2.6 mtt -47.96 -35.03 10.08 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 175.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.849 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -58.22 -51.75 68.43 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.735 177.46 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.95 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 14.3 mt -49.6 -31.96 11.77 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.476 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 28' ' ' MET . 37.4 t -76.77 -31.0 56.75 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -66.94 -60.57 2.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.389 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -53.78 -25.31 18.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.896 178.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.64 -15.3 45.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.482 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 -97.34 -44.38 6.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.923 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.9 t -81.18 -102.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.618 0.247 . . . . 0.0 111.102 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 178.39 -27.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.742 0.306 . . . . 0.0 111.185 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -94.01 123.13 60.21 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.949 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.483 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 23.4 Cg_exo -63.53 86.56 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.679 2.253 . . . . 0.0 112.472 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.689 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -39.15 155.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.156 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 18' ' ' SER . 45.0 mt-10 -127.09 94.47 4.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.158 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.0 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -31.96 146.71 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.313 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.619 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -131.71 -45.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.1 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.621 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -145.86 123.43 11.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.416 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -70.87 58.58 0.21 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.3 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.18 -160.03 20.92 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.483 ' HA ' HG21 ' A' ' 22' ' ' THR . 6.0 mtp180 -89.67 57.45 3.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.027 0.442 . . . . 0.0 110.692 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.621 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.8 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.141 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 1.02 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.855 0.36 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.36 177.23 2.74 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.77 2.314 . . . . 0.0 112.342 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.49 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -115.16 45.57 1.61 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 111.123 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.839 HG22 ' O ' ' A' ' 7' ' ' ILE . 38.1 mt -147.11 62.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.78 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.63 -39.22 24.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.121 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.684 HG23 ' H ' ' A' ' 11' ' ' GLN . 10.3 t -171.68 -166.05 0.41 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.047 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.4 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -123.65 17.95 9.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.307 178.086 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.684 ' H ' HG23 ' A' ' 9' ' ' THR . 13.6 mm-40 -70.81 58.53 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.196 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.472 ' C ' ' O ' ' A' ' 11' ' ' GLN . 2.5 t80 -20.13 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.037 0.836 . . . . 0.0 112.234 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -120.46 69.33 15.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.685 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 17.8 Cg_endo -58.16 101.85 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.581 2.188 . . . . 0.0 112.35 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.964 ' HB ' HD11 ' A' ' 42' ' ' LEU . 30.1 m -99.58 130.35 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.202 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.481 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -79.27 118.35 21.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.555 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.2 136.41 13.37 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.193 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 2.2 t -44.15 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.201 -1.0 . . . . 0.0 110.314 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER 166.39 -24.09 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.404 -179.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.74 27.53 6.67 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.0 mm -123.72 140.64 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.78 99.7 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.656 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.815 ' OH ' HG21 ' A' ' 40' ' ' ILE . 39.4 m-85 -81.88 120.78 25.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.664 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -41.1 -26.85 0.19 Allowed Glycine 0 CA--C 1.506 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.276 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.5 m-20 -165.11 146.12 7.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.778 0.323 . . . . 0.0 111.092 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -48.92 -27.46 3.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.256 0.551 . . . . 0.0 109.781 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.1 m -76.47 -50.62 13.59 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.783 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -47.24 -37.25 10.14 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.002 HD11 HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -56.29 -52.25 65.19 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.326 176.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.02 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 12.2 mt -48.02 -32.43 6.62 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.336 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.3 t -73.91 -33.4 63.97 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.11 -61.36 1.97 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.602 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 t -50.56 -22.87 2.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.033 0.444 . . . . 0.0 109.803 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.65 -41.12 32.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.264 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.412 ' HD3' ' C ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -158.84 51.92 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.744 0.307 . . . . 0.0 111.743 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.536 ' HB2' ' CA ' ' A' ' 32' ' ' ALA . 23.1 t -95.26 -78.95 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.259 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -170.17 -37.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.955 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.777 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -154.46 159.16 32.2 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.777 ' HD2' HG22 ' A' ' 38' ' ' THR . 32.1 Cg_exo -58.55 93.62 0.07 OUTLIER 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.782 2.321 . . . . 0.0 112.21 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.815 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -76.16 154.68 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.138 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 16.6 mt-10 -143.66 97.52 3.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.027 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.002 HD23 HD11 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -33.16 149.82 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.363 0.601 . . . . 0.0 111.859 -179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.635 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -142.05 -39.54 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.365 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.635 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -148.56 121.36 8.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.37 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HA ' HG12 ' A' ' 15' ' ' VAL . 18.0 mttt -68.56 68.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.553 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 175.2 -166.75 38.48 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -83.63 58.76 4.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.288 0.566 . . . . 0.0 110.291 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.609 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 33.5 m . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.063 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.838 ' HB3' HD22 ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.873 0.368 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.01 157.92 41.46 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.598 2.198 . . . . 0.0 111.846 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 28' ' ' MET . 2.6 p -115.78 72.74 0.81 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.27 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.782 HG22 ' O ' ' A' ' 7' ' ' ILE . 4.1 mt -135.93 55.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.664 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 55.7 m -79.6 -37.91 35.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.484 0.659 . . . . 0.0 109.514 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t -171.23 141.99 1.68 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 31.8 mtm -91.7 21.12 4.95 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 0.4 OUTLIER -78.42 -108.24 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.873 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.583 ' CD1' ' HD3' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 178.99 76.09 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.655 0.265 . . . . 0.0 111.427 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.551 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -106.77 68.39 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 15.2 Cg_endo -58.98 97.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.639 2.226 . . . . 0.0 112.767 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.038 ' HB ' HD11 ' A' ' 42' ' ' LEU . 19.9 m -99.66 131.01 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.53 0.681 . . . . 0.0 110.783 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.532 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -79.06 119.06 21.66 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.061 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.682 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.71 136.33 13.37 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.678 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 28.8 t -44.73 96.29 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.463 -0.869 . . . . 0.0 109.891 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.3 OUTLIER 166.59 -25.21 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.618 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.783 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 101.61 25.29 8.21 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.455 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.783 HD12 ' O ' ' A' ' 20' ' ' GLY . 1.2 mp -122.37 126.97 74.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.107 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.406 HG22 ' HB2' ' A' ' 14' ' ' PRO . 2.2 m -88.46 98.88 11.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.268 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.677 ' CE2' HD21 ' A' ' 29' ' ' LEU . 33.7 m-85 -81.0 122.13 26.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.7 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -43.15 -24.67 0.32 Allowed Glycine 0 CA--C 1.503 -0.7 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.12 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -169.65 145.47 3.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.966 0.412 . . . . 0.0 111.015 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . -46.63 -26.77 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.929 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.806 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -74.26 -55.59 5.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.976 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.535 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 4.3 mtt -46.67 -34.71 5.31 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.901 HD11 HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -59.69 -53.78 53.99 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.296 -1.774 . . . . 0.0 109.155 177.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.838 HD22 ' HB3' ' A' ' 4' ' ' ALA . 4.8 mt -48.44 -33.55 9.47 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -73.97 -34.46 64.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.96 177.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.49 -58.46 5.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.355 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.462 ' HB2' HD11 ' A' ' 40' ' ' ILE . 1.4 t -55.98 -22.79 28.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.758 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.35 -16.74 30.34 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -133.67 17.65 3.92 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 t -93.77 -95.98 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.6 0.238 . . . . 0.0 111.224 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 p30 179.68 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.203 0.525 . . . . 0.0 109.935 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.9 t -132.57 127.9 20.76 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.962 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.51 93.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.608 2.206 . . . . 0.0 112.588 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.579 ' N ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -53.84 171.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.256 179.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 42' ' ' LEU . 16.0 mt-10 -146.11 101.1 3.48 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.437 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.038 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -33.59 149.47 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.274 0.559 . . . . 0.0 111.486 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 3.1 t -141.65 -33.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.677 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.643 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -157.48 122.2 4.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.534 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -69.22 67.53 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.528 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.72 -168.46 40.81 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.2 mtp85 -81.0 57.72 3.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.006 0.431 . . . . 0.0 110.393 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.604 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 25.6 m . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.126 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.751 ' HB3' ' CD ' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.422 0.153 . . . . 0.0 110.632 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.751 ' CD ' ' HB3' ' A' ' 4' ' ' ALA . 83.0 Cg_exo -28.69 142.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.77 2.313 . . . . 0.0 111.713 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -96.42 55.28 1.45 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.187 0.517 . . . . 0.0 111.574 -178.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 7' ' ' ILE . 26.8 mm -147.74 87.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.631 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.55 -40.07 4.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.432 0.634 . . . . 0.0 110.084 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 10' ' ' MET . 5.6 t -172.5 -163.27 0.22 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.477 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.52 ' N ' ' OG1' ' A' ' 9' ' ' THR . 5.5 mtt -126.01 17.99 7.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.352 177.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -69.84 59.52 0.16 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.493 179.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.468 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -24.6 84.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.078 -179.478 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.802 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.9 t70 -120.77 61.79 9.5 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.6 Cg_endo -53.07 90.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.68 2.254 . . . . 0.0 111.831 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.96 ' HB ' HD11 ' A' ' 42' ' ' LEU . 21.5 m -93.2 123.94 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.941 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.515 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -77.92 116.9 18.76 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.974 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.44 141.84 15.43 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.97 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 13.7 t -48.56 94.72 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.165 -1.018 . . . . 0.0 109.734 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.481 ' HB2' HG22 ' A' ' 40' ' ' ILE . 5.2 t0 171.21 -27.49 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.606 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.28 31.58 4.01 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.218 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.542 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 11.4 mm -135.6 139.73 45.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 14' ' ' PRO . 6.4 m -99.18 99.35 10.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.429 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.819 ' CE2' HD21 ' A' ' 29' ' ' LEU . 35.7 m-85 -82.16 124.06 29.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.2 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -38.82 -25.58 0.04 OUTLIER Glycine 0 CA--C 1.508 -0.375 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.571 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.507 ' OD1' ' HG3' ' A' ' 28' ' ' MET . 2.7 p30 -175.83 153.1 1.33 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.942 0.401 . . . . 0.0 111.363 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.89 -24.45 0.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.752 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -79.24 -51.79 9.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.513 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -45.57 -38.62 6.64 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.819 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -56.06 -53.09 61.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.952 -1.931 . . . . 0.0 109.172 177.506 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 13.0 mt -48.65 -31.13 6.25 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.551 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 49.7 t -78.48 -31.41 47.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.21 -56.62 11.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.839 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.452 ' OG ' HD13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -67.46 -16.53 64.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.472 179.103 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.733 ' HB1' ' HB1' ' A' ' 4' ' ' ALA . . . -90.83 -19.64 23.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.29 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.526 ' CG ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -120.66 3.97 10.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.115 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.6 t -105.71 -117.83 0.23 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.545 -0.168 . . . . 0.0 110.545 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 179.58 32.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.934 0.397 . . . . 0.0 110.775 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -160.51 126.81 2.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.558 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.05 88.4 0.38 Allowed 'Trans proline' 0 N--CA 1.466 -0.133 0 C-N-CA 122.588 2.192 . . . . 0.0 112.344 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.683 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -53.07 155.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.373 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.502 ' O ' ' CB ' ' A' ' 18' ' ' SER . 17.3 mt-10 -134.41 96.99 3.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.233 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.96 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -29.92 147.71 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.647 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.633 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -136.87 -43.27 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.111 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.633 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.26 120.35 7.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.577 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.93 68.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.063 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 22' ' ' THR . . . 179.23 -165.74 34.76 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -86.13 58.1 4.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.386 0.612 . . . . 0.0 110.533 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.608 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.7 m . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.068 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.931 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 120.585 0.231 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 32.2 Cg_exo -58.48 178.63 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.51 2.14 . . . . 0.0 111.917 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 28' ' ' MET . 26.0 p -170.59 71.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.786 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 7' ' ' ILE . 57.4 mt -138.77 69.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.953 0.406 . . . . 0.0 111.484 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.8 m -86.45 -46.66 10.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.373 0.606 . . . . 0.0 109.978 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 t -172.82 163.58 5.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.38 22.26 8.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 1.0 OUTLIER -90.09 64.48 6.19 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.741 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' GLN . 10.0 t80 -21.04 83.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.848 0.717 . . . . 0.0 112.206 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.73 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -109.45 71.93 0.53 Allowed Pre-proline 0 CA--C 1.517 -0.32 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.9 Cg_endo -55.08 95.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.837 2.358 . . . . 0.0 112.593 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.996 ' HB ' HD11 ' A' ' 42' ' ' LEU . 3.6 m -97.06 129.75 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.637 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.549 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.15 118.95 20.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.346 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.632 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.21 142.67 15.78 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.004 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 2.4 t -46.47 94.48 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 113.986 -1.107 . . . . 0.0 110.215 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.47 ' HB2' HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 168.28 -26.82 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.884 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.85 33.58 4.04 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.279 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.571 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 42.2 mm -135.16 138.2 49.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.616 HG22 ' HB2' ' A' ' 14' ' ' PRO . 3.6 m -95.54 99.91 11.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.927 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.886 ' CE2' HD21 ' A' ' 29' ' ' LEU . 43.1 m-85 -84.46 123.57 30.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.13 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -40.22 -26.57 0.12 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.288 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.467 ' HB2' ' SD ' ' A' ' 28' ' ' MET . 80.9 m-20 -168.46 151.14 5.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.728 0.299 . . . . 0.0 111.571 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.35 -24.56 3.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.182 0.515 . . . . 0.0 110.014 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -81.24 -50.81 9.1 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.482 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -47.74 -35.36 9.71 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.359 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.886 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.44 -53.5 56.74 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.78 176.422 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' CYS . 13.3 mt -49.29 -33.81 13.92 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.302 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.466 ' O ' ' HD2' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -73.84 -31.39 63.17 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.08 -62.11 1.59 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.59 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.05 -30.97 0.81 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.79 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.774 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . . . -78.22 -25.27 46.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.244 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -143.02 38.08 1.43 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.258 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' ALA . 7.0 t -107.26 -79.04 0.58 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.672 0.272 . . . . 0.0 111.059 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 36' ' ' SER . 10.2 t70 179.23 -50.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.906 0.384 . . . . 0.0 110.9 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.496 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -135.85 167.53 21.62 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.063 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.496 ' HD2' HG22 ' A' ' 38' ' ' THR . 36.9 Cg_endo -65.36 88.8 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.803 2.335 . . . . 0.0 112.213 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.672 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -61.65 153.33 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.989 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.497 ' O ' ' HB3' ' A' ' 18' ' ' SER . 10.0 mt-10 -140.51 103.48 4.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.478 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.996 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -27.93 148.95 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.08 0.467 . . . . 0.0 111.852 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.768 HG13 ' CD2' ' A' ' 44' ' ' HIS . 12.6 p -141.59 -39.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.213 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.768 ' CD2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.69 119.64 6.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.167 178.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 1.4 pttt -69.49 68.11 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 0.0 111.173 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.53 -170.75 42.87 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.4 mtp85 -81.64 56.68 3.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.165 0.507 . . . . 0.0 110.511 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.577 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 9.1 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.036 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.746 ' HB3' ' CD ' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.773 0.321 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.746 ' CD ' ' HB3' ' A' ' 4' ' ' ALA . 15.4 Cg_endo -57.64 147.98 76.45 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.47 2.113 . . . . 0.0 111.836 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 13.0 p -140.73 77.44 1.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.426 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.7 mp -133.54 61.78 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.394 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 44.9 m -89.67 -34.7 16.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.416 0.627 . . . . 0.0 110.02 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.519 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -168.5 130.77 1.38 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.616 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.6 mmm -88.25 19.19 3.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.032 0.444 . . . . 0.0 110.191 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -93.89 -101.04 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.725 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.477 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER 179.66 82.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 111.542 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.535 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -108.91 69.07 0.37 Allowed Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.7 Cg_endo -55.72 104.48 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.675 2.25 . . . . 0.0 112.74 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.985 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.8 m -108.42 133.64 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.773 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.569 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.76 121.6 24.97 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.696 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -108.19 140.9 15.66 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.285 -0.96 . . . . 0.0 112.858 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.721 ' OG ' HG22 ' A' ' 43' ' ' VAL . 44.8 m -48.71 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.156 -1.022 . . . . 0.0 110.692 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.5 ' OD2' HG22 ' A' ' 40' ' ' ILE . 0.2 OUTLIER 167.76 -26.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.813 -179.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.25 33.36 3.45 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.633 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.542 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 11.2 mm -136.61 136.75 48.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.739 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.403 ' CG2' ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -95.0 101.8 13.58 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.07 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.851 ' CE2' HD21 ' A' ' 29' ' ' LEU . 45.2 m-85 -84.33 127.13 33.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.453 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.531 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -42.96 -29.95 0.93 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.833 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -160.23 144.12 14.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.943 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.94 -24.32 2.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.346 0.593 . . . . 0.0 110.293 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -80.47 -50.25 10.32 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.828 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.549 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 5.2 mtt -46.92 -33.83 4.94 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.907 HD12 HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -58.33 -55.3 36.78 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.056 176.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 27' ' ' CYS . 10.7 mt -48.75 -32.49 8.63 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.235 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -76.19 -32.15 58.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.991 178.119 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.91 -58.98 4.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.103 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.55 -34.41 17.47 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.154 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . . . -90.61 -4.97 56.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.331 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -100.81 -48.83 4.35 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.649 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 43.2 t -81.7 -98.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.433 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 36' ' ' SER . 16.3 t0 179.02 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.336 . . . . 0.0 111.255 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.5 132.93 60.57 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 121.046 0.45 . . . . 0.0 111.26 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.3 87.96 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.941 2.428 . . . . 0.0 112.452 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.668 HG13 HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -71.71 155.9 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.731 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 18' ' ' SER . 0.6 OUTLIER -146.04 104.47 3.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.862 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.985 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -27.46 148.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.39 0.614 . . . . 0.0 112.181 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.721 HG22 ' OG ' ' A' ' 18' ' ' SER . 1.9 t -137.46 -37.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.378 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.644 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -154.13 125.76 7.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.541 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -71.04 61.47 0.28 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.623 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.52 -162.27 27.85 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.409 ' O ' ' OXT' ' A' ' 48' ' ' CYS . 6.1 mtm180 -88.03 56.67 3.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.93 0.395 . . . . 0.0 110.478 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.58 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 5.5 m . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.029 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.986 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.851 0.357 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 4' ' ' ALA . 86.6 Cg_exo -46.08 -179.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.667 2.244 . . . . 0.0 112.176 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.453 ' O ' HD13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.15 45.61 0.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.035 0.445 . . . . 0.0 110.963 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.798 HG22 ' O ' ' A' ' 7' ' ' ILE . 28.4 mm -151.44 63.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.612 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.86 -43.28 22.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.091 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.7 t -172.47 -172.15 0.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.192 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.497 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -112.61 17.79 18.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 13' ' ' ASP . 1.1 tp60 -69.1 60.41 0.11 Allowed 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.155 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.98 83.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.5 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.624 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -117.65 60.24 3.14 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.8 Cg_endo -57.2 94.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.732 2.288 . . . . 0.0 112.554 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.011 ' HB ' HD11 ' A' ' 42' ' ' LEU . 26.1 m -96.79 126.87 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.126 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.505 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -79.25 115.53 18.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.293 179.388 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.681 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -104.77 139.54 14.66 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.234 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 7.7 t -49.7 93.47 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.115 -1.042 . . . . 0.0 110.416 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' SER . 34.5 t0 171.37 -27.01 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.973 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.83 32.95 3.18 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.358 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.56 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 29.5 mm -136.87 133.53 48.17 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 46' ' ' GLY . 1.4 m -95.26 99.1 11.1 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.708 ' CE2' HD21 ' A' ' 29' ' ' LEU . 38.1 m-85 -79.99 124.02 28.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.097 -178.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.19 -26.89 0.06 OUTLIER Glycine 0 CA--C 1.507 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.394 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.54 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -173.45 150.47 1.83 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.002 0.429 . . . . 0.0 110.979 179.341 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.49 -25.15 1.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.464 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -74.3 -52.54 11.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.54 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -47.86 -40.93 22.85 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.146 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.931 HD11 HD23 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -53.26 -54.09 41.32 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.29 177.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.986 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 13.5 mt -49.15 -33.44 12.08 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.564 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 4.2 t -76.67 -29.88 56.54 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.62 -55.83 15.47 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.295 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -18.8 62.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.587 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.02 -44.15 10.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -98.05 -7.02 30.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 44.6 t -86.33 -105.66 0.06 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.583 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 36' ' ' SER . 14.3 t0 177.54 -28.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.89 0.376 . . . . 0.0 110.568 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.35 139.1 20.44 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.044 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.16 89.06 1.07 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.795 2.33 . . . . 0.0 112.34 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.557 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -56.12 156.26 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.379 179.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 18' ' ' SER . 42.1 mt-10 -134.44 97.33 3.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 111.153 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.011 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -33.65 148.87 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.387 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.766 HG13 ' CD2' ' A' ' 44' ' ' HIS . 8.6 p -138.76 -38.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.053 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.766 ' CD2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -149.44 120.38 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.156 178.26 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -70.47 63.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.454 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 22' ' ' THR . . . -177.28 -159.86 23.13 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -89.93 58.3 4.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.156 0.503 . . . . 0.0 110.486 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.618 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.9 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.146 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.959 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.817 0.341 . . . . 0.0 111.558 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.959 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 82.1 Cg_exo -43.96 159.01 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.678 2.252 . . . . 0.0 112.405 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 26.1 p -163.18 72.65 0.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 7' ' ' ILE . 44.8 mm -132.48 54.03 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.285 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.0 m -79.2 -37.9 37.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.162 0.506 . . . . 0.0 110.087 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -172.2 144.54 1.63 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.183 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.9 26.18 4.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -85.79 -102.55 0.06 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.102 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.526 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER 178.75 73.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.603 0.24 . . . . 0.0 111.048 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.569 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.41 66.91 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 109.757 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 18.9 Cg_endo -60.34 94.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.62 2.213 . . . . 0.0 111.949 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.025 ' HB ' HD11 ' A' ' 42' ' ' LEU . 27.6 m -99.06 129.84 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.032 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.614 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.58 120.7 23.65 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.553 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -111.36 144.57 17.5 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.996 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -44.87 97.75 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.215 -0.993 . . . . 0.0 109.618 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.532 ' HB2' HG22 ' A' ' 40' ' ' ILE . 9.0 t0 165.14 -24.6 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.804 -1.543 . . . . 0.0 108.685 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.895 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 100.54 27.45 7.59 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.52 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.895 HD12 ' O ' ' A' ' 20' ' ' GLY . 1.5 mp -128.8 144.16 38.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.304 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.56 HG22 ' HB2' ' A' ' 14' ' ' PRO . 13.4 m -101.32 99.03 9.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.611 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.897 ' CE2' HD21 ' A' ' 29' ' ' LEU . 49.0 m-85 -80.15 123.37 27.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.287 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -37.45 -29.51 0.04 OUTLIER Glycine 0 CA--C 1.504 -0.648 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.239 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 23' ' ' TYR . 84.6 m-20 -165.14 147.95 8.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.795 0.331 . . . . 0.0 111.092 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.87 -25.75 2.06 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.309 0.576 . . . . 0.0 110.15 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.62 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -78.84 -51.49 9.66 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.428 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.498 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -45.13 -38.97 5.57 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 176.177 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.897 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -54.11 -56.62 16.34 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 113.242 -1.799 . . . . 0.0 109.78 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 27' ' ' CYS . 4.5 mt -47.12 -34.08 5.7 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.286 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 28' ' ' MET . 1.2 m -75.27 -33.58 61.28 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.137 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -64.66 -55.45 20.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.267 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.413 ' OG ' ' HA ' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -52.23 -32.58 37.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.499 179.392 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.659 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . . . -82.76 -15.51 51.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.288 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.471 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 9.6 ptm180 -109.75 -18.28 13.48 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.7 t -83.94 -98.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 111.455 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.8 t70 179.26 -31.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 0.0 110.84 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.408 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 13.9 t -114.03 145.13 32.93 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 51.1 Cg_endo -69.81 80.93 0.86 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.755 2.303 . . . . 0.0 112.769 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.674 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -44.27 157.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.239 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 27.2 mt-10 -140.62 102.92 4.42 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.828 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.025 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.4 OUTLIER -28.95 149.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.191 0.519 . . . . 0.0 111.857 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.655 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.8 t -141.01 -38.54 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.092 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.655 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.51 122.36 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.47 179.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -71.5 61.96 0.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.223 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 22' ' ' THR . . . -176.05 -160.15 23.0 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.0 mtp85 -90.26 56.92 3.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.395 . . . . 0.0 110.67 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.573 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.9 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.138 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.96 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.79 0.329 . . . . 0.0 111.432 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 4' ' ' ALA . 50.6 Cg_exo -53.18 -164.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.646 2.23 . . . . 0.0 111.969 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.458 ' CA ' ' HB2' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -116.57 50.68 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.589 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 7' ' ' ILE . 12.7 mt -148.88 86.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.946 0.403 . . . . 0.0 111.321 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -112.86 -37.51 4.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.838 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -171.78 175.71 3.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.287 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.2 mtm -113.63 17.79 17.98 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -75.02 58.95 0.9 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.0 179.509 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 11' ' ' GLN . 29.6 t80 -19.37 82.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.436 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.664 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -114.27 63.86 1.31 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.0 Cg_endo -53.45 96.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.952 2.435 . . . . 0.0 112.594 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.03 ' HB ' HD11 ' A' ' 42' ' ' LEU . 28.5 m -98.66 126.33 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.487 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.559 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.31 120.44 23.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.02 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -108.12 144.77 16.21 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.858 -178.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.47 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -48.23 93.73 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.066 -1.067 . . . . 0.0 110.364 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.7 t70 167.99 -24.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.241 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.0 32.43 5.0 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.023 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.597 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 26.6 mm -132.82 136.51 55.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.564 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.526 HG21 ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -97.04 101.88 13.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.798 178.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.723 ' CE2' HD21 ' A' ' 29' ' ' LEU . 30.8 m-85 -85.77 121.11 27.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.989 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -40.73 -27.15 0.16 Allowed Glycine 0 CA--C 1.506 -0.523 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.053 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 83.9 m-20 -164.63 145.42 7.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.741 0.305 . . . . 0.0 111.079 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -48.06 -26.8 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.166 0.508 . . . . 0.0 109.891 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -77.18 -51.4 11.03 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 27' ' ' CYS . 0.6 OUTLIER -46.63 -37.17 7.81 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 176.09 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.723 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -54.95 -54.5 42.04 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.263 176.408 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.96 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 12.3 mt -47.5 -32.57 5.36 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.67 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 5.8 t -78.43 -32.26 48.51 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -63.95 -58.72 5.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.576 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.425 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -55.95 -25.97 45.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.488 179.048 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.2 -34.04 61.46 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -129.83 27.3 5.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 43.5 t -92.74 -94.95 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.632 0.253 . . . . 0.0 111.323 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.79 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.935 0.397 . . . . 0.0 110.541 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.41 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 7.9 t -138.41 147.16 54.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.721 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 16.4 Cg_endo -57.74 93.27 0.06 OUTLIER 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.841 2.361 . . . . 0.0 112.393 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.577 ' CG1' ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -79.45 126.85 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.98 0.419 . . . . 0.0 111.075 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.582 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 2.6 mm-40 -97.36 -156.9 0.56 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.073 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.03 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.7 OUTLIER -120.97 149.45 42.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.515 178.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.649 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.4 t -138.36 -36.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.921 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.649 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -157.35 122.13 4.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.815 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -71.2 65.88 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.139 -179.62 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 22' ' ' THR . . . -179.22 -162.25 28.14 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HA ' HG21 ' A' ' 22' ' ' THR . 4.2 mtt180 -87.27 57.64 4.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.944 0.402 . . . . 0.0 110.545 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.606 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 10.9 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.11 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.82 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 121.006 0.431 . . . . 0.0 111.567 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.42 -163.64 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.914 2.409 . . . . 0.0 112.081 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.449 ' CA ' ' HB2' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -119.15 50.02 1.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 111.271 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 7' ' ' ILE . 13.5 mm -146.96 80.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -104.13 -38.06 7.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.456 0.646 . . . . 0.0 109.972 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.505 ' OG1' ' N ' ' A' ' 10' ' ' MET . 6.2 t -171.96 -163.0 0.23 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.112 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.505 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.9 OUTLIER -128.05 16.69 6.74 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.486 178.101 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 2.4 mt-30 -71.53 58.94 0.29 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.906 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.525 ' CD1' ' HD3' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -25.99 87.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.942 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.683 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -121.86 71.29 30.05 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.802 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.0 Cg_endo -55.62 95.95 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.843 2.362 . . . . 0.0 112.545 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.041 ' HB ' HD11 ' A' ' 42' ' ' LEU . 4.4 m -96.74 126.83 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.485 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.525 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.23 118.86 20.85 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.211 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.56 143.16 15.65 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.983 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 40.4 t -50.98 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.253 -0.974 . . . . 0.0 110.17 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.523 ' HB2' HG22 ' A' ' 40' ' ' ILE . 12.7 t0 171.65 -27.69 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.616 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.85 31.06 3.75 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.39 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 23.0 mm -136.91 139.91 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 119.753 -0.779 . . . . 0.0 113.011 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.48 HG22 ' HB2' ' A' ' 14' ' ' PRO . 3.9 m -98.42 102.64 14.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.879 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.877 ' CE2' HD21 ' A' ' 29' ' ' LEU . 37.3 m-85 -84.94 123.96 31.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.887 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -41.25 -25.99 0.17 Allowed Glycine 0 CA--C 1.505 -0.534 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.127 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.8 m-20 -164.91 145.91 7.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.912 0.387 . . . . 0.0 111.454 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.41 -27.46 4.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.347 0.594 . . . . 0.0 109.554 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -78.1 -49.09 14.6 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.49 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -47.8 -37.92 14.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 175.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.877 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -54.96 -52.77 62.01 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 112.908 -1.951 . . . . 0.0 109.168 176.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.82 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 13.2 mt -48.07 -33.35 7.98 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 28' ' ' MET . 24.9 t -75.09 -32.89 61.56 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.1 -57.71 7.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.481 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.97 -23.01 29.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.145 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.83 -17.6 35.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.377 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -133.44 18.11 3.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.2 t -100.72 -97.57 0.26 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.334 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 56.5 t0 179.52 -32.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 0.0 110.643 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 t -126.97 149.5 69.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.801 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -70.03 87.22 0.59 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.613 2.209 . . . . 0.0 112.205 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.676 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -49.88 149.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.427 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 18' ' ' SER . 31.5 mt-10 -130.68 101.88 5.87 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.101 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.041 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -28.32 146.54 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.223 0.535 . . . . 0.0 111.517 -179.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.634 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -132.58 -46.85 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.221 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.634 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.45 123.8 8.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.394 179.671 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -70.25 68.58 0.34 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.201 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 22' ' ' THR . . . 178.42 -158.92 23.9 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 57.36 3.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.165 0.507 . . . . 0.0 110.176 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.627 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 7.0 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.918 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.424 ' HB3' HD22 ' A' ' 30' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 121.009 0.433 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -38.17 120.26 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.8 2.334 . . . . 0.0 112.553 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 4.2 p -84.7 77.36 10.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.159 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.714 HG22 ' O ' ' A' ' 7' ' ' ILE . 8.3 mm -130.36 52.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.508 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 46.0 m -79.53 -35.73 39.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.355 0.598 . . . . 0.0 109.842 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.466 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -170.36 138.41 1.56 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.627 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.7 mtt -94.84 20.65 8.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.902 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 2.8 mm-40 -84.62 -99.75 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.245 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.504 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 7.9 t80 178.18 79.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.528 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.67 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -111.06 64.38 0.48 Allowed Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.1 Cg_endo -56.63 92.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.65 2.233 . . . . 0.0 112.198 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.034 ' HB ' HD11 ' A' ' 42' ' ' LEU . 19.6 m -95.09 126.43 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.516 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.681 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.85 117.4 19.18 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.264 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.42 141.11 15.14 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.513 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 38.1 m -48.86 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.21 -0.995 . . . . 0.0 110.359 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.544 ' OD2' HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 169.07 -25.93 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.142 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.72 30.74 4.47 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.337 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 9.7 mm -131.77 138.91 51.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.667 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.515 HG22 ' HB2' ' A' ' 14' ' ' PRO . 3.1 m -99.76 99.48 10.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.729 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.833 ' CE2' HD21 ' A' ' 29' ' ' LEU . 33.1 m-85 -83.69 122.89 29.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.721 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -42.28 -24.15 0.19 Allowed Glycine 0 CA--C 1.505 -0.579 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.134 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.595 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -169.83 146.68 3.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.754 0.312 . . . . 0.0 111.108 -179.328 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -47.19 -25.54 0.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.292 0.568 . . . . 0.0 110.263 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -76.95 -54.77 6.14 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.817 178.651 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.548 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 36.4 mtp -45.53 -33.3 2.66 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.833 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -59.42 -54.36 47.53 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.469 -1.696 . . . . 0.0 108.892 177.315 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' CYS . 11.8 mt -49.07 -29.43 5.11 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.556 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 28' ' ' MET . 1.4 m -79.64 -31.12 41.52 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -68.93 -58.75 3.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.157 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.46 -33.02 63.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.268 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.44 -3.12 57.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.333 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 4.5 mtp180 -96.56 -51.09 4.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.942 0.401 . . . . 0.0 111.024 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.7 t -86.82 -99.15 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.436 ' O ' ' HD3' ' A' ' 39' ' ' PRO . 6.5 p30 178.92 -26.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.411 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -79.15 111.45 20.33 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.928 0.394 . . . . 0.0 111.121 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 33.5 Cg_exo -57.82 93.75 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.844 2.362 . . . . 0.0 112.486 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.695 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -69.54 157.49 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.767 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 18' ' ' SER . 36.9 mt-10 -140.95 103.46 4.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.049 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.034 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -28.24 147.09 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.169 0.509 . . . . 0.0 111.315 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.768 HG13 ' CD2' ' A' ' 44' ' ' HIS . 13.6 p -139.39 -38.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.495 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.768 ' CD2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.78 123.29 7.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.529 178.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 64.75 0.41 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.294 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.37 -160.31 24.89 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -90.12 54.22 2.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.972 0.415 . . . . 0.0 110.664 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.602 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 4.9 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.056 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.991 0.424 . . . . 0.0 111.061 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.81 176.71 8.57 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.698 2.266 . . . . 0.0 112.11 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 0.6 OUTLIER -66.69 123.76 21.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.859 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -115.78 113.25 42.41 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -42.03 138.81 2.73 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.601 2.2 . . . . 0.0 111.801 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 1.3 p -93.23 56.03 2.42 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.257 0.551 . . . . 0.0 111.532 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.811 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.6 mp -132.05 57.15 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.582 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -78.9 -41.16 30.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.101 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.481 ' OG1' ' N ' ' A' ' 10' ' ' MET . 6.4 t -173.65 -165.88 0.28 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.395 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.481 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -124.1 17.59 9.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.035 177.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -73.08 58.76 0.5 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.993 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.471 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 9.0 t80 -25.18 84.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.292 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.701 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -114.91 64.67 1.63 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 9.3 Cg_endo -51.74 97.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.034 2.489 . . . . 0.0 112.331 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.963 ' HB ' HD11 ' A' ' 42' ' ' LEU . 27.8 m -99.49 127.38 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.524 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.618 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.26 121.47 24.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.0 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -113.52 142.41 17.44 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.161 -1.019 . . . . 0.0 113.184 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 45.0 t -40.1 98.01 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.333 -0.933 . . . . 0.0 109.771 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 18' ' ' SER . 1.7 t0 160.19 -22.71 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.985 -1.462 . . . . 0.0 108.748 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.688 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 94.23 25.08 17.43 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.988 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 20' ' ' GLY . 0.9 OUTLIER -118.45 124.56 73.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.861 -179.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.55 HG22 ' HB2' ' A' ' 14' ' ' PRO . 3.1 m -86.36 98.18 10.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.494 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.809 ' OH ' HG21 ' A' ' 40' ' ' ILE . 52.3 m-85 -79.47 123.81 27.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.017 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -37.49 -27.84 0.03 OUTLIER Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.533 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.7 p30 -174.33 155.54 2.37 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.934 0.397 . . . . 0.0 110.996 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -48.47 -23.03 0.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.928 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.584 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 26.1 m -83.6 -46.77 12.0 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.526 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -48.62 -36.17 15.24 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 175.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.991 HD11 HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -55.93 -50.18 71.45 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 112.933 -1.939 . . . . 0.0 108.837 177.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.584 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 11.7 mt -48.27 -30.56 4.91 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.746 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -73.19 -35.74 66.42 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.61 -57.85 5.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.309 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -61.34 -16.88 50.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.365 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.85 -38.19 13.11 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -149.64 42.66 0.9 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 31.0 t -96.09 -81.52 0.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.897 0.379 . . . . 0.0 110.978 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -175.39 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.242 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.804 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -144.97 154.18 54.53 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.253 179.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.804 ' HD2' HG22 ' A' ' 38' ' ' THR . 38.0 Cg_endo -66.54 81.27 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.586 2.19 . . . . 0.0 112.507 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.809 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -54.5 169.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.219 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 42' ' ' LEU . 19.5 mt-10 -148.68 100.9 3.16 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.89 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.991 HD23 HD11 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -31.02 148.65 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 111.227 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.594 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 2.7 t -144.98 -37.24 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.033 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.618 ' CD2' ' HB3' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -148.97 120.35 7.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.0 110.858 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.6 mttp -70.19 66.5 0.29 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.27 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 22' ' ' THR . . . 179.67 -160.26 25.35 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -90.12 55.14 3.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.904 0.383 . . . . 0.0 110.442 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.577 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 7.1 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.283 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.483 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 3.1 mmtp . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.878 0.37 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 1' ' ' LYS . 59.5 Cg_endo -73.53 -165.34 0.24 Allowed 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.691 2.261 . . . . 0.0 112.551 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.09 123.52 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.95 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.921 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -168.29 -55.25 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.322 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.902 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 35.7 Cg_exo -59.32 170.44 3.12 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.582 2.188 . . . . 0.0 112.026 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 25.4 p -165.77 72.64 0.17 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.441 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.795 HG22 ' O ' ' A' ' 7' ' ' ILE . 26.8 mt -137.67 63.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 0.0 111.719 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 26.8 m -87.09 -40.14 14.94 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.411 0.624 . . . . 0.0 109.367 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 t -172.47 143.91 1.44 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.712 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.18 26.04 3.95 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 47.8 mt-30 -84.11 -103.45 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.322 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.446 ' O ' ' CD ' ' A' ' 14' ' ' PRO . 2.4 t80 179.69 71.9 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.491 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER -106.98 71.07 0.27 Allowed Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 27.6 Cg_endo -61.97 101.49 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.654 2.236 . . . . 0.0 112.842 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.006 ' HB ' HD11 ' A' ' 42' ' ' LEU . 35.1 m -105.9 127.89 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.278 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.554 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -77.81 123.09 26.3 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.218 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -111.49 144.18 17.47 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.826 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.541 ' HB3' ' CG ' ' A' ' 41' ' ' GLU . 16.9 t -45.07 96.91 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 114.35 -0.925 . . . . 0.0 110.07 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.578 ' HB2' HG22 ' A' ' 40' ' ' ILE . 4.9 t0 163.76 -23.01 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.929 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.659 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 98.33 24.13 11.75 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.324 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.661 HG21 ' CE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -119.42 135.03 61.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.911 -179.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.449 ' CG2' ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -94.41 99.63 11.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.563 178.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.833 ' CE2' HD21 ' A' ' 29' ' ' LEU . 51.6 m-85 -82.64 122.56 28.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.055 -178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.476 ' HA3' ' CE ' ' A' ' 28' ' ' MET . . . -41.13 -27.22 0.21 Allowed Glycine 0 CA--C 1.507 -0.468 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.218 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.8 m-20 -164.47 146.32 8.49 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.74 0.305 . . . . 0.0 110.803 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.69 -25.14 2.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.227 0.537 . . . . 0.0 110.358 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -77.81 -50.55 12.1 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.476 ' CE ' ' HA3' ' A' ' 24' ' ' GLY . 2.8 mmm -45.99 -40.4 10.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.882 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -52.69 -55.94 19.07 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 113.445 -1.707 . . . . 0.0 109.775 176.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 13.8 mt -48.58 -32.57 8.29 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.4 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -75.75 -31.72 59.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.632 ' HB3' HD11 ' A' ' 40' ' ' ILE . . . -66.69 -59.23 3.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.951 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.473 ' OG ' HG12 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -52.29 -28.7 19.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.414 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.921 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . . . -70.16 -37.73 75.27 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -135.95 35.69 2.84 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 46.9 t -90.86 -95.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.691 0.281 . . . . 0.0 111.516 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -179.7 -35.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.124 0.488 . . . . 0.0 110.109 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.642 HG23 ' HD2' ' A' ' 39' ' ' PRO . 55.1 m -136.53 142.91 41.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.207 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.642 ' HD2' HG23 ' A' ' 38' ' ' THR . 10.5 Cg_endo -53.52 92.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.906 2.404 . . . . 0.0 112.928 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.632 HD11 ' HB3' ' A' ' 32' ' ' ALA . 0.9 OUTLIER -78.57 148.34 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.139 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.541 ' CG ' ' HB3' ' A' ' 18' ' ' SER . 10.3 pt-20 -152.31 116.78 5.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.262 0.553 . . . . 0.0 111.123 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.006 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -21.61 145.25 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.794 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.636 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -136.4 -42.18 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.469 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.636 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.96 125.97 9.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.206 178.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -70.75 65.72 0.33 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.223 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.59 -160.61 27.37 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.449 ' HA ' ' CG2' ' A' ' 22' ' ' THR . 2.9 mtp180 -90.28 54.15 2.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.161 0.505 . . . . 0.0 110.845 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.594 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 4.2 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.215 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.491 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.951 0.405 . . . . 0.0 111.128 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 1' ' ' LYS . 48.7 Cg_exo -55.83 -166.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.867 2.378 . . . . 0.0 112.504 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 7.3 p-10 -148.56 120.78 8.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.607 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.912 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -173.64 -59.36 0.0 OUTLIER Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.912 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 81.3 Cg_exo -43.61 135.92 6.71 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.611 2.207 . . . . 0.0 112.01 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 7.9 p -132.97 79.88 1.86 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.037 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.762 HG22 ' O ' ' A' ' 7' ' ' ILE . 5.4 mp -133.93 52.47 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 55.3 m -84.39 -34.16 23.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.482 0.658 . . . . 0.0 109.627 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.658 HG23 ' ND2' ' A' ' 25' ' ' ASN . 2.4 t -171.25 136.22 1.03 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.078 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.2 mtt -93.81 24.71 3.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.476 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.9 -100.66 0.17 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.366 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.509 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 1.5 t80 179.54 76.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.61 0.243 . . . . 0.0 110.977 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.528 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.5 69.94 0.29 Allowed Pre-proline 0 CA--C 1.516 -0.332 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.697 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.4 Cg_endo -56.31 102.64 0.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.779 2.319 . . . . 0.0 112.805 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.016 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.9 m -106.76 133.81 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.508 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.561 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.29 119.99 22.43 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.893 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -106.01 140.92 15.33 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.43 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 48.5 t -48.28 94.5 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.245 -0.978 . . . . 0.0 110.414 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.521 ' HB2' HG22 ' A' ' 40' ' ' ILE . 7.1 t0 171.68 -30.52 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.563 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.48 33.76 2.23 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.587 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.1 mt -135.49 154.39 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 14' ' ' PRO . 2.5 m -109.66 99.25 8.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.373 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.88 ' CE2' HD21 ' A' ' 29' ' ' LEU . 53.9 m-85 -83.89 129.28 34.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.321 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.445 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -41.35 -27.15 0.25 Allowed Glycine 0 CA--C 1.504 -0.652 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.328 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.658 ' ND2' HG23 ' A' ' 9' ' ' THR . 81.6 m-20 -166.66 146.05 5.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.792 0.33 . . . . 0.0 111.149 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.02 -25.44 3.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.396 0.617 . . . . 0.0 109.868 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 1.1 m -79.89 -49.6 11.68 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.85 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 27' ' ' CYS . 7.6 mmm -47.04 -37.65 9.74 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.062 HD12 HD23 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -55.69 -56.99 13.94 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 113.258 -1.792 . . . . 0.0 109.498 176.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 27' ' ' CYS . 12.4 mt -48.24 -32.94 7.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.559 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -76.46 -32.11 58.2 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.49 -56.75 10.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.256 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.634 ' OG ' HD11 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -51.11 -36.31 39.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.033 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.69 -0.34 57.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.042 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 24.3 mtp180 -111.81 -38.86 4.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.6 t -85.36 -108.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.561 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p30 179.5 33.0 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.782 0.325 . . . . 0.0 110.944 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 m -146.79 134.12 10.23 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.795 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.71 83.98 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.814 2.343 . . . . 0.0 112.865 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.705 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -70.01 154.49 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.632 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.484 ' O ' ' O ' ' A' ' 42' ' ' LEU . 13.1 mt-10 -143.04 101.83 3.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.09 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.062 HD23 HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -29.46 150.81 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.032 0.444 . . . . 0.0 111.632 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.639 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 1.4 t -144.6 -41.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.185 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.639 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -153.21 121.21 6.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.805 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -68.29 70.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.374 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.35 -164.88 34.94 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.3 56.35 3.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.104 0.478 . . . . 0.0 110.41 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.597 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 20.9 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.173 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.882 0.372 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.21 -166.4 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.804 2.336 . . . . 0.0 112.288 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.93 97.86 8.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.701 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.796 ' HB1' ' CB ' ' A' ' 34' ' ' ALA . . . -164.93 -63.54 0.01 OUTLIER Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.777 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.652 ' CD ' ' HB3' ' A' ' 4' ' ' ALA . 96.4 Cg_exo -26.75 141.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.119 2.546 . . . . 0.0 112.104 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -92.91 52.87 1.9 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.003 0.43 . . . . 0.0 111.122 -179.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.7 mm -145.92 90.75 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.782 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.01 -38.68 3.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.36 0.6 . . . . 0.0 109.894 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 11' ' ' GLN . 10.0 t -172.5 -162.9 0.2 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.268 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.463 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -129.09 16.48 6.18 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.501 177.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -74.03 60.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.995 179.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.56 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 8.4 t80 -20.32 84.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.487 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.658 ' O ' HG13 ' A' ' 15' ' ' VAL . 20.5 t0 -114.47 59.29 1.0 Allowed Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.2 Cg_endo -54.28 96.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.754 2.303 . . . . 0.0 112.223 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.976 ' HB ' HD11 ' A' ' 42' ' ' LEU . 33.8 m -98.22 127.66 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.814 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.586 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.61 116.45 18.99 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.322 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.697 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.92 138.01 13.83 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.681 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 13.3 t -46.62 96.05 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.246 -0.977 . . . . 0.0 110.495 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 165.46 -23.53 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.235 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.77 32.97 4.88 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.318 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 36.3 mm -130.28 130.71 65.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.362 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.18 99.59 11.82 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.605 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.76 ' CE2' HD21 ' A' ' 29' ' ' LEU . 39.4 m-85 -83.03 121.8 27.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.824 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -36.28 -29.38 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.327 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.523 ' OD1' ' HG3' ' A' ' 28' ' ' MET . 2.1 p30 -173.37 154.82 2.71 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.098 0.475 . . . . 0.0 111.067 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.8 -23.53 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.807 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.518 ' HA ' HD12 ' A' ' 30' ' ' LEU . 1.2 m -78.48 -51.98 9.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.523 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 1.2 mtt -46.32 -42.1 14.24 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 176.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.931 HD11 HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -52.46 -54.27 34.5 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.384 -1.735 . . . . 0.0 109.556 177.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 27' ' ' CYS . 7.5 mt -48.22 -31.83 6.33 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.527 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.537 ' CA ' ' O ' ' A' ' 4' ' ' ALA . 7.3 t -76.76 -31.78 57.31 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.209 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -64.03 -58.65 6.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.349 178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.579 ' HB2' HD11 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -63.98 -15.71 59.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.206 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.796 ' CB ' ' HB1' ' A' ' 4' ' ' ALA . . . -90.05 -26.28 20.37 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HD2' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -131.23 18.95 4.89 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 10.2 t -105.62 -119.7 0.23 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p30 179.4 24.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.0 m -161.75 112.54 1.2 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.63 0.252 . . . . 0.0 110.523 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.1 94.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.603 2.202 . . . . 0.0 112.225 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.721 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -63.53 153.36 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.401 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 18' ' ' SER . 10.9 mt-10 -132.82 92.75 3.09 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.084 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.976 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -32.81 148.7 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.258 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.6 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 2.5 t -142.5 -38.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.646 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.6 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.29 117.75 6.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.471 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -69.23 65.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.641 -179.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.55 -163.21 29.49 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -85.59 59.02 5.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.084 0.468 . . . . 0.0 110.497 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.594 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 17.5 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.972 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.933 0.397 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.93 -163.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.918 2.412 . . . . 0.0 112.557 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.554 ' HB3' HD13 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -66.29 -167.67 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.374 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.808 ' HB3' ' CD ' ' A' ' 5' ' ' PRO . . . -162.13 -70.11 0.01 OUTLIER Pre-proline 0 N--CA 1.452 -0.343 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.629 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.808 ' CD ' ' HB3' ' A' ' 4' ' ' ALA . 59.9 Cg_exo -27.38 144.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.309 2.673 . . . . 0.0 112.473 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.411 ' O ' HG12 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -102.01 54.05 0.8 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.97 0.414 . . . . 0.0 111.567 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 7' ' ' ILE . 3.6 mm -146.49 78.18 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.644 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -103.14 -39.34 6.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.325 0.583 . . . . 0.0 110.29 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.582 HG23 ' H ' ' A' ' 11' ' ' GLN . 9.8 t -173.19 -160.93 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.761 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.506 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -128.5 17.88 6.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.367 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.582 ' H ' HG23 ' A' ' 9' ' ' THR . 0.1 OUTLIER -72.29 58.87 0.39 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.345 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' GLN . 1.0 OUTLIER -26.65 85.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.147 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.69 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -121.61 67.25 20.39 Favored Pre-proline 0 N--CA 1.454 -0.241 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.0 Cg_endo -53.0 95.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.897 2.398 . . . . 0.0 112.57 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.961 ' HB ' HD11 ' A' ' 42' ' ' LEU . 25.5 m -95.94 126.91 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.8 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.602 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.69 118.43 20.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.744 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -108.55 145.34 16.4 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.688 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 10.6 p -48.32 97.15 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.501 -0.849 . . . . 0.0 109.991 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.535 ' HB2' HG22 ' A' ' 40' ' ' ILE . 7.6 t70 168.84 -25.83 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.853 -1.521 . . . . 0.0 108.695 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.42 30.65 5.83 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.603 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -127.53 146.29 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.543 HG22 ' HB2' ' A' ' 14' ' ' PRO . 6.2 m -107.39 97.81 7.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.501 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.854 ' CE2' HD21 ' A' ' 29' ' ' LEU . 36.7 m-85 -81.74 123.1 28.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.403 -178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.46 ' H ' ' HE3' ' A' ' 28' ' ' MET . . . -39.9 -26.52 0.1 OUTLIER Glycine 0 CA--C 1.508 -0.406 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.319 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.545 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -171.82 149.21 2.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.003 0.43 . . . . 0.0 110.684 179.132 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.91 -24.55 0.62 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.834 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.615 ' HA ' HD12 ' A' ' 30' ' ' LEU . 1.6 m -77.74 -50.78 11.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.196 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.545 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -46.79 -37.66 8.95 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.854 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.41 -52.66 63.81 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.987 -1.915 . . . . 0.0 109.246 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.621 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 5.5 mt -49.6 -32.12 12.15 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.6 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.531 ' CA ' ' O ' ' A' ' 4' ' ' ALA . 7.7 t -75.9 -29.3 58.39 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -69.5 -62.3 1.44 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.905 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.14 -13.51 27.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.446 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 30' ' ' LEU . . . -82.97 -29.75 28.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.302 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.429 ' CD ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -144.38 29.49 1.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 47.4 t -92.1 -97.04 0.13 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.618 0.247 . . . . 0.0 110.913 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 179.72 -32.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 0.0 110.731 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 9.2 m -127.53 133.06 24.68 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.939 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 38' ' ' THR . 35.0 Cg_exo -60.51 90.11 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.759 2.306 . . . . 0.0 112.579 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.627 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -63.9 163.02 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.543 179.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 18' ' ' SER . 1.5 mt-10 -149.86 107.13 3.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.809 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.961 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -29.27 148.92 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.08 0.466 . . . . 0.0 111.577 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.651 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.8 t -142.65 -39.2 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.416 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.651 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -153.86 121.06 5.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.523 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -69.27 68.3 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.106 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.3 -171.12 44.12 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.41 57.36 2.81 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.084 0.468 . . . . 0.0 110.504 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.56 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 21.1 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.052 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.472 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 2.5 ttmm . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.839 0.352 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' A' ' 1' ' ' LYS . 73.2 Cg_endo -77.14 -172.8 1.54 Allowed 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.716 2.277 . . . . 0.0 112.459 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.695 ' H ' HD13 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -107.45 48.05 0.86 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.903 0.383 . . . . 0.0 111.062 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.565 ' O ' ' CB ' ' A' ' 31' ' ' CYS . . . -35.86 -53.37 1.47 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.539 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 4' ' ' ALA . 33.5 Cg_exo -29.91 126.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.747 2.298 . . . . 0.0 112.158 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.444 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -93.12 44.97 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.081 0.467 . . . . 0.0 110.988 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.815 HG22 ' O ' ' A' ' 7' ' ' ILE . 31.5 mt -152.61 63.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.7 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -80.95 -41.6 22.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.916 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 t -172.02 162.23 5.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.88 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -92.47 18.66 8.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 2.1 tt0 -72.02 58.53 0.35 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.165 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.509 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -21.52 82.96 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.36 -179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.762 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -112.76 62.64 0.72 Allowed Pre-proline 0 N--CA 1.452 -0.341 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.4 Cg_endo -55.58 93.89 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.815 2.343 . . . . 0.0 112.455 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.006 ' HB ' HD11 ' A' ' 42' ' ' LEU . 5.7 m -97.29 125.92 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.719 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.6 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.55 117.23 19.54 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.749 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.647 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -106.16 143.56 15.75 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.298 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 4.2 t -49.27 95.06 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.301 -0.95 . . . . 0.0 110.001 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 168.7 -25.68 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.954 -1.476 . . . . 0.0 109.006 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.3 34.04 3.77 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.377 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.6 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 27.4 mm -137.19 136.19 47.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 14' ' ' PRO . 2.9 m -96.73 97.9 9.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.232 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.82 ' CE2' HD21 ' A' ' 29' ' ' LEU . 41.3 m-85 -80.07 126.37 30.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.299 -178.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.22 -25.51 0.05 OUTLIER Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.505 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.535 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 0.9 OUTLIER -176.41 150.27 0.88 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.957 0.408 . . . . 0.0 111.056 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.2 -25.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.567 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -76.45 -52.86 9.01 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.535 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -44.77 -41.25 6.74 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.124 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.82 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -53.93 -54.37 39.79 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 112.986 -1.916 . . . . 0.0 109.411 177.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.695 HD13 ' H ' ' A' ' 3' ' ' ASP . 13.0 mt -48.88 -33.84 11.47 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.156 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -74.85 -32.62 61.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -62.63 -57.18 11.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.627 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -17.54 56.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.169 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.39 -15.38 35.68 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -136.03 1.45 2.73 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -89.04 -99.15 0.09 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.546 0.213 . . . . 0.0 111.038 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 178.77 -31.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.36 . . . . 0.0 110.953 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.871 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.2 OUTLIER -117.4 151.33 47.94 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.114 0.483 . . . . 0.0 111.42 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.871 ' HD2' HG22 ' A' ' 38' ' ' THR . 97.5 Cg_endo -80.13 86.51 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.997 2.465 . . . . 0.0 112.029 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.717 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -48.47 155.22 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.77 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 18' ' ' SER . 20.9 mt-10 -135.0 96.84 3.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.746 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.006 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -29.26 147.41 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.224 0.535 . . . . 0.0 111.439 -178.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.628 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 1.7 t -135.46 -41.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.295 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.628 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -153.35 121.24 6.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.58 -179.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -70.27 67.33 0.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.0 0.429 . . . . 0.0 111.148 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 22' ' ' THR . . . 179.05 -165.27 34.09 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.76 57.36 4.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.033 0.444 . . . . 0.0 110.649 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.595 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.8 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.871 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.576 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 12.0 mttt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.88 0.371 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 1' ' ' LYS . 58.3 Cg_endo -71.21 -168.3 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.713 2.275 . . . . 0.0 112.27 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.551 ' CB ' HD22 ' A' ' 30' ' ' LEU . 43.4 m-20 -139.53 -176.12 4.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.008 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.938 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -171.99 -58.84 0.0 OUTLIER Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.793 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.938 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 51.9 Cg_exo -53.7 178.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.511 2.14 . . . . 0.0 111.575 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.78 ' C ' HD12 ' A' ' 7' ' ' ILE . 26.2 p -170.47 76.33 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.657 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.786 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.8 mp -131.68 57.56 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.855 0.36 . . . . 0.0 111.667 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 57.6 m -83.08 -38.38 22.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.316 0.579 . . . . 0.0 110.099 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 11' ' ' GLN . 1.8 t -171.61 139.92 1.29 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.432 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.34 25.91 4.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.469 ' HB2' ' OG1' ' A' ' 9' ' ' THR . 55.2 mt-30 -91.68 -100.79 0.11 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.647 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.521 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 179.83 77.55 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 121.183 -0.207 . . . . 0.0 111.117 -179.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.56 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -111.22 65.07 0.53 Allowed Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.666 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 12.9 Cg_endo -56.29 98.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.032 2.488 . . . . 0.0 112.77 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.998 ' HB ' HD11 ' A' ' 42' ' ' LEU . 24.8 m -99.25 130.2 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.779 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.565 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.65 117.69 20.04 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.262 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -109.38 140.93 15.9 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.966 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 2.5 m -42.3 96.97 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.275 -0.963 . . . . 0.0 109.635 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 18' ' ' SER . 7.3 t0 163.34 -22.87 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.913 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.675 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 96.52 23.48 16.17 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.675 HD12 ' O ' ' A' ' 20' ' ' GLY . 0.7 OUTLIER -119.05 131.97 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.923 -179.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 14' ' ' PRO . 1.6 m -92.77 98.2 11.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.418 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.838 ' CE2' HD21 ' A' ' 29' ' ' LEU . 47.3 m-85 -81.03 123.89 28.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.322 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -37.49 -30.47 0.06 OUTLIER Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.15 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' HB2' ' HG3' ' A' ' 28' ' ' MET . 83.8 m-20 -165.34 147.85 7.85 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.361 -0.419 . . . . 0.0 111.073 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.27 -25.74 2.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.298 0.571 . . . . 0.0 110.009 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.504 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -77.19 -51.94 10.11 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.534 178.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.471 ' HG3' ' HB2' ' A' ' 25' ' ' ASN . 2.0 mtt -44.69 -39.78 5.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 176.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.844 HD12 ' CD2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -56.24 -54.61 43.24 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 113.201 -1.818 . . . . 0.0 109.686 176.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.551 HD22 ' CB ' ' A' ' 3' ' ' ASP . 4.1 mt -47.68 -35.11 9.03 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.212 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -74.42 -33.28 62.93 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.022 178.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -63.12 -55.52 24.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.293 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.658 ' OG ' HD11 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -51.8 -35.08 42.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.44 179.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.652 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . . . -90.71 -2.49 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.493 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -120.66 -18.77 7.64 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.2 t -89.83 -98.67 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.456 0.169 . . . . 0.0 111.229 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 38' ' ' THR . 28.8 p30 179.11 -30.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.729 0.3 . . . . 0.0 111.058 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.515 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 3.3 t -107.88 137.18 19.71 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 0.0 110.767 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.74 89.47 0.99 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.74 2.293 . . . . 0.0 112.72 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.677 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -53.96 169.63 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.414 179.154 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 18' ' ' SER . 18.4 mt-10 -147.06 98.3 3.01 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.061 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.998 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -29.13 148.04 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.1 0.476 . . . . 0.0 111.212 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.686 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -138.33 -40.31 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.49 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.686 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -154.41 121.59 5.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.563 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -69.64 67.0 0.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.382 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.18 -161.74 28.12 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.2 56.45 3.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.114 0.483 . . . . 0.0 110.522 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.599 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 6.6 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.096 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.83 0.348 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 3' ' ' ASP . 51.3 Cg_endo -69.03 -167.25 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.762 2.308 . . . . 0.0 112.417 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 2' ' ' PRO . 0.2 OUTLIER -36.19 145.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.738 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -133.82 120.63 15.5 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.234 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 4' ' ' ALA . 83.8 Cg_exo -47.0 -176.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.639 2.226 . . . . 0.0 112.155 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.704 ' C ' HD12 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -108.47 50.53 0.77 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.042 0.449 . . . . 0.0 111.301 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.704 HD12 ' C ' ' A' ' 6' ' ' CYS . 4.8 mp -145.53 89.78 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.03 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.38 -42.1 3.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.58 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.9 t -171.7 -168.71 0.62 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.337 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.515 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -118.01 17.78 14.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.484 178.115 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 13' ' ' ASP . 24.8 mt-30 -69.53 57.67 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.389 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' GLN . 4.6 t80 -27.54 85.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.787 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.579 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -123.86 72.47 53.23 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.0 Cg_endo -55.54 99.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.493 2.129 . . . . 0.0 112.117 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.046 ' HB ' HD11 ' A' ' 42' ' ' LEU . 32.9 m -97.55 128.18 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.979 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.51 116.93 19.24 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.642 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.35 135.99 12.91 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.74 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 11.1 m -49.45 95.03 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.319 -0.94 . . . . 0.0 110.756 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 t70 170.05 -26.13 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.05 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.32 31.19 3.59 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.378 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.517 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 19.3 mm -134.22 138.13 50.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.772 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.428 HG22 ' HB2' ' A' ' 14' ' ' PRO . 1.8 m -100.32 99.64 10.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.414 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.725 ' CE2' HD21 ' A' ' 29' ' ' LEU . 34.3 m-85 -81.4 127.59 32.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.804 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -45.82 -21.57 0.6 Allowed Glycine 0 CA--C 1.509 -0.341 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.521 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.582 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -172.4 146.33 1.77 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 0.0 110.989 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.06 -24.67 1.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.506 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.3 m -78.79 -50.36 11.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.334 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.556 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 16.3 mtt -48.27 -34.58 10.58 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.828 HD11 HD23 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -59.91 -51.86 67.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 113.098 -1.864 . . . . 0.0 108.833 177.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 12.9 mt -48.3 -31.85 6.55 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 28' ' ' MET . 13.9 t -72.86 -34.99 67.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.37 -59.95 2.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.63 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -19.23 3.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.383 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.553 ' HB3' ' HE ' ' A' ' 35' ' ' ARG . . . -77.72 -41.62 37.17 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.553 ' HE ' ' HB3' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -140.49 29.77 1.95 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.5 t -81.16 -93.87 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.718 0.294 . . . . 0.0 110.897 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.35 -34.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.034 0.445 . . . . 0.0 110.466 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.14 129.06 17.8 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.5 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.52 94.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.959 2.439 . . . . 0.0 112.357 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.712 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -59.56 152.96 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.857 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.522 ' O ' ' CB ' ' A' ' 18' ' ' SER . 12.8 mt-10 -134.16 96.95 3.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.02 0.438 . . . . 0.0 110.838 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.046 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -36.9 148.7 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.455 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.643 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -137.45 -37.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.178 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.643 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.34 121.89 7.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.547 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 64.71 0.26 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.647 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -178.76 -158.27 20.94 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.02 57.84 3.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.23 0.538 . . . . 0.0 110.394 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.64 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 10.8 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.183 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.49 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.97 0.414 . . . . 0.0 111.204 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.49 ' HD3' ' CB ' ' A' ' 1' ' ' LYS . 47.1 Cg_endo -84.87 39.59 0.76 Allowed 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.095 2.53 . . . . 0.0 112.538 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -173.54 57.12 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.7 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.01 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -100.13 125.74 38.79 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.233 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.42 ' C ' ' HB2' ' A' ' 31' ' ' CYS . 22.4 Cg_exo -63.76 -166.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.669 2.246 . . . . 0.0 112.06 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.435 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -117.9 50.26 1.16 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 120.984 0.421 . . . . 0.0 110.951 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.817 HG22 ' O ' ' A' ' 7' ' ' ILE . 3.3 mp -146.62 62.61 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.297 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -36.88 18.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.446 0.641 . . . . 0.0 109.826 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.511 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.1 t -171.67 -172.32 1.02 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.015 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.511 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.5 OUTLIER -119.28 17.41 13.09 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 21.0 mm-40 -71.18 59.22 0.25 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.031 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 11' ' ' GLN . 22.2 t80 -19.83 82.77 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.198 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.614 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -118.54 69.26 8.32 Favored Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.869 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 19.5 Cg_endo -59.12 94.77 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.412 2.075 . . . . 0.0 112.068 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.011 ' HB ' HD11 ' A' ' 42' ' ' LEU . 22.6 m -99.33 127.01 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.824 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.603 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.36 122.35 25.65 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.751 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -109.15 144.88 16.55 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.956 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 2.5 t -50.8 95.35 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 114.121 -1.04 . . . . 0.0 110.602 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.605 ' HB2' HG22 ' A' ' 40' ' ' ILE . 5.7 t0 171.67 -30.27 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.66 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.88 33.83 1.96 Allowed Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.184 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.592 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 1.2 mt -138.62 149.53 23.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 46' ' ' GLY . 5.2 m -107.39 99.56 9.07 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.181 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.86 ' CE2' HD21 ' A' ' 29' ' ' LEU . 41.9 m-85 -82.17 123.18 28.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.427 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -40.07 -27.33 0.13 Allowed Glycine 0 CA--C 1.505 -0.557 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.031 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.2 m-20 -164.38 146.24 8.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.779 0.323 . . . . 0.0 111.19 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.18 -27.85 3.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.305 0.574 . . . . 0.0 109.719 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -76.55 -50.12 14.71 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.401 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.492 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -46.5 -39.79 11.41 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 176.118 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.86 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -52.61 -54.59 31.01 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 113.34 -1.754 . . . . 0.0 109.488 176.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.01 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 12.9 mt -48.47 -32.5 7.91 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.223 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 28' ' ' MET . 6.6 t -73.63 -32.69 64.18 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.072 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.63 -59.94 3.43 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.675 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.575 ' HB2' HD11 ' A' ' 40' ' ' ILE . 5.1 t -56.27 -19.14 12.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.029 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.13 -54.52 5.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.546 ' CZ ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -100.5 11.94 38.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 22.0 t -96.34 -116.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 179.11 26.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.43 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -161.21 146.44 10.66 Favored Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.024 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.43 ' HD2' HG22 ' A' ' 38' ' ' THR . 78.3 Cg_endo -79.47 85.06 1.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.686 2.257 . . . . 0.0 112.125 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.661 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -62.23 153.57 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.124 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 18' ' ' SER . 24.5 mt-10 -136.87 102.24 4.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.262 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.011 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.4 OUTLIER -28.96 149.9 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.918 0.389 . . . . 0.0 111.604 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.634 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.7 t -142.37 -39.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.046 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.634 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -152.36 123.41 7.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.927 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 7.5 ptmt -70.4 65.54 0.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.087 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 22' ' ' THR . . . 178.99 -167.76 38.2 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -83.47 55.84 3.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.977 0.418 . . . . 0.0 110.674 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.567 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 9.8 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.858 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.562 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.58 0.229 . . . . 0.0 111.034 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 1' ' ' LYS . 56.2 Cg_endo -70.25 178.59 4.72 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.581 2.187 . . . . 0.0 112.375 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -76.4 67.84 2.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.731 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.95 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -84.64 115.84 62.5 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.204 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -50.96 172.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.519 2.146 . . . . 0.0 111.917 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.81 46.97 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.016 0.436 . . . . 0.0 110.745 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 7' ' ' ILE . 16.4 mt -150.29 72.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.063 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.17 -41.12 13.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.358 0.599 . . . . 0.0 110.158 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.405 ' OG1' ' N ' ' A' ' 10' ' ' MET . 4.2 t -171.5 -178.8 2.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.12 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.405 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -107.43 17.25 23.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.605 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -71.89 58.59 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.906 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.441 ' C ' ' O ' ' A' ' 11' ' ' GLN . 5.6 t80 -30.33 87.93 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.838 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.688 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -120.65 66.96 13.66 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.1 Cg_endo -52.03 97.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.001 2.467 . . . . 0.0 112.442 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.0 ' HB ' HD11 ' A' ' 42' ' ' LEU . 28.8 m -97.43 123.83 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.613 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.535 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.85 118.05 19.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.541 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.71 142.53 15.57 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.883 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 16.0 t -52.29 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.297 -0.951 . . . . 0.0 110.179 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 3.1 t0 171.01 -25.82 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.745 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' ILE . . . 108.58 32.85 3.04 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.532 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' GLY . 42.0 mm -139.27 144.48 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.483 HG21 ' HA ' ' A' ' 47' ' ' ARG . 11.7 m -105.31 98.66 8.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.384 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.849 ' CE2' HD21 ' A' ' 29' ' ' LEU . 35.3 m-85 -80.0 124.21 28.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.926 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA3' ' SD ' ' A' ' 28' ' ' MET . . . -42.0 -24.52 0.18 Allowed Glycine 0 CA--C 1.508 -0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.266 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.585 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 0.2 OUTLIER -172.23 147.22 1.98 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.959 0.409 . . . . 0.0 110.714 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -46.7 -25.03 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.679 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 30' ' ' LEU . 1.6 m -77.75 -50.46 12.33 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.331 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.585 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 2.6 mtt -47.96 -35.03 10.08 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 175.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.849 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -58.22 -51.75 68.43 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 112.937 -1.938 . . . . 0.0 108.735 177.46 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.95 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 14.3 mt -49.6 -31.96 11.77 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.476 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 28' ' ' MET . 37.4 t -76.77 -31.0 56.75 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -66.94 -60.57 2.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.389 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -53.78 -25.31 18.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.896 178.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.64 -15.3 45.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.482 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 -97.34 -44.38 6.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.923 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.9 t -81.18 -102.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.618 0.247 . . . . 0.0 111.102 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 178.39 -27.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.742 0.306 . . . . 0.0 111.185 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -94.01 123.13 60.21 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.949 -179.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.483 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 23.4 Cg_exo -63.53 86.56 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.679 2.253 . . . . 0.0 112.472 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.689 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -39.15 155.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.156 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 18' ' ' SER . 45.0 mt-10 -127.09 94.47 4.02 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.158 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.0 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -31.96 146.71 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.313 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.619 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -131.71 -45.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.1 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.621 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -145.86 123.43 11.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.416 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -70.87 58.58 0.21 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.3 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 14' ' ' PRO . . . -173.18 -160.03 20.92 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.483 ' HA ' HG21 ' A' ' 22' ' ' THR . 6.0 mtp180 -89.67 57.45 3.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.027 0.442 . . . . 0.0 110.692 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.621 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 1.8 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.141 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.88 0.371 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.37 -177.95 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.611 2.207 . . . . 0.0 112.208 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.461 ' HB3' ' CB ' ' A' ' 34' ' ' ALA . 16.7 m-20 -80.6 164.6 22.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.02 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -148.5 151.07 35.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.027 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.36 177.23 2.74 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.77 2.314 . . . . 0.0 112.342 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.49 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -115.16 45.57 1.61 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 111.123 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.839 HG22 ' O ' ' A' ' 7' ' ' ILE . 38.1 mt -147.11 62.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.78 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.63 -39.22 24.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.121 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.684 HG23 ' H ' ' A' ' 11' ' ' GLN . 10.3 t -171.68 -166.05 0.41 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.047 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.4 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -123.65 17.95 9.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.307 178.086 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.684 ' H ' HG23 ' A' ' 9' ' ' THR . 13.6 mm-40 -70.81 58.53 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.196 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.472 ' C ' ' O ' ' A' ' 11' ' ' GLN . 2.5 t80 -20.13 82.72 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 O-C-N 124.037 0.836 . . . . 0.0 112.234 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER -120.46 69.33 15.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.685 179.345 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 17.8 Cg_endo -58.16 101.85 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.581 2.188 . . . . 0.0 112.35 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.964 ' HB ' HD11 ' A' ' 42' ' ' LEU . 30.1 m -99.58 130.35 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.202 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.481 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -79.27 118.35 21.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.555 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.2 136.41 13.37 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.193 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 2.2 t -44.15 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.201 -1.0 . . . . 0.0 110.314 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 18' ' ' SER . 0.5 OUTLIER 166.39 -24.09 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.404 -179.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.74 27.53 6.67 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 3.0 mm -123.72 140.64 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.78 99.7 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.656 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.815 ' OH ' HG21 ' A' ' 40' ' ' ILE . 39.4 m-85 -81.88 120.78 25.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.664 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.465 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -41.1 -26.85 0.19 Allowed Glycine 0 CA--C 1.506 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.276 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.5 m-20 -165.11 146.12 7.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.778 0.323 . . . . 0.0 111.092 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -48.92 -27.46 3.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.256 0.551 . . . . 0.0 109.781 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.1 m -76.47 -50.62 13.59 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.783 178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -47.24 -37.25 10.14 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 176.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.002 HD11 HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -56.29 -52.25 65.19 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-N 113.219 -1.809 . . . . 0.0 109.326 176.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.02 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 12.2 mt -48.02 -32.43 6.62 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.336 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.3 t -73.91 -33.4 63.97 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.11 -61.36 1.97 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.602 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 t -50.56 -22.87 2.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.033 0.444 . . . . 0.0 109.803 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 3' ' ' ASP . . . -78.65 -41.12 32.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.264 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.412 ' HD3' ' C ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -158.84 51.92 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.744 0.307 . . . . 0.0 111.743 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.536 ' HB2' ' CA ' ' A' ' 32' ' ' ALA . 23.1 t -95.26 -78.95 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.259 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -170.17 -37.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.955 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.777 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -154.46 159.16 32.2 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.777 ' HD2' HG22 ' A' ' 38' ' ' THR . 32.1 Cg_exo -58.55 93.62 0.07 OUTLIER 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.782 2.321 . . . . 0.0 112.21 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.815 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -76.16 154.68 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.138 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 16.6 mt-10 -143.66 97.52 3.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.027 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.002 HD23 HD11 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -33.16 149.82 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.363 0.601 . . . . 0.0 111.859 -179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.635 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -142.05 -39.54 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.365 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.635 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -148.56 121.36 8.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.37 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HA ' HG12 ' A' ' 15' ' ' VAL . 18.0 mttt -68.56 68.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.553 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 14' ' ' PRO . . . 175.2 -166.75 38.48 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -83.63 58.76 4.76 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.288 0.566 . . . . 0.0 110.291 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.609 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 33.5 m . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.063 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.534 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.85 0.357 . . . . 0.0 111.208 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 1' ' ' LYS . 35.1 Cg_exo -60.46 -165.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.677 2.251 . . . . 0.0 112.16 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 9.2 p-10 -47.75 108.29 0.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.53 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.838 ' HB3' HD22 ' A' ' 30' ' ' LEU . . . -121.11 150.72 54.17 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.26 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.01 157.92 41.46 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.598 2.198 . . . . 0.0 111.846 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 28' ' ' MET . 2.6 p -115.78 72.74 0.81 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.27 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.782 HG22 ' O ' ' A' ' 7' ' ' ILE . 4.1 mt -135.93 55.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.664 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 55.7 m -79.6 -37.91 35.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.484 0.659 . . . . 0.0 109.514 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t -171.23 141.99 1.68 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 31.8 mtm -91.7 21.12 4.95 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 0.4 OUTLIER -78.42 -108.24 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.873 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.583 ' CD1' ' HD3' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 178.99 76.09 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.655 0.265 . . . . 0.0 111.427 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.551 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -106.77 68.39 0.22 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 15.2 Cg_endo -58.98 97.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.639 2.226 . . . . 0.0 112.767 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.038 ' HB ' HD11 ' A' ' 42' ' ' LEU . 19.9 m -99.66 131.01 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.53 0.681 . . . . 0.0 110.783 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.532 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -79.06 119.06 21.66 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.061 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.682 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.71 136.33 13.37 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.678 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 28.8 t -44.73 96.29 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.463 -0.869 . . . . 0.0 109.891 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' SER . 0.3 OUTLIER 166.59 -25.21 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.618 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.783 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 101.61 25.29 8.21 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.455 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.783 HD12 ' O ' ' A' ' 20' ' ' GLY . 1.2 mp -122.37 126.97 74.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.107 -179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.406 HG22 ' HB2' ' A' ' 14' ' ' PRO . 2.2 m -88.46 98.88 11.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.268 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.677 ' CE2' HD21 ' A' ' 29' ' ' LEU . 33.7 m-85 -81.0 122.13 26.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.7 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -43.15 -24.67 0.32 Allowed Glycine 0 CA--C 1.503 -0.7 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.12 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -169.65 145.47 3.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.966 0.412 . . . . 0.0 111.015 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . -46.63 -26.77 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.929 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.806 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -74.26 -55.59 5.86 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.976 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.535 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 4.3 mtt -46.67 -34.71 5.31 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.901 HD11 HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -59.69 -53.78 53.99 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.296 -1.774 . . . . 0.0 109.155 177.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.838 HD22 ' HB3' ' A' ' 4' ' ' ALA . 4.8 mt -48.44 -33.55 9.47 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -73.97 -34.46 64.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.96 177.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.49 -58.46 5.77 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.355 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.462 ' HB2' HD11 ' A' ' 40' ' ' ILE . 1.4 t -55.98 -22.79 28.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.758 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 3' ' ' ASP . . . -89.35 -16.74 30.34 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -133.67 17.65 3.92 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.5 t -93.77 -95.98 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.6 0.238 . . . . 0.0 111.224 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 p30 179.68 -35.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.203 0.525 . . . . 0.0 109.935 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.9 t -132.57 127.9 20.76 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.962 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.51 93.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.608 2.206 . . . . 0.0 112.588 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.579 ' N ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -53.84 171.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.256 179.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 42' ' ' LEU . 16.0 mt-10 -146.11 101.1 3.48 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.437 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.038 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -33.59 149.47 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.274 0.559 . . . . 0.0 111.486 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 3.1 t -141.65 -33.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.677 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.643 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -157.48 122.2 4.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.534 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -69.22 67.53 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.528 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.72 -168.46 40.81 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.2 mtp85 -81.0 57.72 3.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.006 0.431 . . . . 0.0 110.393 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.604 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 25.6 m . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.126 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 2' ' ' PRO . 14.5 mmtt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.91 0.386 . . . . 0.0 111.303 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 1' ' ' LYS . 52.7 Cg_exo -52.33 -164.03 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.788 2.325 . . . . 0.0 112.289 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.819 ' HB3' HD13 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -78.67 108.82 12.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.918 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.751 ' HB3' ' CD ' ' A' ' 5' ' ' PRO . . . -159.9 -69.13 0.02 OUTLIER Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.632 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.751 ' CD ' ' HB3' ' A' ' 4' ' ' ALA . 83.0 Cg_exo -28.69 142.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.77 2.313 . . . . 0.0 111.713 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -96.42 55.28 1.45 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.187 0.517 . . . . 0.0 111.574 -178.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 7' ' ' ILE . 26.8 mm -147.74 87.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.631 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.55 -40.07 4.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.432 0.634 . . . . 0.0 110.084 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 10' ' ' MET . 5.6 t -172.5 -163.27 0.22 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.477 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.52 ' N ' ' OG1' ' A' ' 9' ' ' THR . 5.5 mtt -126.01 17.99 7.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.352 177.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -69.84 59.52 0.16 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.493 179.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.468 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -24.6 84.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.078 -179.478 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.802 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.9 t70 -120.77 61.79 9.5 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 10.6 Cg_endo -53.07 90.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.68 2.254 . . . . 0.0 111.831 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.96 ' HB ' HD11 ' A' ' 42' ' ' LEU . 21.5 m -93.2 123.94 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.941 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.515 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -77.92 116.9 18.76 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.974 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.44 141.84 15.43 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.308 -0.948 . . . . 0.0 112.97 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 13.7 t -48.56 94.72 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.165 -1.018 . . . . 0.0 109.734 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.481 ' HB2' HG22 ' A' ' 40' ' ' ILE . 5.2 t0 171.21 -27.49 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.694 -1.594 . . . . 0.0 108.606 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.28 31.58 4.01 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.218 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.542 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 11.4 mm -135.6 139.73 45.87 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.091 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 14' ' ' PRO . 6.4 m -99.18 99.35 10.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.429 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.819 ' CE2' HD21 ' A' ' 29' ' ' LEU . 35.7 m-85 -82.16 124.06 29.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.2 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -38.82 -25.58 0.04 OUTLIER Glycine 0 CA--C 1.508 -0.375 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.571 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.507 ' OD1' ' HG3' ' A' ' 28' ' ' MET . 2.7 p30 -175.83 153.1 1.33 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.942 0.401 . . . . 0.0 111.363 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.89 -24.45 0.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.752 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -79.24 -51.79 9.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.513 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -45.57 -38.62 6.64 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.819 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -56.06 -53.09 61.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 112.952 -1.931 . . . . 0.0 109.172 177.506 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.819 HD13 ' HB3' ' A' ' 3' ' ' ASP . 13.0 mt -48.65 -31.13 6.25 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.551 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 4' ' ' ALA . 49.7 t -78.48 -31.41 47.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.21 -56.62 11.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.839 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.452 ' OG ' HD13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -67.46 -16.53 64.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.472 179.103 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.733 ' HB1' ' HB1' ' A' ' 4' ' ' ALA . . . -90.83 -19.64 23.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.29 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.526 ' CG ' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -120.66 3.97 10.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.115 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.6 t -105.71 -117.83 0.23 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.545 -0.168 . . . . 0.0 110.545 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 179.58 32.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.934 0.397 . . . . 0.0 110.775 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -160.51 126.81 2.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.558 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.05 88.4 0.38 Allowed 'Trans proline' 0 N--CA 1.466 -0.133 0 C-N-CA 122.588 2.192 . . . . 0.0 112.344 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.683 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -53.07 155.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.373 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.502 ' O ' ' CB ' ' A' ' 18' ' ' SER . 17.3 mt-10 -134.41 96.99 3.7 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.233 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.96 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -29.92 147.71 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.647 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.633 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -136.87 -43.27 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.111 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.633 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.26 120.35 7.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.577 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.93 68.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.063 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 22' ' ' THR . . . 179.23 -165.74 34.76 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -86.13 58.1 4.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.386 0.612 . . . . 0.0 110.533 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.608 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.7 m . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.025 -0.988 . . . . 0.0 111.068 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.918 0.389 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.86 173.71 13.98 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.942 2.428 . . . . 0.0 112.277 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.27 62.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.421 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.931 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -172.18 -59.55 0.0 OUTLIER Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.364 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 32.2 Cg_exo -58.48 178.63 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.51 2.14 . . . . 0.0 111.917 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 28' ' ' MET . 26.0 p -170.59 71.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.786 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 7' ' ' ILE . 57.4 mt -138.77 69.76 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.953 0.406 . . . . 0.0 111.484 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.8 m -86.45 -46.66 10.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.373 0.606 . . . . 0.0 109.978 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 t -172.82 163.58 5.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.38 22.26 8.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 13' ' ' ASP . 1.0 OUTLIER -90.09 64.48 6.19 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.741 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 11' ' ' GLN . 10.0 t80 -21.04 83.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.848 0.717 . . . . 0.0 112.206 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.73 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -109.45 71.93 0.53 Allowed Pre-proline 0 CA--C 1.517 -0.32 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.9 Cg_endo -55.08 95.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.837 2.358 . . . . 0.0 112.593 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.996 ' HB ' HD11 ' A' ' 42' ' ' LEU . 3.6 m -97.06 129.75 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.637 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.549 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.15 118.95 20.88 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.346 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.632 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -107.21 142.67 15.78 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.004 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 41' ' ' GLU . 2.4 t -46.47 94.48 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 113.986 -1.107 . . . . 0.0 110.215 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.47 ' HB2' HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 168.28 -26.82 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.884 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.85 33.58 4.04 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.279 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.571 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 42.2 mm -135.16 138.2 49.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.616 HG22 ' HB2' ' A' ' 14' ' ' PRO . 3.6 m -95.54 99.91 11.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.927 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.886 ' CE2' HD21 ' A' ' 29' ' ' LEU . 43.1 m-85 -84.46 123.57 30.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.13 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 25' ' ' ASN . . . -40.22 -26.57 0.12 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.288 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.467 ' HB2' ' SD ' ' A' ' 28' ' ' MET . 80.9 m-20 -168.46 151.14 5.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.728 0.299 . . . . 0.0 111.571 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.35 -24.56 3.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.182 0.515 . . . . 0.0 110.014 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -81.24 -50.81 9.1 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.482 ' SD ' ' N ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -47.74 -35.36 9.71 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.359 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.886 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -56.44 -53.5 56.74 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.78 176.422 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 27' ' ' CYS . 13.3 mt -49.29 -33.81 13.92 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.302 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.466 ' O ' ' HD2' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -73.84 -31.39 63.17 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -67.08 -62.11 1.59 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.59 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -44.05 -30.97 0.81 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.79 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.774 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . . . -78.22 -25.27 46.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.244 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -143.02 38.08 1.43 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.258 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' ALA . 7.0 t -107.26 -79.04 0.58 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.672 0.272 . . . . 0.0 111.059 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 36' ' ' SER . 10.2 t70 179.23 -50.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.906 0.384 . . . . 0.0 110.9 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.496 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -135.85 167.53 21.62 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.063 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.496 ' HD2' HG22 ' A' ' 38' ' ' THR . 36.9 Cg_endo -65.36 88.8 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.803 2.335 . . . . 0.0 112.213 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.672 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -61.65 153.33 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.989 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.497 ' O ' ' HB3' ' A' ' 18' ' ' SER . 10.0 mt-10 -140.51 103.48 4.56 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.478 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.996 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -27.93 148.95 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.08 0.467 . . . . 0.0 111.852 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.768 HG13 ' CD2' ' A' ' 44' ' ' HIS . 12.6 p -141.59 -39.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.213 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.768 ' CD2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.69 119.64 6.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.167 178.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 1.4 pttt -69.49 68.11 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.064 0.459 . . . . 0.0 111.173 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.53 -170.75 42.87 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.4 mtp85 -81.64 56.68 3.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.165 0.507 . . . . 0.0 110.511 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.577 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 9.1 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.036 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.933 0.397 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.01 176.34 6.32 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.704 2.269 . . . . 0.0 112.429 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 7.4 p-10 179.75 51.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.068 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.746 ' HB3' ' CD ' ' A' ' 5' ' ' PRO . . . -161.27 -66.62 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.268 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.746 ' CD ' ' HB3' ' A' ' 4' ' ' ALA . 15.4 Cg_endo -57.64 147.98 76.45 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.47 2.113 . . . . 0.0 111.836 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 13.0 p -140.73 77.44 1.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.426 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 7' ' ' ILE . 2.7 mp -133.54 61.78 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.394 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 44.9 m -89.67 -34.7 16.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.416 0.627 . . . . 0.0 110.02 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.519 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -168.5 130.77 1.38 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.616 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.6 mmm -88.25 19.19 3.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.032 0.444 . . . . 0.0 110.191 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -93.89 -101.04 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.725 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.477 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER 179.66 82.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 111.542 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.535 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -108.91 69.07 0.37 Allowed Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.7 Cg_endo -55.72 104.48 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.675 2.25 . . . . 0.0 112.74 -178.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.985 ' HB ' HD11 ' A' ' 42' ' ' LEU . 34.8 m -108.42 133.64 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.773 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.569 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.76 121.6 24.97 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.696 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -108.19 140.9 15.66 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.285 -0.96 . . . . 0.0 112.858 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.721 ' OG ' HG22 ' A' ' 43' ' ' VAL . 44.8 m -48.71 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.156 -1.022 . . . . 0.0 110.692 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.5 ' OD2' HG22 ' A' ' 40' ' ' ILE . 0.2 OUTLIER 167.76 -26.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.813 -179.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.25 33.36 3.45 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.633 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.542 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 11.2 mm -136.61 136.75 48.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.739 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.403 ' CG2' ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -95.0 101.8 13.58 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.07 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.851 ' CE2' HD21 ' A' ' 29' ' ' LEU . 45.2 m-85 -84.33 127.13 33.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.453 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.531 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -42.96 -29.95 0.93 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.833 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.605 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -160.23 144.12 14.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.943 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.94 -24.32 2.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.346 0.593 . . . . 0.0 110.293 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -80.47 -50.25 10.32 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.828 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.549 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 5.2 mtt -46.92 -33.83 4.94 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.907 HD12 HD23 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -58.33 -55.3 36.78 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.056 176.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 27' ' ' CYS . 10.7 mt -48.75 -32.49 8.63 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.235 178.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -76.19 -32.15 58.84 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.991 178.119 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.91 -58.98 4.32 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.103 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.55 -34.41 17.47 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.154 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 4' ' ' ALA . . . -90.61 -4.97 56.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.331 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -100.81 -48.83 4.35 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.649 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 43.2 t -81.7 -98.48 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.433 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 36' ' ' SER . 16.3 t0 179.02 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.336 . . . . 0.0 111.255 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.5 132.93 60.57 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 121.046 0.45 . . . . 0.0 111.26 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.3 87.96 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.941 2.428 . . . . 0.0 112.452 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.668 HG13 HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -71.71 155.9 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.731 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 18' ' ' SER . 0.6 OUTLIER -146.04 104.47 3.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.862 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.985 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -27.46 148.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.39 0.614 . . . . 0.0 112.181 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.721 HG22 ' OG ' ' A' ' 18' ' ' SER . 1.9 t -137.46 -37.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.378 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.644 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -154.13 125.76 7.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.541 ' HA ' HG12 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -71.04 61.47 0.28 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.623 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.52 -162.27 27.85 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.409 ' O ' ' OXT' ' A' ' 48' ' ' CYS . 6.1 mtm180 -88.03 56.67 3.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.93 0.395 . . . . 0.0 110.478 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.58 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 5.5 m . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.029 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.86 0.362 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.8 -166.15 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.794 2.33 . . . . 0.0 112.214 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.4 t0 179.46 155.07 0.51 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.986 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -128.11 95.57 33.61 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.961 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 4' ' ' ALA . 86.6 Cg_exo -46.08 -179.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.667 2.244 . . . . 0.0 112.176 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.453 ' O ' HD13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -107.15 45.61 0.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.035 0.445 . . . . 0.0 110.963 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.798 HG22 ' O ' ' A' ' 7' ' ' ILE . 28.4 mm -151.44 63.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.612 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.86 -43.28 22.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.091 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.497 ' OG1' ' N ' ' A' ' 10' ' ' MET . 2.7 t -172.47 -172.15 0.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.192 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.497 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.0 OUTLIER -112.61 17.79 18.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 13' ' ' ASP . 1.1 tp60 -69.1 60.41 0.11 Allowed 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.155 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -19.98 83.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.5 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.624 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -117.65 60.24 3.14 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.8 Cg_endo -57.2 94.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.732 2.288 . . . . 0.0 112.554 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.011 ' HB ' HD11 ' A' ' 42' ' ' LEU . 26.1 m -96.79 126.87 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.126 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.505 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -79.25 115.53 18.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.293 179.388 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.681 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -104.77 139.54 14.66 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.234 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 7.7 t -49.7 93.47 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.115 -1.042 . . . . 0.0 110.416 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' SER . 34.5 t0 171.37 -27.01 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.973 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.83 32.95 3.18 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.358 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.56 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 29.5 mm -136.87 133.53 48.17 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 46' ' ' GLY . 1.4 m -95.26 99.1 11.1 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.708 ' CE2' HD21 ' A' ' 29' ' ' LEU . 38.1 m-85 -79.99 124.02 28.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.097 -178.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -39.19 -26.89 0.06 OUTLIER Glycine 0 CA--C 1.507 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.394 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.54 ' OD1' ' CG ' ' A' ' 28' ' ' MET . 1.0 OUTLIER -173.45 150.47 1.83 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.002 0.429 . . . . 0.0 110.979 179.341 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.49 -25.15 1.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.464 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -74.3 -52.54 11.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.54 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -47.86 -40.93 22.85 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.146 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.931 HD11 HD23 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -53.26 -54.09 41.32 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.324 -1.762 . . . . 0.0 109.29 177.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.986 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 13.5 mt -49.15 -33.44 12.08 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.564 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 4.2 t -76.67 -29.88 56.54 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.62 -55.83 15.47 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.295 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -18.8 62.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.587 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.02 -44.15 10.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -98.05 -7.02 30.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 44.6 t -86.33 -105.66 0.06 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.583 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 36' ' ' SER . 14.3 t0 177.54 -28.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.89 0.376 . . . . 0.0 110.568 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.35 139.1 20.44 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.044 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.16 89.06 1.07 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.795 2.33 . . . . 0.0 112.34 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.557 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -56.12 156.26 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.379 179.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 18' ' ' SER . 42.1 mt-10 -134.44 97.33 3.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.887 0.375 . . . . 0.0 111.153 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.011 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -33.65 148.87 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.387 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.766 HG13 ' CD2' ' A' ' 44' ' ' HIS . 8.6 p -138.76 -38.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.053 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.766 ' CD2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -149.44 120.38 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.156 178.26 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -70.47 63.96 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.454 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 22' ' ' THR . . . -177.28 -159.86 23.13 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -89.93 58.3 4.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.156 0.503 . . . . 0.0 110.486 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.618 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 8.9 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.164 -0.922 . . . . 0.0 111.146 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 15.4 mttp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.914 0.388 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.58 178.06 5.87 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.976 2.45 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -111.55 134.74 52.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.582 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.959 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -160.96 -63.9 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 111.558 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.959 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 82.1 Cg_exo -43.96 159.01 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.678 2.252 . . . . 0.0 112.405 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 26.1 p -163.18 72.65 0.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 7' ' ' ILE . 44.8 mm -132.48 54.03 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.285 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.0 m -79.2 -37.9 37.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.162 0.506 . . . . 0.0 110.087 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 t -172.2 144.54 1.63 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.183 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.9 26.18 4.26 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -85.79 -102.55 0.06 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.102 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.526 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 0.4 OUTLIER 178.75 73.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.603 0.24 . . . . 0.0 111.048 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.569 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.41 66.91 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.068 0.461 . . . . 0.0 109.757 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 18.9 Cg_endo -60.34 94.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.62 2.213 . . . . 0.0 111.949 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.025 ' HB ' HD11 ' A' ' 42' ' ' LEU . 27.6 m -99.06 129.84 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.032 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.614 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.58 120.7 23.65 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.553 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -111.36 144.57 17.5 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.996 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -44.87 97.75 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.215 -0.993 . . . . 0.0 109.618 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.532 ' HB2' HG22 ' A' ' 40' ' ' ILE . 9.0 t0 165.14 -24.6 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.804 -1.543 . . . . 0.0 108.685 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.895 ' O ' HD12 ' A' ' 21' ' ' ILE . . . 100.54 27.45 7.59 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.52 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.895 HD12 ' O ' ' A' ' 20' ' ' GLY . 1.5 mp -128.8 144.16 38.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.304 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.56 HG22 ' HB2' ' A' ' 14' ' ' PRO . 13.4 m -101.32 99.03 9.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.611 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.897 ' CE2' HD21 ' A' ' 29' ' ' LEU . 49.0 m-85 -80.15 123.37 27.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.287 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.47 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -37.45 -29.51 0.04 OUTLIER Glycine 0 CA--C 1.504 -0.648 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.239 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 23' ' ' TYR . 84.6 m-20 -165.14 147.95 8.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.795 0.331 . . . . 0.0 111.092 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.87 -25.75 2.06 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.309 0.576 . . . . 0.0 110.15 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.62 ' HA ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -78.84 -51.49 9.66 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.428 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.498 ' O ' ' HB2' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -45.13 -38.97 5.57 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 176.177 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.897 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -54.11 -56.62 16.34 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 113.242 -1.799 . . . . 0.0 109.78 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 27' ' ' CYS . 4.5 mt -47.12 -34.08 5.7 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.286 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 28' ' ' MET . 1.2 m -75.27 -33.58 61.28 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.137 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -64.66 -55.45 20.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.267 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.413 ' OG ' ' HA ' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -52.23 -32.58 37.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.499 179.392 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.659 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . . . -82.76 -15.51 51.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.288 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.471 ' HG2' ' HA ' ' A' ' 32' ' ' ALA . 9.6 ptm180 -109.75 -18.28 13.48 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.7 t -83.94 -98.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 111.455 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.8 t70 179.26 -31.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 0.0 110.84 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.408 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 13.9 t -114.03 145.13 32.93 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.67 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 51.1 Cg_endo -69.81 80.93 0.86 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.755 2.303 . . . . 0.0 112.769 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.674 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -44.27 157.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.239 179.178 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 27.2 mt-10 -140.62 102.92 4.42 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.828 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.025 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.4 OUTLIER -28.95 149.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.191 0.519 . . . . 0.0 111.857 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.655 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.8 t -141.01 -38.54 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.092 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.655 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.51 122.36 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.47 179.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -71.5 61.96 0.36 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.223 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 22' ' ' THR . . . -176.05 -160.15 23.0 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.0 mtp85 -90.26 56.92 3.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.928 0.395 . . . . 0.0 110.67 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.573 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 2.9 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.138 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 1' ' ' LYS . 16.2 tttt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.973 0.416 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.32 -167.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.77 2.313 . . . . 0.0 112.507 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.67 134.86 32.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.655 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.96 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -129.25 115.47 18.61 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.432 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 4' ' ' ALA . 50.6 Cg_exo -53.18 -164.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.646 2.23 . . . . 0.0 111.969 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.458 ' CA ' ' HB2' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -116.57 50.68 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.589 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 7' ' ' ILE . 12.7 mt -148.88 86.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.946 0.403 . . . . 0.0 111.321 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -112.86 -37.51 4.82 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.838 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -171.78 175.71 3.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.287 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.2 mtm -113.63 17.79 17.98 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -75.02 58.95 0.9 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.0 179.509 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.481 ' C ' ' O ' ' A' ' 11' ' ' GLN . 29.6 t80 -19.37 82.49 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.436 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.664 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -114.27 63.86 1.31 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 11.0 Cg_endo -53.45 96.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.952 2.435 . . . . 0.0 112.594 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.03 ' HB ' HD11 ' A' ' 42' ' ' LEU . 28.5 m -98.66 126.33 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.487 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.559 ' HB3' ' CD2' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.31 120.44 23.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.02 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -108.12 144.77 16.21 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.858 -178.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.47 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 1.4 t -48.23 93.73 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.066 -1.067 . . . . 0.0 110.364 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.7 t70 167.99 -24.62 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.241 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.0 32.43 5.0 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.023 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.597 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 26.6 mm -132.82 136.51 55.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.564 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.526 HG21 ' HA ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -97.04 101.88 13.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.798 178.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.723 ' CE2' HD21 ' A' ' 29' ' ' LEU . 30.8 m-85 -85.77 121.11 27.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.989 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -40.73 -27.15 0.16 Allowed Glycine 0 CA--C 1.506 -0.523 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.053 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 83.9 m-20 -164.63 145.42 7.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.741 0.305 . . . . 0.0 111.079 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -48.06 -26.8 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.166 0.508 . . . . 0.0 109.891 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -77.18 -51.4 11.03 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 27' ' ' CYS . 0.6 OUTLIER -46.63 -37.17 7.81 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 176.09 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.723 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -54.95 -54.5 42.04 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.263 176.408 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.96 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 12.3 mt -47.5 -32.57 5.36 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.67 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 5.8 t -78.43 -32.26 48.51 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -63.95 -58.72 5.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.576 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.425 ' OG ' ' CD1' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -55.95 -25.97 45.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.488 179.048 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.2 -34.04 61.46 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -129.83 27.3 5.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 43.5 t -92.74 -94.95 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.632 0.253 . . . . 0.0 111.323 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.79 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.935 0.397 . . . . 0.0 110.541 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.41 ' OG1' ' HD2' ' A' ' 39' ' ' PRO . 7.9 t -138.41 147.16 54.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.721 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.41 ' HD2' ' OG1' ' A' ' 38' ' ' THR . 16.4 Cg_endo -57.74 93.27 0.06 OUTLIER 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.841 2.361 . . . . 0.0 112.393 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.577 ' CG1' ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -79.45 126.85 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.98 0.419 . . . . 0.0 111.075 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.582 ' O ' ' CA ' ' A' ' 17' ' ' GLY . 2.6 mm-40 -97.36 -156.9 0.56 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.073 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.03 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.7 OUTLIER -120.97 149.45 42.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.515 178.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.649 ' CG1' ' CE1' ' A' ' 44' ' ' HIS . 2.4 t -138.36 -36.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.921 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.649 ' CE1' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -157.35 122.13 4.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.815 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -71.2 65.88 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.139 -179.62 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 22' ' ' THR . . . -179.22 -162.25 28.14 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HA ' HG21 ' A' ' 22' ' ' THR . 4.2 mtt180 -87.27 57.64 4.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.944 0.402 . . . . 0.0 110.545 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.606 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 10.9 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.11 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.902 0.382 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.55 -173.68 1.23 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.717 2.278 . . . . 0.0 112.333 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.66 158.23 44.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.609 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.82 ' HB3' ' HB3' ' A' ' 30' ' ' LEU . . . -142.24 151.15 57.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.006 0.431 . . . . 0.0 111.567 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.42 -163.64 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.914 2.409 . . . . 0.0 112.081 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.449 ' CA ' ' HB2' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -119.15 50.02 1.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 111.271 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 7' ' ' ILE . 13.5 mm -146.96 80.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.184 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -104.13 -38.06 7.07 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.456 0.646 . . . . 0.0 109.972 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.505 ' OG1' ' N ' ' A' ' 10' ' ' MET . 6.2 t -171.96 -163.0 0.23 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.112 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.505 ' N ' ' OG1' ' A' ' 9' ' ' THR . 0.9 OUTLIER -128.05 16.69 6.74 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.486 178.101 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' ASP . 2.4 mt-30 -71.53 58.94 0.29 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.906 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.525 ' CD1' ' HD3' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -25.99 87.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.942 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.683 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -121.86 71.29 30.05 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.802 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 13.0 Cg_endo -55.62 95.95 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.843 2.362 . . . . 0.0 112.545 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.041 ' HB ' HD11 ' A' ' 42' ' ' LEU . 4.4 m -96.74 126.83 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.485 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.525 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -78.23 118.86 20.85 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.211 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -105.56 143.16 15.65 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.983 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 40.4 t -50.98 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.253 -0.974 . . . . 0.0 110.17 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.523 ' HB2' HG22 ' A' ' 40' ' ' ILE . 12.7 t0 171.65 -27.69 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.616 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.85 31.06 3.75 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.39 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 23.0 mm -136.91 139.91 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 119.753 -0.779 . . . . 0.0 113.011 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.48 HG22 ' HB2' ' A' ' 14' ' ' PRO . 3.9 m -98.42 102.64 14.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.879 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.877 ' CE2' HD21 ' A' ' 29' ' ' LEU . 37.3 m-85 -84.94 123.96 31.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.887 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.473 ' O ' ' OD1' ' A' ' 25' ' ' ASN . . . -41.25 -25.99 0.17 Allowed Glycine 0 CA--C 1.505 -0.534 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.127 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 24' ' ' GLY . 84.8 m-20 -164.91 145.91 7.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.912 0.387 . . . . 0.0 111.454 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -49.41 -27.46 4.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.347 0.594 . . . . 0.0 109.554 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 1.2 m -78.1 -49.09 14.6 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.49 ' O ' ' HB3' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -47.8 -37.92 14.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 175.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.877 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -54.96 -52.77 62.01 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 112.908 -1.951 . . . . 0.0 109.168 176.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.82 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 13.2 mt -48.07 -33.35 7.98 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 28' ' ' MET . 24.9 t -75.09 -32.89 61.56 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -65.1 -57.71 7.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.481 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.97 -23.01 29.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.145 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.83 -17.6 35.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.377 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -133.44 18.11 3.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.2 t -100.72 -97.57 0.26 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.334 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 56.5 t0 179.52 -32.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 0.0 110.643 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 t -126.97 149.5 69.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.801 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -70.03 87.22 0.59 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.613 2.209 . . . . 0.0 112.205 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.676 ' CD1' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -49.88 149.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.427 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 18' ' ' SER . 31.5 mt-10 -130.68 101.88 5.87 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.101 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.041 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -28.32 146.54 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.223 0.535 . . . . 0.0 111.517 -179.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.634 ' HB ' ' CE1' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -132.58 -46.85 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.221 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.634 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -150.45 123.8 8.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.394 179.671 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -70.25 68.58 0.34 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.201 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 22' ' ' THR . . . 178.42 -158.92 23.9 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.95 57.36 3.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.165 0.507 . . . . 0.0 110.176 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.627 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 7.0 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.918 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.585 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.964 0.412 . . . . 0.0 111.168 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 1' ' ' LYS . 61.1 Cg_endo -73.17 -167.04 0.33 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.785 2.323 . . . . 0.0 112.523 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.446 ' HA ' ' CB ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -34.48 134.03 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.637 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.424 ' HB3' HD22 ' A' ' 30' ' ' LEU . . . -112.68 110.24 52.51 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.724 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -38.17 120.26 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.8 2.334 . . . . 0.0 112.553 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 27' ' ' CYS . 4.2 p -84.7 77.36 10.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.159 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.714 HG22 ' O ' ' A' ' 7' ' ' ILE . 8.3 mm -130.36 52.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.508 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 46.0 m -79.53 -35.73 39.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.355 0.598 . . . . 0.0 109.842 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.466 ' O ' ' ND2' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -170.36 138.41 1.56 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.627 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.7 mtt -94.84 20.65 8.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.902 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 2.8 mm-40 -84.62 -99.75 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.245 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.504 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 7.9 t80 178.18 79.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.528 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.67 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -111.06 64.38 0.48 Allowed Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 14.1 Cg_endo -56.63 92.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.65 2.233 . . . . 0.0 112.198 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.034 ' HB ' HD11 ' A' ' 42' ' ' LEU . 19.6 m -95.09 126.43 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.516 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.681 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -77.85 117.4 19.18 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.264 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' A' ' 42' ' ' LEU . . . -103.42 141.11 15.14 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.513 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 41' ' ' GLU . 38.1 m -48.86 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.21 -0.995 . . . . 0.0 110.359 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.544 ' OD2' HG22 ' A' ' 40' ' ' ILE . 0.4 OUTLIER 169.07 -25.93 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.142 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.72 30.74 4.47 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.337 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 23' ' ' TYR . 9.7 mm -131.77 138.91 51.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.667 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.515 HG22 ' HB2' ' A' ' 14' ' ' PRO . 3.1 m -99.76 99.48 10.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.729 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.833 ' CE2' HD21 ' A' ' 29' ' ' LEU . 33.1 m-85 -83.69 122.89 29.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.721 -178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' C ' ' OD1' ' A' ' 25' ' ' ASN . . . -42.28 -24.15 0.19 Allowed Glycine 0 CA--C 1.505 -0.579 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.134 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.595 ' N ' ' OD1' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -169.83 146.68 3.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.754 0.312 . . . . 0.0 111.108 -179.328 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . -47.19 -25.54 0.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.292 0.568 . . . . 0.0 110.263 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -76.95 -54.77 6.14 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.817 178.651 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.548 ' CG ' ' OD1' ' A' ' 25' ' ' ASN . 36.4 mtp -45.53 -33.3 2.66 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.833 HD21 ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -59.42 -54.36 47.53 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.469 -1.696 . . . . 0.0 108.892 177.315 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' CYS . 11.8 mt -49.07 -29.43 5.11 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.556 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 28' ' ' MET . 1.4 m -79.64 -31.12 41.52 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 29' ' ' LEU . . . -68.93 -58.75 3.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.157 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.46 -33.02 63.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.268 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 3' ' ' ASP . . . -90.44 -3.12 57.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.333 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 4.5 mtp180 -96.56 -51.09 4.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.942 0.401 . . . . 0.0 111.024 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.7 t -86.82 -99.15 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.248 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.436 ' O ' ' HD3' ' A' ' 39' ' ' PRO . 6.5 p30 178.92 -26.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.411 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -79.15 111.45 20.33 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.928 0.394 . . . . 0.0 111.121 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 37' ' ' ASP . 33.5 Cg_exo -57.82 93.75 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.844 2.362 . . . . 0.0 112.486 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.695 HG21 ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -69.54 157.49 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.767 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 18' ' ' SER . 36.9 mt-10 -140.95 103.46 4.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.049 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.034 HD11 ' HB ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -28.24 147.09 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.169 0.509 . . . . 0.0 111.315 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.768 HG13 ' CD2' ' A' ' 44' ' ' HIS . 13.6 p -139.39 -38.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.495 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.768 ' CD2' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.78 123.29 7.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.529 178.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 64.75 0.41 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.294 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.37 -160.31 24.89 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -90.12 54.22 2.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.972 0.415 . . . . 0.0 110.664 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.602 ' HA ' ' CD2' ' A' ' 44' ' ' HIS . 4.9 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.056 179.242 . . . . . . . . 1 1 . 1 stop_ save_